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          Abstract  
  
Abstract  
The research in this thesis describes an asymmetric pericyclic cascade approach to the synthesis of a 
range of enantioenriched oxindoles using enantiopure oxazolidine derived nitrones and 
disubstituted ketenes. 
Chapter 1 aims to place this work in the context of the literature, describing other commonly 
employed or state-of-the-art asymmetric approaches to oxindoles and related compounds. 
Examples of where these approaches have been used successfully in the total synthesis of related 
indole alkaloids are also presented. The conception of this project within the group is also 
described alongside initial attempts to develop the first enantioselective variant of the same reaction 
using nitrone chiral auxiliaries.  
Chapter 2 details the optimisation of this asymmetric oxindole forming reaction by structural 
variation of the nitrone component, culminating in the preparation of an N-TIPBS nitrone based 
on an oxazolidine framework, which proved to be optimal for this process. Also detailed are 
attempts to gain insight towards the mechanism of this transformation and to understand the mode 
of chirality transfer.  
Chapter 3 details the use of the N-TIPBS nitrone scaffold as a transmitter of chiral information in 
the synthesis of 3-alkyl-3-aryloxindoles and spirocyclic oxindoles.  
Chapter 4 delineates the mechanism of this transformation as a pericyclic cascade process. The key 
stereo-determining features are discussed including the conformational preferences of such chiral 
oxazolidine derived nitrones and the influence of the N-protecting group on the stereochemical 
outcome. Synthetic endeavours to provide evidence as to the validity of this computational 
mechanistic rationale are also presented. 
Chapter 5 describes regioselectivity studies, and tolerance of both the racemic and asymmetric 
reactions to varying substitution on the nitrone N-aryl ring. Initial studies were undertaken using 
achiral nitrones before the interplay between regio- and stereoselectivity was explored, initially with 
enantiopure N-Boc Garner’s aldehyde derived nitrones, and further with N-TIPBS nitrones. 
Chapter 6 initially describes attempts to transform this chiral auxiliary methodology into a catalytic 
asymmetric protocol, by investigating in situ ketene formation via various strategies including 
activation of carboxylic acids. Also described are investigations into related nitrone-ketenimine 
cycloadditions, and related [3+2] nitrone cycloadditions. 
Chapter 7 describes the application of this methodology toward the synthesis of compounds with 
biological relevance. The concise asymmetric synthesis of a Roche anti-cancer agent is outlined, as 
is the extension of this methodology to the synthesis of indole alkaloid-like species. Finally, the 
attempted application of this methodology toward the asymmetric synthesis of (+)-gliocladin C is 
outlined. 
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Chapter 1: Introduction 
1.1. The Importance of Oxindoles 
Oxindoles and related alkaloids draw significant interest in the chemical community owing to the 
breadth and diversity of their biological activities. Naturally occurring oxindoles, which typically 
bear disubstitution at the C(3) position, have been found to exhibit anti-HIV,1 anti-cancer2 and 
anti-malarial3 activities. Various receptor modulation properties4 have also been reported and new 
species are continually being discovered with an array of novel properties. A second explanation for 
the attention garnered by such species is that from a synthetic standpoint the tetra-substituted 
juncture at the C(3) position of the oxindole presents a formidable synthetic challenge, particularly 
for those interested in absolute stereocontrol.5 As such, the oxindole core motif has become a 
common scaffold on which to develop and refine asymmetric methodologies.6 
1.2. Spirooxindoles 
1.2.1 Pyrrolidinyl Derivatives  
The 3,3!-pyrrolidinyl-spirooxindole moiety is a privileged heterocyclic framework, formally derived 
from tryptophan which forms the interior of many bioactive natural products (Fig 1.1).7 The family 
of natural products that contains such spirooxindoles was first isolated from plants of the 
Apocyanaceae and Rubiacae families.8 The main interest in compounds of this class derives from their 
significant biological efficacy against malignant cell lines as well as secondary activities such as 
inhibition of central nervous system function. For example, chitosenine 1 has been shown to inhibit 
ganglionic transmission in vivo in rabbits and rats9 while strychnofoline 2 inhibits mitosis in various 
cell lines including mouse melanoma B16, as well as Ehrlich and Hepatom HW165.10 With such 
desirable biological profiles, the syntheses of such natural 3,3!-spirooxindoles and their analogues 
are areas of great interest. Numerous syntheses of the relatively simple spirooxindoles  
(–)-coerulescine 3 and (–)-horsfiline 4 have been reported both racemically11-13 and asymmetrically 
(vide infra),14 as have those of more functionalised oxindoles such as (–)-spirotryprostatin B 5.15,16  
 
Fig 1.1: 3,3!-Pyrrolidinyl-spirooxindole containing natural products. 
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1.2.2. Carbospirocyclic Oxindoles 
Numerous oxindole species bearing various spirocarbocyclic ring systems at the 3-position have 
been isolated from naturally occurring sources, whilst others have been prepared synthetically. 
Amongst the latter, spiro-cyclopropyloxindoles such as 6 and 7 are capable of acting as non-
nucleoside reverse transcriptase inhibitors (Fig 1.2).1  
 
Fig 1.2: Spirocyclopropyloxindoles (±)-6 and (±)-7 exhibit anti-HIV activity. 
The welwitindolinone family of natural products was isolated in 1994 by Moore and co-workers 
from a blue-green alga with certain members possessing notable cytotoxic activity. 17, 18 Whilst other 
members of the family contain a common core structure, welwitindolinone A 8 is unique in its 
unusual spirocyclobutane-oxindole C(3) junction, prompting speculation that this species comprises 
an intermediate along the biosynthetic pathway to the rest of the family. It was also revealed that 
welwitindolinone A possesses potent anti-fungal activity, and has subsequently been the subject of 
several total syntheses, notably by the groups of Baran19 and Wood.20 The strategy employed by 
Wood leaves the key oxindole forming cyclisation until the last step, employing a cascade isonitrile-
isocyanate formation followed by a base-induced cyclisation to furnish the target as a single 
diastereoisomer in 47% yield (Fig 1.3). 
 
Fig 1.3: Wood’s final step in the synthesis of Weltwitindlinone A. 
The citrinadin family, also exhibiting cytotoxic activity,21 is a further example of spirocarbocyclic 
oxindole containing natural products; this time bearing a 5-membered carbocycle at the C(3) ring 
juncture. Recent total syntheses of (–)-citrinadin A by Martin22 and (+)-citrinadin B by Wood23 have 
allowed stereochemical reassignment of the proposed structures. It is notable that Wood and co-
workers made use of a stereoselective intermolecular [3+2] nitrone-olefin cycloaddition with 
enantioenriched nitrone 9 to generate key citrinadin precursor 10 in 38% isolated yield (the major 
product being the undesired C(3)-epimer) (Fig 1.4). 
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Fig 1.4: Citrinadin B total synthesis: a key nitrone-olefin cycloaddition. 
Gelsemine 11 is another spirocarbocyclic oxindole alkaloid that has perhaps received the most 
attention from the synthetic community over the decades, not because of potent biological activity, 
which hitherto remains unclear, but rather because of its intriguing hexacyclic three-dimensional 
structure and the synthetic challenge it poses. The attention devoted to this complex target over 
thirty years of research has allowed for the development of numerous new chemical methodologies, 
and has produced over sixty research articles despite the synthesis being competed only eight 
times.24 To date only two asymmetric syntheses of (+)-gelsemine have been published, by the 
groups of Fukuyama25 and Qin.26 Qin and co-workers adopted a biomimetic approach in which the 
spirocyclic junction is formed at a very late stage of the synthesis via an acid-mediated enol-
oxonium cyclisation. Treatment of substrate 12 with stoichiometric p-TsOH initiated a cascade 
comprised of in situ deprotection, oxonium formation and cyclisation. This gave spirocycle 13 in 
73% yield and good diastereoselectivity. This diastereomeric preference is rationalised by the 
authors as a consequence of both steric and electronic repulsion in the disfavoured transition state. 
Three further steps gave (+)-gelsemine 11 in 1% overall yield over twenty-five steps (Fig 1.5). 
 
Fig 1.5: Qin’s biomimetic spiro-cyclisation approach to gelsemine. 
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1.3. 3,3-Disubstituted Oxindoles 
A second class of oxindole derivative, containing a non-spirocyclic quaternary stereocentre at the 
oxindole C(3)-position is of equal importance, with numerous biologically active compounds 
bearing such substitution in development. These include the Roche anti-cancer agent 14, which 
inhibits p53-MDM2 interactions and was shown to be more active as a single enantiomer;27 
insecticide 15, one of numerous related scaffolds described in a patent by BASF,28 and other 
cytotoxic compounds including 16, one of thirty eight structurally related oxindoles investigated in a 
medicinal chemistry study.29 Naturally occurring oxindoles of this class commonly contain a 
stereodefined-hydroxyl group in the 3-position, for example maremycin 17, deoxibrassinin 18 and 
the convolutamydine family, typified by convolutamydine B 19 which also exhibit anti-cancer 
efficacy against various cell-lines (Fig 1.6).30 
 
Fig 1.6: Representative 3,3-disubstituted oxindole species exhibiting biological activities. 
Non-spirocyclic 3,3-disubstituted oxindole species also serve as valuable synthetic intermediates 
towards the hexahydropyrroloindole skeleton found in many bioactive natural product species.31-33 
For example, the flustramine family exhibits a variety of biological effects; flustramines A and B 20 
are known to have muscle relaxant properties,34 whilst other members of the family possess 
antibacterial properties,35,36 and have recently been shown to inhibit activity on voltage activated 
potassium channels.37 The gliocladin family of secondary marine metabolites, typified by  
(+)-gliocladin B 21, are also known to possess cytotoxic activity, and again share the 
hexahydropyrroloindole core structure (Fig 1.7).38,39 Similarly, the familial chimonanthine 22, 23 and 
hodgkinsine alkaloids 24 have demonstrated antinociceptive properties,40 and all of the 
aforementioned pyrroloindolyl natural products have been accessed synthetically from disubstituted 
oxindole intermediates. With such a widespread interest in these highly bioactive oxindole species 
and related alkaloids, the necessity for rapid, highly enantioselective access to the 3,3-oxindole 
subunit is becoming increasingly important. 
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Fig 1.7: Hexahydropyrroloindole natural products. 
1.4. Synthetic Approaches to Oxindoles 
Parent oxindole (indolin-2-one) was first prepared by Baeyer as early as 1866 by reduction of isatin 
using sodium amalgam in water.41 Later, in the early 20th century, Stollé developed an 
intramolecular Friedel-Crafts cyclisation to prepare oxindole using stoichiometric AlCl3 and heating 
the reaction mixture to 180 °C.42 Around the same time, Brunner developed an acyl hydrazide-[3,3]-
rearrangement reaction,43 bearing significant resemblance to the Fischer indole synthesis,44 where 
an analogous alkyl hydrazide rearrangement gives the corresponding indole species (Fig 1.8). 
Brunner’s original report describes rearrangement of acyl hydrazides under basic conditions, and 
would eventually become known as the Brunner oxindole synthesis, with subsequent modifications 
allowing for a greater variety of substitution at the oxindole C(3)-position.45 
 
Fig 1.8: Classical approaches to the oxindole core. 
Although these reactions employ harsh conditions that would typically be incompatible with 
modern asymmetric synthesis, the enduring influence of these three approaches is clear given the 
commonly adopted approaches to oxindoles over the past twenty years. These are summarised in 
the following sections. 
1.5. Common Approaches to Asymmetric Oxindoles 
Common approaches to oxindoles bearing a C(3)-asymmetric quaternary centre include (Fig 1.9):  
a) amide α-arylation commonly with a suitably halogenated aryl-ring, although more recent 
examples have demonstrated a direct ArH-CH coupling strategy; b) intramolecular Heck 
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cyclisations under palladium catalysis, which has been employed to access a range of substitution 
patterns at C(3); c) enolisation of a suitable C(3)-tertiary substrate under basic conditions followed 
by trapping of this enolate with a suitable electrophile; d) cycloadditions with isatin derived 
oxoindolin-3-ylidenes allowing access to spirocyclic oxindoles, many of which utilise 
organocatalysts; e) direct asymmetric nucleophilic additions enabled by either metal-based or 
organocatalysts have also found wide application; f) although not represented in Fig 1.9 due to the 
diversity of strategies employed, a variety of rearrangements have also found utility in the 
asymmetric syntheses of oxindoles. Representative examples of each of these approaches and 
applications in complex molecule synthesis are discussed in more detail in the following sections. 
 
Fig 1.9: Typical approaches to asymmetric 3,3-oxindoles: a) arylation reactions; b) intramolecular Heck 
cyclisation; c) enolate alkylation; d) cycloadditions; e) nucleophilic addition to isatins.  
1.6. Oxindoles from Anilides or Similar Systems 
Stollé’s stoichiometric AlCl3 mediated Friedel-Crafts approach to oxindoles provided a benchmark 
for the conversion of anilides into oxindoles, and related approaches are still one of the most 
commonly employed today (Fig 1.9 a)). Protocols based on similar starting materials have been 
developed which utilise sub-stoichiometric quantities of a transition-metal catalyst (typically copper 
or palladium) in combination with a chiral ligand in order to generate an oxindole species with a 
stereogenic C(3) quaternary centre.  
1.6.1 Overman’s Intramolecular Heck Approach 
Overman and co-workers have widely utilised intramolecular asymmetric Heck reactions in their 
approach to 3,3-disubstituted oxindoles. Such a reaction is already known to be applicable to the 
construction of asymmetric quaternary centres and has been successfully applied in various natural 
product syntheses, allowing access to members of the terpenoid, alkaloid and polyketide families in 
high enantioselectivities.46 After much screening of conditions and ligands, and beginning with 
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precursor 25, reaction with a Pd-BINAP derived catalyst effected an intramolecular Heck 
cyclisation in good yields and with impressive enantioselectivity (Fig 1.10).47  
 
Fig 1.10: Overman’s asymmetric intramolecular Heck reaction. 
This core methodology has been used to great effect by Overman over the years, and has formed 
the basis of numerous indole alkaloid total synthesis projects,48 including the total synthesis of  
(–)-spirotryprostatin B.49 This synthesis began with preparation of a highly substituted aryl-iodide 
precursor, which upon exposure to optimised intramolecular Heck conditions led to a 1:1 
diastereoisomeric mixture of oxindoles in 72% yield. The intramolecular  -allyl capture is 
proposed to be highly anti-selective and therefore the 1:1 ratio of diastereomers arises as a 
consequence of poor selectivity in the initial Heck cyclisation. Nevertheless, of the two produced 
stereoisomers, 26 could be deprotected to give (–)-spirotryprostatin B (Fig 1.11). Despite efforts to 
do so, the Overman group were unable to accomplish selectivity for the configuration required to 
furnish spirotryprostatin B. However using chiral BINAP ligands, they were able to achieve a 6:1 
diastereomeric preference in related reaction systems. 
 
Fig 1.11: Overman’s asymmetric intramolecular Heck reaction in application to the total synthesis of 
spirotryprostatin B. 
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1.6.2. Hartwig’s Amide α-Arylation 
Hartwig and co-workers sought to develop an asymmetric route to aryl-alkyl C(3) substituted 
oxindoles and did so under palladium catalysis. In combination with a chiral N-heterocyclic carbene 
ligand such as 28 and base, the group was able to access 3-methyl-3-aryloxindoles in excellent yields 
with good enantioselectivities (up to 95% yield, up to 76% ee) (Fig 1.12).50  
 
Fig 1.12: Hartwig’s Amide α-Arylation. 
1.6.3 Taylor & Kündig’s Direct Coupling Approach 
The groups of Taylor and Kündig both independently adopted similar approaches to generate 
oxindoles bearing this C(3) quaternary centre via a direct coupling reaction, removing the necessity 
to pre-functionalise the aromatic ring with a halide or pseudohalide to allow coupling to proceed. 
Consequently, the number of steps towards such oxindoles is reduced whilst the atom economy is 
improved. Using a copper oxidant and base in DMF, Kündig was able to access a selection of  
3-alkyl-3-aryl oxindole species in high yields.51 Taylor was able to access 3,3-disubstituted oxindoles 
using a similar copper mediated approach (Fig 1.13). However, rather than an aryl-group in the  
3-position, Taylor instead installed an electron withdrawing group.52 This approach was also further 
extended to the synthesis of spirocyclic oxindoles, and in doing so achieved the formal total 
synthesis of (±)-horsfiline.53 Although as yet no enantioselective variant of such a reaction has been 
reported, this reaction is worthy of comment as it represents an idealised system with no necessity 
for pre-activation or leaving group incorporation. 
 
Fig 1.13: Taylor and Kündig’s C-H activation oxindole forming cyclisations. 
1.7. Oxindole Elaboration Reactions 
Conceptually, one of the simplest ways of generating a C(3)-quaternary substituted oxindole would 
be from an enolisable C(3)-tertiary oxindole, and such approaches have been successful in forming 
oxindoles with high levels of stereocontrol. Notably in Trost’s development of the now widely 
adopted AAA (asymmetric allylic alkylation) methodology,54 silylenol-oxindoles proved amenable 
substrates for generation of all-carbon quaternary stereogenic centres. This and other related 
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approaches have been used as methods to access simple 3,3!-pyrrolidinyl-spirooxindoles such as 
horsfiline 4, and are summarised below. 
1.7.1 Trost’s Palladium Mediated Allylation Approach 
Trost et al. recently employed a palladium catalysed AAA reaction in order to generate the 
quaternary stereocentre from a protected silylenol-oxindole core. Using a tetra-n-butylammonium 
triphenyldifluorosilicate (TBAT) additive to liberate the enolate and a chiral palladium complex 
formed from ligand 29, Trost was able to generate this quaternary centre in almost quantitative 
yields and with high enantioselectivity (Fig 1.14). The high levels of ee observed in this 
methodology are rationalised by Trost to arise from steric interactions between the anisole residue 
and chiral ligand 29 thereby raising the energy of the disfavoured transition state.55 
 
Fig 1.14: Trost’s palladium catalysed AAA approach to horsfiline. 
1.7.2 Fuji’s Asymmetric Nitroolefination Approach 
Fuji and co-workers developed an asymmetric nitro-olefination protocol making use of an  
(S)-proline derived chiral auxiliary 30 in order to generate the asymmetric quaternary centre. The 
reaction proceeds via an addition-elimination mechanism initiated by attack of the oxindole-enolate 
onto the chiral nitroenamine auxiliary, generating the asymmetric quaternary centre in the process. 
The reaction proceeds in good yield and with excellent enantioselectivity, and this methodology has 
been applied to the synthesis of oxindole alkaloids (–)-horsfiline 456 and (–)-spirotryprostatin B 5 
(Fig 1.15).57 
 
Fig 1.15: Fuji’s chiral auxiliary nitro-olefination approach to horsfiline. 
N
OTIPS
CO2Et
MeO
N
O
CO2EtMeO
[Pd(C2H5)Cl]2 (0.25 mol %)
29 (1 mol %)
TBAT (15 mol %)
allyl acetate
5 steps
N
H
O
MeO
96% yield
84% ee
NMe
(−)-horsfiline, 4
29
HNNH
OO
PPh2 Ph2P
DMB DMB
DMB = 2,4-dimethoxybenzyl
N
O
MeO
TBS
H
toluene/Et2O (4:1) N
O
MeO
TBS
NO2
9 steps
N
H
O
MeO
NMe
84% yield
 97% ee
(−)-horsfiline, 4
N
NO2
Ph
Ph
OMe
n-BuLi
30
 
    Chapter 1: Introduction 
 10 
1.8. Catalytic Asymmetric Additions to Isatins & Isatin Derivatives 
Isatins and their derivatives are commonly selected starting materials for the synthesis of 
asymmetric oxindole derivatives.58 They are often commercially available, inexpensive, or able to be 
synthesised on multi-gram scale according to known, robust procedures.59 Direct asymmetric 
nucleophilic additions to isatins are attractive given the resulting compounds bear the 3-hydroxyl-
residue found in several of the aforementioned natural product families. Feng and co-workers aptly 
demonstrated the appeal of such an approach in the two-step preparation of (R)-convolutamydine 
A 31 from 4,6-dibromoisatin.60 This asymmetric carbonyl-ene reaction, catalysed by a C2-symmetric 
Mg-N,N!-bisoxide catalyst system 32 provides intermediate species 33 in excellent yield and 
enantioselectivity (87% yield, 97% ee) which is then converted to the desired natural product by 
treatment with dilute acid (Fig 1.16).  
 
Fig 1.16: Feng’s asymmetric Mg-bis-N-oxide catalysed synthesis of convolutamydine A. 
Oxoindolin-3-ylidenes, often accessed by Wittig reaction of the parent isatin, have also found 
common usage as cycloaddition partners, especially under thiourea hydrogen bonding catalysis. 
Barbas and co-workers exploited this in a catalytic asymmetric [4+2]-cycloaddition approach to 
carbazolespiroxindoles,61 using oxoindolin-3-ylidenes and 3-vinylindole, obtaining excellent 
enantiocontrol when using bis-thiourea catalyst 34. Subsequent isomerisation of the product under 
acidic conditions gave the desired carbazole without loss of stereointegrity. The high stereocontrol 
observed in this reaction can tentatively be rationalised as a consequence of bidentate co-ordination 
to the bis-carbonyl moiety of the N-Boc protected oxoindolin-3-ylidenes (Fig 1.17).62 Control 
experiments performed by the authors corroborate this hypothesis. 
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Fig 1.17: Barbas’ bis-thiourea catalysed asymmetric carbazolespiroxindole forming [4+2] cycloaddition. 
1.9. Rearrangement-based Approaches to Asymmetric Oxindoles 
Classically, the Fischer indole44 and Brunner oxindole syntheses,43 both of which centre around a 
key [3,3]-sigmatropic rearrangement, have been used to great effect in the synthesis of the 
respective heterocycles and derivatives thereof. Several other elegant approaches based on less-
classical rearrangements have also provided asymmetric access to oxindoles that, in turn, have 
proved valuable synthetic intermediates en route to natural product targets and are summarised 
below. 
1.9.1 Fu’s O-to-C  Carboxyl Transfer  
Fu and co-workers used chiral PPY (4-pyrrolidinopyridine) derivative 35 in order to promote a 
catalytic asymmetric O-to-C carboxyl transfer of indole substrates such as 36. Optimisation revealed 
the use of trichloro-tert-butoxycarbonyl (TCBoc) carbonate groups resulted in optimum yields and 
enantioselectivities in this transfer process. Oxindoles bearing a variety of aryl-C(3) substituents 
were accessed in good yields and routinely excellent enantiomeric excesses (up to 94% yield, 94-
99% ee) (Fig 1.18).63  
 
Fig 1.18: Fu’s asymmetric Steglich rearrangement. 
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quaternary stereocentres in a single operation.64 After optimisation, the reaction was successfully 
accomplished using palladium catalysis in combination with chiral ligand 38 and an ammonium 
additive ((n-hex)4NBr) that proved crucial in engendering good levels of diastereo- and 
enantioselectivity. This reaction system showed a moderate preference for the desired C2-symmetric 
diastereoisomer of around 3:1 with the product isolated in 74% yield and 91 % ee on 15 mmol 
scale; thus generating over nine grams of enantioenriched material (Fig 1.19). 3,3!-Bisoxindole 39 
was then converted to 40, a formal precursor of three calabar alkaloids (–)-chimonanthine,  
(–)-folicanthine and (+)-calycanthine. 
 
Fig 1.19: Trost’s palladium catalysed DAAA approach. 
A related catalytic enantioselective Meerwein-Eschenmoser Claisen rearrangement furnishing 
quaternary centred allyl oxindoles has also been reported by the Koslowski group.65  
1.9.3 Carreira’s MgI2 Mediated Ring Expansion 
Carreira and co-workers employed an iodide induced ring expansion methodology introduced by 
Ila and Junjappa66 to generate spirocyclic oxindole derivatives. Whereas prior studies had focused 
on aziridine ring expansion, the Carreira group used cyclopropyloxindoles such as 41 in reaction 
with an N-tosyl imine in the presence of a MgI2 catalyst, effecting ring-expansion to spirocycles 
such as 42 in good yields and reasonable dr (typically >75:25) for a variety of alkyl and aryl 
substituents (Fig 1.20).67 This approach was successfully extended and used in the synthesis of  
(±)-horsfiline 4,68 (±)-strychnofoline 269 and (–)-spirotryprostatin B 570 which was accomplished 
with the aid of a resolution step. 
 
Fig 1.20: Carreira’s MgI2 cyclopropane mediated ring-expansion. 
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1.9.4 Danishefksy’s NBS-mediated Oxidative Rearrangement 
Danishefksy and co-workers adopted an oxidative rearrangement approach to forming spirocyclic 
oxindoles using N-bromosuccinimide (NBS).71 After preparation of 43 via a Pictet-Spengler 
reaction, treatment with NBS under aqueous acidic conditions triggered an oxidative 
rearrangement, with the resulting 1,2-shift installing the desired relative stereochemistry at the C(3)-
spirocyclic juncture. Oxindole 44 was then elaborated, giving (–)-spirotryprostatin A (Fig 1.21). 
Earlier oxidative rearrangement studies with substrates bearing the full ketopiperazine unit of 
spirotryprostatin A consistently resulted in formation of the undesired C(3)-epimer as a result of 
opposite facial selectivity in the initial bromination step. This was found to be a general 
phenomenon across a range of oxidising reagents, rationalised by the authors as a “poorly 
understood conformational preference” induced by the ketopiperazine ring. On account of this, the 
authors chose to perform the oxidative rearrangement earlier in the synthesis on a less densely 
functionalised indole core, which led to the desired configuration at C(3). 
 
Fig 1.21: Danishefsky’s NBS mediated oxidative rearrangement approach to (–)-spirotryprostatin A. 
1.9.5 Martin’s Oxidative Semi-Pinacol Rearrangement 
Martin and co-workers adopted an alternative oxidative rearrangement approach for the 
construction of carbospirocyclic oxindole scaffolds.72 By appending a suitable, menthol derived 
chiral auxiliary to indole precursor 45, subsequent diastereoselective epoxidation with DMDO gave 
epoxide intermediate 46. Upon exposing this epoxide to silica, acidic ring opening of the epoxide 
and concomitant 1,2-alkyl shift give spirocarbocyclic oxindole 47 in excellent yield and dr (78%, 
94:6 dr) (Fig 1.22). Such an approach served the Martin group well in their total synthesis of  
(–)-citrinadin A, where Davis’ oxaziridine was used as the epoxidising agent (vide supra).22 
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Fig 1.22: Martin’s semi-pinacol approach to the citrinadin core. 
1.10. Summary of Approaches 
A wide variety of synthetic approaches have been adopted for the asymmetric preparation of 
oxindole species. Many have proven their worth as key steps in complex molecule synthesis, an area 
that has been frequently and extensively reviewed.73-76 It is notable that these approaches still bear 
resemblance to the first synthetic preparations of oxindole species over one hundred years ago, 
albeit now routinely conducted in an enantioselective manner with the aid of more active and 
selective catalyst architectures. For example, intramolecular Heck reactions have proven one of the 
most widely adopted methods for the asymmetric preparation of oxindole species and its origins 
can be directly traced back to Stollé’s initial AlCl3 catalysed procedure. Similarly, isatins are still 
commonly used as oxindole precursors and a variety of catalytic, asymmetric processes have been 
developed based on such scaffolds. Correspondingly, although mechanistically distinct from the 
Brunner oxindole synthesis, numerous rearrangement approaches toward oxindoles have been 
developed either to meet a direct need in the construction of a single complex molecule, or as a 
more general approach to the asymmetric synthesis of oxindole species. The methodology 
described in this thesis falls into the latter category, and the forthcoming sections aim to detail its 
conception within the group and closely related sigmatropic rearrangement approaches toward the 
synthesis of oxindoles. 
1.11. Staudinger’s Studies 
In 1919, Staudinger published work detailing the reactions of nitrones with ketenes for the first 
time.77 He observed that upon treating diphenylnitrone 48 with diphenylketene 49, a “1:1 adduct” 
was formed. If this adduct was then treated with an additional equivalent of diphenylketene, a “2:1 
adduct” was formed. Staudinger was unable to assign the structures of these two adducts 
satisfactorily, and it was not until the work was revisited that the structures of these adducts were 
elucidated. Firstly, in the 1950s Hassall and Lippman repeated Staudinger’s work and were able to 
identify the 1:1 adduct as imino acid 50 and in the process proposed a [3,3]-sigmatropic 
rearrangement mechanism for its formation.78 The work was again revisited in the 1980s by Hafiz 
and Taylor who confirmed these observations with regard to the 1:1 adduct. They also went on to 
propose that the 2:1 adduct was in fact cyclised oxindole derivative 51 and that the 1:1 adduct could 
be directly cyclised to diphenyloxindole 52 by treatment with aqueous acid (Fig 1.23).79 
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Fig 1.23: Staudinger’s initial discovery of adduct formation from the reaction of nitrones and ketenes. 
Throughout these investigations, symmetrical ketenes were used in combination with achiral 
nitrones, and the possibility of forming an asymmetric quaternary centre at the oxindole C(3)-
position using this type of approach was not explored or commented upon. 
1.12. Chiral Nitrones 
Chiral nitrones are most commonly derived from sugars and amino acids. Often these nitrones bear 
the stereogenic group appended to the N-terminus of the nitrone to effectively control facial 
selectivity in [3+2]-cycloadditions.80 Nitrones that bear stereogenicity at the C-terminus are often 
derived from chiral aldehydes, for example the (L)-serine derived Garner’s aldehyde.81 Chiral 
nitrones derived from Garner’s aldehyde display excellent diastereocontrol in reaction with 
nucleophiles, as demonstrated by Garner and co-workers in their preparation of bioxalomycin β2 
and cyanocycline A.82 Aryl-Grignard addition to N-benzyl-nitrone 52 occurs in excellent syn-
diastereoselectivity and can be explained by a transition state invoking a nitrone conformation that 
minimises 1,3-allylic strain,83 potentially reinforced by bis-chelation to magnesium (Fig 1.24). 
 
Fig 1.24: Diastereoselective nucleophilic addition to Garner’s nitrone. 
In reaction with a traditionally non-chelating metal species such as heteroaryl-lithium 54, N-Bn 
Garner’s derived nitrone 53 displays the same, formally anti-Felkin stereocontrol,84 giving the 
addition product in excellent syn-diastereoselectivity and excellent yield, which can again be 
rationalised through the same 1,3-allylic strain transition state model (Fig 1.25).85  
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Fig 1.25: Nucleophilic addition to Garner’s nitrone. 
This conformational preference, adopted so as to minimise 1,3-allylic strain between the nitrone 
oxygen and the group forced to adopt the eclipsing position three atoms away, is a powerful 
stereodetermining constraint for diastereoselective reactions involving such nitrones. This stands in 
stark contrast to that observed in additions to the parent Garner’s aldehyde, which displays Felkin-
Anh selectivity84 with non-chelating nucleophiles.86 Addition of the same heteroaryl-lithium 
nucleophile to the corresponding aldehyde results in a complete reversal in diastereoselectivity to 
favour the anti-product (92:8 dr) once more in excellent yield (Fig 1.26). 
 
Fig 1.26: Felkin-Anh addition to Garner’s aldehyde. 
1.13. [3,3]-Sigmatropic Rearrangements 
1.13.1 Definition 
Pericyclic reactions are those proceeding via a cyclic transition state where bond-breaking and 
bond-forming takes place simultaneously, without intermediate formation, leading to the descriptor: 
‘concerted reactions’.87 Sigmatropic rearrangements are one such class of reaction, and are 
intramolecular isomerisations formally involving the migration of a σ-bond from one position in a 
molecule to another. Such a migration is facilitated by the re-organisation of adjacent -systems in 
order to accommodate the migrating σ-bond. The oldest example of such a rearrangement is the 
Claisen rearrangement, where an allyl vinyl ether rearranges to give an unsaturated carbonyl 
compound.88 Similarly, a commonly used variation of this reaction is the Overman rearrangement; 
an overall transformation of an allylic alcohol into an allylic amine, via the intermediacy of a 
trichloroacetimidate (Fig 1.27).89  
 
Fig 1.27: Common [3,3]-sigmatropic rearrangements. 
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1.13.2 Sigmatropic Rearrangements using Ketenes 
Both the C=C and C=O bonds of ketenes are well-described 2 components in cycloaddition 
reactions. In addition, the heterocumulene-like nature of ketenes means that additional pericyclic 
processes often occur in a tandem or cascade process. For example, in the reaction of 
diphenylketene and cyclopentadiene, it was long assumed that direct [2+2] cycloaddition across the 
ketene C=C bond generated the observed cyclobutanone product. However, with more careful 
study, intermediate 55 has been observed, arising from an initial [4+2] cycloaddition across the 
ketene C=O bond. Intermediate 55 then undergoes [3,3]-sigmatropic rearrangement upon 
moderate warming to give the cyclobutanone (Fig 1.28).90 
 
Fig 1.28: [4+2] cycloaddition of diphenylketene and cyclopentadiene followed by [3,3]-rearrangement. 
1.13.3 The Belluš-Claisen Rearrangement 
The Belluš-Claisen rearrangement is a modification of the original Claisen rearrangement whereby a 
suitable nucleophile such as an allylic ether adds into a ketene to give a zwitterionic enolate 
intermediate. This enolate then undergoes facile [3,3]-sigmatropic rearrangement to give a homo-
allylic ester (Fig 1.29).91 It is notable that rearrangements such as the Cope or Claisen 
rearrangements require high temperatures to promote reaction, whilst those involving ketenes often 
occur at low or even cryogenic temperatures, and are accelerated by the charged, zwitterionic nature 
of the intermediates.92 The Belluš-Claisen rearrangement is a particularly strong example of such an 
effect.  
 
Fig 1.29: Belluš-Claisen rearrangement. 
In 1999, MacMillan and co-workers developed a catalytic variant of the aza-Belluš-Clasien 
rearrangement. In combination with a Lewis acid and a tertiary amine base, the requisite acid 
chloride was dehydrohalogenated in situ to generate a ketene, which after nucleophilic addition 
underwent highly diastereoselective [3,3]-sigmatropic rearrangement yielding syn-homo-allylic 
amides in excellent yield (Fig 1.30).93 
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Fig 1.30: MacMillan’s catalytic aza-Belluš-Claisen rearrangement. 
1.14. Sigmatropic Rearrangements toward Oxindole Synthesis 
Padwa and co-workers also investigated related ketene chemistry with more direct application to 
oxindole synthesis.94 They compared previous work conducted by Gassman95,96 in which a thio-
oxindole species 56 can be generated by a proposed [2,3]-sigmatropic rearrangement of 
intermediate ylide 57 (Fig 1.31).  
 
Fig 1.31: Gassmann’s sulfur-ylide [2,3]-rearrangement approach to oxindoles. 
They reasoned that by combining elements of this protocol and a similar procedure developed by 
Marino for the synthesis of butyrolactones,97,98 it would be possible to instigate a [3,3]-sigmatropic 
rearrangement with a ketene to yield an oxindole after trapping of the sulfonium ion via a 
Pummerer type reaction and loss of a thiol (Fig 1.32).99 Using dichloroketene, they report low yields 
for oxindole formation, but had much greater success when applying this methodology towards 
extended calabar alkaloid-like structures. Again, like Staudinger’s initial work and the follow up 
studies by Taylor and Lippman, this protocol makes use of a symmetrical ketene to form the 
quaternary centre, and the possibility of forming a stereogenic centre here is not exploited.  
 
Fig 1.32: Padwa’s [3,3]-rearrangement approach to 3,3-dichlorooxindoles. 
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Although a conceptually attractive process, the necessity of mercaptan elimination, which proved 
problematic in some cases, limits the potential utility of such a process. Other pericyclic approaches 
towards oxindole-like heterocycles are much more established. For instance, the key steps in both 
the Fischer indole synthesis44 and Brunner oxindole synthesis43 are [3,3]-sigmatropic 
rearrangements, however both methods require forcing conditions. More recently it has been 
shown that oxindoles and oxindole precursors can be accessed via related reaction processes under 
relatively mild conditions. Whereas in the Brunner oxindole synthesis, [3,3]-rearrangement 
necessitates breaking a relatively strong C-N σ-bond, the same overall transformation can be 
achieved by rearranging the order of atoms to allow breakage of the weaker N-O σ-bond. Endo 
and co-workers exploited such a rearrangement in the synthesis of aniline derivatives that are 
formally oxindole precursors. Taking N-phenyl-O-acyl hydroxylamines 58 and using KHMDS, they 
were able to access the corresponding amino-acid species 59 that was directly converted to its 
methyl ester in situ with diazomethane (Fig 1.33).100  
 
Fig 1.33: Endo’s anionic [3,3]-sigmatropic rearrangement. 
More recently, Baldwin used a similar reaction procedure whilst investigating the formation of 
spirocyclic oxindole species.101 Again, using an N-phenyl-O-acyl hydroxylamine precursor and base, 
the anion assisted [3,3]-sigmatropic rearrangement of the key spirocycle-forming step was found to 
be relatively facile, and numerous examples are reported in reasonable yields (Fig 1.34).  
 
Fig 1.34: Baldwin’s rearrangement approach to spirocyclic oxindoles. 
Baldwin and co-workers also investigated the stereoselectivity of this rearrangement process using a 
number of chiral carboxylic acid derivatives as exemplified by the camphor-appended carboxylic 
acid below. In each case however, only modest diastereoselectivity was observed (Fig 1.35). 
 
Fig 1.35: Baldwin’s continuation towards a stereoselective rearrangement utilising a camphor-derived acid. 
N
tBu
O
O
R
R'
NH
tBu
R'
CO2HKHMDS
NH
tBu
R'
CO2Me
CH2N2
R R
[3,3]
58 59
N
MeO2C O
O KHMDS
NaOAc/Ac2O
N
O
CO2Me
61-79% yield
NH
CO2Me
CO2H
[3,3]
1.KHMDS
Me
Me Me
NO
CO2Me
Me
Me Me
N
O
CO2Me
1:2.3
Me
Me Me
2. NaOAc/Ac2O
O
O
N
CO2Me
 
    Chapter 1: Introduction 
 20 
1.15. Project Background Within the Smith Group 
This project arose from the observation within the group that whilst attempting an N-heterocyclic 
carbene catalysed [3+2] cycloaddition between a nitrone and a ketene, none of the expected 5-
membered heterocycle 60 was formed. Rather, a different heterocyclic product, oxindole 61 was 
observed along with the regeneration of the aldehyde used in nitrone formation, in this case 
benzaldehyde (Fig 1.36). Unaware of the previously described studies into this reaction, the reaction 
was repeated and found to proceed in the absence of the N-heterocyclic carbene, yielding the same 
unexpected oxindole 61. 
 
Fig 1.36: Attempted NHC catalysed [3+2] cycloaddition between nitrone and ketene yielded oxindole 61. 
Further preliminary investigations into the mechanism of this transformation were undertaken, and 
it was found that reaction of hydroxylamine with ketene did not yield the observed oxindole, 
indicating the necessity of pre-forming the nitrone. During the course of these studies it was 
observed that on using p-bromobenzaldehdye to form the nitrone, after cyclisation and work-up,  
p-bromobenzaldehyde was once more regenerated. Also, prior to quenching the reaction an 
intermediate species could be observed by 1H NMR spectroscopy, which was tentatively assigned as 
imino-acid 62, and is consistent with reaction via a [3,3]-sigmatropic rearrangement pathway (Fig 
1.37).  
 
Fig 1.37: Reaction with a p-bromobenzaldehyde derived nitrone. 
Exploration into the scope of this transformation was then conducted using benzaldehyde derived 
achiral nitrones and found to be extremely broad, tolerating an array of ketenes to yield a selection 
of 3,3-disubstituted racemic oxindoles in good to excellent yields. Due to the apparent broad 
tolerance of this transformation, attention then turned to developing an asymmetric version of this 
protocol. Several chiral nitrones were considered, and a mannitol derived aldehyde 63 and Garner’s 
aldehyde 64 were prepared according to literature procedures from simple, commercially available 
starting materials.102,103 The phenyl nitrones of these aldehydes were then prepared by condensation 
with phenylhydroxylamine, and the rearrangements conducted with alkylarylketenes. Using the 
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mannitol-derived nitrone 65, oxindoles with enantiomeric excesses of up to 70% were obtained 
(Fig 1.38), whilst using Garner’s aldehyde-derived nitrone 66, oxindoles of up to 90% ee were 
obtained in generally excellent yield (Fig 1.39).  
 
Fig 1.38: Evaluation of a mannitol derived stereodirecting nitrone. 
 
Fig 1.39: Evaluation of a serine derived stereodirecting nitrone. 
The higher enantiomeric excess, coupled with the simpler synthesis and purification of the Garner’s 
species compared to the mannitol derived nitrone, led to 66 being selected as the leading 
stereodirecting unit. To highlight the synthetic utility of this asymmetric process, the Garner’s 
derived nitrone 66 was used in the asymmetric synthesis of the 3-phenyl-hexahydropyrroloindole 
skeleton 67, common to numerous natural alkaloids. This was achieved over seven steps with an ee 
of 80% after the initial reaction, which was improved to >99% by recrystallisation (Fig 1.40).104 
 
Fig 1.40: Demonstration of synthetic utility. 
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Our original mechanistic proposal for this transformation centred on a [3,3]-sigmatropic 
rearrangement of enolate 68 after initial nucleophilic addition of the nitrone component into the 
ketene C(2) carbon. Whilst feasible for both racemic and asymmetric variations of the same 
reaction, presumably in the asymmetric version the conformation adopted by the remote 
stereocentre would be crucial in order to generate the high levels of enantioselectivity observed in 
this process. Thus, it was possible to draw both boat and chair transition states for the sigmatropic 
rearrangement, both of which could be used to rationalise the formation of the observed 
enantiomer, yet the origin of this enantiocontrol still remained unclear (Fig 1.41).  
 
Fig 1.41: Original mechanistic considerations centred around [3,3] sigmatropic rearrangement of key enolate 
precursor 68. 
1.16. Overview of Previous Work 
Since Staudinger’s initial discovery of the reaction between nitrones and ketenes, several similar 
reaction processes toward the synthesis of oxindoles have been investigated, with varying degrees 
of success, including related processes with ketenes. However, as described in the prior section this 
work has been limited to the use of symmetrically substituted ketenes and, therefore, 
enantioselective approaches have not been described. Baldwin and co-workers began to explore 
stereoselectivity in their camphor derived acyl-hydroxylamine rearrangement, yet saw only modest 
selectivity. The development of a highly asymmetric hetero-Claisen [3,3]-sigmatropic rearrangement 
for the synthesis of enantioenriched 3,3-oxindoles represents an attractive methodology due to the 
desirability of such compounds. Additionally, the mild conditions under which the reaction occurs 
and the broad potential scope suggested by initial studies into this reaction system further highlight 
the promise of such a methodology. 
1.17. Aims & Objectives 
As a continuation of the work described in the previous section and the published communication 
regarding this discovery,104 the initial aims of this project were to explore the parameters for 
formation of asymmetric oxindoles from ketenes and chiral nitrone species (Fig 1.42). Firstly, 
structural variation of the chiral nitrone component would be assessed and the necessary structural 
motifs identified in order to optimise the levels of asymmetry in this transformation (a). In parallel, 
varying substitution patterns on the aryl ring of the nitrone component would be investigated to 
probe the tolerance of the transformation and in doing so, provide proof of concept studies as to 
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the potential of accessing higher-value products in the future. Similarly, differing substitution 
patterns on the N-aryl nitrone substituent would provide insight as to the regioselectivity of the 
reaction and its impact upon the enantioselectivity of the transformation (b). With the optimum 
nitrone in hand, variation of the ketene species (c) would also allow facile access to highly 
enantioenriched novel oxindole species that would be of interest to CRUK/NCI multi-cellular 
screening programs.  
 
Fig 1.42: Initial aims & objectives of this research project. 
The combination of these structural variations would also allow insight into the origin of 
asymmetric induction in this reaction process and help rationalise the observed enantiomeric 
excesses by providing information as to the reaction mechanism in operation. With this mechanistic 
knowledge in hand, it was anticipated that further extensions and applications of this methodology 
could be designed, and the potential for developing a catalytic asymmetric variant of this 
transformation explored. It was also foreseen that this methodology could then be applied to the 
preparation of a series of drug-like species and natural product targets (Fig 1.43). 
 
Fig 1.43: Other potential avenues for exploration based upon this methodology. 
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Chapter 2: Initial Studies & Investigating the Origin of Enantioselectivity 
2.1. Introduction & Aims 
To this point, only a mannitol derived nitrone 65 and Garner’s nitrone 66 had been investigated 
and applied in this asymmetric oxindole forming methodology. This chapter primarily describes 
optimisation of the enantioselectivity of this process through modification of the stereodirecting 
unit within a series of chiral nitrones. Making using of readily available chiral starting materials, the 
necessity for an α-heteroatom such as in Garner’s nitrone 66 was investigated, as was variation of 
N-protecting group size. Due to the uncertainty surrounding the mechanistic rationale at this point, 
we also sought to probe this experimentally through this structural variation (Fig 2.1).  
 
Fig 2.1: Aims and objectives for Chapter 2. 
2.2. Starting Materials 
In order to allow for chiral HPLC analysis of the asymmetric oxindoles described in this thesis, it 
was also necessary to prepare authentic racemic samples of each oxindole under investigation. This 
was achieved from the requisite achiral diarylnitrone and alkylarylketene. Achiral diaryl nitrones 
were typically prepared on large scale owing to their long-term stability and inexpensive nature of 
the required starting materials. The inherent reactivity of alkylarylketenes necessitated a more 
careful approach to their synthesis and storage. Development of a robust procedure that allows for 
their preparation, manipulation and in-line purification all under an inert atmosphere is described in 
the following section.  
2.2.1 Diarylnitrone Synthesis 
Two methods for preparing diarylnitrones were commonly employed. For larger scale preparations, 
a one-pot zinc mediated reduction105 of the corresponding nitroarene in the presence of 
benzaldehyde typically allowed access to diarylnitrones in moderate to good yields, providing up to 
ten grams of material after a single recrystallisation (Fig 2.2). Due to the nature of purification 
employed, these reactions were invariably higher yielding when performed on larger scale and the 
recrystallised material could be stored on the benchtop for periods of up to one year without 
significant decomposition or hydrolysis. 
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Nitrone X Yield (%) 
48 H 53 
69 p-Cl 47 
70 p-MeO 97 
71 o-Me 52 
Fig 2.2: One-pot diarylnitrone preparation. 
Alternatively, transfer hydrogenation106 of the nitroarene using hydrazine monohydrate and 
rhodium on carbon in THF could be employed, allowing the intermediate hydroxylamines to be 
accessed selectively, again after a single recrystallisation. This method proved applicable to the 
preparation of several ortho-, meta- and para-substituted arylhydroxylamines on gram scale in good, 
but variable yields (Fig 2.3). Such reactions could also be performed on smaller, milligram scales, 
allowing access to the desired products, however the ‘wet’ nature of the reaction conditions 
sometimes made isolation of a dry crude solid suitable for recrystallisation more troublesome. 
Nevertheless, once prepared and recrystallised, these hydroxylamines could be stored for a few 
months in the freezer, but were typically condensed with the requisite aldehyde immediately to 
provide access to either the necessary diarylnitrones, or chiral nitrones (vide infra). 
 
Hydroxylamine X Yield (%)  Nitrone X Yield (%) 
72 H 82  - - - 
73 o-Me 70  71 o-Me >99 
74 m-Me 85  85 m-Me >99 
75 p-Me 67  86 p-Me >99 
76 o-Cl 78  87 o-Cl >99 
77 m-Cl 67  88 m-Cl >99 
78 p-Cl 32  - - - 
79 p-F 92  89 p-F 64 
80 p-CF3 69  90 p-CF3 98 
81 p-MeO 56  - - - 
82 o-Br 72  91 o-Br 48 
83 m-Br 78  92 m-Br 72 
84 p-Br 85  93 p-Br 78 
Fig 2.3: Nitrone preparation v ia  the isolated intermediate hydroxylamine (no entry in the nitrone column means 
this nitrone was only ever prepared v ia  the previously described one-pot method (Fig 2.2)). 
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2.2.2 Ketene Preparation 
The ketenes described in this thesis were synthesised according to literature procedures107-111 or, 
where novel, according to modifications of these literature procedures. Typically, the ketenes were 
prepared via tertiary-amine mediated dehydrohalogenation of the corresponding acyl chloride, or in 
certain cases via zinc mediated reduction112 of the corresponding α-halo acyl halide (vide Chapter 3). 
Ethylphenylketene is the most accessible alkylarylketene, primarily due to the commercial, low cost-
availability of the precursor 2-phenylbutyric acid. The acid is readily converted into the acyl chloride 
by treatment with thionyl chloride, with this reaction routinely conducted on up to fifty-gram scale. 
Dehydrohalogenation with N,N-dimethylethylamine (N,N-DMEA) in Et2O at 0 °C then affords 
the crude ketene solution after filtration of the amine hydrochloride salt. Due to the reactive nature 
of the ketenes, rigorous exclusion of air from the reaction vessel is necessary at all times and 
consequently the set-up represented in Fig 2.4 was devised for the preparation of ketenes. After 
conducting the reaction in the lower round-bottomed flask (A), the amine hydrochloride salt could 
be filtered using the in-line frit, and the crude ketene filtrate collected in flask B, all performed 
whilst maintaining an inert atmosphere. The crude ethereal solution of ketene could be 
concentrated in vacuo directly using a vacuum pump to yield the crude ketene. Whereas literature 
procedures invariably use Et3N as a base in such preparations, as a group we switched to routinely 
preparing ketenes using N,N-DMEA as a direct consequence of this in-line concentration. The 
increased volatility of any excess N,N-DMEA remaining in the reaction medium at this point 
makes it easier to remove, consequently providing a higher purity crude material. The crude 
solution of ethylphenylketene could then be transferred into a flame-dried Kugelrohr flask by 
cannula and purified by bulb-to-bulb Kugelrohr distillation at 88 °C under vacuum (3 mmHg) to 
afford ethylphenylketene as a yellow liquid in 61% yield, which could be stored in the freezer under 
an inert atmosphere for up to three months without significant degradation. If left for greater 
periods of time, evidence of hydrolysis can be observed by NMR analysis and even visually by the 
appearance of crystals in the ketene solution. 
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Fig 2.4: Ketene preparation apparatus and procedure. 
With a robust route and reaction procedure in hand, other alkylarylketenes were prepared in an 
analogous manner, yet out of necessity these syntheses began with alkylation of the requisite 
arylacetic acid. This was achieved by double deprotonation at -78 °C using n-butyllithium followed 
by alkylation with the required alkyl-halide. This procedure typically gave the desired disubstituted 
acids in good yield (65-90%) and again was routinely performed on upwards of ten-gram scale 
(Scheme 2.1). The disubstituted acids were then converted into the corresponding acid chlorides 
and subsequently the ketenes by the same method as described previously. Known ketenes 
ethylphenylketene 94, methylphenylketene 95, ethyl-(4-chlorophenyl)ketene 96, ethyl-(4-
fluorophenyl)ketene 97, methyl-(4-tolyl)ketene 98, ethyl-(4-methoxyphenyl)ketene 99, and ethyl-(4-
tolyl)ketene 100 were prepared and isolated by the author, whilst any other known alkylarylketenes 
referred to in this thesis were prepared by either Dr James J. Douglas or Dr Stuart M. Leckie with 
the syntheses and characterisation data described in their theses.113,114 Further novel ketene species 
were prepared and used in situ and will be discussed on an individual basis in later chapters. 
 
 
Scheme 2.1: Reagents and conditions: i) n-BuLi (2.1 eq), THF, -78 °C to rt, 2h then R-X (1.0-2.0 eq). ii) SOCl2 (2.0 eq), 
PhCH3, 80 °C, 16 h. iii) N,N-DMEA (1.1 eq), Et2O, 0 °C, 16 h. 
2.3 Investigating the Origin of Enantioselectivity 
With the necessary starting materials in hand in order to generate racemic oxindoles, attention 
turned to optimisation of the enantioselectivity in this reaction process by preparation of a range of 
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enantiopure N-phenyl nitrones. These nitrones were then evaluated in reaction with 
alkylarylketenes to assess their ability to form oxindoles in good yield and with high 
enantioselectivity (Fig 2.5). 
 
Fig 2.5: Evaluation of enantiopure nitrones in the formation of asymmetric oxindoles. 
2.3.1 Alternative Acyclic Stereodirecting Structures 
To explore the necessary structural requirements for generating high enantiocontrol, a range of 
alternative enantiopure N-phenyl nitrones was synthesised from readily available chiral pool starting 
materials. These nitrones were then evaluated in reaction with ethylphenylketene 94 under optimal 
reaction conditions (as previously determined for Garner’s nitrone 66). Initially, Naproxen 101 was 
investigated as an alternative stereodirecting unit, with aldehyde 103 synthesised in two steps via 
LiAlH4 reduction to alcohol 102, and subsequent oxidation using Dess-Martin periodinane. 
However, after formation of the phenylnitrone 104 and subsequent treatment with 
ethylphenylketene, only a moderate 43% yield of oxindole was obtained with modest 27% ee 
(Scheme 2.2).  
 
Scheme 2.2: Reagents and conditions: i) LiAlH4 (1.8 eq), Et2O, 0 °C to rt, 16 h. ii) Dess-Martin periodinane (1.2 eq), 
CH2Cl2, rt, 40 min. iii) PhNHOH (1.0 eq), EtOH, 4 °C, 40 h. iv) Ethylphenylketene (1.0 eq), THF, -78 °C, 3 h. 
A mandelic acid derived nitrone 109 was also investigated as an alternative stereodirecting unit. 
Methyl ester formation and O-TBS protection were followed by direct DIBAL-H reduction to 
aldehyde 108, which was then treated with phenyl hydroxylamine to yield nitrone 109. However, 
when this nitrone was treated with ethylphenylketene only a poor 25% yield of racemic oxindole 
was obtained (Scheme 2.3).  
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Scheme 2.3: Reagents and conditions: i) SOCl2 (0.15 eq), MeOH, reflux, 1.5 h. ii) ImH (1.3 eq), TBSCl (1.2 eq), DMF, rt, 
16 h. iii) DIBAL-H (1.3 eq), PhCH3, -78 °C, 2h. iv) PhNHOH (1.0 eq), MgSO4 (1.1 eq), rt, 16 h. v) Ethylphenylketene 
(1.0 eq), THF, -78 °C, 3h. 
Subsequently, silyl-lactate derived nitrone 113 was synthesised via O-TBS protection of (S)-ethyl 
lactate followed by DIBAL-H reduction directly to aldehyde 112 and condensation with phenyl 
hydroxylamine. This species proved to be more successful in terms of stereocontrol, yielding the 
oxindole in 60% ee and moderate 32% yield (Scheme 2.4).  
 
Scheme 2.4: Reagents and conditions: i) ImH (1.3 eq), TBSCl (1.2 eq), DMF, rt, 16 h. ii) DIBAL-H (1.3 eq), PhCH3, -78 
°C, 2 h. iii) PhNHOH (1.0 eq), MgSO4, (1.1 eq), rt, 16 h. iv) Ethylphenylketene (1.0 eq), THF, -78 °C, 3 h. 
A series of analogues of 113 was then synthesised via the same synthetic sequence to monitor the 
change in oxindole ee with varying O-substituent size (Scheme 2.5). In the course of these 
reactions, it was extremely difficult to purify the silyl nitrones. Trituration proved moderately 
successful in some cases, however in other cases column chromatography was used with limited 
success. The nitrones are seemingly highly susceptible to hydrolysis on silica, and both the nitrone 
and parent aldehyde were often found to co-elute and could not be purified sufficiently to 
characterise. Therefore, the nitrones of these species were prepared and used directly in the next 
reaction step without further purification and only limited characterisation data were obtained. 
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Scheme 2.5: Reagents and conditions: i) a) NaH (1.8 eq), MeI (1.2 eq), THF, 0 °C to rt, 16 h. b) ImH (1.3 eq), R3SiCl (1.2 
eq), DMF, rt, 16 h. ii) DIBAL-H (1.3 eq), PhCH3, -78 °C, 2 h. iii) PhNHOH (1.0 eq), MgSO4 (1.1 eq), rt, 16 h.  
A general trend of increasing ee with increasing O-substituent size was observed with O-TIPS 
nitrone 119 giving oxindole 61 in 80% ee and 70% yield (Scheme 2.6). However, use of the TBDPS 
protecting group resulted in a significant drop in enantioselectivity.  
 
Nitrone PG Oxindole Yield (%) ee (%) 
116 Me 37 50 
113 TBS 32 60 
119 TIPS 70 80 
122 TBDPS 38 32 
Scheme 2.6: Reagents and conditions: i) Ethylphenylketene (1.0 eq), THF, -78 °C, 3 h. 
After no improvement in ee (compared to Garner’s nitrone) and due to the difficulties in purifying 
these silyl species, it was decided to return to an oxazolidine-derived architecture and explore 
structural variations around this cyclic core. 
2.4 Oxazolidine Derived Nitrones 
2.4.1 Garner’s (N-Boc) Nitrone Synthesis 
Since its inception in 1984, Garner’s aldehyde 64 has found widespread use as a starting material in 
asymmetric synthesis due to its relative ease of preparation and the high levels of diastereocontrol it 
affords in nucleophilic addition reactions (see Chapter 1).81 In our hands, repetition of a five-step 
literature preparation115 beginning from (L)-serine afforded the desired aldehyde in 34 % overall 
yield (Scheme 2.7). The only modification made to the original literature preparation was the use of 
the more hindered DIPEA as a base, rather than Et3N during the final Swern oxidation step, as it 
has been reported that Et3N can cause racemisation of the stereogenic centre in this process.116 
Subsequent treatment of the aldehyde with phenyl hydroxylamine 72 afforded Garner’s nitrone 66 
in 87% yield as an off-white solid with analytical data in agreement with previous preparations in 
the group. 
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Scheme 2.7: Reagents and conditions: i) SOCl2 (6.0 eq), MeOH, 0 °C to rt, 16 h. ii) Et3N (2.5 eq), (Boc)2O (1.1 eq), 0 °C 
to rt, 4 h. iii) 2,2-Dimethoxypropane (15.0 eq), BF3•Et2O (0.2 eq), Et3N (0.3 eq), acetone, rt, 3 h. iv) NaBH4 (2.0 eq), LiCl 
(2.0 eq), EtOH, THF, 0 °C to rt, 4 h. v) (COCl)2 (2.0 eq), DMSO (4.0 eq), DIPEA (6.0 eq), CH2Cl2, -78 °C to rt, 2 h. vi) 
PhNHOH (1.05 eq), MgSO4 (1.1 eq), CH2Cl2, rt, 1 h. 
2.4.2 Solvent Screen 
Initially, a solvent screen was conducted using Garner’s nitrone 66 and ethylphenylketene at -78 °C 
to assess the impact of solvent polarity on the reaction yield and enantioselectivity. However in all 
four of the solvents evaluated, the yields were reasonable and enantiomeric excesses remained the 
same (Fig 2.6). As THF gave a moderately higher yield and due to its greater miscibility with H2O, 
which we thought would be beneficial for the aqueous acidic quench at the end of the reaction, 
THF was maintained as the reaction solvent of choice.  
 
Solvent Yield (%) ee (%) 
THF 77 84 
Toluene 46 87 
Hexane 52 82 
CH2Cl2 64 84 
Fig 2.6: Solvent screen: evaluation of N-Boc nitrone 66 in reaction with ethylphenylketene. 
2.4.3 Variation of the Garner’s Aldehyde Structure 
Due to the prevalence of Garner’s aldehyde in asymmetric synthesis and the high ee observed in 
our initial studies with the derived nitrone, it was decided to retain the oxazolidine core structure, 
(allowing (L)-serine to be retained as the starting material) and modify the nature of N-substituent. 
Initially, N-benzyl nitrone 129 was prepared in 35% yield from known aldehyde 128117 by 
condensation with phenylhydroxylamine. Treatment of N-benzyl nitrone with ethylphenylketene 
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under our standard conditions however, yielded the expected oxindole 61 in a good 60% yield, but 
with markedly lower enantiocontrol (20% ee) (Scheme 2.8). 
 
Scheme 2.8: Reagents and conditions: i) PhNHOH (1.0 eq), MgSO4 (1.1 eq), rt, 16 h. ii) Ethylphenylketene (1.0 eq), THF, 
-78 °C, 3 h. 
This result inspired the hypothesis that structural rigidity or limited rotation in this position may 
play an important role in controlling the enantiodiscriminatory step and prompted us to investigate 
a range of N-sulfonamide-protecting groups. This work was conducted with the aid of a final year 
project student, Lois Manton.118 It was found that for sulfonamide substrates 130, 135 and 140, the 
first N-protection step proceeded without issue in reasonable yields (43, 79 and 99% respectively). 
However, by employing the same BF3 mediated amido-alcohol cyclisation procedure as in the 
Garner’s aldehyde synthesis, very low levels of cyclised product were observed for all three 
substrates. Therefore, an alternative cyclisation procedure119 using PPTS in toluene was adopted, 
proving more successful, with cyclised yields of up to 60% and also allowing recovery of the 
majority of unreacted starting material. The LiBH4 reduction was also replaced with a LiAlH4 
reduction, resulting in an increased reaction yield (> 85% in all three cases) and crucially no 
observed racemisation of the stereocentre. Oxidation under Swern conditions proceeded in almost 
quantitative yield for all three substrates, again using Hünig’s base to prevent any potential 
racemisation. Condensation with phenylhydroxylamine then provided the desired nitrones 134, 139 
and 144 in moderate yields (40, 45 and 56% respectively) (Scheme 2.9). The quoted yields and 
procedures in Scheme 2.9 are not heavily optimised and are based on a single preparation, however 
the route to 2,4,6-triisopropylbenzenesulfonyl nitrone 144, has been further developed and 
performed multiple times by the author (vide infra). 
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Scheme 2.9: Reagents and conditions: i) Et3N (2.4 eq), ArSO2Cl (1.05 eq), 0 °C to rt, 16 h. ii) 2,2-Dimethoxypropane 
(15.0 eq), PPTS (0.25 eq), PhCH3, 80 °C, 16 h. iii) LiAlH4 (1.5 eq), THF, 0 °C, 30 min. iv) (COCl)2 (2.0 eq), DMSO (4.0 
eq), DIPEA (6.0 eq), CH2Cl2, -78 °C. v) PhNHOH (1.05 eq), MgSO4 (1.1 eq), CH2Cl2, rt, 1 h. 
The reaction of N-tosyl protected nitrone 134 with ethylphenylketene under our standard reaction 
conditions gave the expected oxindole 61 in 75% yield and excellent ee (91%), whilst N-
mesitylsulfonyl protected nitrone 139 provided oxindole 61 in a slightly diminished 61% yield and 
89% ee. Increasing the size of the sulfonamide group further increased the product ee, with N-
TIPBS (2,4,6-triisopropylbenzenesulfonyl) nitrone 144 giving oxindole 61 in 86% yield and 96% ee 
(Fig 2.7). 
 
Nitrone PG Yield (%) ee (%) 
129  Benzyl 60 20 
66  Boc 83 84 
134  Tosyl 75 91 
139 Mesitylsulfonyl 61 89 
144  TIPBS 86 96 
Figure 2.7: Evaluation of oxazolidine derived N-protected nitrones in asymmetric oxindole formation. 
The absolute configuration of the asymmetric oxindoles 61 generated using nitrones 129, 134, 139 
and 144 was found to be consistent with that observed using Garner’s nitrone 66, which was 
assigned as (S) by derivatisation of the oxindole to a known species.104 
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2.4.4 Optimised Synthetic Route to Nitrone 144 
It was clear at this stage that N-TIPBS nitrone 144 possessed the required structural attributes to 
impart high levels of enantioinduction in the preparation of a range of asymmetric oxindoles. 
Therefore, to commence the studies described in the following sections, an array of substituted N-
aryl nitrones were required and consequently preparation of N-TIPBS-aldehyde 143 was 
undertaken on multi-gram scale (Scheme 2.10). N-Protection of (L)-serine methyl ester with 
TIPBSCl proceeded in 97% yield, followed by cyclisation with 2,2-dimethoxypropane under PPTS 
catalysis to yield 141 in 47% yield (80% b.r.s.m.). This cyclisation step proved problematic in larger 
scale preparations due to generation of water as a by-product of cyclisation, resulting in an 
equilibrium between starting material and product. Attempting to conduct the reaction under 
Dean-Stark conditions to circumvent this proved difficult due to the significantly lower boiling 
point of 2,2-dimethoxypropane compared with toluene and, as yet, this is an unresolved problem in 
the preparation of nitrone 144. If more time were to be invested to this, varying solvent and acid 
combinations may be able to affect a more complete cyclisation. 
With the cyclised ester in hand, reduction with LiAlH4 then provided alcohol 142 in up to 99%  
yield (85% average yield based on numerous preparations) as a crystalline solid. Alcohol 142 
displayed rotamers via NMR spectroscopy at ambient temperature in CDCl3, however analysis in 
C6D6 allowed observation of only a single rotational isomer. Alcohol 142 also provides a convenient 
storage point on the synthetic route, and samples have routinely been kept on the benchtop for up 
to two years with no degradation or loss of enantiointegrity. Alcohol 142 is then oxidised under 
Swern conditions as and when required, once more using DIPEA as the tertiary amine base, before 
condensation with the requisite hydroxylamine to provide the necessary N-aryl nitrone. A single 
crystal X-ray structure of N-phenyl TIPBS nitrone 144 was also obtained and gives an excellent 
graphical representation as to the steric impact of the N-TIPBS residue (Fig 2.8). 
 
Scheme 2.10: Reagents and conditions: i) Et3N (2.4 eq), 2,4,6-TIPBSCl (1.05 eq), 0 °C to rt, 16 h. ii) 2,2-
Dimethoxypropane (15.0 eq), PPTS (0.25 eq), PhCH3, 80 °C, 16 h. iii) LiAlH4 (1.5 eq), THF, 0 °C, 30 min. iv) (COCl)2 
(2.0 eq), DMSO (4.0 eq), DIPEA (6.0 eq), CH2Cl2, -78 °C. v) PhNHOH (1.05 eq), MgSO4 (1.1 eq), CH2Cl2, rt, 1 h. 
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Fig 2.8: Single crystal X-ray representation of N-phenyl TIPBS nitrone 144. 
2.5. Conclusions for Chapter 2 
Through variation of the nitrone architecture a superior stereodirecting nitrone 144 was identified 
for the synthesis of oxindoles, which was subsequently prepared on a larger scale via an optimised 
synthetic strategy. In this variation, the incorporation of an α-heteroatom in combination with a 
sterically demanding residue proved beneficial, in order to presumably provide a directionality to 
the facial approach of the ketene. This is evident with O-TIPS nitrone 119 that provided the 
oxindole species in 70% yield and 80% ee upon treatment with ethylphenylketene. Ultimately, the 
combination of these structural features in N-TIPBS nitrone 144 proved most successful in 
amplification of enantiocontrol and can be attributed to the large size of the TIPBS substituent, but 
also perhaps crucially as a direct consequence of the rigidity and lack of free rotation afforded by 
this sulfonamide residue. In comparison, N-benzyl nitrone 129 provided the oxindole in a much-
diminished 20% ee. Although not necessarily representative of reaction in the solution phase, the 
obtained crystal structure of nitrone 144 gives a clear insight as to the steric impact of the N-TIPBS 
residue. From the conformation depicted in this solid phase representation, it can be surmised that 
the N-TIPBS group effectively shields the Re face of the nitrone from approach by the ketene. Our 
synthetic endeavours provide insight into the necessary features for stereocontrol and are in good 
agreement with our computational mechanistic rationale that is discussed at length in Chapter 4. 
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Chapter 3: Application of N-TIPBS Nitrone 144 in Synthesis 
3.1. Introduction & Aims 
Chapter 2 identified nitrone 144 as a suitable transmitter of chiral information in the generation of 
ethylphenyloxindole 61 in high levels of asymmetry. However, this result had only been validated 
on a single reaction system, using a single alkylarylketene. Therefore, the aims of the following 
chapter were to probe the generality of this process with a variety of alkylarylketenes and so validate 
the N-TIPBS nitrone architecture in the preparation of a range of asymmetric oxindoles. Further 
extension of this concept towards the synthesis of oxindoles bearing a spirocyclic juncture at this 
position would also be investigated.  
 
Fig 3.1: Aims and objectives for Chapter 3. 
3.2. Synthesis of Asymmetric 3-Alkyl-3-aryl Oxindoles 
Using optimised N-TIPBS nitrone 144, reaction with a range of alkylarylketenes was undertaken. 
Initially, we selected the same alkylarylketenes as had been used with Garner’s nitrone 66 in our 
previous publication,104 to provide a direct comparison between the N-TIPBS and N-Boc nitrone 
chiral auxiliaries. The results of this screen are summarised in Fig 3.2. In all cases, an increase in 
enantiomeric excess was observed with N-TIPBS nitrone 144 compared with N-Boc nitrone 66. 
The enantiomeric excesses and yields of all reactions were excellent (>60% yield; >94% ee) and the 
system is tolerant of various alkyl substituents (methyl, ethyl, n-butyl) and a variety of para-
substituted aryl rings without significant impact on the yield or enantioselectivity. 
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Fig 3.2: Asymmetric oxindole synthesis from N-TIPBS nitrone 144 and alkylarylketenes. Ee values in 
parentheses refer to those in ref 104 from N-Boc Garners nitrone 66 and the same alkylarylketenes (N. Duguet).  
In a further more extensive ketene screen, numerous other alkylarylketenes were also well tolerated, 
yielding the respective oxindoles in good yields although with varying ee (Fig 3.3). Alkyl-β 
branching of the ketene component was well tolerated (151) and halo-arylketenes yielded oxindoles 
152, 153 and 154 in excellent ee. Nevertheless, use of a ketene bearing an α-branched alkyl 
substituent resulted in complete loss of stereocontrol, generating racemic oxindole 155. Lower 
enantiocontrol was also observed using ketenes bearing a 2-substituted aryl ring, yet these reactions 
still proceeded in good or excellent yields (156, 157). The generation of oxindole 158 from N-
TIPBS nitrone with ethyl(1-naphthyl)ketene proceeded in low yield (30%) and moderate 
enantiocontrol (40% ee). The absolute configuration of the product oxindoles was assigned by 
analogy to that previously determined for ethylphenyloxindole 61.104 
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Fig 3.3: Further asymmetric oxindole synthesis from N-TIPBS nitrone 144 and alkylarylketenes. 
We were also intrigued at this point as to the possibility of generating C(3)-tertiary asymmetric 
oxindoles via the same methodology, as relatively few examples of such species exist in the 
literature.120 Methylketene was chosen for a model study, and was prepared as a THF solution by 
zinc-mediated reduction of the commercially available 2-bromopropionyl bromide as described by 
Ward.112 Treatment of achiral nitrone 48 with this freshly prepared solution of methylketene 
solution 159 in THF provided 3-methyloxindole 160 in an encouraging 70% yield (Scheme 3.1).  
 
Scheme 3.1: Reagents and conditions: i) Activated zinc (excess), THF, -78 °C under reduced pressure. ii) 48, THF, 30 
min, rt then 2M HCl. 
However, upon repeating the same procedure using enantiopure N-TIPBS nitrone 144 under our 
standard asymmetric reaction conditions, the generated oxindole 160 was found to be racemic. 
Similarly, when phenylketene was used, the product oxindole was also found to be racemic. 
However, when n-butylketene was used under our standard reaction conditions with enantiopure 
N-TIPBS nitrone 144, the desired asymmetric oxindole 162 was generated in good yield and 
moderate ee (72%, 50% ee) (Fig 3.4). One possible explanation for these observations is that the 
newly installed C(3) proton of the oxindole is subject to racemisation under the reaction conditions, 
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particularly in the methyl- and phenyl-cases, but less so for 3-butyl oxindole 162. To test this 
hypothesis, the same HPLC sample of 3-butyloxindole was re-analysed after a fortnight and the ee 
was found to have decreased to 32%, lending credence to the hypothesis of in situ or post reaction 
racemisation. 
 
Fig 3.4: Asymmetric synthesis of C(3)-tertiary oxindoles from N-TIPBS nitrone 144 and monosubstituted 
alkylketenes. (Absolute configuration for 162 was assigned arbitrarily by analogy to previous 
alkylarylsubstituted oxindoles). 
3.3. Synthesis of Spirocyclic Oxindoles 
3.3.1 Introduction 
After the excellent results obtained in the synthesis of 3-alkyl-3-aryloxindoles, we next sought to 
extend this protocol to the synthesis of a range of achiral and asymmetric spirocyclic oxindole 
species. We began by investigating formation and reaction of spirocyclic ketenes already known in 
the literature, before continuing to investigate structural variation of the ketene component to 
ascertain the limitations of the system, and whether or not it might prove applicable to the 
synthesis of alkaloids such as those described in Chapter 1. 
3.3.2 Initial Achiral Spiro-oxindole Formation 
Initially, to validate the ability to form spirocyclic junctions via this type of methodology, zinc-
mediated reduction of acyl bromide 163 was used to access symmetrical pentamethyleneketene 164 
in situ, with subsequent addition of achiral diaryl nitrone 48 generating oxindole 165 in 65% yield 
(Scheme 3.2).  
 
Scheme 3.2: Reagents and conditions: i) Activated zinc (excess), THF, -78 °C under reduced pressure. ii) 48, THF, 30 
min, -78 °C then 2M HCl. 
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Next, stable hexamethyleneketene 167, prepared via N,N-dimethylethylamine mediated 
dehydrohalogenation of the corresponding acid chloride 166 was investigated.108 In an optimised 
procedure, treatment of nitrone 48 with ketene 167 gave spirocyclic oxindole 168 in 79% isolated 
yield (Scheme 3.3). 
 
Scheme 3.3: Reagents and conditions: i) N,N-DMEA (1.05 eq), Et2O, 48 h, rt. ii) 48, THF, 30 min, -78 °C then 2M HCl. 
Following these successful demonstrations, a range of substituted N-arylnitrones incorporating 
either electron-donating or withdrawing 4-substituents, as well as 2-substitution, was prepared. 
Treatment with either ketene 164 or 167 allowed access to the desired achiral 5- and 7-substituted 
spirooxindoles 169-175 in good to excellent yields (68-92%) (Fig 3.5). 
 
Fig 3.5: Spirocarbocyclic oxindoles; achiral generality. 
3.3.3 Extension to Asymmetric Spirocarbocyclic Oxindole Synthesis 
A model asymmetric spirocyclic oxindole synthesis was next investigated using N-TIPBS nitrone 
144 and isolable ketene 176. This ketene was chosen due to its facile preparation (three steps from 
commercial materials121) and due to its structural similarities to the non-cyclic alkylarylketenes 
already found to give excellent stereocontrol. However, in preliminary studies, low yields of the 
oxindole 178 were obtained, with intermediate imino-acid 177 (>99:1 dr) isolated as the major 
component of the crude reaction mixture, albeit in 26% yield after column chromatography. In 
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contrast to investigations conducted thus far, spirocyclic imino-acid 177 was found to be stable 
under mild acidic hydrolysis conditions, thereby preventing cyclisation but allowing for isolation 
and full characterisation. However, treatment of 177 with more concentrated acid (6M HCl) 
ensured complete imine hydrolysis and cyclisation to the desired oxindole (Fig 3.6).  
 
Fig 3.6: Initial asymmetric studies found intermediate imino-acid 177 to be resistant to mild acidic hydrolysis, 
and therefore, harsher conditions were employed. 
After overcoming this hydrolysis issue, treatment of nitrone 144 with ketene 176 gave, after 
aqueous work-up and column chromatography, the desired asymmetric oxindole 178 in 91% yield 
and 98% ee (Fig 3.7), with spectroscopic data in agreement with those previously reported for the 
racemate by Padwa.122 The absolute configuration within (S)-178 was confirmed by single crystal X-
ray diffraction (for further details see Cambridge Crystallographic Data Centre - CCDC 871574), 
with the observed sense of asymmetric induction consistent with our previous work using simple 
disubstituted alkylarylketenes (Fig 3.8).  
 
Fig 3.7: Initial ‘hit’ in the asymmetric spirocyclic reaction series. 
 
Fig 3.8: Single crystal X-ray representation of spirooxindole 178 confirming the absolute configuration as (S). 
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We next sought to extend the scope of this reaction process by preparing novel ketene species 184 
and 190. These syntheses began from the corresponding methoxy-tetralone in both cases. Low 
temperature deprotonation with LHMDS followed by trapping of the enolate with N-phenyl 
triflimide gave triflates 180 and 186 in quantitative yield. Palladium catalysed carbonylation in 
MeOH afforded the homologated methylesters in 43 and 62% yield for the 6- and 7-substituted 
series respectively. Hydrogenation, ester hydrolysis and acid chloride formation then proceeded 
smoothly in greater than 75% yield over three steps for both substrates giving 183 and 189, which 
were purified via Kugelrohr distillation. The acid chlorides could then be subjected to the same 
dehydrohalogenation procedure used for the preparation of ketene 176 (Scheme 3.4).  
 
Scheme 3.4: Reagents and Conditions: i) LiHMDS (1.1 eq), THF, -78 °C, 45 min then PhNTf2 (1.01 eq), 0 °C, 3h. ii) 
Pd(OAc)2 (0.1 eq), PPh3 (0.4 eq), Et3N (1.6 eq), CO (gas – 1 atm), DMF/MeOH, 65 °C, 16 h. iii) Pd/C (0.1 eq), H2 (gas – 
1 atm), EtOH, rt, 16h. iv) LiOH (5.0 eq), H2O/MeOH, rt, 16 h. v) (COCl)2 (2.0 eq), DMF (1 drop), PhCH3, rt, 3 h. vi) 
N,N-DMEA (1.1 eq), Et2O, 0 °C, 16 h. 
Dehydrohalogenation was initially performed on acid chloride 183 according to our typical reaction 
procedure, with ketene 184 seemingly formed as expected. However, on attempted purification of 
the crude ketene via Kugelrohr distillation, complete decomposition of the material was observed. 
Consequently when preparing 184 and 190, no purification was attempted and instead the ketene 
was used as a crude solution in THF. We had already observed that the reaction was tolerant of 
crude ketene solutions in our initial studies using ketene 164 and achiral nitrones and, as expected, 
using unpurified solutions of ketenes in the asymmetric reaction protocol presented no issue. This 
process was found to be tolerant of 2- and 4-substitution within the N-aryl unit of the chiral 
nitrone, allowing selective access to the corresponding 5- and 7-substituted oxindoles 196-205 that 
were isolated in good yield (48-97%) and excellent ee (90-99%) (Fig 3.9).  
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Fig 3.9: Synthesis of asymmetric spirocarbocyclic oxindoles; generality. 
For such a chiral auxiliary methodology to find wider application, we felt it would be necessary to 
verify the enantiomeric integrity of the aldehyde chiral auxiliary after quenching the reaction. At this 
point, therefore, the recyclability of the nitrone chiral auxiliary was investigated. After using N-
TIPBS nitrone to generate oxindole 178 in 90% yield and 98% ee, N-TIPBS aldehyde 143 was 
isolated in 74% yield, and retreated with PhNHOH to regenerate N-TIPBS nitrone 144 in 99% 
yield after trituration from petroleum ether. The regenerated nitrone was once more treated with 
ketene 176, giving oxindole 178 in 46% yield and 91% ee. Aldehyde 143 could be once more 
isolated in 61% yield, but did begin to show signs of degradation presumably as a consequence of 
hemi-aminal opening under the aqueous acidic conditions (Fig 3.10). 
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Fig 3.10: Recyclability experiments. 
3.3.4 Further Investigations Toward 3,3’-Pyrrolidinyl Scaffolds 
While the previous section demonstrates the ability to form 6- and 7-membered spirocyclic 
oxindole junctions via this methodology, numerous examples of naturally occurring species contain 
a 3,3’-pyrrolidinyl scaffold such as coerulescine 3 and horsfiline 4. To access such an architecture 
would require the formation of a 5-membered cyclic ketene formally derived from β-proline, and so 
as a proof-of-principle we elected to focus on α-proline homologues. Although not common, there 
are two reports of such species in the literature by Betrand123 and Gonzalez,124 the latter of which is 
formed via dehydrohalogenation of the parent acid chloride and is then used in [2+2] 
cycloadditions with imines (also generated in situ) to form spirocyclic β-lactams (Fig 3.11). 
 
Fig 3.11: Literature precedent for cycloaddition reactions of 5-membered cyclic ketenes. 
The requisite precursor acid chloride 206 was prepared in almost quantitative yield over two steps 
from commercially available (±)-proline. Upon treatment with base, however, no ketene was 
observed prior to reaction with the nitrone (Fig 3.12), yet it could not be clearly determined if this 
was exclusively a consequence of dimer formation, as the crude reaction mixture was composed of 
multiple products. Therefore, it was attempted to form oxindole 207 via an in situ ketene formation 
reaction; dropwise addition of Et3N to a solution of nitrone 48 and acid chloride 206 in CH2Cl2 
resulted in almost spot-to-spot conversion of nitrone 48 into another species as observed by TLC 
analysis. However, after isolation in almost quantitative yield via column chromatography, this 
species was identified as imide 208, with the CH proton signal at 4.62 ppm clearly indicative of the 
imide structure rather than oxindole (Fig 3.13). 
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Fig 3.12: Attempted in  s i tu  preparation of oxindole 207. 
 
Fig 3.13: 1H NMR spectrum of imide 208. 
Imide 208 arises from a Beckmann-type125 rearrangement under the basic reaction conditions, 
proposed to proceed through an association-dissociation mechanism as depicted in Fig 3.14. Initial 
nucleophilic addition of nitrone 48 into the acid chloride generates ion pair 209, which can be 
deprotonated by the tertiary amine base leading to formation of a second ion pair composed of 
nitrilium ion 210 and carboxylate 211. Addition of the carboxylate to the nitrilium ion generates 
imidic anhydride 212, which undergoes a Mumm rearrangement126 to the more stable imide 208.  
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Fig 3.14: Potential mechanistic rationale for formation of imide 208. 
A labeling study127 into a very similar reaction with tolylnitrone 213 and 18O-benzoyl chloride was 
conducted by Heine and VandenHeuvel, where they observe a 50:50 ratio of 18O-labelled 
carboxylate groups in the final imide product (Fig 3.15). For this reason they propose a dissociative 
mechanism via a carboxylate anion akin to 211, resulting in scrambling of the 18O-carbonyl label.  
 
Fig 3.15: VandenHeuvel’s 18O-labelling study. 
In our hands, this rearrangement was found to occur regardless of the tertiary amine used in the 
reaction, and is not limited to diphenylnitrone (as demonstrated in the study by Heine and 
VandenHeuvel). However, this is the first reported observation of non-aroyl derived acid chlorides 
undergoing such rearrangement. Based on literature precedent,128 we briefly explored the possibility 
of cyclising imide 208 via a copper catalysed direct coupling reaction, however using conditions as 
described in the literature, we saw no cyclisation to the desired oxindole, but instead saw 
debenzoylation and the beginnings of starting material decomposition (Fig 3.16). 
 
Fig 3.16: Attempted direct coupling-cyclisation of 208. 
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3.4. Conclusions for Chapter 3 
N-Phenyl substituted N-TIPBS nitrone 144 proved extremely versatile and tolerant, reacting with 
numerous alkylarylketenes to give the corresponding asymmetric 3-alkyl-3-aryloxindoles in 
uniformly good to excellent yields with excellent enantioselectivites.  A direct comparison with the 
previous N-Boc Garner’s nitrone 66 showed an average 12% increase in ee over seven examples. 
Other alkylarylketenes were investigated and were generally well tolerated. para-Substitution of the 
ketene aryl ring was well tolerated as demonstrated in generating oxindoles 147, 148, 149, and 150 in 
high yields and enantioselectivites. β-Branching of the alkyl unit was also reasonably well tolerated 
(151, 84% ee), whilst α-branching of the alkyl unit resulted in complete loss of stereocontrol 
generating racemic material (155). Similarly, a limitation of the asymmetric system seems to be the 
incorporation of an ortho-substituent on the ketene aryl portion as evidenced by examples 156, 157 
and 158. Nevertheless, despite the lower ees observed in certain cases, all reaction products were 
isolated in good to excellent yield. The possibility of generating C(3)-tertiary asymmetric oxindoles 
using this methodology was also briefly explored, however after very mediocre initial results and 
concerns about the acidity of the C(3)-proton, this was not pursued further. Nevertheless, these few 
initial examples demonstrate that racemic tertiary substituted C(3)-oxindoles can be formed via this 
methodology in good yields.  
This asymmetric methodology has also been extended to the synthesis of 6-membered 
spirocarbocyclic oxindoles in good yields and excellent enantioselectivities. In a related yet achiral 
series, 7-membered junctions were also successfully incorporated in excellent yield. In the course of 
these experiments, two novel ketene species were prepared, yet upon attempted purification by 
distillation were shown to degrade on heating. Therefore an alternative procedure was adopted 
whereby a moderate excess of ketene solution was used in situ after filtration of the Et2NMe!HCl 
salt. The use of crude ketene solutions had no impact upon the yield or enantioselectivity of the 
reactions. Also demonstrated in this section was the ability to recycle the N-TIPBS nitrone 
(reisolated as the aldehyde after aqueous work-up) and resubject this nitrone to the reaction 
conditions to generate the oxindole in only moderately diminished yield and ee. In attempting to 
extend the scope of this spirocyclic transformation to incorporate 5-membered rings, the necessary 
ketenes were found to be non-isolable. Attempting to circumvent this by adopting an in situ 
preparation directly from the acid chloride resulted in formation of an imide species via an 
interesting but non-productive Beckmann-type nitrilium ion rearrangement. Although not 
constructive for the formation of oxindoles, this is an interesting transformation from a synthetic 
and mechanistic standpoint. The proposed intermediacy of 210 and 211 raises the possibility of 
further investigation of this system, potentially using ACDC, a term coined by List to describe 
catalysis employing asymmetric counterions.129  
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Chapter 4: Mechanistic Investigations 
4.1. Introduction 
The following chapter describes results obtained in collaboration with Drs Yu-hong Lam, Nihan 
Çelebi-Ölçüm and Prof. Kendall Houk at UCLA. All calculations described were performed by the 
group at UCLA using data generated by the practical experiments described in this thesis. The 
results of these modelling studies are described in this chapter as they elegantly explain the origin of 
stereocontrol in this system and the conclusions drawn from these studies are required in order to 
understand the decisions and strategies employed in subsequent chapters. 
4.2. Original Mechanistic Proposal 
Originally, we made certain assumptions about the potential mechanism in operation in our system. 
The major assumption was that the initial mechanistic step in this transformation was nucleophilic 
addition of nitrone into the electron deficient ketene C(2) carbon (Fig 4.1).  
 
Fig 4.1: Original mechanistic considerations. 
Given our background in NHC catalysis, this seemed a reasonable proposal based on the breadth 
of literature130 in the area where the catalytic cycle begins with addition of NHC into the ketene-
C(2) carbon to generate an azolium enolate. In the case of the nitrone system, we reasoned that the 
enolate 214 generated via this nucleophilic addition would then undergo [3,3]-sigmatropic 
rearrangement in order to generate oxindole precursor 215. Several other related systems also 
proposed a similar mechanistic rationale,78,79,131-134 and our initial synthetic studies aimed at 
clarifying the reaction mechanism had provided direct evidence that related enolate 216 was a viable 
precursor for this sigmatropic rearrangement generating amino-acid 217, analogous to imino-acid 
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215 (Fig 4.1).135 Nevertheless, we lacked a convincing rationale as to the mode of chirality transfer 
in our asymmetric system and as such, embarked on a computational collaboration to shed light on 
this. 
4.3. Revised and Computationally Validated Mechanistic Proposal 
The model reactants chosen for initial computational investigation were N-phenyl-C-isopropyl 
nitrone 218, as a simple mimic of our asymmetric nitrones, and methylphenylketene 95. Despite the 
similarities between the proposed pericyclic step in our initial mechanistic rationale to those in the 
proposed mechanisms of Brunner oxindole synthesis136 and Fischer indole synthesis,137,138 all 
attempts in locating the enolate-based transition structure (TS) for this [3,3]-rearrangement failed. 
Attempts to constrain the forming C-C bond and the breaking N-O bond at various partial bond 
distances resulted in highly unstable TSs with a free energy of at least 44.1 kcal/mol relative to the 
separated reactants. Given the facile conditions under which the reaction occurs, it is highly 
implausible that reaction occurs via a mechanism of this type. Further computational studies instead 
revealed an alternative pathway for the formation of key imino-acid precursor 215, through a 
pericyclic cascade composed of a 1,3-dipolar cycloaddition and a hetero-[3,3]-sigmatropic 
rearrangement (Fig 4.2).  
 
Fig 4.2: New mechanistic proposal composed of initial [3+2] cycloaddition across the ketene C=O bond 
followed by [3,3]-sigmatropic rearrangement, rearomatisation and ring-opening to give imino-acid 221. 
Studying the TSs for the [3+2] cycloaddition of 218 and 95 and the subsequent fate of the 
intermediates led to the discovery that the most favourable mode of cycloaddition was predicted to 
be across the C=O bond of 95 forming the substituted 1,4,2-dioxazolidine 219, with an activation 
free energy of only 11.8 kcal/mol (Figure 4.5). Alternatively, cycloaddition across the C=C bond 
was found to have a considerably higher activation free energy (22.4 kcal/mol). This is a surprising, 
but not unprecedented observation. Although ketene cycloaddition literature is dominated by 
cycloaddition across the C=C bond of the ketene component, the ketene C=O group has been 
shown to participate in [2+2],139 [3+2]140 and [4+2]141 cycloadditions (Fig 4.3).  
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Fig 4.3: Other literature examples of ketene cycloadditions across the C=O bond. 
An initial reaction step across the C=O bond has also been proposed in early experimental reports 
on the reactions of ketenes with nitrones142,143 and similar 5-membered intermediates have been 
proposed in reactions of silylketenes and nitrones (Fig 4.4).144  
 
Fig 4.4: Proposed 5-membered intermediate after ketene-nitrone cycloaddition across the C=O bond. 
In the initial cycloaddition between model nitrone 218 and ketene 95, the transition state was also 
shown to have a notably short partial CO bond (dCO = 1.57 Å), which causes further polarisation 
of the C=N bond of the nitrone (Fig 4.5). At the transition state, the carbon of the 1,3-dipole 
possesses electrophilic character (0.1e), and there is substantial build up of negative charge on the 
ketene oxygen (–0.6e). The total charge transfer in this cycloaddition transition state is 0.2e. These 
findings led our collaborators to conclude that the initial cycloaddition step is concerted yet 
moderately asynchronous, as the findings seem to indicate the primary partial formation of the C-O 
bond. The resulting cycloadduct of the initial [3+2] cycloaddition, 219 features an exocyclic 
alkylidene group which is suitably positioned with respect to the nitrogen-bound phenyl ring for an 
aromatic hetero-[3,3]-rearrangement to proceed. This process is predicted to be facile, with an 
activation free energy of 11.2 kcal/mol, giving intermediate 220 with the quaternary stereocentre 
installed, with an exergonicity of 33.5 kcal/mol (Fig 4.5). The transition state is highly 
asynchronous; an excessively long forming C–C bond (dCC = 3.47 Å) predicts almost no bonding 
between the interacting orbitals at the TS. Despite this observation, both the intrinsic reaction 
coordinate (IRC) calculations and the potential energy surface (PES) scan in the gas phase and in 
solvent revealed no intermediates between TS-219/220 and the resulting cyclic compound 220. 
Cleavage of the hemi-aminal linkage of 220 and aromatisation gives aromatic imino-acid 221 with 
the free energy barrier calculated to be 17.2 kcal/mol for this step. This imino-acid intermediate is 
predicted to be stable under the reaction conditions until aqueous acid is introduced affecting imine 
hydrolysis and concomitant cyclisation to form the isolated oxindole species. 
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Fig 4.5: Energy profile for the pericyclic cascade mechanism of 218 and 95. 
These calculations established that the tandem [3+2] cycloaddition–hetero-[3,3]-sigmatropic 
rearrangement pathway is energetically viable under the experimental conditions, yet the method of 
asymmetric induction in this mechanism remained undetermined. By considering a typical reaction 
between a ketene and enantiopure N-TIPBS nitrone, it can be seen that the initial cycloaddition 
installs a stereogenic centre at C(3) and an unsymmetrically substituted C=C double bond, thereby 
yielding diastereomeric intermediates (Fig 4.2). The resident stereochemical information is then 
transferred to the intermediate 220 through the stereospecific [3,3]-rearrangement. Ring-opening 
and rearomatisation, followed by acidic quench destroys the diastereomeric nature of the adduct by 
releasing the chiral aldehyde and thus the original, controlling stereocentre, but the newly installed 
‘diastereomeric’ quaternary stereocentre remains intact. The configuration of the quaternary 
stereocentre in the imino acid and the oxindole is, therefore, determined at the [3+2] cycloaddition 
step simultaneously by two factors: the face of the nitrone exposed for cycloaddition, and the 
direction of ketene approach, where the larger, aryl group can be oriented cis or trans to the 
incipient bond between the oxygen of the nitrone and the central ketene carbon (Fig 4.6).  
 
Fig 4.6: Mechanistic considerations for asymmetric induction. 
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by Lippmann[10] and Taylor.[11] According to their proposed pathway 
(pathway I, Scheme 1), the ketene (shown here as 2a) would react 
as an electrophile towards the nitrone (shown here as 4), giving, 
after rearomatization, the experimentally isolable imino acids 5 
bearing a quaternary carbon. Subsequent hydrolysis and cyclization 
afford the oxindole products 3. We computationally explored 
possible reaction pathways, using 4 and 2a as model reactants 
(Scheme 1). Intriguingly, although the pericyclic step in pathway I 
is analogous[12] to the proposed mechanisms of Brunner oxindole 
synthesis[13] and Fischer indole synthesis,[14] all our attempts in 
locating the transition structure (TS) for this step failed.[15] Instead, 
we identify a new mechanism for the formation of 5. The key imino 
acid 5 arises from 4 and 2a through a pericyclic cascade composed 
of a 1,3-dipolar cycloaddition and a hetero-[3,3]-sigmatropic 
rearrangement (Scheme 1, pathway II). A novel mode of chirality 
transfer through the pericyclic steps explains the origin of the 
asymmetric induction. 
Ketenes are versatile compounds that can react as electrophiles 
or 2π components in cycloadditions.[16] We studied the TSs for the 
3+2 cycloaddition of 4 and 2a (pathway II) and the subsequent fate 
of the intermediates (Figure 1). Remarkably, the most favorable 
mode of the cycloaddition was predicted to be across the C=O bond 
of 2a forming the substituted 1,4,2-dioxazolidine 6, with an 
activation free energy of only 11.8 kcal/mol (TS-32, Figure 1). The 
cycloaddition across the C=C bond has a considerably higher 
activation free energy (22.4 kcal/mol). The ketene C=O group has 
been shown to participate in 4+2[3,17] and 2+2[18] cycloadditions. An 
initial reaction step across the C=O bond has also been proposed in 
early experimental reports on the reactions of ketenes with 
nitrones.[19] TS-32 has a significantly short partial C–O bond (dCO = 
1.57 Å), which causes further polarization of the C=N bond of the 
nitrone. At the transition state, the carbon of the 1,3-dipole 
possesses electrophilic character (0.1e), and there is substantial 
negative charge building up on the ketene oxygen (-0.6e). The total 
charge transfer in TS-32 is 0.2e. The cycloaddition is concerted; the 
IRC path connected reactants 4 and 2a to 6.[20] 
The cycloadduct 6 features an exocyclic alkylidene group 
suitably positioned with respect to the nitrogen-bound phenyl ring 
for an aromatic hetero-[3,3]-rearrangement to proceed. This process 
(TS-33) is predicted to be facile, with an activation free energy of 
11.2 kcal/mol, giving the intermediate 7 with the quaternary 
stereocenter installed, with an exergonicity of 33.5 kcal/mol. The 
transition state is highly asynchronous; an excessively long forming 
C–C bond (dCC = 3.47 Å) predicts almost no bonding between the 
interacting orbitals at the TS. However, both the IRC calculations 
and the potential energy surface (PES) scan in the gas phase and in 
solvent reveal no intermediates between TS-33 and 7. The PES (see 
the SI) also shows that the transition state is mainly associated with 
the breaking of the N–O bond. The formation of the C–C bond is 
found to be a spontaneous downhill process, presumably driven by 
the high exergonicity of the transformation. Intermediate 7 then 
undergoes cleavage of the hemiaminal linkage and aromatization via 
TS-RO to give the aromatic imino acid 5. The free energy barrier is 
calculated to be 17.2 kcal/mol for this step. However, TS-RO 
involves an intramolecular proton transfer, which is more likely to 
be a catalyzed process under experimental conditions. 
These calculations establish that pathway II, composed of 
tandem 3+2 cycloaddition–hetero-[3,3] sigmatropic rearrangement 
is energetically viable under the experimental conditions, while the 
hetero-Claisen rearrangement of the ketene–nitrone adduct in 
pathway I is prohibitively high in energy. We then proceeded to 
study the stereochemical aspects of pathway II. 
 
Figure 1. Energy profile for pericyclic cascade mechanism of 6 and 2a. TS-32, TS-33 and TS-RO refer to the transition structures for the [3+2]-
cycloaddition, the hetero-Claisen rearrangement, and the rearomatization with concomitant ring-opening, respectively. (M06-2X/6-
311+G(d,p)(THF)//B3LYP/6-31G(d), gas phase B3LYP/6-31G(d) energies are given in brackets) 
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The initial stereodetermining factor to consider is the π-facial selectivity induced by the chiral 
auxiliary on the nitrone. Reaction through the Si face of the nitrone is favoured due to the 
respective conformations adopted by the nitrone in order to present the Re or Si face. In the case of 
the favoured, Si face approach, the hydrogen atom and the ring methylene group adopt the inside 
and the outside positions, respectively (TS-A1 and TS-B1, Fig 4.7). In this model, the inside position 
is sterically more demanding due to 1,3-allylic strain of any substituent with the nitrone oxygen. Re 
face approach is disfavoured due to the destabilisation of the associated transition state which 
requires the methylene unit to adopt the inside position thereby increasing 1,3-allylic strain145 (TS-C1 
and TS-D1). Garner’s aldehyde, from which our chiral oxazolidine nitrones are formally derived, is 
well known to obey Felkin–Anh stereochemical control in a wide variety of nucleophilic 
additions.146 A feature shared by this model and the cycloaddition TSs here is the preference for the 
C–N bond on the stereocentre to be anti to the forming bond. As approach of the ketene does not 
occur at the traditional Bürgi–Dunitz angle as in carbonyl additions under Felkin-Anh control, but 
rather at an almost perpendicular angle (84.5 ° with respect to the nitrone C=N bond), there is no 
energetic penalty for approach over the methylene unit occupying the outside position, again 
rendering reaction through the Si face more favourable. This perpendicular approach of the ketene 
occurs anti to the oxazolidine C-N bond and consequently away from the steric bulk provided by 
the N-protecting group of the oxazolidine. 
The other stereodetermining factor is the orientation adopted by the ketene during approach and 
can be rationalised in that the steric contact of the ketene cis substituent with the oxazolidine N-PG 
is more unfavourable for the bulkier aryl group than for the alkyl group. Consequently, our 
stereochemical model predicts that the ketene approaches with the larger substituent trans to the 
forming C-O bond, and that increasing the size of the N-protecting group would result in a net 
increase in enantioselectivity; precisely the results observed in our previous experimental 
endeavours (vide infra). In summary, the transition state TS-B1 corresponds to the most favourable 
mode of cycloaddition, involving the Si face of the nitrone and the ketene with a trans-oriented 
phenyl group. This will give rise to cycloadduct 219 featuring an (E)-configured exocyclic olefin. 
Subsequent [3,3]-sigmatropic rearrangement through the Re face of the alkene will install the (S)-
configured stereocentre, which is consistent with the enantiomer observed experimentally.  
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Fig 4.7: Transition state comparisons and chirality transfer between pericyclic steps. 
Alternatively, in the disfavoured pathways, the (R)-enantiomer can theoretically be obtained 
through the other TSs TS-A1 and TS-C1, depicted in Fig 4.7. Reversing either the orientation of 
the ketene (TS-A1) or the face of the nitrone attacked (TS-C1) results in the opposite selectivity, 
however, TS-A1 and TS-C1 are calculated to be less stable by 1.5 and 4.9 kcal/mol, respectively. 
The free energy difference between TS-B1 and TS-A1 corresponds to an ee value of 84% 
(calculated for N-Boc), which is in good agreement with experiment (86% ee with Garner’s nitrone 
66 and methylphenylketene 95).  
4.4. Summary of Lowest Energy [3+2], [3,3] Cascade Pathway 
The favoured reaction pathway and the computational rationale provided in the previous section 
can be summarised graphically as depicted by Fig 4.8. The key features in determining the 
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stereochemical outcome are: a) the conformation adopted by the chiral nitrone, whereby the double 
bond is eclipsed by the nitrone C(2) proton to minimise 1,3-allylic strain with the nitrone oxygen;  
b) this conformation sets the facial selectivity of the cycloaddition in that the Re face of the nitrone 
is shielded by the oxazolidine ring, leaving the Si face accessible for approach of the ketene; c) the 
ketene then approaches in such a manner so as to place the more sterically demanding of the 
substituents (i.e. aryl), anti to the N-TIPBS group, thereby controlling the geometry of the incipient 
exocyclic olefin, which is transferred via [3,3]-sigmatropic rearrangement to the quaternary centre in 
the oxindole product. 
 
Fig 4.8: Overview of lowest energy mode of reaction leading to the (S)-configured oxindole. 
The transition state for the initial [3+2] cycloaddition can also be represented as a Newman 
projection (Fig 4.9). Although modeled for enantiopure N-Boc nitrone 66, this transition state gives 
an alternative view of the conformation adopted by the nitrone, the ketene approach and the 
developing bond-forming interactions in this cycloaddition. 
 
Fig 4.9: Newman projection of the favoured [3+2] transition state. 
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the nearly perpendicular angle of attack from the ketene
oxygen (O4-C3-N7= 84.58), rather than the obtuse, B!rgi–
Dunitz angle in carbonyl additions.[27] Thus, although the anti
relationship between the forming C!O bond and the C!N
bond is maintained in both TS-32-R2 and TS-32-S1, TS-32-R2
is destabilized by steric crowding because of the ring
methylene group occupying the inside position.
In summary, for the chiral auxiliary-controlled synthesis
of oxindoles from nitrones and ketenes, the enantioselectivity
of this process has been optimized (up to 98% ee) through the
use of an oxazolidine N-2,4,6-triisopropylbenzenesulfonyl
substituent. We delineated a new pericyclic cascade com-
posed of a 3+2 cycloaddition involving the ketene carbonyl
group and a hetero-[3,3]-sigmatropic rearrangement. The
high enantioselectivity is attained by both effective p-facial
control from the chiral auxiliary of the nitrone and the high
propensity of the ketene to adopt the aryl-trans orientation
during the cycloaddition. The stereochemical information
embedded in the cycloadduct formed is then transferred,
through the sigmatropic rearrangement, to the imino acid (S)-
5b, which is converted in situ to oxindole (S)-3a, thus
achieving an overall acyclic 1,6-stereochemical induction
from the chiral auxiliary to the final product. Computational
data on reactants with different N-protecting groups and
substituents on the nitrone C=N bond and the nitrone
aromatic ring are consistent with our model and will be
disclosed in a full article. The findings described here
demonstrate the power of modern, accurate quantum
mechanical computations in the discovery of novel asymmet-
ric pericyclic cascades of synthetic interest.
Experimental Section
Representative procedure: To a solution of nitrone 1c (0.070 g,
0.144 mmol) in dry tetrahydrofuran (THF) (2 mL) under nitrogen at
!78 8C was added dropwise a solution of ketene 2c (0.043 g,
0.288 mmol) in dry THF (1 mL). The mixture was stirred at !78 8C
overnight. The reaction was then quenched with 2m HCl (aq)
(0.5 mL) and stirred for 30 min, allowing to warm to RT before
extraction with Et2O (3" 10 mL). The combined organic phases were
washed with NaHCO3 (aq), dried over Na2SO4, filtered, and
concentrated in vacuo to give a crude oil which was purified by
column chromatography over silica (0–30% EtOAc in petroleum
ether) to yield 3c (0.031 g, 81%) as an off-white solid.
All calculations were carried out at the M06-2X/6-311+G(d,p)-
(THF)//B3LYP/6-31G(d) level of theory with Gaussian 09.[28] Com-
putational details are given in the Supporting Information. In the text,
M06-2X free energies including solvation corrections are reported.
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4.5. Attempts to Synthetically Validate the Proposed Mechanism 
4.5.1 Using 2,6-(N-Xylyl)nitrone 
With experimental results in agreement with the proposed stereoselectivity model, we set out to 
validate the computationally predicted cycloaddition pathway experimentally by trapping proposed 
reaction intermediates. Initially we hypothesised that by utilising 2,6-(N-xylyl)nitrone 222, [3+2] 
cycloaddition would occur, as would [3,3]-sigmatropic rearrangement, however rearomatisation 
would be prevented by the methyl group now occupying the ring juncture, thereby allowing  
7-membered intermediate 223 to be isolated (Fig 4.10). Rather, upon conducting the reaction, 
dearomatised imino-lactone 224 was isolated cleanly as a 3.5:1 mixture of diastereoisomers, whilst 
expected intermediate 223 was never observed. The major diastereoisomer was isolated in 66% 
yield by recrystallisation of the crude reaction mixture from MeOH. 
 
Fig 4.10: Formation of dearomatised imino-lactone 224. 
Intriguingly, imino-lactone 224 contains three contiguous quaternary stereocentres as can be seen 
from the single crystal X-ray structural analysis (Fig 4.11). The relative configuration of these 
stereocentres was also assigned from this crystal structure. 
 
Fig 4.11: Single crystal X-ray structure of 224, allowing relative assignment of (±)-(3SR),(3aSR),(7aSR). 
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We explored the possibility of derivatising this lactone and attempted numerous reactions including 
reductions, hydrogenations, ring-openings and Diels-Alder cycloadditions, however these reactions 
invariably resulted in decomposition of starting material. Consultation of the literature revealed a 
previous study by Taylor and Stokes, who isolated structurally related imino-lactone from 2,6-
xylylnitrone and dimethylketene via a similar reaction pathway.132 In their publication, the authors 
also report difficulties in using this material in further reactions, but were able to perform a di-
bromination of the diene-system and an ozonolysis fragmentation. 
4.5.2 Using (N-tBu)nitrone 
With this alternative reaction pathway hindering attempts to isolate intermediate 223, replacement 
of the nitrone N-aryl substituent with an alkyl substituent was next investigated, thereby removing 
the potential for [3,3]-sigmatropic rearrangement. tert-Butylnitrone 225 was prepared via 
condensation of the commercially available tert-butylhydroxylamine hydrochloride and 
benzaldehyde under basic conditions. Treatment of nitrone 225 with an equivalent of  
ethyl(p-chlorophenyl)ketene 96 allowed oxazolidinone 227 to be isolated in 41% yield, with the 
major crude reaction product being N-tert-butyl imine 228 (Fig 4.12). Structural assignment of the 
major diastereoisomer of 227 was also confirmed by single crystal X-ray crystallography (Fig 4.13).  
 
Fig 4.12: Isolation of oxazolidinone 227. 
N
PhH
tBu O
O
Et
THF, rt
N
O
O Et
Ph
tBu
5 min
Cl
Cl
N
OPh
tBu
O
Et
Cl
227, 
41% yield,
 3:1 dr
A
B
N
HO
O Et
Ph
tBu
Cl
225 96 226
228
 
 Chapter 4: Mechanistic Investigations 
 57 
 
Fig 4.13: Single crystal X-ray structure of oxazolidinone 227. 
Isolation of 227 provides direct evidence for the computed reaction mechanism via initial [3+2] 
cycloaddition across the ketene C=O bond to furnish transient intermediate 226 which, via radical 
or ionic cleavage of the N-O bond, rearranges to generate the more stable oxazolidinone 227 
(Pathway A). However, this oxazolidinone was isolated in relatively poor yield with formation of 
tert-butyl imine seemingly the preferential pathway. From intermediate 226, it can be envisaged that 
cleavage of the N-O bond without recyclisation may result in formation of this imine and 
elimination of the alkylarylacid (Pathway B), however the evidence of broad undefined signals in 
the crude 1H NMR, which may imply formation of polymeric material, also suggests a radical 
decarboxylation mechanism may also be in operation. 
4.6. Conclusions from Chapter 4 
At the outset of our synthetic investigations using enantiopure Garner’s aldehyde derived nitrones 
for the asymmetric synthesis of oxindoles, we lacked a convincing rationale for the chirality transfer 
from the remote stereocentre. Our original mechanistic rationale centred on formation of an 
enolate via nucleophilic addition of nitrone into ketene, and subsequent [3,3]-sigmatropic 
rearrangement. However, computational investigations suggest that this reaction pathway is not 
energetically viable under the reaction conditions. Rather, a lower energy pericyclic cascade 
composed of a [3+2] cycloaddition followed by a [3,3]-sigmatropic rearrangement is proposed and 
allows for rationalisation of the high enantioselectivity in this reaction. Facial selectivity of the 
reaction is governed by 1,3-allylic strain in the chiral nitrone, while the large N-protecting group of 
the nitrone controls the directionality of the ketene approach so as to place the aryl group anti to 
this steric bulk. This approach fixes the E/Z geometry of the exocyclic olefin, the orientation of 
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which is then transferred through the ensuing [3,3]-sigmatropic rearrangement to set the 
asymmetric quaternary centre of the oxindole product. 
We sought to provide synthetic backing for this proposed mechanism via visualisation or isolation 
of one of the proposed intermediates. In doing so, imino-lactone 224 with three contiguous 
quaternary stereocentres was isolated likely via the same [3+2] cycloaddition, [3,3]-rearrangement 
cascade and subsequent trapping as a consequence of prohibited rearomatisation. However, this is 
entirely speculative and provides no direct corroboratory evidence for the mechanistic proposal. A 
second mechanistic probe using a N-tert-butyl nitrone 225, chosen to preclude sigmatropic 
rearrangement, provides evidence for the intermediacy of 5-membered heterocycle 226, which, 
unable to undergo [3,3]-rearrangement, instead opens via N-O bond cleavage and recyclises to give 
oxazolidinone 227. 
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Chapter 5: Regioselectivity Studies 
5.1. Introduction & Aims 
Given the results of the computational analysis described in Chapter 4, we next felt it prudent to 
examine regioselectivity trends in this oxindole forming reaction. To date, investigations had mainly 
focused on variation of the ketene component, thereby generating a range of oxindoles with a 
variety of substitution patterns at the C(3) position. A limited number of para-substituted nitrones 
had been prepared in our spirocyclic studies and reacted well, yet provided little further information 
as to the regioselectivity trends of the reaction. Modification of the other positions on the nitrone 
aryl ring and thereby selective functionalisation of the oxindole core at C(4) to C(7) had yet to be 
investigated (Fig 5.1). In theory, using this approach, the methodology should allow for the 
introduction of structurally important motifs such as the 5-methoxy residue found in horsfiline 4 
and the 6-bromo residue found in flustramines A and B 20. Also of interest were halogen 
substituents owing to the possibility for further functionalisation through transition metal catalysed 
cross-coupling.  
 
Fig 5.1: Anticipated regioselectivity investigations and possible extensions. 
Initially, attention focused on the formation of racemic oxindoles from a range of achiral 
diarylnitrones before applying similar methodology to the asymmetric protocol using enantiopure 
N-Boc Garner’s derived nitrones and finally N-TIPBS derived nitrones. 
5.2. Regioselectivity with Achiral Nitrones 
5.2.1 Reactions with Achiral 4-Substituted Arylnitrones 
Initial studies probed regioselectivity in the formation of racemic oxindoles using ethylphenylketene 
and 4-substituted arylnitrones 48, 69, 70, 89, 90 and 91. A single C(5)-substituted oxindole 
regioisomer was observed in all cases, generally in high yields, with 4-OMe, -F, -CF3, -Br, -Me and  
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-Cl groups all tolerated in good yields. The varying electronic characteristics of these substituents 
seemed to have little effect on the reaction rate or yield of these transformations (Fig 5.2).  
 
Fig 5.2: Preparation of 5-substituted oxindoles from 4-substituted nitrones. 
Additionally, 5-bromooxindole (±)-234 generated in the course of these studies was successfully 
cross-coupled under Suzuki-Miyuara conditions with phenylboronic acid to yield biaryl species  
(±)-235, illustrating the potential of this method for the synthesis of analogues (Fig 5.3). 
 
Fig 5.3: Cross-coupling derivatisation of 5-bromooxindole. 
5.2.2 Reactions with Achiral 2-Substituted Arylnitrones 
Treatment of 2-Me and 2-Cl substituted arylnitrones 71 and 87 with ethylphenylketene generated 
the corresponding C(7)-substituted oxindoles as single regioisomers in moderate to excellent yields, 
with electron-donating and electron-withdrawing substituents tolerated (Fig 5.4). 
 
Fig 5.4: Preparation of 7-substituted oxindoles from 2-substituted nitrones. 
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With 2-bromophenylnitrone 91 and ethylphenylketene, imino-acid 238 was isolated as the major 
product of this reaction, rather than the expected oxindole (Fig 5.5). This seems to arise as a direct 
consequence of the sterically demanding bromide substituent in the 7-position reducing the 
propensity for cyclisation compared with the unsubstituted variant. Imino-acid 238 was purified via 
column chromatography over silica with only moderate cyclisation to oxindole 239 observed. An 
X-ray structure of intermediate 238 was also obtained (Fig 5.6), confirming the NMR structural 
assignment. The desired 7-bromooxindole 239 was isolated in 60% yield by repeating the reaction 
with nitrone 91 and ketene 94, and simply extending the length of acidic quench from 5 min to 2 h. 
 
Fig 5.5: Isolation of 7-bromo imino-acid 238 en route to oxindole 239. 
 
Fig 5.6: Single crystal X-ray structure of 7-bromo imino-acid 238. 
5.2.3 Regioselectivity with Achiral 3-Substituted Arylnitrones 
3-Methyl, 3-chloro and 3-bromo substituted nitrones 85, 88 and 92 were prepared as previously 
described and treated in turn with ethylphenylketene, yielding in all cases an approximate 4:6 
mixture of the C(4)- and C(6)-substituted oxindoles in good combined yields (Fig 5.7). The 4- and 
6-chlorooxindoles were separated via column chromatography to give authentic samples (±)-240 
and (±)-241 that could be analysed and identified, thereby allowing the crude regioisomeric ratio to 
be determined from the crude 1H NMR spectrum. Similarly, 4- and 6-bromooxindoles (±)-242 and 
(±)-243 were also separable via column chromatography and were subsequently identified. 4- and 6-
Methyl oxindoles (±)-244 and (±)-245 however, could not be separated and instead the 
regioisomers in the 1H NMR mixture were assigned by comparison with the spectral data obtained 
for their chlorinated and brominated counterparts. Nevertheless, the methyl-substituted 
regioisomers and their enantiomers could be separated by chiral HPLC analysis to give four distinct 
239, 60% yield
N
H
O
Et Ph
Br
N
H Ph
O THF, 3 hrt
then 
1M HCl
O
Ph EtBr
Br
N
H Ph
O
OH
Ph Et
1M HCl
2 h
91 94 238
 
 Chapter 5: Regioselectivity Studies 
 62 
peaks with approximate regioisomeric ratios in agreement with those determined from 1H NMR 
analysis.  
 
Fig 5.7: Preparation of 4- and 6-substituted oxindoles from 3-substituted nitrones. 
5.3 Regio- and Stereoselectivity using N-Boc Garner’s Nitrones 
Next, attention turned to the investigation of regioselectivity in tandem with stereoselectivity and 
was initially investigated using chiral N-Boc Garner’s derived nitrones. Garner’s aldehyde was 
treated in turn with the previously synthesised 4-substituted arylhydroxylamines to yield nitrones 
246, 247 and 248 in 60, 54 and 38% yield respectively (Fig 5.8).  
 
X = Nitrone Yield (%) 
CH3 246 60 
OMe 247 54 
Br 248 38 
Fig 5.8: Preparation of 4-substituted N-aryl Garner’s derived nitrones. 
These Garner’s derived nitrones proved relatively unstable, hydrolysing rapidly on silica gel, in 
CDCl3, and in a range of other solvents when preparing NMR samples. This, coupled with the 
rotameric nature of these Garner’s derived species, made analysis problematic. Nevertheless, the 
large polarity difference between the nitrone species and Garner’s aldehyde made it possible to 
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purify the nitrones rapidly over silica, achieving isolated yields in the region of 50-60% and with 
acceptable levels of purity. This allowed nitrones 246 and 247 to be stored for a short period of 
time and fully characterised, however, nitrone 248 was found to degrade rapidly on attempted 
characterisation and so only limited data were obtained. For subsequent reactions, nitrone 248 was 
purified and used immediately in the next reaction step. Treatment of these 4-arylsubstituted 
nitrones with ethylphenylketene at -78 °C yielded exclusively the C(5)-substituted oxindole 
products in good yield and with comparable enantioselectivity to the unsubstituted variant (Fig 5.9). 
A slight drop in ee was observed with 4-bromophenyl nitrone 248, however, no reaction was 
observed at -78 °C and consequently this reaction was performed at room temperature, which may 
account for the lower enantioselectivity observed (70% ee).  
 
Nitrone  Oxindole Yield (%) ee (%) 
246 X = CH3 231 48 81 
247 X = OMe 229 61 81 
248 X = Br 234 65 70 
Fig 5.9: Preparation of 5-substituted oxindoles from 4-substituted aryl Garner’s nitrone derivatives. 
The required 2-substituted arylnitrones 249 and 250 were once more obtained from Garner’s 
aldehyde (Fig 5.10) however brominated nitrone 250 degraded upon standing and attempted 
characterisation, forcing us to prepare and use this nitrone immediately.  
 
X = Nitrone Yield (%) 
CH3 249 51 
Br 250 61 
Fig 5.10: Preparation of 2-substituted N-aryl Garner’s derived nitrones. 
In reaction with ethylphenylketene (Fig 5.11), this 2-bromosubstituted nitrone 250 generated the 
corresponding 7-substituted oxindole product as a single regioisomer. However, low reactivity was 
observed at -78 °C, and so the reaction was performed at ambient temperature. The  
7-bromooxindole 251 was isolated in poor yield and ee (13% yield; 31% ee) attributable to the poor 
quality of nitrone introduced to the reaction and the necessity to raise the reaction temperature. 
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The 2-tolyl nitrone 249 however, did react at -78 °C with ethylphenylketene and yielded  
7-methyloxindole 236 in 61% yield and 74% ee.  
 
Nitrone  Oxindole Yield (%) ee (%) 
249 X = CH3 236 61 74 
250 X = Br 251 13 31 
Fig 5.11: Preparation of 7-substituted oxindoles from 2-substituted aryl Garner’s nitrone derivatives. 
Next, the 3-substituted aryl Garner’s nitrones 252 and 253 were prepared in 52 and 51% yield 
respectively from Garner’s aldehyde and the requisite meta-substituted hydroxylamine (Fig 5.12).  
 
X = Nitrone Yield (%) 
CH3 252 52 
Br 253 51 
Fig 5.12: Preparation of 3-substituted N-aryl Garner’s derived nitrones. 
Treatment of nitrones 252 and 253 with ethylphenylketene yielded a ca. 6:4 mixture of regioisomers 
in both cases, once more in favour of the C(6)-substituted isomer. As in the racemic case, the 4- 
and 6-methyl oxindoles 254 and 255 could not be separated by silica gel chromatography, although 
the ees were determined by chiral HPLC analysis of the isomeric mixture. The 4-methyloxindole 
isomer was found to have an ee of 87%, while the 6-methyloxindole isomer was found to have an 
ee of 89%. Authentic samples of 4-bromooxindole 256 and 6-bromooxindole 257 were obtained by 
chromatography and their ees determined via chiral HPLC analysis. The 6-bromooxindole 257 was 
found to have an ee of 84% with the 4-bromooxindole 256 having a slightly lower ee of 76% (Fig 
5.13).  
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 4-substituted oxindole isomer 6-substituted oxindole isomer 
Nitrone Oxindole Yield (%) ee (%) Oxindole Yield (%) ee (%) 
252 X = CH3 254 30 (combined) 87 255 30 (combined) 89 
253 X = Br 256 56 (combined) 76 257 56 (combined) 84 
Fig 5.13: Preparation of 4- and 6-substituted oxindoles from 3-substituted aryl Garner’s nitrone derivatives. 
Exploration of the regioselectivity of the reaction system proved successful when using substituted 
achiral nitrones with a variety of N-aryl substituents tolerated in good yields. Although we had 
begun to observe trends in both regio- and stereoselectivity using N’-Boc N-aryl nitrones, certain 
nitrones proved particularly unstable, thereby preventing proper characterisation and raising 
questions about the stability of such nitrones to the reaction conditions used. In these asymmetric 
reactions, poor oxindole yields were obtained, particularly when using ortho-substituted aryl nitrones 
and the limited reactivity of the bromo-substituted aryl nitrones necessitated raising the reaction 
temperatures, impacting the enantiocontrol. As a consequence of these issues, further 
regioselectivity studies were conducted using enantiopure nitrones based on the more stable and 
non-rotameric N-TIPBS nitrone framework. 
5.4. Regio- and Stereoselectivity Using N-TIPBS Nitrones 
A range of substituted aryl N-TIPBS nitrones were prepared according to the previously described 
procedures and were once more treated in turn with ethylphenylketene 94. However, rather than 
preparing bromo-aryl nitrones which had proved unstable to silica-gel column chromatography, 
this time chloro-aryl nitrones were prepared. Enantiopure para-substituted N-aryl TIPBS nitrones 
194 and 258 were prepared and isolated via column chromatography in reasonable to good yields 
(Fig 5.14).  
 
X = Nitrone Yield (%) 
CH3 194 43 
Cl 258 76 
Fig 5.14: Preparation of 4-substituted aryl N-TIPBS nitrones. 
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Treatment of 194 and 258 in turn with ethylphenylketene gave the expected C(5)-substituted 
oxindoles, in excellent ee and good yields (Fig 5.15). 
 
Nitrone  Oxindole Yield (%) ee (%) 
194 X = CH3 231 48 94 
258 X = Cl 230 87 97 
Fig 5.15: Preparation of 5-substituted asymmetric oxindoles from 4-substituted aryl N-TIPBS nitrones. 
2-Substituted N-aryl TIPBS nitrones 195 and 259 were prepared and isolated by column 
chromatography in 52 and 19% yield respectively (Fig 5.16). 
 
X = Nitrone Yield (%) 
CH3 195 52 
Cl 259 19 
Fig 5.16: Preparation of 2-substituted aryl N-TIPBS nitrones. 
Treatment of enantiopure 2-tolylnitrone 195 and 2-chlorophenylnitrone 259 in turn with 
ethylphenylketene gave C(7)-substituted oxindoles 236 and 237 respectively, again in good yield and 
good ee (Fig 5.17).  
 
Nitrone  Oxindole Yield (%) ee (%) 
195 X = CH3 236 80 80 
259 X = Cl 237 66 68 
Fig 5.17: Preparation of 7-substituted asymmetric oxindoles from 2-substituted aryl N-TIPBS nitrones. 
3-Substituted N-aryl TIPBS nitrones 260 and 261 were also prepared and isolated by column 
chromatography in 65 and 71% yield respectively (Fig 5.18). 
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X = Nitrone Yield (%) 
CH3 260 65 
Cl 261 71 
Fig 5.18: Preparation of 3-substituted aryl N-TIPBS nitrones. 
Treatment of 3-substituted aryl N-TIPBS nitrones 260 and 261 with ethylphenylketene gave, as 
expected from our previous studies, a 6:4 regioisomeric mixture of the C(6)- and C(4)-substituted 
oxindole isomers respectively, in good yields. The tolyloxindoles 244 and 245 were isolated in a 
combined 88% yield, whilst 4-chlorooxindole 240 and 6-chlorooxindole 241 were separated via 
column chromatography and isolated in 32% and 47% yield respectively. With 3-tolyl nitrone 260, 
the observed enantioselectivity for both regioisomers was the same (91% ee), whilst with  
3-chlorophenyl nitrone 261, both the 6- and 4-chlorooxindole isomer were isolated in 86% ee (Fig 
5.19). 
 
 4-substituted oxindole isomer 6-substituted oxindole isomer 
Nitrone Oxindole Yield (%) ee (%) Oxindole Yield (%) ee (%) 
260 X = CH3 244 88 (combined) 91 245 88 (combined) 91 
261 X = Cl 240 32 86 241 47 86 
Fig 5.19: Preparation of 4- and 6-substituted asymmetric oxindoles from 3-substituted aryl N-TIPBS nitrones. 
As these results demonstrate, almost no regioselectivity is observed when using 3-substituted-aryl 
nitrones. However, in certain cases, it would be desirable to obtain selective access to both the 
C(4)- and C(6)-substituted oxindole regioisomeric products when necessary. A potential method of 
doing so would be to include a removable blocking group in the ortho-position of the aryl ring, 
thereby precluding sigmatropic rearrangement through this position and giving selective access to 
one oxindole regioisomer (Fig 5.20). For example, a 2-TMS, 3-substituted aryl nitrone, would 
theoretically allow selective access to the C(6)-substituted oxindole after proto-desilylation with an 
appropriate acid.147,148 Similarly, a halogen-based blocking scheme can be envisaged whereby 
treatment with SnBu3H149 or lithium-halogen150 exchange would liberate the desired mono-
substituted oxindole as a single regioisomer. We sought to investigate the viability of such an 
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approach using a 2-bromo-3-methyl substituted nitrone in order to access 6-methyl substituted 
oxindoles. 
 
Fig 5.20: Potential selective access to 6- and 4-substituted oxindoles using temporary blocking groups. 
Subjecting 2-bromo-3-nitrotoluene 262 to the standard one-pot nitrone formation methodology 
utilised previously failed to provide any evidence of nitrone formation, with the only identifiable 
product suggesting homo-coupling between two molecules of 2-bromo-3-nitrotoluene. Similarly, 
attempted isolation of the intermediate hydroxylamine prior to condensation with benzaldehyde 
also resulted in failure (Fig 5.21).  
 
Fig 5.21: Attempted preparation of a 2-bromo-3-tolyl substituted nitrone. 
Further studies into such a strategy have not been undertaken due to the prohibitively expensive 
nature of the required starting materials and the apparent necessity to develop a new synthetic route 
to access the requisite substrates. 
5.5. Overview and Mechanistic Aspects of Regioselectivity in the Rearrangement 
The findings of these regioselectivity studies are consistent with the proposed [3+2] cycloaddition-
[3,3]-sigmatropic rearrangement mechanism. In the case of the para-substituted aryl nitrones, due to 
the symmetric nature of the para-aryl ring, C(2) and C(6) are equivalent and rearrangement through 
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either of these carbons yields the same C(5)-substituted iminium intermediate and hence the C(5)-
substituted oxindole, as was observed in both the racemic and asymmetric studies (Fig 5.22).  
 
Fig 5.22: Mechanistic considerations using para-substituted aryl nitrones. 
In the case of ortho-substituted aryl nitrones, again only a single regioisomer is observed, consistent 
with rearrangement through C(6) as seen in pathway 1 in Fig 5.23. It may be possible for the 
reaction to proceed through an alternative intermediate, resulting from C(2) addition as in pathway 
2, however via this pathway the key rearomatisation step prior to cyclisation is prevented. Due to 
the high yields observed for the C(7)-substituted oxindoles, it is likely that the second reaction 
pathway is initially disfavoured on steric grounds, although it may be possible that if it does 
proceed, the [3,3]-rearrangement of this transformation is reversible, resulting in funnelling back 
through reaction pathway 1.  
 
Fig 5.23: Mechanistic considerations using or tho-substituted aryl nitrones. 
In the rearrangements of meta-substituted aryl nitrones however, there are two viable reaction 
pathways. Rearrangement can proceed through C(6), as in pathway 1 (Fig 5.24), to yield the C(4)-
substituted oxindole product. Alternatively, rearrangement through C(2), as in pathway 2, yields the 
C(6)-substituted oxindole product. A moderate preference (6:4) for the C(6)-substituted isomer was 
observed on rearrangement with m-methyl-, m-chloro-, and m-bromo-substituted aryl nitrones. This 
moderate preference is perhaps to be expected given that in the C(4)-substituted case, 
rearrangement occurs on the carbon adjacent to the substituent, whereas in the C(6)-substituted 
case, the substitution is more remote from the reactive centre. 
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Fig 5.24: Mechanistic considerations using meta-substituted aryl nitrones. 
The observed regioselectivity in the case of meta-substituted nitrones was also examined 
computationally by our collaborators using model 3-substituted-aryl nitrones 263 and 264. The 
computational results (Fig 5.25) predict the [3,3]-sigmatropic rearrangement transition states for the 
formation of both the C(4)-substituted and C(6)-substituted oxindole regioisomers to be 
isoenergetic in the case of both the chloro- and methyl- substituted variants, so it is perhaps 
unsurprising that experimentally we observe only a moderate 6:4 regioisomer ratio. 
 
Fig 5.25: Computational investigation into the influence of meta-substitution on the rearrangement. 
5.6. Conclusions for Chapter 5 
Using ortho-, meta- and para-substituted aryl nitrones, selective functionalisation of the oxindole core 
at C(4) to C(7) has been achieved using both achiral and chiral nitrones. Such results are consistent 
with a reaction proceeding via a [3,3]-sigmatropic rearrangement. Using achiral nitrones, a range of 
N
H
O
1
6
5
4
3
2
[3,3] rearomatisation
N
Ph Et
CO2
4
N
H
O
Ph Et
hydrolysis and
cyclisation
H
H 4-substituted oxindole
[3,3] rearomatisation
N
Ph Et
CO2
6 N
H
O
Ph Et
hydrolysis and
cyclisation
H
H 6-substituted oxindole
X
X
X
X
X
R
R
R
PATHWAY 1
PATHWAY 2
O
Ph
Et
N
O O
RAr
R
H
X
N
O O
RAr
R
H
X
[3+2]
[3+2]
 
263 
264 
 
 Chapter 5: Regioselectivity Studies 
 71 
substituted racemic oxindoles was generated in good to excellent yields. Initial asymmetric 
regioselectivity studies were conducted using enantiopure N-Boc Garner’s derived nitrones, with 
many proving unstable and difficult to isolate and characterise. The use of substituted nitrones 
based on our optimal stereodirecting scaffold (N-TIPBS) was found to be beneficial as they proved 
more stable precursors. Rearrangement with o-aryl nitrones yielded a single regioisomeric product, 
the C(7)-substituted oxindole in good yields. Also observed in the asymmetric reactions of ortho-
substituted arylnitrones was a decrease in ee with increase of ortho-substituent size suggesting that 
larger ortho-substituents somehow disrupt either the approach of the ketene, or the transfer of the 
chiral information through the [3,3]-sigmatropic rearrangement step of the reaction. A tentative 
explanation for the former may be due to a conformational preference (Fig 5.26). If the N-aryl ring 
is assumed to adopt an out-of-plane conformation so as again to minimise 1,3-allylic strain across 
the nitrone, the ortho-substituent must adopt one of two conformations. In conformation A, there 
would presumably be significant energetic penalty for the close proximity of this ortho-substituent to 
the N-TIPBS residue. Therefore, conformation B would be assumed to be favoured whereby this 
ortho-substituent now shields the Si face of the nitrone somewhat, lowering the difference in 
transition state energies for cycloaddition through the Re or Si face, perhaps providing an 
explanation for the lower enantioselectivities observed using ortho-substituted nitrones. 
 
Fig 5.26: One potential explanation for lower ees observed with or tho-substituted N-aryl nitrones. 
Also, with larger 2-substitution a reluctance for the intermediate imino-acids to cyclise to the 
desired oxindole species was noted, thereby allowing a crystal structure of brominated imino-acid 
238 to be obtained. para-Substituted arylnitrones also provided a single oxindole regioisomer in 
good yields and good to excellent ees regardless of substituent size, attributable to the remoteness 
of this substituent from the reaction centre. Rearrangement with m-aryl nitrones yields a mixture of 
the 4- and 6-substituted oxindole products with a slight preference towards the 6-isomer exhibited 
(6:4) in all cases, however in asymmetric studies, the ees for both the C(4)- and C(6)-substituted 
isomers were found to be the same (91% for 4- and 6-Me and 86% for 4- and 6-Cl). This suggests 
that the enantioselectivity in the reaction is fixed by facial selectivity in the initial [3+2] 
cycloaddition, and is then transferred faithfully through the [3,3]-sigmatropic rearrangement 
without erosion. These results are also in good agreement with DFT calculations that predict the 
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transition states for generation of the two regioisomers to be isoeneregetic, and therefore predict 
almost no regioisomeric preference. 
At the outset of these studies, the main objective was to investigate the feasibility of generating 
functionalised asymmetric oxindoles using our methodology bearing substituents at any position of 
the oxindole core aromatic ring. This has been shown to be possible for a variety of substituents 
including 5-OMe (as found in horsfiline 4), and for methyl, -chloro and –bromo substituents in all 
four available positions around the ring. The ability to incorporate halogens at all positions is 
promising from a standpoint of analogue/small molecule library generation via cross-coupling, a 
proof of concept of which is provided in the generation of biphenyl oxindole 235. Indeed, this 
biphenyl oxindole and numerous other novel oxindole species prepared in Chapters 3 and 5 have 
been evaluated in the NCI open-access multi-cellular screening. Unfortunately, none of the 
compounds evaluated displayed promising efficacy against cancerous cell-lines. Nevertheless, an 
independent collaboration with the CRUK laboratory based at the University of Newcastle has 
been established and will evaluate the potential of these novel oxindoles as p53-MDM2 protein 
interaction inhibitors. The assay results for the initial batch of oxindoles are pending. 
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Chapter 6: Further Areas of Investigation  
6.1. Introduction & Aims 
After investigating the generality of this reaction process through variation of both the nitrone and 
ketene reactants, we next contemplated further improvements of this asymmetric methodology. We 
identified two limitations of the current system. Although N-TIPBS nitrone 144 performs as an 
excellent chiral auxiliary for the preparation of enantioenriched oxindoles, it is used as a 
stoichiometric reagent, of high molecular weight. An idealised version of this reaction would 
employ an achiral nitrone in combination with a sub-stoichiometric quantity of chiral catalyst in 
place of the chiral auxiliary. For example, thioureas151 and phosphoric acids152 have been 
demonstrated as suitable asymmetric catalysts for cycloadditions involving nitrones. In such 
processes, both classes of catalyst are presumed to act in different ways; the former via hydrogen-
bonding activation153 and the latter via a Brønsted acid154 activation mechanism, potentially allowing 
for investigation of two distinct modes of activation in our system (Fig 6.1).  
The second area for improvement was the ketene species. Although the reaction system is tolerant 
of crude solutions of ketenes, their reactive nature means they are not ideal reagents to work with. 
They typically require synthesis and manipulation under an inert atmosphere, and are only ‘stable’ 
for a limited period at low temperatures. Again, an idealised version of this reaction would employ 
a ketene surrogate or precursor, such as the parent acid chloride or preferably the commercially 
available, bench stable carboxylic acid, and would allow the ketene or ketene equivalent to be 
generated during the course of the reaction in the same reaction vessel. Given our group’s 
developing expertise in the field of carboxylic acid activation,155 we chose to begin our 
investigations in this domain. 
 
Fig 6.1: Aims and Objectives for Chapter 6 – potential improvements of the reaction system. 
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6.2. Carboxylic Acid Activation 
Our investigations in this area began by taking our model oxindole forming reaction between 
diphenylnitrone 48 and ethylphenylketene 94, and attempting to recreate this by in situ generation of 
the ketene species from 2-phenylbutyric acid 265. Various combinations of base, solvent and 
activating agents were screened, but with no success. Even repetition of literature procedures156 by 
Olah and co-workers using DCC provided no direct evidence of ketene generation in our hands. 
The materials returned from these attempts were the nitrone (or benzaldehyde in extended, heated 
reactions), the parent acid, and the ‘oxidised’ form of the activating agent. For example, in reactions 
employing Mukaiyama reagent 266,157 formation of the pyridone 268 provides evidence for the 
formation of activated species 267, however the lack of reaction with nitrone suggests a lack of 
ketene generation (Fig 6.2). Reactions were also conducted in the presence of MgSO4 and 
molecular sieves in an attempt to minimise the amount of water present in the reaction, however 
pyridone generation via assumed hydrolysis was still the major transformation in these reactions. As 
these studies provided no promising reactivity, we began to consider alternative approaches. 
 
Fig 6.2: Attempted formation of ketenes v ia  in  s i tu  acid activation. 
6.3. In Si tu  Ketene Generation from Acid Chlorides 
The Lectka group has pioneered a ‘shuttle-base’ deprotonation method for the in situ generation of 
mono-substituted ketenes from acid chloride precursors158, 159 whereby substoichiometric amounts 
of cinchona alkaloid bases are used in combination with stoichiometric inorganic bases such as 
NaH or K2CO3. We briefly explored this strategy in relation to our asymmetric oxindole forming 
methodology and found the work to be repeatable for the formation of mono-substituted ketenes, 
but not viable for the generation of the necessary disubstituted ketene species (Fig 6.3).  
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Fig 6.3: Lectka’s shuttle base deprotonation methodology. 
Also investigated was the attempted generation of disubstituted ketenes at low temperatures from 
the desired acid chloride and base, in the presence of diphenylnitrone 48. A variety of bases were 
again evaluated for ketene formation including Et3N, DIPEA, cinchona alkaloids, isothioureas, 
proton sponge and polymer supported BEMP, however upon attempted reaction with 
diphenylnitrone 48, each resulted in a complex mixture of products. Significant hydrolysis or 
decomposition of the nitrone species was observed consistently in the crude 1H NMR spectra. Also 
observed were at least four distinct ethyl systems suggesting that multiple acid chloride derived 
products were being formed via this attempted in situ approach. It was possible to isolate the desired 
oxindole species after careful column chromatography, but never in more than a 5-10% yield.  
In a similar vein, the in situ photochemical Wolff rearrangement160 of diazoketones was also briefly 
investigated as a method to generate ketenes. Diazoketone 269 was used as a basis to generate 
phenylketene, and reaction with achiral nitrone 48 under a variety of irradiation sources was 
investigated. This method proved moderately successful and provided the desired  
3-phenyloxindole 161 in between 20 and 50% yield based on numerous preparations. However, the 
reaction was highly irreproducible, and significant nitrone decomposition was observed in the 
majority of reactions (Fig 6.4). 
 
Fig 6.4: Attempted photochemical Wolff-rearrangement and application to oxindole synthesis. 
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to generate a stable, isolable ketene (or related heterocumulene) species, prior to the introduction of 
the nitrone to the reaction vessel. 
6.4. Investigating the Reaction Rate and First Steps to Developing a Catalytic Version 
6.4.1 Initial Studies 
The cycloaddition-pericyclic cascade described herein is a facile, energetically downhill process with 
an approximate exogenicity of 64 kcal/mol. As a consequence, the typical reaction rate is extremely 
fast and the reaction is essentially complete by the time the ketene has been added to the reaction 
vessel and a TLC analysis can be conducted. We reasoned that by modification of the electronic 
properties of the nitrone component, it might be possible to slow the rate of this reaction, and as 
such allow for the evaluation of the ability of asymmetric catalytic additives to promote the 
reaction. Given that modification of the N-aryl ring would necessitate incorporation of the 
modifying group into the product, we chose to modify the C-aryl ring given that any substitution 
here would form part of the aldehyde and would be extruded in the quench of the reaction. 
Synthesis of nitrones 270-275 proceeded without difficulty from the corresponding aldehydes and 
phenyl hydroxylamine according to the standard preparation method. However, even by reducing 
the reaction concentration ten-fold and cooling to -78 °C, upon treatment with ethylphenylketene, 
no significant reduction in reaction rate was observed (Fig 6.5). Rather, complete starting material 
consumption and resultant formation of ethylphenyloxindole 61 was observed in all cases by TLC 
and 1H NMR analysis. 
 
Fig 6.5: Alternative nitrones explored in an attempt to reduce reaction rate. 
The results of these investigations with modified nitrones reinforced the hypothesis that the 
inherent background reaction of this transformation would prove too fast to be effectively 
controlled by a sub-stoichiometric quantity of chiral catalyst. Therefore we began to consider 
alternative substrates as a means to access similar intermediates, albeit at a reduced reaction rate. 
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6.4.2 Nitrone-Ketenimine Cycloadditions 
Ketenimines are nitrogen-containing structural analogues of ketenes, which are also known to 
participate in similar [3+2] cycloadditions with nitrones,161-163 including a corresponding literature 
report164 describing the formation of analogous five-membered intermediate, and imino-amide 276. 
The heterocyclic products accessed in such literature reports suggest that the mode of cycloaddition 
is highly dependent on the substitution pattern of the ketenimine (Fig 6.6).  
 
Fig 6.6: Literature examples of ketenimine-nitrone cycloadditions. 
Given the ability to tune the electronic properties of the ketenimine by variation of the N-aryl 
substituent in combination with modification of the nitrone component, we hoped it might be 
possible to control both the favoured reaction pathway and the rate of background reaction to 
allow initial investigations toward development of a catalysed cycloaddition process to begin.  
6.4.3 Investigations using Ketenimines 
The requisite amide precursors for ketenimine preparation were synthesised according to literature 
procedures and converted into the chloroimine precursors in situ prior to dehydrohalogenation.165 
This process proved facile for the generation of N-aryl ketenimines 279 and 280, however the 
corresponding ketenimines from substrates 281 and 282 were not formed even at elevated reaction 
temperatures (Fig 6.7).  
 
Fig 6.7: Preparation of ketenimines. 
The reaction between diphenylnitrone 48 and ketenimine 279 was chosen as a starting point, to 
allow for the reaction to be monitored by 19F NMR if necessary. However, initial TLC analysis after 
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1 h showed partial consumption of starting material. The reaction was allowed to stir overnight at 
rt, after which time TLC analysis showed full consumption of starting material. After a 1M HCl 
quench and aqueous work-up, crude 1H and 19F NMR analysis suggested formation of the desired 
imino-acid oxindole precursor (±)-283 in greater than 90% purity. This imino acid was purified by 
recrystallisation from cyclohexane and isolated as a pale-yellow solid in 74% yield (Fig 6.8). 
 
 
Fig 6.8: Reaction between nitrone 48 and ketenimine 279 to give imino-amide 283. 
This was an extremely promising result and an initial proof-of-concept as to the significant 
reduction in reaction rate using ketenimines. Nevertheless, our earlier studies toward C(3)-tertiary 
asymmetric oxindole species had suggested that the C(3)-proton is prone to racemisation and as 
such, substrates such as 279 would not be viable for investigations towards an enantioselective 
version of such a reaction. Therefore, attention was turned toward synthesis of an N-aryl 
phenylethyl-substituted ketenimine, in order to access a C(3)-quaternary substituted oxindole. 
Treatment of 2-phenylbutanoyl chloride with p-fluoroaniline gave amide 284, which was subjected 
to the same chlorination-dehydrohalogenation protocol as previously to give ketenimine 285. 
However, on treatment with diphenylnitrone at room temperature, ketenimine 285 failed to react. 
Even refluxing the reaction at 80 °C for 24 h failed to suggest any reaction with nitrone 48 clearly 
visible by TLC analysis and both starting materials still present in the crude 1H NMR spectrum.  
 
Fig 6.9: Attempted reaction between nitrone 48 and ketenimine 285. 
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This system represents an attractive alternative to the ketene-nitrone cycloaddition approach to 
oxindoles described in this thesis, especially given that the background rate of the reaction is 
significantly slower than that in the case of the same cycloaddition with ketenes. Generation of 
imino-amide 283 provides a proof-of-principle for the generation of oxindoles using such a 
methodology, presumably by an analogous [3+2]-cycloaddition, [3,3]-rearrangement cascade 
mechanism. Further development of this system with a view to understand substituent effects of 
the ketenimine is necessary, and studies towards this, and the eventual aim of developing a general, 
catalytic, enantioselective oxindole forming methodology by the introduction of suitable 
organocatalysts are under consideration within the research group. 
6.5. Conclusions from Chapter 6 
Originally, we attempted to develop a more tractable variant of our oxindole forming methodology 
whereby the requisite carboxylic acid could be activated in situ rather than using preformed ketene 
components. This proved an extremely difficult task, and we saw no evidence of desired reactivity 
in these studies. Further investigations probed in situ formation of a ketene from the requisite acid 
chloride yet only provided the desired oxindoles as minor components (ca. 5-10% isolated yield) in 
crude spectra composed of a multitude of products.  
The key to the success of the work described in Chapters 2 through 5, appears to be the 
favourability of the cycloaddition reaction between nitrones and ketenes. This reaction is extremely 
facile, and energetically downhill, resulting in rapid reaction rates. As such, attempts to slow the 
background reaction between ketenes and nitrones by lowering temperature, increasing dilution, 
and by electronic variation of the nitrone component were all unsuccessful. Nevertheless, the use 
of structurally related ketenimines in the cycloaddition with achiral nitrones did result in a much 
reduced reaction rate. Evaluation of the ability to form racemic oxindole precursors by this 
methodology proved initially promising for the generation of C(3)-tertiary substituted imino-acids, 
however our previous studies suggested such species were not configurationally stable. In order to 
investigate a catalytic, asymmetric variant of this reaction process, trisubstituted ketenimine 285 was 
prepared, but proved much less reactive with nitrone 48 than disubstituted ketenimine 279. Further 
investigation and development of this system within the group is warranted to ascertain if the 
development of a general, catalytic, highly enantioselective cycloaddition between nitrones and 
ketenimines would be achievable. 
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Chapter 7: Application Towards the Synthesis of Biologically Relevant Species 
7.1. Introduction & Aims 
Previous studies had established a versatile synthetic methodology that allows the preparation of 
asymmetric oxindole species bearing alkyl and aryl substituents at the C(3) position. Given the 
prevalence of the core oxindole motif,166, 167 we next sought to demonstrate the ability of this 
methodology to deliver specific targets such as medicinal agents and natural product species. Roche 
p53 inhibitor 14 was selected as a medicinal target due to its known anti-cancer activity168 and due 
to the substitution pattern at the C(3)-position. Our previous studies using i-butyl(phenyl)ketene 
generated the desired oxindole in 89% yield and 84% ee, demonstrating β-alkyl branching is well 
tolerated in this system, and access to Roche p53 inhibitor 14 would require preparation of a novel, 
yet effectively β-branched aryl-benzyl ketene (Fig 7.1).  
 
Fig 7.1: Proposed application to Roche p53 inhibitor 14. 
7.2. Roche p53 inhibitor 
7.2.1 Introduction 
At the time of undertaking this study, no asymmetric preparation of oxindole 14 had been reported 
in the literature, with the patented Roche route169 reliant on chiral HPLC separation of the two 
enantiomers. Recently, Kündig and co-workers reported the first asymmetric synthesis of this 
therapeutic agent using a palladium catalysed intramolecular amide α-arylation, furnishing the 
product in 45% overall yield and 90% ee prior to recrystallisation (Scheme 7.1).170 Their approach 
began with alkylation of the requisite aryl acetic acid 286 to give disubstituted acid 287 in 91% yield. 
Conversion to the acid chloride and subsequent amide formation occurred in 89% over two steps. 
MOM-Protection of this amide and subsequent asymmetric α-arylation with a palladium-NHC 
catalyst system afforded oxindole 291 in 86% yield and 90% ee. Deprotection of the MOM group 
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and recrystallisation gave Roche p53 inhibitor 14 in 45% overall yield and 97% ee. Although this 
synthetic route gives the desired oxindole as the sole regioisomer, it is not without room for 
improvement. The employed palladium-catalysed α-arylation step necessitates protection, and 
subsequent deprotection of the oxindole lactam, elongating the synthetic sequence (eight steps 
overall). This reaction is also long, 48 h, and furnishes the oxindole with good, but not excellent 
enantiocontrol prior to recrystallisation (90% ee). In contrast, a route employing our asymmetric 
nitrone-ketene cycloaddition methodology would be protecting group free, and could potentially 
provide access to the desired compound in only four steps from commercially available materials.  
 
Scheme 7.1: Reagents and Conditions: i) LDA, THF, -78 °C then m-Cl(C6H4)CH2Br, then 1M HCl (91%). ii) SOCl2, 
reflux, 2h. iii) Et3N, 2-bromo-5-chloroaniline, CH2Cl2, 0 °C to rt, 18 h (89% over 2 steps). iv) NaH, MeOCH2Cl, THF, 0 
°C to rt, 21 h (86%). v) [Pd(dba)2] (5 mol%), 292 (5 mol%), tBuONa (1.5 eq), PhCH3, 50 °C, 48 h (86%, 90% ee). vi) 
TMSCl, NaI, MeCN, 0 °C, 1 h, then Et3N, MeOH, 55 °C, 30 min (91% over 2 steps) Recrystallisation (79%, 96% ee). 
The second asymmetric preparation of this species, which is much more expedient, has been 
reported within the past month by Feng and co-workers. In one step, treatment of precursor 
oxindole 293 with aryl iodonium salt 294, in the presence of a C2-symmetric Sc-N,N’-bisoxide 
catalyst system, gave 14 in 71% yield and 94% ee (Fig 7.2).171 
O
OH
O
OH
O
Cli) ii)
OMe
OMe OMe
iii)
O
N
H
OMe
Cl
O
N
OMe
Cl CH2OMe
Br
Cl
Cl
Br
N
O
OMe
Cl
Cl
N
H
O
OMe
Cl
Cl
CH2OMe
ClCl
iv)
vi)
v)
NN
tBu tBu
OMeMeO
Ph Ph
I
292
286 287 288
289290291
14
 
 Chapter 7: Application Towards the Synthesis of Biologically Relevant Species 
 82 
 
Fig 7.2: Feng’s preparation of 14. 
7.2.2 Synthetic Approach 
Our synthetic approach began in the same manner as Kündig’s; with alkylation of the commercially 
available m-anisylacetic acid 286, followed by conversion to the acid chloride 288 occurring in 
>85% yield over two steps. Dehydrohalogenation with N,N-DMEA then provided the necessary 
novel ketene species 296 which was used as a crude solution in THF. In congruence with our 
previous regioselectivity studies, treatment of modified N-3-chlorophenyl N’-TIPBS nitrone 261 
with ketene 296 provided a 6:4 mixture of regioisomers that could be separated by column 
chromatography over silica. Roche p53 inhibitor 14 was isolated in 52% yield and 96% ee, whilst 
novel regioisomer 297 was isolated in 36% yield and 79% ee (Scheme 7.2). Racemic samples of 
both the 4- and 6-substituted oxindole regioisomers were prepared from N-3-chlorophenylnitrone 
88 and the same crude solution of ketene 296. 
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Scheme 7.2: Reagents and Conditions: i) n-BuLi (2.5 eq), -78 °C then m-Cl(C6H4)CH2Br (1.1 eq), 0 °C to rt, 16 h. ii) 
(COCl)2, DMF (1 drop), PhCH3, 0 °C, 3 h. iii) N,N-DMEA (1.05 eq), Et2O, 0 °C, 16 h then filtration, conc. in vacuo and 
dissolution in THF. iv) 261, THF, -78 °C, 3 h, then 2M HCl. 
While this route provides access to the desired p53 inhibitor in little over 50% yield for the final 
step, it also furnishes the novel yet structurally similar isomer 297 in 38% yield, which may also be 
of interest for biological screening. Whilst the generation of two biologically interesting compounds 
in a single reaction vessel may be seen as a positive on small-scale where reactions are easily 
purified by column chromatography over silica, this lack of selectivity poses a problem when 
material is required on such a scale so as to make column chromatography impractical. In such 
cases, Kündig’s route is much preferable given that it forms a single regioisomer. However, access 
to a single 4- or 6-substituted oxindole regioisomer via our methodology could prove possible in 
the future if further effort were to be invested in the blocking strategy outlined in Chapter 5.  
7.3. Targeting Indolyl Natural Products 
7.3.1 Introduction 
A frequently encountered class of indole alkaloids is the pyrroloindoline family. This family can be 
subdivided into those formally dimeric members such as folicanthine and idiospermuline, or those 
such as gliocladin, bionectin and the numerous other members of the epipolythiodiketopiperazine 
(ETP) family which bear a C(3)-C(3’)-indole residue formally derived from a C(3)-C(3’)-tryptophan 
dimerisation (Fig 7.3).172, 173 The ETPs are fungal secondary metabolites with recognised cytotoxic 
activity toward myeloma174 and solid tumour masses.175 Related family members are also know to 
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possess antibacterial, antiviral, antifungal and immunosuppressive properties.176, 177 In particular, the 
gliocladin family has been shown to possess significant cytotoxic activity against murine P388 
lymphocytic leukaemia cell-lines.178  
 
Fig 7.3: Representative pyrroloindoline alkaloids. 
The biochemical synthetic pathway to such alkaloids is proposed to occur via electrophilic addition 
to the C(3)-position of tryptamine or tryptophan, followed by trapping of the generated iminium 
ion with the pendant amine residue, thereby generating the pyrroloindoline core.179 Multiple 
biomimetic syntheses have been conducted to allow access to natural products of this kind.180-182 
Early non-biomimetic synthetic approaches to members of these families established the key all-
carbon quaternary centre by dialkylation or Heck cyclisations,183 yet in subsequent years, more 
concise approaches to members of these alkaloid families have been sought. To this end, in 2007, 
the Movassaghi laboratory developed a homo-coupling approach from key enantiopure bromide 
300 under heavily optimised cobalt catalysis conditions to furnish hexacycle 301 on three gram scale 
in an impressive 60% yield given that the transformation generates a pair of all-carbon vicinal 
quaternary centres (Fig 7.4).184 From this intermediate 301, the group were able to access  
(–)-calycanthine, (+)-chimonanthine and (+)-folicanthine, and by developing this methodology 
further, in 2012, the Movassaghi laboratory also reported the synthesis of gliocladins B and C.185  
 
Fig 7.4: Movassaghi’s Co(I) mediated reductive dimerisation. 
The Stephenson group also reported their own elegant approach to gliocladin C forming the key 
quaternary centre via visible-light mediated photoredox catalysis between brominated precursor 302 
and 2-formylindole.186 The key photoredox step was achieved using only 1 mol% of a [Ru(byp)3Cl2] 
catalyst under blue LED irradiation for 12 h which provided 82% of the desired material 303. 
Removal of the aldehyde group and further functional group manipulation provided advanced 
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intermediate 304 which was oxidised with NBS to give imine 305, and then cyclised with ethyl 
oxalyl chloride under basic conditions to give 306 which was deprotected with BCl3 to give (+)-
gliocladin C in ten steps and 30% overall yield (Scheme 7.3). 
 
Scheme 7.3: Reagents and Conditions: i) [Ru(bpy)3Cl2] (1.0 mol%), Bu3N (2.0 eq), 2-formylindole (5.0 eq), DMF, blue 
LEDs, 12 h, (82%). ii) NBS (1.0 eq), CH2Cl2, DBU, rt, (99%). iii) ClCOCO2Et, Et3N, 150 °C, microwaves, 30 min, (76%). 
iv) BCl3, CH2Cl2, -78 °C to rt, 12 h, (80%). 
Seminal contributions to this area of synthesis have also emanated from the Overman laboratory. 
After publishing the first synthesis of (+)-gliocladin C in 2007,187 the group revisited this target, 
streamlining the synthesis and using (+)-di-(Boc)gliocladin 312 as a platform for the preparation of 
no fewer than five ETP natural products188 and the first total synthesis of plectosphaeroic acid B.189 
In this second generation synthesis of (+)-gliocladin, an asymmetric Steglich rearrangement of 
indolyl carbonate 308 using Fu’s chiral PPY catalyst 314 was performed on scales of up to fifteen 
grams to generate the required 3,3-disubstituted oxindole 309 in 96% yield and 96% ee. Further 
elaboration and coupling of aldehyde 310 with trioxopiperazine derivative 315 gave (+)-di-
(Boc)gliocladin 312 on multigram scale that could either be deprotected to give (+)-gliocladin, or 
used as a convenient starting material in the synthesis of further ETP derivatives (Scheme 7.4).190 
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Scheme 7.4: Reagents and Conditions: i) 2,2,2-Trichloro-1,1-dimethylethyl chloroformate, Et3N, THF, 0 °C (97%). ii) 314 
(5 mol%), THF, rt, (96%, 98% ee). iii) NaBH4, MeOH, 0 °C (81%). iv) HC(OMe)3, PPTS (10 mol%), MeOH, 65 °C 
(83%, 1.2:1 dr). v) a) LiBH4!MeOH, Et2O, rt to 40 °C. b) Dess-Martin periodinane, pyridine, CH2Cl2, rt (80%; 2 steps). 
vi) LDA, 315, THF, -78 °C then 310 then AcOH, -78 °C to rt (75%). vii) BF3!Et2O, CH2Cl2, -78 °C to -40 °C (80%). viii) 
Neat, 175 °C (89%). 
7.3.2 Retrosynthetic Core Strategy 
Our interest in these indole alkaloid scaffolds stemmed from the considerable synthetic challenge 
associated with stereocontrolled generation of the C(3)-quaternary all carbon centre. While 
Overman adopted Fu’s indolyl carbonate rearrangement methodology to great effect, it was 
necessary for the groups of Movassaghi and Stephenson to develop bespoke methodologies for this 
purpose. Given the high levels of stereocontrol obtained using simple alkylarylketenes, our 
methodology could be applicable to this class of natural products and would provide an ideal 
scaffold on which to explore its strengths and limitations. Consequently, initial investigations 
toward asymmetric 3-alkyl-3-indolyl oxindoles were undertaken. 
7.3.3 Synthetic Investigations 
Investigations began with preparation of N-(methyl-3-indolyl)benzylketene according to a literature 
preparation by Fu and co-workers.108 N-Methylation of indole-3-acetic acid using NaH and MeI 
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proceeded on forty gram scale with the product 316 isolated after a single aqueous work-up.  
n-BuLi mediated double deprotonation of acid 316 and alkylation with benzyl bromide gave acid 
317 in 90% yield without the need for chromatographic purification. Conversion of acid 317 to the 
corresponding acid chloride with oxalyl chloride occurred in almost quantitative yield, giving 318. 
Acid chloride 318 was found to decompose on attempted purification via Kugelrohr distillation or 
rapid flash column chromatography over silica. Instead, this acid chloride was prepared and used 
directly to form the desired ketene 319, which was also used as a crude solution in THF. Treatment 
of enantiopure N-TIPBS nitrone 144 with an excess of N-(methyl-3-indolyl)benzylketene yielded 
oxindole 320 in 88% yield and 88% ee (Scheme 7.5) (a racemic sample of oxindole (±)-320 for 
HPLC analysis was obtained from the same ketene solution and diphenylnitrone 48 in comparable 
yield). 
The related N-(methyl-3-indolyl)benzylketene was also prepared in a similar manner. Alkylation of 
N-(methyl)indole-3-acetic acid 316 with MeI provided disubstituted acid 321 in 97% yield. 
Treatment of acid 321 with oxalyl chloride gave acid chloride 322 in quantitative yield, which was 
used directly without purification. Dehydrohalogenation of acid chloride 322 under slightly 
modified conditions gave N-(methyl-3-indolyl)methylketene 323, used as a crude solution in THF. 
Treatment of enantiopure N-TIPBS nitrone 144 with an excess of N-(methyl-3-
indolyl)methylketene solution gave the desired oxindole species 324 in moderate 58% yield, but 
promising 84% ee (Scheme 7.5).  
 
Scheme 7.5: Reagents and Conditions: i) NaH (5.0 eq), MeI (2.7 eq), 0 °C to rt, 16 h. ii) n-BuLi (2.1 eq), -78 °C then R-X 
(2.1 eq), 0 °C to rt, 16 h. iii) (COCl)2, DMF (1 drop). PhCH3, 0 °C, 3 h. iv) a) N,N-DMEA (4.0 eq), THF, 0 °C, 16 h. b) 
N,N-DMEA (3.0 eq), THF, 0 °C, 16 h. 
After promising initial results with model alkyl-indolyl substrates, attention was next turned to 
incorporation of a suitable functional handle to allow expedient access to the desired 
hexahydropyrrole core structure. Consequently the following retrosynthetic analysis was proposed, 
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where it was hoped to incorporate a pendant phthalimide protected nitrogen in order to facilitate 
cyclisation after deprotection (Fig 7.5).  
 
Fig 7.5: Original retrosynthetic analysis of pyrroloindoline alkaloid core structure. 
Originally, we planned to alkylate N-methyl-3-indoleacetic acid using 316 in a similar manner to 
previous alkylations using the requisite bromide 325 and n-BuLi. However, upon attempting this 
procedure, solely β-elimination from N-(2-bromoethyl)phthalimide was observed, forming olefin 
326 and returning unreacted N-methyl-3-indoleacetic acid. This proved to be a recurring problem 
with this bromide species. Alternative reaction conditions and bases were evaluated in this reaction, 
as was the use of phenylacetic acid methyl ester 327, however all proved ineffective at preferentially 
enabling alkylation over elimination (Fig 7.6).  
 
Starting Material Base/Reagents Solvent/Conditions 
316 n-BuLi (2.1 eq) THF/-78 °C to rt 
316 LDA (2.2 eq) THF/-78 °C to rt 
316 LDA (2.2 eq) or n-BuLi (2.1 eq) THF/DMPU -78 °C to rt 
316 n-BuLi (2.1 eq)/5.0 eq R-Br THF/-78 °C to rt 
327 LDA (1.1 eq) THF/-78 °C to rt 
327 NaH (1.0 eq) DMF/ rt 
327 NaH (4.0 eq) DMF/ rt 
Fig 7.6: Attempted alkylations using N-(2-bromoethyl)phthalimide. 
As sporadic literature reports191 suggested that alkylations of malonates with N-(2-
bromoethyl)phthalimide 325 were possible in polar solvents, this was the next approach we chose 
to explore. Indol-3-ylmalonate species 328 was already available in the laboratory, and so a screen 
of conditions was undertaken to ascertain the feasibility of alkylating this species. However, the 
variety of conditions tested all failed to provide the desired alkylated material 329 in greater than 
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10% conversion. Once more, the major reaction product was that of β-elimination: 2-
vinylisoindoline-1,3-dione, 326 (Fig 7.7). 
 
Base/Reagents Solvent/Conditions 329:(328 and 326) 
NaH (1.1 eq) then R-Br (1.0 eq) DMF/100 °C, 5h 0:100 
NaH (1.1 eq) then R-Br (5.0 eq) DMF/rt, 72 h 5:95 
K2CO3 (1.1 eq) then R-Br (1.5 eq) DMF/rt, 24 h 0:100 
K2CO3 (1.1 eq) then R-Br (1.5 eq) Acetone/50 °C, 24 h No reaction 
KOtBu (1.1 eq) then R-Br (1.5 eq) Acetone/50 °C, 24 h 0:100 
LHMDS (1.05 eq) then R-Br (3.0 eq) THF/ 0 °C to rt, 16 h No reaction 
LHMDS (1.05 eq) then R-Br (3.0 eq) THF/ 0 °C to 60 °C, 16 h 0:100 
Fig 7.7: Attempted malonate alkylations using N-(2-bromoethyl)phthalimide. 
With preferential elimination preventing direct alkylation with N-(2-bromoethyl)phthalimide, we 
selected an alternative alkylation strategy using 1,2-dibromoethane. With the desired malonate in 
hand from our previous approach, we sought to mono-alkylate, thereby leaving a pendant bromide 
functionality to allow for phthalimide substitution. Alkylation of 328 with 1,2-dibromoethane 
proceeded in 61% yield without the need for purification. Direct substitution of terminal bromide 
330 with potassium phthalimide in DMF at 140 °C then provided an approximately 2:1 mixture of 
329 and 331, 331 presumably formed by in situ decarboxylation under the reaction conditions 
mediated by the KBr by-product. 329 and 321 could be separated by column chromatography, 
although at this point, they were isolated only on a small scale (Scheme 7.6).  
 
Scheme 7.6: Reagents and Conditions: i) NaH (1.5 eq), 1,2-dibromoethane (2.0 eq), THF, 75 °C, 16 h, (61%). ii) 
K+Phthalimide- (1.2 eq), DMF, 140 °C, 16 h, 329 (30%), 331 (62%). 
This strategy provided a proof-of-concept that the desired ketene precursors could be generated, 
however, as less than 100 mg of material was available, it was not possible to effectively validate the 
ketene forming reaction on such a scale. Therefore, the simpler phenyl derivative 336 was 
synthesised by a similar route in order to investigate the stability of phthalimido-substituted 
O
MeO
O
OMe
NMe
O
MeO
O
OMe
NMe
N
O
O
O
MeO
O
OMe
MeN
N
O
O
328 329 328 326
O
MeO
O
OMe
NMe
O
MeO
O
OMe
BrMeN
O
MeO
O
OMe
MeN
N
O
O
O
MeO
MeN
N
O
O
i) ii)
61% yield
92% combined yield
329 = 30%/331 = 62%
328 330 329
331
 
 Chapter 7: Application Towards the Synthesis of Biologically Relevant Species 
 90 
ketenes. Initially, commercially available malonate 332 proved reticent to alkylation under the same 
reaction conditions as the previous indolyl series, however after optimisation 333 was isolated on 
four gram scale in 34% yield. Substitution with potassium phthalimide occurred as desired with no 
in situ decarboxylation observed. Krapcho decarboxylation192 gave ethyl ester 335 in 44% yield and 
basic hydrolysis gave just over one gram of acid 336 as a white solid. Treatment with oxalyl chloride 
and catalytic DMF gave acid chloride 337, which was used without further purification. However, 
attempted dehydrohalogenation with N,N-DMEA in either Et2O, or THF, failed to provide any 
evidence of ketene formation after monitoring over time via IR and 1H NMR spectroscopy 
(Scheme 7.7). 
 
Scheme 7.7: Reagents and Conditions: i) NaH (2.0 eq), DMF, 1,2-dibromoethane (2.0 eq), 90 °C, 16 h. ii) K+Phthalimide- 
(1.2 eq), DMF, 80 °C, 16 h. iii) LiCl (5.0 eq), H2O (2.0 eq), DMF, 180 °C, 4 h. iv) LiOH (5.0 eq), EtOH/H2O, rt, 4 h. v) 
(COCl)2 (2.0 eq), DMF (1 drop), PhCH3, rt, 3 h. vi) N,N-DMEA (1.05 eq), THF or Et2O, 0 °C 1-8 h. 
As the initial expectation had been that alkylation with N-(2-bromoethyl)phthalimide would 
provide rapid, convenient access to pyrrolindoline core structures, the lengthy synthetic 
preparations of these derivatives and poor results in initial ketene forming evaluations led us to 
abandon this approach and instead focus on preparation of allyl(indolyl)ketenes. Within the group, 
allylphenylketene was prepared previously and was well tolerated in reaction with enantiopure 
nitrones giving the desired oxindole in 93% yield and 80% ee (with N-Boc nitrone 66). 
Additionally, a robust three-step synthetic route for the transformation of such allyl-oxindoles to 
hexahydropyrrolidines had also been demonstrated.104 Consequently the following revised 
retrosynthetic analysis was proposed incorporating an allyl- functional handle (Fig 7.8).  
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Fig 7.8: Revised retrosynthetic analysis of pyrroloindoline alkaloid core structure. 
7.3.4 Further Studies with Allyl(Indolyl)Ketenes 
With N-Methylindole-3-acetic acid 316 already available, the analogous N-Bn protected variant 338 
was prepared in 61% yield and acid chlorides 341 and 342 prepared according to known chemistry. 
Double deprotonation with n-BuLi and allylation with allyl bromide again proceeded well on 
multigram scale giving the desired disubstituted acids 339 and 340 in consistently greater than 75% 
yield (based on multiple preparations). The acids could then be converted to the acid chlorides 
under standard oxalyl chloride/DMF conditions as and when required. Again, as previously found 
with related indolyl substrates, these acid chlorides were difficult to purify, not amenable to storage 
and consequently were prepared and used directly (Scheme 7.8). 
 
Scheme 7.8: Reagents and Conditions: i) NaH (5.0 eq), R-X (2.7 eq), 0 °C to rt, 16 h. ii) n-BuLi (2.1 eq), -78 °C then Allyl-
Br (1.5 eq), 0 °C to rt, 16 h. iii) (COCl)2, DMF (1 drop), PhCH3, 0 °C, 3 h. iv) N,N-DMEA (1.5 eq), 0 °C, 2 h. 
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After optimisation and monitoring of the reaction via IR spectroscopy, the optimum conditions for 
formation of allyl(indolyl)ketenes from the acid chloride were found to be using 1.5 equivalents of 
N,N-DMEA in THF and stirring at 0 °C for 1h 15 min before treating the reaction mixture with 
hexane prior to filtration. This allowed for the generation of relatively clean THF/hexane solutions 
of crude ketene, albeit in very poor yields (estimated at <25% yield based on observed levels of 
conversion). Both N-Me 343 and N-Bn 344 variants of the allyl(indole)ketene could be formed 
under the same conditions, and were evaluated in reaction with achiral nitrone 48 and enantiopure 
N-TIPBS nitrone 144. However upon treating a THF solution of nitrone 48 with an excess of 
either crude ketene solution 343 or 344, no oxindole formation was observed. In these reactions, 
consumption of the nitrone starting material was observed by TLC and crude 1H NMR 
spectroscopy but no concomitant generation of product. Similarly on treatment of enantiopure N-
TIPBS nitrone 144 with an excess of the crude ketene solution at either rt or -78 °C, no reaction 
was observed and the nitrone was clearly visible by TLC analysis. 
Seeking an explanation for this puzzling result, a recent publication138 by Houk and co-workers on 
the Fischer indole cyclisation, a related [3,3]-heteroaromatic sigmatropic rearrangement, caused us 
to consider alternative nitrone structures. In a synthetic and computational study, the authors 
sought an explanation as to the failure of certain Fischer indole cyclisations and concluded that 
“…excessive stabilisation of heterolytic N-N bond cleavage precludes the products of the [3,3]-
sigmatropic rearrangement, leading instead to the dissociation of the ene-hydrazine intermediate.” 
In effect an electron-donating residue, for example an indolyl group, is suggested to disfavour the 
[3,3]-pathway of the Fischer indole reaction and instead lead to dissociative fragmentation, which is 
in turn stabilised by formation of a -complex prior to fragmentation in solution. This can be 
tentatively extrapolated to our related system, in that if the combination of indolyl and allyl residues 
contributes to a stabilisation of the N-O bond, then [3,3]-rearrangement would be inhibited and 
instead a fragmentation event would occur, leading to decomposition. Indeed, we had previously 
observed the deoxygenative fragmentation of the 5-membered intermediate resulting from initial 
[3+2] cycloaddition in our earlier studies using N-tBu nitrone 225 and alkylarylketenes that resulted 
in formation of tBu-imine and an acid (Chapter 4). This was a result of a system where further [3,3]-
rearrangement is precluded by the N-tBu group, however if the intermediate 5-membered 
heterocycle were inherently unstable and/or [3,3]-rearrangement were disfavoured on account of 
stereoelectronic factors, then a similar reaction outcome might be expected even with an N-aryl 
substituent (Fig 7.9).  
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Fig 7.9: Dissociative reaction pathway by analogy to Houk’s computational exploration of precluded Fischer 
indole cyclisations. 
On account of this, we next considered modification of the electronic character of the reaction 
components. To modify the indole-ring of the ketene by incorporating an electron withdrawing 
substituent would seem logical, but would then be undesirable for further elaboration to natural 
product species. Similarly, modifying the N-aryl nitrone ring would again introduce a group not 
desired in the targeted natural products. Therefore, modification of the aldehyde-derived portion of 
the nitrone was investigated, as although this imparts a stereochemical influence on the reaction, it 
would ultimately be cleaved in the acidic quench. After surveying the literature, we selected (Z)-N-
(cyclohexylmethylene)aniline oxide 345 so as to strongly modify the electronic character compared 
to standard achiral diaryl-nitrones, but also because in contrast to other C-alkyl substituted nitrones, 
345 is a recrystallisable solid at room temperature.193  
Condensation of cyclohexanecarbaldehyde and phenylhydroxylamine gave nitrone 345 in 55% yield 
after recrystallisation. Treatment of 345 with crude ketene solution 344 gave, after chromatographic 
purification, the desired 3-allyl-3-indolyl-oxindole 346 in an acceptable 58% yield (Fig 7.10). 
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Additionally, this reaction proved repeatable and scalable (four separate preparations, all within 6% 
yield; up to 300 mg scale). 
 
Fig 7.10: Preparation of cyclohexylnitrone 345 and treatment with ketene 344 to give oxindole 346. 
We next considered translation of these results to our asymmetric reaction protocol. Consequently, 
chiral nitrone 352 was synthesised as its racemate in an identical manner to our preparations of our 
standard TIPBS Garner’s nitrone 144, however beginning from (±)-pipecolinic acid 347 rather than 
(L)-serine. Throughout the synthesis each species could be purified by recrystallisation rather than 
column chromatography, greatly expediting the preparation of 352. 
 
Scheme 7.9: Reagents and Conditions: i) SOCl2 (4.0 eq), MeOH, 0 °C to rt, 16 h. ii) Et3N (2.4 eq), 2,4,6-TIPBSCl (1.05 
eq), CH2Cl2, 0 °C to rt, 16h. iii) LiAlH4 (1.5 eq), THF, 0 °C, 30 min. iv) (COCl)2 (2.0 eq), DMSO (4.0 eq), DIPEA (6.0 
eq), CH2Cl2 -78 °C. vi) PhNHOH (1.05 eq), EtOH, 4 °C, 16 h. 
Treatment of nitrone 352 with crude ketene solution 344 at room temperature however resulted in 
no reaction. Monitoring the reaction via TLC analysis for 24 h clearly showed nitrone 352, and no 
formation of another species. 
 
Fig 7.11: Attempted reaction between allyl(indolyl)ketene and modified chiral nitrone 352. 
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Despite not yet developing a system allowing asymmetric access to the desired oxindole, it was 
decided to use the racemic oxindole, obtained using achiral nitrone 345, to develop and validate a 
concise synthetic route towards (±)-gliocladin C. 
7.3.5 (±)-Gliocladin C 
With racemic oxindole 346 in hand, we explored elaboration toward (±)-gliocladin C. This was 
planned to initiate with ozonolysis, followed by imine formation and reductive cyclisation in a 
similar manner to the route employed in our previous publication104 (Chapter 1 - Fig 1.40). The 
ability to utilise this methodology in the synthesis of gliocladin C would rest in the ability to 
intercept imine intermediate 354 with a suitable nucleophile in order to provide a synthetic handle 
for the synthesis of the ketopiperazine ring fragment of the molecule. Trost and co-workers 
managed this via a Strecker reaction with TMS-CN followed by a nitrile hydrolysis under extremely 
specific conditions.194 Seeking to avoid this complex approach, we envisaged accessing 353 via a 
multi-component Ugi reaction,195 which would introduce the necessary α-amide group necessary 
for elaboration to the ketopiperazine-ring of the gliocladin family, along with the required amine in 
order to affect cyclisation to the pyrroloindoline core (Fig 7.12).  
 
Fig 7.12: End-game retrosynthetic strategy. 
Firstly, N-benzyl protection of oxindole 346 yielded dibenzyl species 355 in 94% yield. Subjecting 
this material to ozonolysis conditions however provided none of the expected aldehyde. Rather, 
broad undefined signals were observed by 1H NMR spectroscopy, suggesting formation of 
polymeric material. Treatment of 355 with catalytic OsO4 and NMO afforded crude dihydroxyl-
intermediate 356 as an inconsequential 1:1.6 mixture of diastereoisomers that were directly 
subjected to oxidative cleavage conditions with NaIO4, giving aldehyde 357 in quantitative yield 
over two steps. Pre-formation of imine 358 and then treatment with benzyl isocyanide and TFA 
provided diamide 359 as a 1.5:1 mixture of diastereoisomers. After column chromatography, a 
single diastereoisomer was isolated cleanly in 42% yield. It was envisaged that the relative 
configuration of this diastereoisomer could be tentatively assigned after deprotection and 
cyclisation by comparison to 1H NMR data of related species before being confirmed later by X-ray 
crystallographic analysis. However, attempted N-trifluoroacetamide deprotection and cyclisation in 
a single step using DIBAL-H failed to provide any of the desired hexahydropyrrolindole, instead 
giving a complex mixture of products including residual starting material as observed by 1H and 19F 
NMR spectroscopy (Scheme 7.10).  
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Scheme 7.10: Reagents and conditions: i) NaH (1.2 eq), BnBr (1.2 eq), DMF, 0 °C to rt, 2h. ii) OsO4 (cat.), NMO (2.0 eq), 
CH2Cl2, rt, 48 h. iii) NaIO4 (2.0 eq), CH2Cl2, rt, 6 h. iv) BnNH2 (1.0 eq), MgSO4 (1.0 eq), THF, rt, 16 h. v) BnNC (0.95 
eq), TFA (1.05 eq), CH2Cl2, rt, 16 h. vi) DIBAL-H (10.0 eq), THF, rt, 8 h.  
7.3.6. Towards Completing a Synthesis of (±)-Gliocladin C 
Currently, synthetic efforts within the group are focused on preparing more racemic oxindole 357 
in order to optimise the Ugi reaction, by variation of reaction conditions and of the imine 
component and in doing so facilitate a more divergent protecting group strategy. In parallel with 
this, investigations aim to validate the chosen synthetic route by converging with a known 
intermediate en route to Gliocladin C. In order to converge with Stephenson’s route to Gliocladin 
C, it would first be necessary to affect N-trifluoroacetamide deprotection and cyclisation to give bi-
cycle 360. Subsequent methylation of the exocyclic amide and selective double deprotection would 
afford required precursor 362. We were hopeful that with judicious choice of protecting groups and 
reaction conditions, this selective double deprotection would be achievable. For example, variation 
of the amine or the isocyanide components of the Ugi reaction would allow for introduction of 
differing protecting groups such as N-PMP or N-Cbz. Whilst we were conducting this work, 
Zhang and co-workers provided validation for such a route by publishing a similar approach to a 
formal intermediate of gliocladin C, in which they adopted an almost identical strategy196 using a 
catalytic Ugi protocol introduced by List.197 Subsequent repetition of Stephenson’s two-step 
protocol186 with NBS and  ethyl oxalyl chloride would install the desired ketopiperazine ring and 
finally, a double benzyl deprotection, which has been reported by Overman,187 would give the 
desired (±)-gliocladin C 299 (Scheme 7.11). At this stage, time constraints, coupled with the 
necessity to synthesise more precursor material meant that efforts towards the synthesis of  
(±)-gliocladin C are still on-going within the laboratory. 
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Scheme 7.11: Proposed reagents and conditions: i) NaH, MeI. ii) tbc – dependent on Ugi reaction. iii) NBS, CH2Cl2, 
DBU. iv) ClCOCO2Et, Et3N, heat (according to Stephenson prep.).186 v) Na/NH3 (according to Overman prep.).187 
7.4. Conclusions from Chapter 7 
Two distinct applications of our oxindole forming nitrone-ketene cycloaddition methodology have 
been demonstrated. Firstly, the asymmetric preparation of known Roche anti-cancer agent 14 in 
52% yield and 96% ee has been achieved in four steps making use of a novel ketene species that did 
not necessitate purification. At the time of undertaking this synthesis, no asymmetric route to this 
compound was known, with the Roche route reliant on a chiral HPLC separation of the 
enantiomers. Furthermore, our synthesis provided novel regioisomeric oxindole 297 that would 
also be of interest for biological evaluation.  
A second more widespread approach aimed to demonstrate the potential utility of this asymmetric 
oxindole forming methodology as a key-step in natural product synthesis. This has provided insight 
into and highlighted limitations of this reaction system. Initial attempts to prepare a 
indole(phthalimido)substituted ketene proved unsuccessful and therefore use of an allyl group as a 
functional handle was adopted. Treatment of achiral diarylnitrones and enantiopure N-TIPBS 
nitrones with such indolyl(allyl)ketenes failed to provide any evidence of oxindole formation, yet 
did result in consumption of starting material. However, cyclohexanecarboxaldehyde derived 
nitrone 345 proved a compatible substrate for such ketene species, generating the requisite oxindole 
(±)-346 in 58% yield. Given the success with this nitrone, we prepared a structurally related chiral 
nitrone 352 as its racemate, yet on treatment with ketene 344 this nitrone also failed to show any 
evidence of reactivity. Currently, we do not have a satisfactory explanation for these observations. 
Continuing with our racemic material, the product oxindole 346 was then elaborated through a four 
step-protocol en route to a formal intermediate of (±)-gliocladin C 299. This synthetic route is only 
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in its infancy, and does need to be repeated and optimised to assign the relative configuration of the 
Ugi reaction product 359 and to complete the formal synthesis of (±)-gliocladin C. Elucidation of 
the appropriate chiral nitrone, or the incorporation of a resolution step would render the synthesis 
asymmetric. 
The ability to access key oxindole intermediate 346 in essentially a single step clearly demonstrates 
the potential utility of this nitrone-ketene cycloaddition methodology in total synthesis. The C(3)-
indolyl group is common to a range of oxindole alkaloids and the allyl group provides a 
manipulable synthetic handle for potential elaboration to numerous members based around a 
hexahydropyrrolindolyl core (Fig 7.13).  
 
Fig 7.13: Key oxindole intermediate 346, proposed access to Gliocladin C and potential access to calabar 
alkaloid (±)-chimonanthine. 
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Conclusions & Outlook 
This thesis has described the optimisation and application of a novel asymmetric pericyclic cascade 
approach to 3,3-disubstituted oxindoles. Initial studies focused on optimisation of the 
stereoinduction in the reaction between nitrones and ketenes by variation of the nitrone 
component. In doing so, N-TIPBS nitrone 144, derived from a modified Garner’s aldehyde 
oxazolidine core structure, was identified as the optimal nitrone component in terms of the yield 
and enantiomeric excess of the generated oxindoles. Additionally, this N-TIPBS nitrone scaffold 
proved reasonably stable, and able to tolerate a variety of N-aryl substituents. These substituted 
nitrones were then used to great effect in both our regioselectivity studies and in the synthesis of a 
range of asymmetric 3-alkyl-3-aryl and spirocyclic oxindoles. Also demonstrated, using a substituted 
N-TIPBS nitrone, was the concise asymmetric synthesis of Roche p53 inhibitor 14, which was 
achieved in 52% yield and 96% ee. This highlights the potential of such a methodology to deliver 
other specific medicinal targets based around this oxindole framework. This pericyclic cascade 
methodology has also formed the key part of an emerging natural product program allowing access 
to a key intermediate en route to ketopiperazine-derived indole alkaloid gliocladin C 299, albeit in 
racemic form at present. Similarly, these investigations have highlighted limitations of the current 
system in that no reactivity is observed between enantiopure N-TIPBS nitrones and the requisite 
allyl(indolyl)ketenes. Therefore, further study is warranted to ascertain why this lack of reactivity is 
observed with such ketenes and if this could be circumvented, either through redesign of the chiral 
nitrone, or through modification of the ketene component. 
 
Concluding Figure 1: Conclusions from the work described in this thesis. 
Further investigations in this area should focus on development of an asymmetric catalytic variant 
of the same reaction, building on the initial studies with ketenimines as described in Chapter 6 of 
this thesis. These initial studies identified promising reactivity between ketenimines and achiral 
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diarylnitrones, but much further study would be needed in order to identify a suitable catalytic 
system capable of delivering the desired oxindoles in good yields and enantioselectivities. 
Nevertheless, these initial studies highlighted the increased stability of ketenimine species relative to 
standard ketenes, raising the possibility of generating more highly functionalised ketenimine 
components and so expediting the construction of biologically relevant species. The development 
of such a catalytic asymmetric cycloaddition cascade between nitrones and ketenimines is highly 
desirable and could prove amenable to further complex molecule synthesis. 
 
Concluding Figure 2: Potential development of a catalytic asymmetric system using ketenimines and proposed 
application to complex molecule synthesis. 
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Chapter 8: Experimental Details 
8.1. General Information  
Reactions involving moisture sensitive reagents were performed under an argon atmosphere using 
standard vacuum line techniques with anhydrous solvents. In this instance, glassware was flame 
dried and allowed to cool under vacuum prior to use. Solvents (THF, CH2Cl2, toluene, hexane and 
Et2O) were obtained anhydrous and purified by an alumina column (Mbraun SPS-800). Petroleum 
ether is defined as petroleum ether 40-60 °C. Benzaldehyde was purified by washing with 2M 
NaOH solution, followed by 10% Na2CO3 solution and finally H2O. It was then dried over MgSO4 
and distilled under reduced pressure. Et3N was dried by distillation from CaH2 and stored under an 
atmosphere of argon. All other solvents and commercial reagents were used as supplied without 
further purification unless stated otherwise.  
Room temperature (rt) refers to 20-25 °C. Temperatures of 0 °C and -78 °C were obtained using 
ice/water and CO2(s)/acetone baths respectively. Any other cryogenic temperatures used are 
described within the procedures. Reflux conditions were obtained using DrySyn heating apparatus 
and a contact thermometer.  
In vacuo refers to the use of a Büchi Rotavapor R-2000 rotary evaporator with a Vacubrand CVC2 
vacuum controller or a Heidolph Laborota 4001 rotary evaporator with a vacuum controller. 
Kugelrohr distillations were performed on an apparatus with a Büchi glass oven and drive unit 
operating at high vacuum (2-3 mmHg). 
Analytical thin layer chromatography was performed on pre-coated aluminium plates (Kieselgel 60 
F254 silica). TLC visualisation was carried out with ultraviolet light (254 nm), followed by staining 
with a 1% aqueous KMnO4 solution. Flash column chromatography was performed on Kieselgel 
60 silica eluting with the solvent system stated.  
1H, 13C and 19F nuclear magnetic resonance (NMR) spectra were acquired on either a Bruker 
Avance 300 (300 MHz 1H, 75 MHz 13C, 282 MHz 19F), Bruker Avance II 400 (400 MHz 1H, 100 
MHz 13C, 376 MHz 19F) or a Bruker Avance II 500 (500 MHz 1H, 125 MHz 13C, 470 MHz 19F) 
spectrometer at ambient temperature in the deuterated solvent stated. All chemical shifts are quoted 
in parts per million (ppm) relative to the residual solvent as the internal standard. All coupling 
constants, J, are quoted in Hz to the nearest 0.1 Hz. Multiplicities are indicated by: s (singlet), d 
(doublet), t (triplet), q (quartet), quint (quintet), sept (septet), oct (octet), m (multiplet), dd (doublet 
of doublets) etc. The abbreviation br denotes broad and app. denotes apparent. The abbreviation 
Ar is used to denote aromatic, and Ph used to denote a singularly substituted phenyl ring for 
reasons of clarity when it may otherwise be ambiguous. CHaHb is used to denote diastereotopic 
vicinal protons. Infrared spectra (νmax) were either recorded on a Perkin-Elmer Spectrum GX FT-
IR spectrometer using thin-films on KBr discs or a Shimadzu ATR (attenuated total reflectance) 
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zinc-selenide cell FTIR 8400S. Only the characteristic peaks are quoted. Melting points were 
recorded on an Electrothermal 9100 apparatus. The abbreviation (decomp.) denotes 
decomposition. HPLC analyses were obtained on a Gilson HPLC consisting of a Gilson 305 pump, 
Gilson 306 pump, Gilson 811C dynamic mixer, Gilson 805 manometric module, Gilson 401C 
dilutor, Gilson 213XL sample injector and sample detection was performed with a Gilson 118 
UV/vis detector. Separation was achieved using Chiralcel OD-H and OJ-H columns or a Chiralpak 
AD-H and AS-H column using the eluent system and flow rate stated. Mass spectrometry (m/z) 
data were acquired by electrospray ionisation (ES), electron impact (EI) or nanospray ionisation 
(NSI) either at the University of St Andrews or the EPSRC National Mass Spectrometry Service 
Centre, Swansea. At the University of St Andrews, low and high resolution ESI-MS were carried 
out on a Micromass LCT spectrometer. At the EPSRC National Mass Spectrometry Service Centre, 
low resolution NSI-MS was carried out on a Micromass Quattro II spectrometer and high 
resolution NSI-MS on a Thermofisher LTQ Orbitrap XL spectrometer. Optical rotations were 
measured on a Perkin Elmer Precisely/Model-341 polarimeter operating at the sodium D line with 
a 100 mm path cell. 
8.2. General Procedures 
General Procedure A for Alkylarylketene Preparation All alkylarylketenes were prepared from 
the corresponding acid chlorides according to literature procedures and with analytical data in 
accordance with the literature.1 Representative Procedure: To a stirred solution of the requisite 
acid chloride (1.0 eq) in dry Et2O (1 mmol/mL) at 0 °C was added N,N-dimethylethylamine  
(1.1 eq) dropwise and the reaction stirred for 16 h at 0 °C. After this time, the reaction mixture was 
allowed to warm to rt before being filtered under argon. The Et2O was then removed under 
reduced pressure and the resulting crude oil purified via Kugelrohr distillation under reduced 
pressure to furnish the ketene which was stored under nitrogen in the freezer. 
General Procedure B for Hydroxylamine Preparation To a stirred solution of nitro-aromatic 
compound (1.0 eq) in THF (1 mmol/mL) at 0 °C was added Rh/C (ca. 10 mol %), followed by 
hydrazine monohydrate (1.2 eq) dropwise and the reaction stirred rapidly for 3 h allowing to warm 
to rt. The reaction mixture was filtered through a celite plug, the residue rinsed with CH2Cl2 and the 
filtrate concentrated in vacuo. The crude solid was purified via recrystallisation from 
CH2Cl2:petroleum ether to yield a solid which was stored in the freezer. 
General Procedure C for Nitrone Preparation To a stirred solution of the requisite nitro-
aromatic compound (1.0 eq) in EtOH:H2O (1:1 – 0.5 mmol/mL) was added the requisite aldehyde 
(1.0 eq) and NH4Cl (1.3 eq). The reaction mixture was cooled to 0 °C and zinc powder (2.0 eq) 
added portionwise over 1h, before being stirred 16 h, allowing to warm to rt. The reaction mixture 
was filtered through a celite plug that was rinsed several times with CH2Cl2 and the phases 
separated. The aqueous phase was extracted with CH2Cl2 (×3) and the combined organic phases 
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concentrated in vacuo. The crude solid was purified via recrystallisation from CH2Cl2:petroleum ether 
to yield a solid which was stored on the benchtop unless otherwise stated. 
General Procedure D for Nitrone Preparation To a stirred solution of the requisite aldehyde 
(1.0 eq) in CH2Cl2 (0.25 mmol/mL) under argon was added MgSO4 (1.1 eq) and the reaction 
mixture stirred for 5 min at rt. After this time, the requisite hydroxylamine (1.0 eq) was added and 
the reaction stirred until analysis by TLC showed consumption of starting material. The mixture 
was filtered to remove MgSO4 and concentrated in vacuo. The crude nitrones were either purified by 
column chromatography over silica (10-50% EtOAc in petroleum ether) or used crude with no 
further purification. 
General Procedure E for Racemic Oxindole Synthesis To a stirred solution of the requisite 
diarylnitrone (1.0 eq) in dry THF (0.15 mmol/mL) under argon was added dropwise a solution of 
the requisite ketene (1.0 eq) in dry THF (1 mL) and the reaction stirred at rt for 30 min. The 
reaction was quenched with aq. 2M HCl (ca. 0.5 mL) and stirred for a further 15 min before being 
extracted with Et2O (3 × 10 mL). The combined organic phases were washed with sat. aq. 
NaHCO3, dried over Na2SO4, filtered and concentrated in vacuo to give a crude oil which was 
purified by column chromatography over silica (0-40% EtOAc in petroleum ether) to yield the 
oxindole.  
General Procedure F for Asymmetric Oxindole Synthesis A stirred solution of the requisite 
enantiopure nitrone (1.0 eq) in dry THF (0.15 mmol/mL) under argon was cooled to -78 °C. To 
the reaction was added dropwise a solution of the requisite ketene (1.0 - 2.0 eq) in dry THF (1 mL) 
and the reaction stirred at -78 °C until analysis by TLC showed consumption of nitrone. The 
reaction was quenched with aq. 2M HCl (ca. 0.5 mL) and stirred for 30 min, allowing to warm to rt 
before being extracted with Et2O (3 × 10 mL). The combined organic phases were washed with sat. 
aq. NaHCO3, dried over Na2SO4, filtered and concentrated in vacuo to give a crude oil which was 
purified by column chromatography over silica (0-40% EtOAc in petroleum ether) to yield the 
oxindole. 
General Procedure G for Alkylation of Arylacetic acids A stirred solution of the requisite 
arylacetic acid (1.0 eq) in dry THF (0.2 mmol/mL) under argon was cooled to -78 °C. A solution of 
n-butyllithium (2.1 eq, 2.5 M in hexanes) was added dropwise and the reaction stirred at -78 °C for 
35 min. The cooling bath was then removed and the reaction mixture allowed to warm to ambient 
temperature for ca. 45 min. The requisite alkyl bromide or chloride (1.2 - 2.0 eq) was added slowly 
and the reaction mixture stirred 16 h at rt. After such time, the resulting suspension was quenched 
with H2O and diluted with Et2O. The resulting layers were separated and the aqueous phase acified 
with 2M HCl. The aqueous phase was extracted with Et2O (× 3) and the combined organic phases 
washed with brine, dried over MgSO4, filtered and concentrated in vacuo to yield the crude 
disubstituted acids as solids, or as viscous oils which crystallised on standing. The crude acids were 
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generally used without purification, unless otherwise stated, however if necessary were triturated 
with warm petroleum ether before filtering and washing repeatedly with hexane to yield the solid 
disubstituted acids. 
General Procedure H for Acid Chloride Preparation To a stirred solution of the requisite 
carboxylic acid (1.0 eq) in toluene (0.5 mmol/mL) was added thionyl chloride (2.0 eq) dropwise and 
the reaction mixture heated to 80 °C for 3-16 h. After such time, the reaction mixture was filtered 
and concentrated in vacuo to yield crude brown oils which were either used crude without 
purification or purified by Kugelrohr distillation to yield the acid chlorides as colourless or pale 
yellow liquids which were stored under argon in the fridge. 
General Procedure I for Acid Chloride Preparation A stirred solution of the requisite carboxylic 
acid (1.0 eq) and catalytic DMF (2 drops) in toluene (0.5 mmol/mL) was cooled to 0 °C. Oxalyl 
chloride (1.0 - 2.0 eq) was added dropwsie to the reaction mixture which was stirred for between  
1-4 h at 0 °C. The reaction mixture was filtered and concentrated in vacuo to yield crude brown oils 
which were either used crude without purification or purified by Kugelrohr distillation to yield the 
acid chlorides as colourless or pale yellow liquids which were stored under argon in the fridge. 
References for this section: 
1. a) Douglas, J.; Taylor, J. E.; Churchill, G.; Slawin, A. M. Z.; Smith, A. D. J. Org. Chem. 2013, 78, 
3925-3938. b) Hodous B. L.; Fu G. C. J. Am. Chem. Soc. 2002, 124, 1578-1579. c) Baigrie L. M.; 
Seiklay H. R.; Tidwell T. T. J. Am. Chem. Soc. 1985, 107, 5391-5396. d) Pracejus H.; Wallura G. J. 
Prakt. Chem. 1963, 19, 33-38. e) Sudo, A.; Uchino, S.; Endo, T. J. Polym. Sci. Part A: Polym. Chem. 
2001, 39, 2093-2102. 
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8.3. Experimental Details for Chapter 2: Initial Studies & Investigating the Origin of 
Asymmetry 
Hydroxylaminesa  
N-Phenylhydroxylamine 72 
The hydroxylamine was prepared according to general procedure B from 
nitrobenzene (2.00 g, 16.4 mmol), Rh/C (0.020 g, cat.) and hydrazine monohydrate (0.88 mL, 1.2 
eq, 19.7 mmol) in THF (20 mL) to give 72 (1.47 g, 82%) as a white solid; mp 82-83 °C {lit.1 80-81 
°C}; 1H NMR (400 MHz, CDCl3) δ 7.30-7.26 (2H, m, ArH), 7.05-7.01 (3H, m, ArH), 6.82 (1H, br 
s), 5.68 (1H, br s). 
N-(o-Tolyl)hydroxylamine 73 
The hydroxylamine was obtained from 2-nitrotoluene (2.00 g, 14.5 mmol), Rh/C 
(0.020 g, cat.) and hydrazine monohydrate (0.84 mL, 1.2 eq, 17.4 mmol) in THF (20 mL) following 
general procedure B to yield 73 (1.25 g, 70%) as a white solid; mp 36-37 °C {lit.2 44 °C}; 1H NMR 
(300 MHz, CDCl3) δ 7.32-7.26 (2H, m, ArH), 7.13 (1H, d, J = 7.2, ArH), 6.97 (1H, td, J = 7.2, 1.7, 
ArH), 6.80 (1H, br s), 5.80 (1H, br s), 2.20 (3H, s, ArCH3). 
N-(m-Tolyl)hydroxylamine 74 
The hydroxylamine was obtained from 3-nitrotoluene (2.00 g, 14.5 mmol), Rh/C 
(0.020 g, cat.) and hydrazine monohydrate (0.84 mL, 1.2 eq, 17.4 mmol) in THF (20 mL) following 
general procedure B to yield 74 (1.52 g, 85%) as an off-white solid; mp 66-67 °C {lit.3 66-68 °C}; 
1H NMR (300 MHz, CDCl3) δ 7.17 (1H, t, J = 7.8, ArH), 6.85-6.81 (3H, m, ArH), 6.80 (1H, br s), 
5.79 (1H, br s), 2.33 (3H, s, ArCH3). 
N-(p-Tolyl)hydroxylamine 75 
The hydroxylamine was obtained from 4-nitrotoluene (2.00 g, 14.5 mmol), Rh/C 
(0.020 g, cat.) and hydrazine monohydrate (0.84 mL, 1.2 eq, 17.4 mmol) in THF (20 mL) following 
general procedure B to yield 75 (1.20 g, 67%) as a white solid; mp 82-83 °C {lit.4 82-84 °C};  
                                                      
a In certain instances discrepencies between the melting points of our hydroxylamines and the literature data 
exist. However, given the 1H NMR data obtained for these compounds and that for other hydroxylamines 
prepared via the same method (e.g. 74 and 75) the melting points correlate well with the literature data, we are 
confident in data presented here-in. 
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1H NMR (300 MHz, CDCl3) δ 7.10 (2H, d, J = 8.3, ArH(3,5)), 6.92 (2H, d, J = 8.3, ArH(2,6)), 6.70 
(1H, br s), 5.48 (1H, br s), 2.30 (3H, s, ArCH3). 
N-(2-Chlorophenyl)hydroxylamine 76 
 The hydroxylamine was prepared according to general procedure B from 1-chloro-2-
nitrobenzene (7.00 g, 44.4 mmol), Rh/C (0.100 g, cat.) and hydrazine monohydrate (2.59 mL, 1.2 
eq, 53.3 mmol) in THF (60 mL). The crude product was purified by recrystallisation from ice-cold 
CH2Cl2:petroleum ether to yield 76 (5.03 g, 78%) as a white solid; mp 43-44 °C {lit.5 52 °C};  
1H NMR (300 MHz, CDCl3) δ 7.07-6.96 (4H, m, ArH). 
N-(3-Chlorophenyl)hydroxylamine 77 
The hydroxylamine was prepared according to general procedure B from 1-chloro-3-
nitrobenzene (7.00 g, 44.4 mmol), Rh/C (0.080 g, cat.) and hydrazine monohydrate solution (2.59 
mL, 1.2 eq, 53.3 mmol) in THF (60 mL). The crude product was recrystallised from ice cold 
CH2Cl2:petroleum ether to yield 77 (4.25 g, 67%) as a white solid; mp 56-57 °C {lit.5 49 °C};   
1H NMR (400 MHz, CDCl3) δ 7.19 (1H, t, J = 8.0, ArH(5)), 7.04 (1H, t, J = 2.0, ArH(2)), 6.94 (1H, 
ddd, J = 8.0, 2.0, 0.9, ArH(6)), 6.83 (1H, ddd, J = 8.0, 2.0, 0.9, ArH(4)), 6.80 (1H, br s), 5.47 (1H, br 
s). 
N-(4-Chlorophenyl)hydroxylamine 78 
 The hydroxylamine was prepared according to general procedure B from 1-
chloro-4-nitrobenzene (2.00 g, 12.7 mmol), Rh/C (0.020g, cat.) and hydrazine monohydrate (0.47 
mL, 1.2 eq, 15.2 mmol) in THF (20 mL) to yield 78 (0.590 g, 32%) as a white solid; mp 80-81 °C 
{lit.5 88 °C}; 1H NMR (300 MHz, CDCl3) δ 7.27-7.23 (2H, m, ArH(3,5)), 6.96-6.92 (2H, m, 
ArH(2,6)). 
N-(4-Fluorophenyl)hydroxylamine 79 
 The hydroxylamine was prepared according to general procedure B from 1-
fluoro-4-nitrobenzene (7.00 g, 49.6 mmol), Rh/C (0.100 g, cat.) and hydrazine monohydrate (2.89 
mL, 1.2 eq, 59.5 mmol) in THF (60 mL) to leave a crude yellow solid that was purified by 
trituration from petroleum ether to leave 79 (4.74 g, 92%) as a grey solid; mp 84-85 °C {lit.5 100 
°C}; 1H NMR (300 MHz, CDCl3) δ 7.03-6.99 (2H, m, ArH(3,5)), 6.97-6.94 (2H, m, ArH(2,6)). 
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N-(4-(Trifluoromethyl)phenyl)hydroxylamine 80 
 The hydroxylamine was prepared according to general procedure B from 4-
nitrobenzotrifluoride (6.00 g, 31.4 mmol), Rh/C (0.080 g, cat.) and hydrazine monohydrate (1.83 
mL, 1.2 eq, 37.7 mmol) in THF (65 mL) to yield 80 (3.85 g, 69%) as a white solid; mp 83-84 °C;  
1H NMR (300 MHz, CDCl3) δ 7.53 (2H, d, J = 8.5, ArH(3,5)), 7.05 (2H, d, J = 8.5, ArH(2,6)); 19F 
NMR (282 MHz, CDCl3) δ -63.7 (ArCF3). 
N-(4-Methoxyphenyl)hydroxylamine 81 
 The hydroxylamine was prepared according to general procedure B from 4-
nitroanisole (1.00 g, 6.53 mmol), Rh/C (0.010 g, cat.) and hydrazine monohydrate (0.69 mL, 1.2 eq, 
7.84 mmol) in THF (10 mL) to yield 81 (0.505 g, 56%) as an off-white solid; mp 84-85 °C {lit.6 86-
94 °C}; 1H NMR (400 MHz, CDCl3) δ 7.03-7.00 (2H, m, ArH(3,5)), 6.89-6.87 (2H, m, ArH(2,6)), 
5.70 (1H, br s), 3.81 (3H, s, OMe). 
N-(2-Bromophenyl)hydroxylamine 82 
 The hydroxylamine was obtained from 1-bromo-3-nitrobenzene (1.50 g, 7.43 mmol), 
Rh/C (0.030 g, cat.) and hydrazine monohydrate (0.43 mL, 1.2 eq, 8.91 mmol) in THF (20 mL) 
following general procedure B to yield 82 (0.991 g, 72%) as an off-white solid; mp 60-61 °C  
{lit.5 34 °C}; 1H NMR (300 MHz, CDCl3) δ 7.45 (1H, d, J = 7.8, ArH), 7.32-7.29 (2H, m, ArH), 
7.10 (1H, br s), 6.86-6.84 (1H, m, ArH), 5.39 (1H, br s).  
N-(3-Bromophenyl)hydroxylamine 83 
 The hydroxylamine was obtained from 1-bromo-3-nitrobenzene (1.50 g, 7.43 
mmol), Rh/C (0.030 g, cat.) and hydrazine monohydrate (0.43 mL, 1.2 eq, 8.91 mmol) in THF (20 
mL) following general procedure B to yield 83 (1.08 g, 78%) as an off-white solid; mp 67-68 °C 
{lit.5 66 °C}; 1H NMR (300 MHz, CDCl3) δ 7.21-7.19 (1H, m, ArH), 7.11-7.08 (2H, m, ArH), 6.90-
6.87 (1H, m, ArH), 6.78 (1H, br s), 5.27 (1H, app. d, J = 2.4).  
N-(4-Bromophenyl)hydroxylamine 84 
 The hydroxylamine was prepared according to general procedure B from 1-
bromo-4-nitrobenzene (1.50 g, 7.43 mmol), Rh/C (0.030 g, cat.) and hydrazine monohydrate (0.43 
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mL, 1.2 eq, 8.91 mmol) in THF (20 mL) to yield 84 (1.17 g, 85%) as an off-white solid; mp 94-95 
°C {lit.5 91 °C}; 1H NMR (300 MHz, CDCl3) δ 7.38 (2H, d, J = 9.0, ArH(3,5)), 6.87 (2H, d, J = 9.0, 
ArH(2,6)), 6.76 (1H, br s), 5.44 (1H, br s).  
Diarylnitrones 
(Z)-N-Benzylideneaniline oxide 48 
  The nitrone was prepared according to general procedure C from nitrobenzene (10.3 
mL, 100 mmol), benzaldehyde (10.2 mL, 1.0 eq, 100 mmol), NH4Cl (6.96 g, 1.2 eq, 120 mmol) and 
zinc powder (13.1 g, 2.0 eq, 200 mmol) in EtOH:H2O (1:1 400 mL) to yield 48 (10.5 g, 53%) as a 
white solid; mp 115-116 °C {lit.7 110-112 °C}; 1H NMR (300 MHz, CDCl3) δ 8.42-8.39 (2H, m, 
+N-ArHortho), 7.93 (1H, s, +N=CH), 7.80-7.77 (2H, m, ArH), 7.51-7.47 (6H, m, ArH). 
(Z)-N-Benzylidene-4-fluoroaniline oxide 89 
 The nitrone was prepared according to general procedure D from 79 (4.74 g, 37.3 
mmol), MgSO4 (0.500 g, 1.1 eq, 41.0 mmol) and benzaldehyde (3.69 mL, 0.97 eq, 36.2 mmol) in 
CH2Cl2 (35 mL) and the reaction mixture stirred 2 h at rt before filtering and concentrating in vacuo 
to yield 89 (5.17 g, 64%) as a grey solid which was used without further purification; mp 154-155 
°C {lit.8 169-170.3 °C}; 1H NMR (400 MHz, CDCl3) δ 8.42-8.40 (2H, m, +N-ArHortho), 7.91 (1H, s, 
+N=CH), 7.83-7.80 (2H, m, ArH), 7.52-7.51 (3H, m, ArH), 7.22-7.17 (2H, m, ArH). 
 (Z)-N-Benzylidene-4-(trifluoromethyl)aniline oxide 90 
  The nitrone was prepared according to general procedure D from 80 (3.00 g, 
16.9 mmol), MgSO4 (0.400g, 1.1 eq, 18.6 mmol) and benzaldehyde (1.72 mL, 0.97 eq, 16.4 mmol) 
in CH2Cl2 (30 mL) and the reaction mixture stirred for 2 h at rt. After this time, the reaction 
mixture was filtered and concentrated in vacuo to yield an off-white solid which was triturated with 
petroleum ether to yield 90 (4.38 g, 98%) as a white solid; mp 150 °C {lit.9 54-56 °C}; 1H NMR 
(400 MHz, CDCl3) δ 8.42-8.39 (2H, m, +N-ArHortho), 7.91 (1H, s, +N=CH), 7.83-7.80 (2H, m, ArH), 
7.52-7.51 (3H, m, ArH), 7.22-7.17 (2H, m, ArH). 
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(Z)-N-Benzylidene-4-methoxyaniline oxide 70 
 The nitrone was prepared according to general procedure C from p-nitroanisole 
(5.00 g, 1.0 eq, 32.2 mmol), benzaldehyde (3.29 mL, 1.0 eq, 32.2 mmol), NH4Cl (2.27 g, 1.3 eq, 42.0 
mmol) and zinc powder (4.26 g, 2.0 eq, 64.4 mmol) in EtOH:H2O (1:1 200 mL) to yield 70 (7.10 g, 
97%) as a grey solid; mp 122-123 °C {lit.9 129-130 °C}; 1H NMR (400 MHz, CDCl3) δ 8.39-8.37 
(2H, m, +N-ArHortho), 7.88 (1H, s, +N=CH), 7.75-7.72 (2H, m, ArH), 7.50-7.45 (3H, m, ArH), 6.99-
6.95 (2H, m, ArH), 3.87 (3H, s, OMe). 
(Z)-N-Benzylidene-2-chloroaniline oxide 87 
   The nitrone was prepared according to general procedure D from 76 (2.50 g, 17.4 
mmol), MgSO4 (2.30 g, 1.1 eq, 19.1 mmol) and benzaldehyde (0.89 mL, 0.5 eq, 8.70 mmol) in 
CH2Cl2 (25 mL) to yield 87 as a yellow oil (3.86 g, quant.); 1H NMR (300 MHz, CDCl3) δ 8.43-8.40 
(2H, m, ArH), 7.68-7.65 (2H, m, ArH), 7.62 (1H, s, +N=CH), 7.57-7.53 (3H, m, ArH), 7.45-7.42 
(2H, m, ArH). 
(Z)-N-Benzylidene-3-chloroaniline oxide 88 
  The nitrone was prepared according to general procedure D from 
hydroxylamine 77 (3.10 g, 21.6 mmol), MgSO4 (2.37 g, 1.1 eq, 23.8 mmol) and benzaldehyde (2.01 
mL, 0.9 eq, 19.6 mmol) in CH2Cl2. (30 mL) to give 88 (4.80 g, quant.) as a pale yellow solid;  
mp 69-70 °C {lit.10 96-96.5 °C}; 1H NMR (400 MHz, CDCl3) δ 8.43-8.40 (2H, m, +N-ArHortho), 7.93 
(1H, s, +N=CH), 7.85 (1H, td, J = 6.9, 0.7, ArH), 7.71 (1H, dt, J = 6.9, 2.2, ArH), 7.53-7.45 (5H, m, 
ArH). 
(Z)-N-Benzylidene-4-chloroaniline oxide 69 
 The nitrone was prepared according to general procedure C from benzaldehyde 
(1.29 mL, 12.7 mmol), 1-chloro-4-nitrobenzene (2.00 g, 1.0 eq, 12.7 mmol), NH4Cl (0.88 g, 1.3 eq, 
16.5 mmol) and zinc (1.66 g, 2.0 eq, 25.4 mmol) in EtOH:H2O (1:1 40 mL) to yield 69 (1.36 g, 
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47%) as an off-white solid; mp 152-153 °C {lit.9 164-166 °C}; 1H NMR (400 MHz, CDCl3) δ 8.40-
8.37 (2H, m, +N-ArHortho), 7.91 (1H, s, +N=CH), 7.76-7.74 (2H, m, ArH), 7.50-7.45 (5H, m, ArH). 
(Z)-N-Benzylidene-4-methylaniline oxide 71 
 The nitrone was prepared according to general procedure D from 73 (0.234 g, 1.89 
mmol), benzaldehyde (0.200 mL, 1.0 eq, 1.89 mmol) and MgSO4 (0.250 g, 1.0 eq, 2.26 mmol) in 
CH2Cl2 (7 mL) to yield 71 (0.406 g, quant.) as a yellow solid; mp 101-102 °C {lit.11 95-96 °C};  
1H NMR (400 MHz, CDCl3) δ 8.40-8.38 (2H, m, ArH), 7.60 (1H, s, +N=CH), 7.53-7.49 (3H, m, 
ArH), 7.43-7.41 (1H, m, ArH), 7.38-7.30 (3H, m, ArH), 2.47 (3H, s, ArCH3). 
(Z)-N-Benzylidene-3-methylaniline oxide 85 
 The nitrone was prepared according to general procedure D from 74 (0.234 g, 
1.89 mmol), benzaldehyde (0.200 mL, 1.0 eq, 1.89 mmol) and MgSO4 (0.250 g, 1.2 eq, 2.26 mmol) 
in CH2Cl2 (7 mL) to yield 85 (0.502 g, quant.) as a yellow oil, which after extended standing in the 
fridge crystallised to give 85 as a yellow solid; mp 58-59 °C {lit.11 91-92 °C}; 1H NMR (400 MHz, 
CDCl3) δ 8.43-8.41 (2H, m, +N-ArHortho), 7.90 (1H, s, +N=CH), 7.55 (2H, d, J = 8.2, ArH), 7.51-
7.48 (3H, m, ArH), 7.36 (1H, t, J = 8.2, ArH), 7.28 (1H, s, ArH), 2.44 (3H, s, ArCH3). 
(Z)-N-Benzylidene-4-methylaniline oxide 86 
 The nitrone was prepared according to general procedure D from 75 (0.234 g, 
1.89 mmol), benzaldehyde (0.200 mL, 1.0 eq, 1.89 mmol) and MgSO4 (0.250 g, 1.2 eq, 2.26 mmol) 
in CH2Cl2 (7 mL) to yield 86 (0.489 g, quant.) as an off-white solid; mp 105-106 °C {lit.12 114-115 
°C}; 1H NMR (400 MHz, CDCl3) δ 8.39 (2H, dd, J = 8.0, 2.2, +N-ArHortho), 7.90 (1H, s, +N=CH), 
7.67 (2H, d, J = 8.0, ArH), 7.48-7.44 (3H, m, ArH), 7.28-7.25 (2H, m, ArH), 2.42 (3H, s, ArCH3). 
(Z)-N-Benzylidene-2-bromoaniline oxide 91  
 The nitrone was prepared according to general procedure D from 82 (0.438 g, 2.36 
mmol), benzaldehyde (0.240 mL, 1.0 eq, 2.36 mmol) and MgSO4 (0.313 g, 1.1 eq, 2.60 mmol) in 
CH2Cl2 (5 mL) to yield 91 (0.310 g, 48%) as a yellow solid; mp 75-76 °C; νmax cm-1 (KBr) 1406 (N-
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O), 1041 (Ar-Br); 1H NMR (400 MHz, CDCl3) δ 8.38-8.36 (2H, m, ArH), 7.89 (2H, dd, J = 8.2, 1.4, 
ArH), 7.69 (1H, dd, J = 8.2, 1.4, ArH), 7.62 (1H, dd, J = 7.9, 1.6, ArH), 7.58 (1H, s, +N=CH), 7.52-
7.49 (3H, m, ArH); 13C NMR (75 MHz, CDCl3) δ 192.8 (C=N), 148.6 (+NArCipso), 139.4 (ArC), 
134.3 (ArC), 131.8 (ArC), 131.1(ArC), 130.4 (ArC), 130.2 (ArC), 129.5 (ArC), 126.1 (ArC), 116.9 
(ArCBr); m/z (EI+) 276 ([M(79Br)+H]+, 100%) 278 ([M(81Br)+H]+, 100%); HRMS (EI+) 
C13H1179BrON+ ([M+H]+) found 276.0024 requires 276.0019 (+ 0.5 ppm). 
(Z)-N-Benzylidene-3-bromoaniline oxide 92 
 The nitrone was prepared according to general procedure D from 83 (0.438 g, 
2.36 mmol), benzaldehyde (0.240 mL, 1.0 eq, 2.36 mmol) and MgSO4 (0.313 g, 1.1 eq, 2.60 mmol) 
in CH2Cl2 (5 mL) to yield 92 (0.472 g, 72%) as an off-white solid; mp 81-82 °C {lit.13 92 °C};  
1H NMR (400 MHz, CDCl3) δ 8.40-8.37 (2H, m, +N-ArHortho), 7.97 (1H, t, J = 2.0, ArH), 7.90 (1H, 
s, +N=CH), 7.73 (1H, dd, J = 8.1, 2.0, ArH), 7.60 (1H, dt, J = 8.1, 0.9, ArH), 7.49-7.48 (3H, m, 
ArH), 7.36 (1H, t, J = 8.1, ArH). 
(Z)-N-Benzylidene-4-bromoaniline oxide 93 
  The nitrone was prepared according to general procedure D from 84 (0.438 g, 
2.36 mmol), MgSO4 (0.313 g, 1.1 eq, 2.60 mmol) and benzaldehyde (0.240 mL, 1.0 eq, 2.36 mmol) 
in CH2Cl2 (10 mL) to yield 93 (0.51 g, 78%) as an off-white solid; mp 148-149 °C {lit.14 179.5-180 
°C}; 1H NMR (400 MHz, CDCl3) δ 8.39 (2H, td, J = 3.9, 1.7, ArH), 7.92 (1H, s, +N=CH), 7.70-
7.61 (4H, m, ArH), 7.60-7.49 (3H, m, ArH). 
Ethylphenylketene 94 
  The ketene was prepared according to general procedure A, from 2-phenylbutanoyl 
chloride (5.00 g, 27.4 mmol) and N,N-dimethylethylamine (3.27 mL, 30.1 mmol) in Et2O and 
purified by distillation (88 °C, 3 mmHg; {lit.11 88 °C, 3 mmHg}) to yield 94 (2.43 g, 61%) as a 
yellow liquid; 1H NMR (300 MHz, CDCl3,) δ 7.35-7.28 (2H, m, ArH), 7.11-7.02 (3H, m, ArH), 2.30 
(2H, q, J = 7.4, CH2), 1.15 (3H, t, J = 7.4, CH3). 
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Alkylarylketenes 
Methylphenylketene 95 
  The ketene was prepared according to general procedure A, from 2-phenylpropanoyl 
chloride (4.00 g, 23.7 mmol) and N,N-dimethylethylamine (2.83 mL, 1.1 eq, 26.1 mmol) in Et2O 
and purified by Kugelrohr distillation (60 °C, 3 mmHg; {lit.15 40-42 °C, 1 mmHg}) to yield 95 (1.21 
g, 39%) as a yellow liquid; 1H NMR (400 MHz, CDCl3) δ 7.30-7.11 (3H, m, ArH), 7.10-7.02 (2H, 
m, ArH), 2.01 (3H, s, CH3). 
i so-Butylphenylketene 365 
 The ketene was prepared by either Dr Stuart Leckie or Dr James Douglas according to 
general procedure A. 
n-Butylphenylketene 366 
 The ketene was prepared by either Dr Stuart Leckie or Dr James Douglas according to 
general procedure A. 
i so-Propylphenylketene 367 
 The ketene was prepared by either Dr Stuart Leckie or Dr James Douglas according to 
general procedure A. 
Ethyl-(4-methoxyphenyl)ketene 99 
 The ketene was prepared according to general procedure A, from 2-(4-
methoxyphenyl)butanoyl chloride (2.38 g, 11.2 mmol) and Et3N (3.12 mL, 2.0 eq, 22.4 mmol) in 
Et2O and purified by Kugelrohr distillation (170 °C, 3 mmHg) to yield 99 (1.21 g, 61%) as a yellow 
liquid; 1H NMR (300 MHz, CDCl3) δ 6.99-6.75 (2H, m, ArH(2,6)), 6.91-6.86 (2H, m, ArH(3,5)), 
3.79 (3H, s, OMe), 2.41 (2H, q, J = 7.4, CH2), 1.21 (3H, t, J = 7.4, CH3). Data in accordance with 
the literature.16 
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Ethyl-(4-chlorophenyl)ketene 96 
 The ketene was prepared according to general procedure A, from 2-(4-
chlorophenyl)butanoyl chloride (4.00 g, 18.4 mmol) and N,N-dimethylethylamine (2.19 mL, 1.1 eq, 
20.2 mmol) in Et2O and purified by Kugelrohr distillation (134 °C, 3 mmHg) to yield 96 (1.30 g, 39 
%) as a yellow liquid; 1H NMR (300 MHz, CDCl3) δ 7.07-6.94 (4H, m, ArH), 2.41 (2H, q, J = 7.4, 
CH2), 1.21 (3H, t, J = 7.4, CH3). Data in accordance with the literature.16 
Ethyl-(4-bromophenyl)ketene 368 
 The ketene was prepared by either Dr Stuart Leckie or Dr James Douglas 
according to general procedure A. 
Ethyl-(4-fluorophenyl)ketene 97 
 The ketene was prepared according to general procedure A, from 2-
(fluorophenyl)butanoyl chloride (4.70 g, 23.4 mmol) and N,N-dimethylethylamine (2.79 mL, 1.1 eq, 
25.7 mmol) in Et2O and purified by Kugelrohr distillation (104 °C, 3 mmHg) to yield 97 (1.50 g, 
39%) as a yellow liquid; 1H NMR (300 MHz, CDCl3) δ 7.07-6.94 (4H, m, ArH), 2.41 (2H, q, J = 
7.4, CH2), 1.21 (3H, t, J = 7.4, CH3); 19F NMR (282 MHz, CDCl3,) δ -119.4. 
Methyl-(4-tolyl)ketene 98 
 The ketene was prepared according to general procedure A, from 2-(4-
tolyl)propanoyl chloride (3.11 g, 17.0 mmol) and N,N-dimethylethylamine (2.03 mL, 1.1 eq, 18.7 
mmol) in Et2O and purified by Kugelrohr distillation (107 °C, 3 mmHg) to yield 98 (1.56 g, 63%) 
as a yellow liquid; 1H NMR (300 MHz, CDCl3) δ 7.04 (2H, d, J = 8.2, ArH), 6.34 (2H, d, J = 8.2, 
ArH), 2.23 (3H, s, ArCH3), 1.90 (3H, s, CH3). Data in accordance with the literature.17 
O
Et
Cl
O
Et
Br
O
Et
F
O
Me
Me
 
 Chapter 8: Experimental Details 
 122 
Methyl-(4-chlorophenyl)ketene 369 
 The ketene was prepared by either Dr Stuart Leckie or Dr James Douglas 
according to general procedure A. 
Ethyl-(4-tolyl)ketene 100 
 The ketene was prepared according to general procedure A, from 2-(4-
tolyl)butanoyl chloride (2.16 g, 11.0 mmol) and N,N-dimethylethylamine (1.28 mL, 1.1 eq, 12.1 
mmol) in Et2O and purified by Kugelrohr distillation (107 °C, 3 mmHg {lit.18 68-72 °C, 0.2 
mmHg}) to yield 100 (0.92 g, 52%) as a yellow liquid; 1H NMR (300 MHz, CDCl3) δ 7.21 (2H, d, J 
= 8.1, ArH), 7.02 (2H, J = 8.1, ArH), 2.50 (2H, q, J = 7.4, CH2), 2.40 (3H, s, ArCH3), 1.29 (3H, t, J 
= 7.4, CH3). 
Ethyl-(1-naphthyl)ketene 370 
 The ketene was prepared by either Dr Stuart Leckie or Dr James Douglas 
according to general procedure A. 
Ethyl-(2-chlorophenyl)ketene 371 
 The ketene was prepared by either Dr Stuart Leckie or Dr James Douglas according 
to general procedure A. 
Ethyl-(2-tolyl)ketene 372 
 The ketene was prepared by either Dr Stuart Leckie or Dr James Douglas according 
to general procedure A. 
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i so-Propyl(3-thiophene)ketene 373 
 The ketene was prepared by either Dr Stuart Leckie or Dr James Douglas according 
to general procedure A. 
Methylketene 159 
  A stirred solution of zinc powder (excess) in THF at 0 °C was allowed to reflux gently by 
placing the system under partial vacuum. A solution of 2-bromopropionyl bromide (1.20 mL, 11.5 
mmol) in THF was then added dropwise and the etherial solution of methylketene allowed to co-
distill through a condenser into a two neck round bottom flask cooled to -196 °C with liquid 
nitrogen. The solution of ketene was slowly allowed to warm to -78 °C, at which point a pale green 
colour became apparent. The crude solution of ketene was then used immediately in the required 
reactions. 
n-Butylketene 374 
 To a stirred solution of zinc powder (excess) in THF at 0 °C was added dropwise a 
solution of 2-bromohexanoyl bromide (1.0 mL, 6.32 mmol), the reaction stirred 15 minutes at 0 °C 
before stirring was ceased and the solid residues allowed to settle. The crude pale yellow ketene 
solution was then use immediately in the required reactions. 
Phenylketene 375 
  To a stirred solution of zinc powder (excess) in THF at 0 °C was added dropwise a 
solution of 2-chloro-2-phenylacetyl chloride (1.0 mL, 6.29 mmol), the reaction stirred 15 minutes at 
0 °C before stirring was ceased and the solid residues allowed to settle. The crude pale yellow 
ketene solution was then use immediately in the required reactions. 
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Summary of yields and enantiomeric excesses obtained for 3-Ethyl-3-phenylindolin-2-one 
61 using Nitrones Prepared in the Following Section 
The oxindole was obtained according to general procedure F as an off-white solid; 
HPLC analysis: (Daicel Chiralcel OD-H column, eluent: hexane/i-PrOH 80:20, flow 1.5 mL/min, 
wavelength: 254 nm, retention times: 4.1 min (major) and 8.1 min (minor)). The results of the 
HPLC analyses are given in the table below. 
Nitrone Used Oxindole Yield (%) Oxindole e.e. (%) 
104 43 27 (ent.) 
109 25 (±) (<5%) 
113 32 60 
116 37 50 
119 70 80 
122 38 32 
129 60 20 
66 83 84 
134 75 91 
139 61 89 
144 60 96 
Enantiopure Nitrones 
(S)-Ethyl 2-((t e r t-butyldimethylsilyl)oxy)propanoate 111 
To a stirred solution of the commercially available (S)-ethyl 2-hydroxypropanoate 
(3.70 g, 22.3 mmol) in DMF (23 mL) was added imidazole (2.05 g, 1.35 eq, 30.1 mmol) and TBSCl 
(4.20 g, 1.25 eq, 27.8 mmol) and the reaction mixture stirred for 16 h at rt. The reaction mixture 
was then diluted with Et2O (30 mL) and washed successively with H2O (30 mL), aq. 0.1M HCl (30 
mL) and brine (2 × 25 mL). The organic phase was dried over Na2SO4, filtered and concentrated in 
vacuo to yield 111 as a yellow oil (6.26 g, quant.); [α]D
20-23.3° (c = 0.96, CHCl3) {lit.19 [α]D
20 -29.6° (c = 
1.57, CHCl3)}; 1H NMR (300 MHz, CDCl3) δ 4.31 (1H, q, J = 6.8, CH(Me)), 4.22-4.13 (2H, m, 
OCH2CH3), 1.39 (3H, d, J = 6.8, C(H)Me), 1.28 (3H, t, J = 7.1, OCH2CH3), 0.90 (9H, s, tBu), 0.09 
(6H, d, J = 11.8, diMe). 
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(S)-2-((t e r t-Butyldimethylsilyl)oxy)propanal 112 
Dry toluene (10 mL) was charged with DIBAL-H (1M in toluene, 2.80 mL, 2.80 
mmol) under nitrogen and the resulting suspension cooled to -78 °C. A solution of 111 (0.500 g, 
2.15 mmol) in dry toluene (2 mL) was then added dropwise. The reaction was stirred at -78 °C for  
1 h 30 min before being quenched with MeOH (1 mL). A saturated Rochelle salt solution (7 mL) 
was added to the reaction which was stirred rapidly for 10 min allowing to warm to rt. The reaction 
mixture was then extracted with Et2O (3 × 20 mL) and the organic phase washed with sat. aq. 
NaHCO3, dried over Na2SO4, filtered and concentrated in vacuo to yield 112 as a colourless oil (0.29 
g, 70%); [α]D
20 +11.3° (c = 0.96, CHCl3) {lit.20 [α]D
20 +12.8° (c = 1.59, CHCl3)}; 1H NMR (300 MHz, 
CDCl3) δ 9.61 (1H, d, J = 1.3, CHO), 4.09 (1H, qd, J = 6.9, 1.3, CH(Me)), 1.28 (3H, d, J = 6.9, 
C(H)Me), 0.92 (9H, s, tBu), 0.10 (6H, d, J = 3.5, diMe).  
(S)-Ethyl 2-((triisopropylsilyl)oxy)propanoate 117 
To a stirred solution of the commercially available (S)-ethyl 2-hydroxypropanoate 
(1.00 mL, 8.75 mmol) in DMF (10 mL) was added imidazole (0.775 g, 1.3 eq, 11.3 mmol) and 
TIPSCl (2.25 mL, 1.2 eq, 10.5 mmol) and the reaction mixture stirred for 16 h at rt. The reaction 
mixture was then diluted with Et2O (15 mL) and washed successively with H2O (15 mL), 0.1M HCl 
(15 mL) and brine (2 × 10 mL). The organic phase was then dried over Na2SO4, filtered and 
concentrated in vacuo to yield 117 as a colourless oil (2.88 g, quant.) which was used without further 
purification; [α]D
20-11.8° (c = 1.11, CHCl3) {lit.21 [α]D
20 -16.5° (c = 1.95, CHCl3)}; 1H NMR (300 
MHz, CDCl3) δ 4.41 (1H, q, J = 6.7, CH(Me)), 4.18 (2H, dq, J = 7.1, 1.7, OCH2CH3), 1.42 (3H, d, J 
= 6.7, CH(Me)), 1.28 (3H, t, J = 7.1, OCH2CH3), 1.10 (3H, br s, iPrH), 1.07-1.05 (18H, m, iPrCH3).  
(S)-2-((Triisopropylsilyl)oxy)propanal 118 
Dry toluene (10 mL) was charged with DIBAL-H (1M in toluene, 3.79 mL, 3.79 
mmol) under nitrogen and the resulting suspension cooled to -78 °C. A solution of 117 (0.800 g, 
2.92 mmol) in dry toluene (2 mL) was then added dropwise. The reaction was stirred at -78 °C for  
1 h 30 min before being quenched with MeOH (1 mL). A saturated Rochelle salt solution (7 mL) 
was then added to the reaction which was stirred rapidly for 10 min allowing to warm to rt. The 
reaction was then extracted with Et2O (3 × 20 mL) and the organic phase washed with sat. aq. 
NaHCO3, dried over Na2SO4, filtered and concentrated in vacuo to yield 118 as a colourless oil (0.66 
g, 98%); [α]D
20 -5.2° (c = 1.16, CHCl3) {lit.22 [α]D
20 -8.4° (c = 2.72, CHCl3)}; 1H NMR (300 MHz, 
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CDCl3) δ 9.66 (1H, d, J = 1.7, CHO), 4.18 (1H, dq, J = 6.8, 1.7, CHMe), 1.31 (3H, d, J = 6.8, 
CHMe), 1.08-1.05 (21H, m, iPr). 
(S)-Ethyl 2-((tert-butyldiphenylsilyl)oxy)propanoate 120 
To a stirred solution of the commercially available (S)-ethyl 2-hydroxypropanoate 
(1.20 g, 10.2 mmol) in DMF (12 mL) was added imidazole (0.899 g, 1.3 eq, 13.3 mmol) and 
TBDPSCl (2.65 mL, 1.2 eq, 12.2 mmol) and the reaction mixture stirred for 16 h at rt. The reaction 
mixture was then diluted with Et2O (15 mL) and washed successively with H2O (15 mL), aq. 0.1M 
HCl (15 mL) and brine (2 × 10 mL). The organic phase was dried over Na2SO4, filtered and 
concentrated in vacuo to yield a colourless oil which was purified via column chromatography over 
silica (0-20% EtOAc in petroleum ether) to yield 120 as a colourless oil (2.00 g, 55%); [α]D
20 +27.5° 
(c = 1.03, EtOH) {lit.23 [α]D
20 +46° (c = 1.97, EtOH)};  1H NMR (300 MHz, CDCl3) δ 7.73-7.64 
(4H, m, ArH), 7.46-7.33 (6H, m, ArH), 4.27 (1H, q, J = 6.7, CHMe), 4.02 (2H, qd, J = 7.0, 0.6, 
OCH2CH3), 1.37 (3H, d, J = 6.7, CHMe), 1.15 (3H, t, J = 7.0, OCH2CH3), 1.10-1.09 (9H, m, tBu). 
(S)-2-((t e r t-Butyldiphenylsilyl)oxy)propanal 121 
Dry toluene (10 mL) was charged with DIBAL-H (1M in toluene, 1.82 mL, 1.82 
mmol) under nitrogen and the resulting suspension cooled to -78 °C. A solution of 120 (0.500 g, 
1.40 mmol) in dry toluene (2 mL) was then added dropwise. The reaction was stirred at -78 °C for  
1 h 30 min before being quenched with MeOH (1 mL). A saturated Rochelle salt solution (7 mL) 
was then added to the reaction which was stirred rapidly for 10 min allowing to warm to rt. The 
reaction mixture was extracted with Et2O (3 × 20 mL) and the organic phase washed with sat. aq. 
NaHCO3, dried over Na2SO4, filtered and concentrated in vacuo to yield 121 as a colourless oil 
(0.484 g, quant.); [α]D
20-6.9° (c = 1.02, CHCl3) {lit.24 [α]D
20 -15.0° (c = 1.07, CHCl3)}; 1H NMR (300 
MHz, CDCl3) δ 9.65 (1H, d, J = 1.2, CHO), 7.74-7.63 (4H, m, ArH), 7.49-7.33 (6H, m, ArH), 4.09 
(1H, qd, J = 6.9, 1.2, CHMe), 1.22 (3H, d, J = 6.9, CHMe), 1.11 (9H, s, tBu). 
 (R)-Methyl 2-hydroxy-2-phenylacetate 106 
A stirred solution of the commercially available (R)-mandelic acid (4.0 g, 26.3 mmol) 
in MeOH (32 mL) was cooled to 0 °C. To this solution was added thionyl chloride (0.29 mL, 0.15 
eq, 3.95 mmol) dropwise. The ice bath was then removed and the reaction heated at reflux for 1 h 
30 min. After allowing to cool, the reaction was quenched with H2O (10 mL) and extracted with 
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Et2O (3 × 30 mL). The organic phase was washed with sat. aq. NaHCO3 (40 mL), dried over 
Na2SO4, filtered and concentrated in vacuo to yield 106 as a white solid (4.18 g, 96%) which was used 
without further purification; mp 60-61 °C {lit.25 58 °C}; [α]D
20-138.0° (c = 1.02, CHCl3) {lit.26 [α]D
20  
-116° (c = 1.0, CHCl3)}; 1H NMR (400 MHz, CDCl3) δ 7.43-7.31 (5H, m, ArH), 5.11 (1H, d, J = 
5.6, OH), 3.77 (3H, s, OMe), 3.42 (1H, d, J = 5.6, CH(OH)). 
(R)-Methyl 2-((t e r t-butyldimethylsilyl)oxy)-2-phenylacetate 107 
To a stirred solution of 106 (3.70 g, 22.3 mmol) in DMF (23 mL) was added 
imidazole (2.05 g, 1.35 eq, 30.1 mmol) and TBSCl (4.20 g, 1.25 eq, 27.9 mmol) and the reaction 
mixture stirred for 16 h at rt. The reaction mixture was then diluted with Et2O (30 mL) and washed 
successively with H2O (30 mL), aq. 0.1M HCl (30 mL) and brine (2 × 25 mL). The organic phase 
was then dried over Na2SO4, filtered and concentrated in vacuo to yield 107 as a yellow oil (5.92 g, 
quant.); [α]D
20-57.3° (c = 1.00, CHCl3) {lit.27 [α]D
20 -50.0° (c = 1.04, CHCl3)}; 1H NMR (300 MHz, 
CDCl3) δ 7.49-7.45 (2H, m, ArH), 7.32 (3H, td, J = 4.5, 1.6, ArH), 5.24 (1H, s, CH(OTBS)), 3.69 
(3H, s, OMe), 0.92-0.91 (9H, m, tBu), 0.11 (3H, s, SiMe), 0.03 (3H, s, SiMe). 
(R)-2-((t e r t-Butyldimethylsilyl)oxy)-2-phenylacetaldehyde 108 
Dry toluene (10 mL) was charged with DIBAL-H (1M in toluene, 2.32 mL, 2.32 
mmol) under nitrogen and the resulting suspension cooled to -78 °C. A solution of 107 (0.500 g, 
1.78 mmol) in dry toluene (2 mL) was then added dropwise. The reaction was stirred at -78 °C for  
1 h 30 min before being quenched with MeOH (1 mL). A saturated Rochelle salt solution (7 mL) 
was then added to the reaction which was stirred rapidly for 10 min allowing to warm to rt. The 
reaction mixture was extracted with Et2O (3 × 20 mL) and the organic phase washed with sat. aq. 
NaHCO3, dried over Na2SO4, filtered and concentrated in vacuo to yield 108 as a colourless oil 
(0.460 g, quant.); [α]D
20+8.0° (c = 1.07, CHCl3) {lit.28 [α]D
20 +3.1° (c = 1.22, CHCl3)}; 1H NMR (300 
MHz, CDCl3) δ 9.51 (1H, d, J = 2.1, CHO), 7.39-7.38 (4H, m, ArH), 7.36-7.31 (1H, m, ArH), 5.01 
(1H, d, J = 2.1, CH(OTBS)), 0.96-0.94 (9H, m, tBu), 0.12 (3H, s, SiMe), 0.04 (3H, s, SiMe). 
(S)-2-(6-Methoxynaphthalen-2-yl)propanal 103 
 
Dry Et2O (10 mL) was charged with LiAlH4 (2.0 M in THF) (3.91 mL, 1.8 eq, 7.82 mmol) and the 
reaction cooled to 0 °C. A solution of Naproxen (1.00 g, 1.0 eq, 4.34 mmol) in THF (2 mL) was 
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then added dropwise and the reaction stirred for 16 h allowing to warm to rt. The reaction was then 
recooled to 0 °C and quenched with dropwise addition of H2O (2 mL) followed by 1M NaOH(aq) 
solution (10 mL). After stirring for 15 min, the reaction mixture was saturated with MeOH (25 
mL), filtered through a celite plug and the solids washed thoroughly with MeOH (25 mL). The 
MeOH was then removed under reduced pressure, the residue taken up in Et2O (25 mL) and 
washed with brine (3 × 15 mL). The organic phase was dried over Na2SO4, filtered and 
concentrated in vacuo to yield 102 (0.762 g, 82 %) as a white solid; [α]D
20-19.6° (c = 0.94, CHCl3) 
{lit.29 [α]D
20 -17.7° (c = 2.20, CHCl3)}. Alcohol 102 (0.700 g, 3.25 mmol) was then suspended in 
CH2Cl2 (30 mL) at rt to which Dess-Martin periodinane (1.65 g, 1.2 eq, 3.90 mmol) was added and 
the reaction stirred for 40 min at rt. A solution of sodium thiosulfate (8.80 g, 11.0 eq, 35.8 mmol) in 
sat. aq. NaHCO3 (30 mL) was then added to the reaction followed by Et2O (30 mL) and the 
reaction mixture stirred rapidly for ca. 10 mins until it became biphasic and both phases colourless. 
The phases were separated and the aqueous phase extracted with Et2O (3 × 20 mL). The combined 
organic extracts were then washed sequentially with sat. aq. NaHCO3 (20 mL), H2O (20 mL) and 
brine (20 mL) before being dried over Na2SO4, and concentrated in vacuo to yield 103 (0.720 g, 
quant.) as a light brown solid; mp 73-74 °C {lit.30 71-72 °C}; [α]D
20 +5.8° (c = 1.00, CHCl3) {lit.30 
[α]D
20 + 37° (c = 1.00, CHCl3)}; 1H NMR (400 MHz, CDCl3) δ 9.75 (1H, d, J = 1.5, CHO), 7.74 
(2H, dd, J = 13.8, 8.6, ArH), 7.60 (1H, d, J = 1.1, ArH), 7.28 (1H, dd, J = 8.6, 1.8, ArH), 7.17 (1H, 
dd, J = 8.6, 2.4, ArH), 7.13 (1H, d, J = 2.4, ArH), 3.93 (3H, s, OMe), 3.77 (1H, q, J = 6.6, CH(Me)), 
1.52 (3H, d, J = 7.0, CH(Me)). 
(S,Z)-N-(2-(6-Methoxynaphthalen-2-yl)propylidene)aniline oxide 104  
To a solution of 103 (0.173 g, 6.18 mmol) dissolved in a minimum 
quantity of ethanol (ca. 1.5 mL) was added phenylhydroxyalmine 72 (0.130 g, 2.0 eq, 12.4 mmol), 
then the reaction vessel sealed and stored in the fridge for 40 h to yield a white precipitate. This 
precipitate was filtered, washed with EtOH (2 × 5 mL), and dried to yield nitrone 104 (0.105 g, 
56%) as a white solid; mp 115-116 °C; [α]D
20 -77.1° (c = 0.96, CHCl3); 1H NMR (300 MHz, CD2Cl2) 
δ 7.75-7.63 (5H, m, ArH), 7.43-7.39 (4H, m, ArH), 7.14-7.11 (3H, m, ArH & H(R)C=N+), 4.64 
(1H, quint., J = 7.2, CHMe), 3.90 (3H, s, OMe), 1.63 (3H, d, J = 7.2, CHMe); 13C NMR (75 MHz, 
CD2Cl2) δ 158.4 (4ry ArC), 156.7 (ArC), 147.7 (4ry ArC), 142.4 (ArC), 138.3 (HC=N+), 130.6 (ArC), 
129.9 (ArC), 129.8 (ArC), 128.0 (ArC), 127.3 (ArC), 126.2 (ArC), 122.4 (ArC), 119.7 (ArC), 118.4 
(4ry ArC), 106.3 (ArC), 56.1 (OMe), 38.0 (CH(CH3)), 18.6 (CH(CH3)); m/z (EI+) 306 ([M+H]+, 
100%); HRMS (EI+) C20H20O2N+ ([M+H]+) found 306.1491 requires 306.1489 (+ 0.2 ppm). 
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The following β-silyloxy nitrones were found to be unstable with respect to aqueous work-up and purification by silica 
gel column chromatography. Therefore, they were formed invariably in more than quantitative yield due to 
contamination by impurities that were not removed prior to evaluation in our oxindole preparation studies. As a 
consequence, limited characterisation data was obtained. 
(R ,Z)-N-(2-((t e r t-Butyldimethylsilyl)oxy)-2-phenylethylidene)aniline oxide 109 
 The nitrone was obtained from aldehyde 108 (0.320 g, 1.23 mmol), 
phenylhydroxylamine 72 (0.167 g, 1.25 eq, 1.53 mmol) and MgSO4 (0.163 g, 1.1 eq, 1.35 mmol) 
according to general procedure D to yield 109 (0.422 g, 97%) as a crude yellow oil; 1H NMR (300 
MHz, CDCl3) δ 7.55-7.38 (11H, m, ArH & HCN+), 5.07-5.00 (1H, m, CH(OTBS)), 0.93-0.90 (9H, 
m, tBu), 0.10-0.05 (6H, m, diMe).  
(S,Z)-N-(2-((t e r t-Butyldimethylsilyl)oxy)propylidene)aniline oxide 113 
 The nitrone was obtained from aldehyde 112 (0.163 g, 0.87 mmol), 
phenylhydroxylamine 72 (0.113 g, 1.2 eq, 1.04 mmol) and MgSO4 (0.124 g, 1.1 eq, 0.96 mmol) 
according to general procedure D to yield 113 (0.284 g, quant.) as a crude yellow oil which was used 
without further purification; 1H NMR (300 MHz, CDCl3) δ 7.70-7.64 (1H, m, ArH), 7.46-7.40 (4H, 
m, ArH), 7.30-7.27 (1H, m, H(R)C=N+), 5.19 (1H, quint., J = 6.3, CHMe), 1.48 (3H, d, J = 6.3, 
CHMe), 0.92-0.88 (9H, m, tBu), 0.12 (6H, d, J = 6.9, CMe2). 
(S,Z)-N-(2-((Triisopropylsilyl)oxy)propylidene)aniline oxide 119  
 The nitrone was obtained from aldehyde 118 (0.300 g, 1.30 mmol), 
phenylhydroxylamine 72 (0.142 g, 1.0 eq, 1.30 mmol) and MgSO4 (0.172 g, 1.1 eq, 1.40 mmol) 
according to general procedure D to yield 119 (0.424 g, quant.) as a crude yellow oil which was used 
without further purification; 1H NMR (300 MHz, CDCl3) δ 7.70-7.64 (2H, m, ArH), 7.48-7.42 (3H, 
m, ArH), 7.00 (1H, m, H(R)C=N+), 5.27 (1H, quint., J = 6.3, CHMe), 1.51 (3H, d, J = 6.3, CHMe), 
1.09-1.04 (21H, m, iPr). 
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(S,Z)-N-(2-((t e r t-Butyldiphenylsilyl)oxy)propylidene)aniline oxide 122 
 The nitrone was obtained from aldehyde 121 (0.450 g, 1.44 mmol), 
phenylhydroxylamine 72 (0.189 g, 1.2 eq, 1.73 mmol) and MgSO4 (0.191 g, 1.1 eq, 1.58 mmol) 
according to general procedure D to yield 122 (0.663 g, quant.) as a crude yellow oil which was used 
without further purification; 1H NMR (300 MHz, CDCl3) δ 7.71-7.64 (3H, m, ArH), 7.41-7.32 
(12H, m, ArH), 7.14 (1H, d, J = 5.6, H(R)C=N+), 5.30-5.22 (1H, m, CHMe), 1.50 (3H, d, J = 6.4, 
CHMe), 1.12-1.06 (9H, m, tBu). 
(R,Z)-N-((3-(t e r t-Butoxycarbonyl)-2,2-dimethyloxazolidin-4-yl)methylene)aniline oxide 66  
 To a stirred solution of Garner’s aldehyde31 64 (1.10 g, 4.80 mmol) and MgSO4 
(0.433 g, 1.1 eq, 5.28 mmol) was added phenylhydroxylamine 72 (0.524 g, 1.0 eq, 4.80 mmol) and 
the reaction stirred for 16 h at rt. The reaction mixture was then filtered to remove MgSO4 and 
concentrated in vacuo to yield a yellow semi-solid which was purified over silica (0-30% EtOAc in 
petroleum ether) to yield 66 (0.350 g, 23%) as an off-white solid; mp 93-94 °C {lit.11 101 °C}; 
[α]D
20 -83.7° (c = 0.47, CHCl3) {lit.11 [α]D
20 -94.4° (c = 1.00, CHCl3)}; 1H NMR (300 MHz, CDCl3, 
rot.) δ 7.67 (2H, br s, ArH), 7.47 (3H, d, J = 4.0, ArH), 7.34-7.29 (1H, m, H(R)C=N+), 5.17 (1H, t, J 
= 5.1, CH(NRBoc)), 4.31-4.24 (2H, m, CH2OR), 1.66-1.62 (3H, m, CMe), 1.57-1.54 (3H, m, CMe), 
1.51-1.45 (9H, m, tBu). 
Solvent Screen using nitrone 66: (S)-3-Ethyl-3-phenylindolin-2-one 61 
       The oxindole was obtained from chiral 
nitrone 66 (0.070 g, 0.220 mmol) and ethylphenylketene 94 (0.032 g, 1.0 eq, 0.220 mmol) following 
general procedure F in the requisite solvent, and at the required temperature to yield 61 as an off-
white solid; HPLC analysis: (Daicel Chiralcel OD-H column, eluent: hexane/i-PrOH 80:20, flow 
1.5 mL/min, wavelength: 254 nm, retention times: 4.2 min (major) and 8.9 min (minor)). The yields 
and enantiomeric excesses obtained from the screen are given in the table above with typical HPLC 
traces also given overleaf (for the example obtained from THF at -78 °C). 
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HPLC trace for (±)-61: 
 
Peak tR (min) Area (%) 
1 4.07 52.51 
2 8.11 47.49 
HPLC trace for (S)-61: 
 
Peak tR (min) Area (%) 
1 4.21 91.86 
2 8.90 8.14 
 (S)-Methyl 2-amino-3-hydroxypropanoate hydrochloride 124 
 To a stirred solution of (L)-Serine (44.0 g, 0.419 mol) in MeOH (900 mL) cooled to 
< 0 °C using a salted ice bath was added thionyl chloride (153.0 mL, 6.0 eq, 2.10 mol) dropwise and 
the reaction stirred for 16 h allowing to warm to rt.  The reaction mixture was then concentrated in 
vacuo and the residue taken up in Et2O (500 mL) and re-concentrated several times before being 
taken up in Et2O (500 mL) a final time and cooled with an ice bath to allow formation of a white 
precipitate. This precipitate was filtered and washed with cold Et2O (3 × 150 mL) to yield 124 
(59.20 g, 92%) as a white solid; mp 157-158 °C {lit.32 163-165 °C}; [α]D
20 +3.9° (c = 1.14, MeOH) 
{lit.32 [α]D
20 +3.7° (c = 4.0, MeOH)}; 1H NMR (300 MHz, D2O) δ 4.29 (1H, t, J = 3.8, CH(NH2)), 
4.08 (2H, dq, J = 12.5, 3.8, CH2OH), 3.87 (3H, s, CO2Me). 
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(S)-Methyl 3-hydroxy-2-(4-methylphenylsulfonamido) propanoate 130 
To a stirred solution of 124 (2.33 g, 1.0 eq, 15.0 mmol) in CH2Cl2 (50 mL) at 0 °C, 
was added Et3N (3.60 g, 2.4 eq, 35.0 mmol) and the reaction mixture stirred for 5 min at 0 °C. 
Tosyl chloride (3.15 g, 1.1 eq, 16.5 mmol) was added and the reaction mixture stirred for 16 h, 
allowing to warm to rt. The reaction was quenched by addition of H2O (50 mL), the layers 
separated and the aqueous layer extracted with CH2Cl2 (3 × 30 mL). The combined organic layers 
were washed in succession with sat. aq. NaHCO3 (30 mL), 10% aq. citric acid (30 mL), H2O (30 
mL) and brine (30 mL) , dried over MgSO4, filtered and concentrated in vacuo to yield 130 (2.01 g, 
43%) as a white solid; mp 84-86 °C {lit.33 mp 84-85 °C};  + 3.0 (c = 1.0, MeOH) {lit.
33   
+ 12.2 (c = 0.83, CHCl3)}; 1H NMR (400 MHz, CDCl3) δ 7.77 (2H, d, J = 8.3, ArH), 7.34 (2H, d, J 
= 8.0, ArH), 5.35 (1H, d, J = 6.7, NH), 4.02 (1H, dt, J = 7.3, 3.6, NCH), 3.93-3.91 (2H, m, CH2), 
3.65 (3H, s, OCH3), 2.45 (3H, s, ArCH3).   
(S)-Methyl 2,2-dimethyl-3-tosyloxazolidine-4-carboxylate 131 
To a stirred solution of 130 (1.00 g, 1.0 eq, 3.25 mmol) and 2,2-dimethoxypropane 
(6.26 mL, 15.0 eq, 48.0 mmol) in acetone was added BF3!Et2O (0.08 mL, 0.2 eq, 0.600 mmol) and 
the reaction mixture stirred for 3 h at rt. The reaction was treated with Et3N (0.09 mL, 0.2 eq, 0.675 
mmol), stirred for 15 min at rt and then concentrated in vacuo. The residue was then taken up in 
Et2O (25 mL) and washed with sat. aq. NaHCO3 (25 mL). The phases were separated and the 
aqueous layer extracted with Et2O (3 × 25 mL). The combined organic layers were dried over 
MgSO4, filtered and concentrated in vacuo to yield the crude product as a yellow oil which was 
purified via column chromatography over silica (0-30% EtOAc in petroleum ether) to yield 131 
(0.050 g, 45%) as a white solid; mp 98-102 °C {lit.34 mp 95-97 °C};  -86.0 (c = 1.0, CH2Cl2) 
{lit.34  -80.2 (c = 1.0, CH2Cl2)}; 1H NMR (400 MHz, CDCl3) δ 7.80 (2H, d, J = 8.3, ArH), 7.32 
(2H, d, J = 7.9, ArH), 4.46 (1H, dd, J = 6.7, 2.8, CH), 4.16 (1H, dd, J = 9.2, 6.7, CHaHb), 4.08 (1H, 
dd, J = 9.2, 2.8, CHaHb), 3.64 (3H, s, OCH3), 2.45 (3H, s, ArCH3), 1.73 (3H, s, CH3), 1.61 (3H, s, 
CH3). 
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(S)-2,2-Dimethyl-3-tosyloxazolidine-4-carbaldehyde 133 
 To a stirred solution of 131 (0.200 g, 1.0 eq, 0.70 mmol) in toluene at -78 °C was 
added DIBAL-H (0.85 mL, 1.2 eq, 0.85 mmol) dropwise and the reaction stirred at -78 °C for 2 h. 
The reaction was quenched by slow addition of a saturated Rochelle salt solution (5 mL) followed 
by rapid stirring for 30 min, allowing to warm to rt. The reaction mixture was extracted with Et2O 
(3 × 10 mL). The combined organic layers were then washed with sat. aq. NaHCO3, dried over 
MgSO4, filtered and concentrated in vacuo to yield a crude yellow oil which was purified via column 
chromatography over silica (0-15% EtOAc in petroleum ether) to yield 133 (0.168 g, 94%) as a 
colourless oil which was used immediately in the next reaction; 1H NMR (400 MHz, CDCl3) δ 9.49-
9.48 (1H, m, CHO), 7.74 (2H, d, J = 8.3, ArH), 7.32 (2H, d, J = 7.8, ArH), 4.12 (1H, dd, J = 9.2, 
6.7, CHN), 4.11-4.06 (1H, m, CHaHb), 4.05-4.00 (1H, m, CHaHb), 2.44 (3H, s, ArCH3), 1.73 (3H, s, 
CH3), 1.53 (3H, s, CH3). 
(R ,Z)-N-((2,2-Dimethyl-3-tosyloxazolidin-4-yl)methylene)aniline oxide 134 
 To a stirred solution of 133 (0.160 g, 1.0 eq, 0.64 mmol) and MgSO4 (0.084 g, 
1.1 eq, 0.70 mmol) in CH2Cl2 (5 mL) was added phenylhydroxylamine 72 (0.138 g, 2.0 eq, 1.30 
mmol) and the reaction mixture stirred 16 h at rt. The reaction mixture was concentrated in vacuo to 
yield the crude product as a yellow oil which was purified by column chromatography over silica 
(10-60% EtOAc in petroleum ether) to yield 134 (0.152 g, 72 %) as a yellow foam; mp 48-49 °C; 
 -174.5° (c = 1.09, CHCl3); νmax cm-1 (thin-film) 3446, 2310, 1924, 1733, 1458, 1339; 1H NMR 
(400 MHz, CDCl3) δ 7.83 (2H, d, J = 8.3, TsH), 7.64 (2H, d, J = 8.5, TsH), 7.49-7.41 (3H, m, ArH), 
7.34 (2H, d, J = 7.9, ArH), 7.28 (1H, d, J = 6.0, +N=CH), 5.07-5.11 (1H, m, CH), 4.23 (1H, dd, J = 
9.1, 4.8, CHaHb), 4.17 (1H, dd, J = 11.4, 5.1, CHaHb), 2.44 (3H, s, ArCH3), 1.74 (3H, s, CH3), 1.55 
(3H, s, CH3); 13C NMR (125 MHz, CDCl3) δ 147.0 (ArCN+), 144.6 (ArC), 138.8 (ArC), 137.7 (ArC), 
130.8 (ArC), 130.2 (ArC), 129.4 (ArC), 128.0 (ArC), 121.7 (ArC), 99.0 (C(Me2)), 67.6 (CH2), 56.7 
(CHN), 29.2 (CMe2), 24.8 (CMe2), 21.6 (ArCH3); m/z (ES+) 397 ([M+Na]+, 100%), 398 
([M+Na+H]+, 40%); HRMS (ES+) C19H22O4N2SNa+ ([M+Na]+) found 397.1198 requires 397.1199 
(+ 0.2 ppm). 
O
H
N
O
Ts
N
H
O
N
O
Ts
€ 
α[ ]D
20
 
 Chapter 8: Experimental Details 
 134 
(R ,Z)-N-((3-Mesitylsulfonyl-2,2-dimethyloxazolidin-4-yl)methylene)aniline oxide 139 
 (R,Z)-N-((3-Mesitylsulfonyl-2,2-dimethyloxazolidin-4-yl)methylene)aniline oxide 
139 was prepared by project student Lois Manton from serine methyl ester hydrochloride 124.35 
(S)-3-Benzyl-2,2-dimethyloxazolidine-4-carbaldehyde 128 
 (S)-3-Benzyl-2,2-dimethyloxazolidine-4-carbaldehyde 128 was prepared from (S)-
Methyl 2-amino-3-hydroxypropanoate hydrochloride 124 according to a known literature 
procedure36 to yield 128 as a yellow oil (0.206 g, quant.) with data in accordance with the literature 
and used without further purification; [α]D
20 + 3.0° (c = 0.60, CHCl3) {[α]D
20 lit.36 + 5.96° (c = 0.95, 
CHCl3)}; 1H NMR (300 MHz, CDCl3) δ 8.94 (1H, d, J = 4.2, CHO), 7.33-7.28 (5H, m, ArH), 4.08 
(1H, t, J = 8.9, CHCH2), 3.98 (1H, d, J = 12.7, CHaHbPh), 3.87 (1H, dd, J = 8.9, 5.8, CHaHb), 3.45 
(1H, d, J = 12.7, CHaHbPh), 3.36 (1H, ddd, J = 8.9, 5.8, 4.2, CHaHb), 1.46 (3H, s, CH3), 1.32 (3H, s, 
CH3). 
(R ,Z)-N-((3-Benzyl-2,2-dimethyloxazolidin-4-yl)methylene)aniline oxide 129  
 To a stirred solution of 128 (0.206 g, 0.94 mmol) and MgSO4 (0.125 g, 1.1 eq, 
1.03 mmol) in CH2Cl2 (5 mL) was added PhNHOH (0.120 g, 1.2 eq, 1.13 mmol) and the reaction 
stirred for 2 h at rt. The reaction mixture was then concentrated in vacuo and purified via column 
chromatography over silica (0-100% EtOAc in petroleum ether) to yield 129 (0.101 g, 35 %) as a 
yellow solid; mp 72-73 °C; [α]D
20 +31.7° (c = 0.58, CH2Cl2); νmax cm-1 (KBr); 1H NMR (300 MHz, 
CDCl3) δ 7.43-7.40 (2H, m, +N-ArHortho), 7.35-7.22 (6H, m, ArH), 7.00-6.97 (2H, m, ArH), 6.67 
(1H, d, J = 5.5, +NC=H), 4.50-4.42 (2H, m, CHCH2), 3.96 (1H, d, J = 12.8, CH2Ph), 3.83 (1H, td,  
J = 5.5, 2.0, CHCH2), 3.46 (1H, d, J = 12.8, CH2Ph), 1.50 (3H, s, CH3), 1.34 (3H, s, CH3); 13C NMR 
(75 MHz, CDCl3) δ 146.5 (ArCN+), 141.7 (ArCCH2N), 139.6 (HC=N+), 129.9 (ArC), 129.1 (ArC), 
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128.7 (ArC), 128.3 (ArC), 127.5 (ArC), 121.3 (ArC), 96.1 (CMe2), 67.2 (CH2O), 60.1 (CH2Ph), 54.2 
(CHN), 26.9 (2 x CMe2). 
(S)-Methyl 3-hydroxy-2-(2,4,6-triisopropylphenylsulfonamido)propanoate 140   
  To a stirred solution of 124 (4.67 g, 0.030 mol) in CH2Cl2 (60 mL) was added 
dropwise Et3N (9.98 mL, 2.4 eq, 0.07 mol) at 0 °C and the reaction mixture stirred for 5 min at 0 
°C. After this time, 2,4,6-triisopropylbenzenesulfonyl chloride (9.54 g, 1.05 eq, 0.032 mol) was 
added in one portion and the reaction stirred for 16 h allowing to warm to rt. The reaction was 
quenched with H2O (100 mL) before being extracted with CH2Cl2 (3 × 120 mL). The combined 
organic layers were then washed in succession with sat. aq. NaHCO3 (100 mL), 10% citric acid 
solution (100 mL), H2O (100 mL) and brine (100 mL) before being dried over MgSO4, filtered and 
concentrated in vacuo to yield 140 (11.23 g, 97%) as an off-white solid; mp 109-111 °C; [α]D
20 +4.3°  
(c = 0.91, CHCl3); νmax cm-1 (KBr) 3359 (N-H), 3356 (O-H), 2959 (C-H), 1733 (C=O); 1H NMR 
(400 MHz, CDCl3) δ 7.17 (2H, s, ArH), 4.12-4.06 (3H, m, o-iPrH & CHNR), 3.91-3.90 (2H, m, 
CH2), 3.66 (3H, s, COOMe), 2.90 (1H, dt, J = 13.8, 6.9), 1.29-1.24 (18H, m, iPrCH3); 13C NMR (75 
MHz, CDCl3) δ 170.4 (C=O), 153.3 (4ryArC(p-iPr)), 150.3 (4ryArC(o-iPr)), 132.2 (4ryArCSO2), 124.0 
(ArCH), 101.3 (CMe2), 63.7 (CH(COOMe), 57.2 (CH2), 53.0 (COOMe), 34.2 (p-iPrC(CH3)2), 30.0 (o-
iPrC(CH3)2), 24.9 (CMe2, d, J = 12.9), 23.6 (p-iPrC(CH3)2), 23.6 (o-iPrC(CH3)2); m/z (EI+) 386 
([M+H]+, 100%); HRMS (EI+) C19H32O5NS+ ([M+H]+) found 386.1998 requires 386.1996 (+ 0.2 
ppm). 
(S) -Methyl 2,2-dimethyl-3-((2,4,6-triisopropylphenyl)sulfonyl)oxazolidine-4-carboxylate 141 
 To a stirred solution of 140 (5.78 g, 0.015 mol) and pyridinium para-
toluenesulfonate (0.94 g, 0.25 eq, 3.75 mmol) in toluene (200 mL) was added 2,2-
dimethoxypropane (27.7 mL, 15.0 eq, 0.225 mol) and the reaction stirred at 80 °C for 16 h. After 
cooling, the reaction mixture was concentrated in vacuo to yield a crude light-brown oil which was 
purified by column chromatography over silica (0-20% EtOAc in petroleum ether) to yield 141 
(3.00 g, 47 %) as a white solid; mp 106-107 °C; [α]D
20 -32.8° (c = 1.02, CHCl3); νmax cm-1 (KBr) 2963 
(C-H), 1763 (C=O); 1H NMR (300 MHz, CDCl3) δ 7.15 (2H, s, ArH), 4.40 (1H, dd, J = 7.4, 2.1, 1 
× CH2), 4.31-4.24 (3H, m, CHNR & o-iPrH), 4.06 (1H, dd, J = 9.2, 2.1, 1 × CH2), 3.23 (3H, s, 
COOMe), 2.89 (1H, dt, J = 13.8, 6.9, p-iPrH), 1.80 (6H, d, J =11.6), 1.30-1.22 (18H, m, iPrCH3); 13C 
NMR (75 MHz, CDCl3) δ 170.4 (C=O), 153.8 (4ryArC(p-iPr)), 151.8 (4ryArC(o-iPr)), 131.9 (4ry 
ArCSO2), 100.7 (CMe2), 67.5 (CH(COOMe)), 59.1 (CH2OR), 51.9 (COOMe), 34.2 (p-iPrC(CH3)2), 
29.5 (o-iPrC(CH3)2), 27.6 (p-iPrC(CH3)2), 24.8 (CMe2, d, J = 6.7), 23.6 (o-iPrC(CH3)2); m/z (EI+) 426 
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([M+H]+, 100%); HRMS (EI+) C22H36O5NS+ ([M+H]+) found 426.2312 requires 426.2309 (+ 0.3 
ppm). 
Alternative preparation of 141 (avoiding column chromatography): To a stirred solution of 140 (5.78 g, 0.015 
mol) and pyridinium para-toluenesulfonate (0.94 g, 0.25 eq, 3.75 mmol) in toluene (200 mL) was 
added 2,2-dimethoxypropane (27.7 mL, 15.0 eq, 0.225 mol) and the reaction stirred at 100 °C for 
16 h under Dean-Stark conditions. After cooling, the reaction mixture was poured into water, the 
layers partitioned, the organic layer diluted with EtOAc (400 mL) and washed sequentially with sat. 
aq. NaHCO3 (300 mL) and brine (300 mL). The organic layer was then dried over MgSO4, filtered 
and concentrated in vacuo to give a yellow semi-solid which was purified via recrystallisation from 
hexane to give 141 as a white solid in yields of between 40-60% based on multiple preparations. 
(R)-(2,2-Dimethyl-3-((2,4,6-triisopropylphenyl)sulfonyl)oxazolidin-4-yl)methanol 142 
 To a stirred solution of 141 (2.55 g, 6.00 mmol) in THF (18 mL) was added dropwise 
LiAlH4 (2.0M in THF) (4.50 mL, 1.5 eq, 9.00 mmol) at 0 °C, and the reaction stirred at 0 °C for 30 
min. The reaction was then quenched with dropwise addition of H2O (1 mL), followed by addition 
of 40% KOH (1 mL), H2O (3 mL) and EtOAc (5 mL). The resulting slurry was then stirred 
vigorously for 1 h allowing to warm to rt before being filtered through a celite plug and the residue 
washed with EtOAc (30 mL). The reaction mixture was then dried over MgSO4 before being 
filtered and concentrated in vacuo to yield 142 (2.39 g, quant.) as a very viscous colourless oil which 
crystallised as a white solid on standing; mp 80-82 °C; [α]D
20 +5.5° (c = 1.01, CHCl3); νmax cm-1 (thin-
film) 3527 (O-H), 2960 (C-H); 1H NMR (300 MHz, C6D6) δ 7.18 (2H, s, ArH), 4.67 (2H, dt, J = 
13.6, 6.8, o-iPrH), 3.87-3.80 (3H, m, CH2 & CHNR), 2.92 (1H, t, J = 9.3, 1 × CH2OH), 2.70-2.58 
(2H, m, p-iPrH & 1 × CH2OH), 1.88 (3H, s, CMe), 1.77 (3H, s, CMe), 1.36 (3H, d, J = 6.8, o-
iPrCH3), 1.30 (3H, d, J = 6.8, o-iPrCH3), 1.09 (3H, d, J = 6.9, p-iPrCH3); 13C NMR (75 MHz, C6D6) 
δ 153.7 (4ryArC), 151.9 (4ryArC), 134.2 (4ryArCSO2), 124.3 (ArCH), 99.8 (CMe2), 66.2 (CH2), 62.8 
(CH(CH2OH), 59.0 (CH2OH), 34.3 (p-iPrC(CH3)), 29.3 (o-iPrC(CH3)2), 28.8 (p-iPrC(CH3)2), 25.0 
(CMe), 24.8 (CMe), 23.6 (o-iPrC(CH3)), 23.6 (o-iPrC(CH3)); m/z (EI+) 398 ([M+H]+, 100%); HRMS 
(EI+) C21H36O4NS+ ([M+H]+) found 398.2363 requires 398.2360 (+ 0.3 ppm). 
(S)-2,2-Dimethyl-3-((2,4,6-triisopropylphenyl)sulfonyl)oxazolidine-4-carbaldehyde 143 
A solution of DMSO (1.43 mL, 4.0 eq, 20.1 mmol) in CH2Cl2 (25 mL) was added 
dropwise to a stirred solution of oxalyl chloride (0.88 mL, 2.0 eq, 10.1 mmol) in CH2Cl2 (15 mL) 
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cooled to -78 °C and stirred for 15 min. A solution of 142 (2.00 g, 1.0 eq, 5.03 mmol) in CH2Cl2 (30 
mL) was then added slowly and the reaction stirred for 35 min. At -78 °C was added DIPEA (5.22 
mL, 6.0 eq, 30.2 mmol) and the reaction mixture stirred, allowing to warm to rt before being 
quenched with sat. aq. NH4Cl (25 mL). The organic phase was then separated and washed with sat. 
aq. NaHCO3 (30 mL), then brine (2 × 30 mL) before being dried over Na2SO4, filtered and 
concentrated in vacuo to yield 143 (2.03 g, quant.) as a viscous yellow oil which was used without 
further purification; [α]D
20 -23.5° (c = 1.22, CHCl3); νmax cm-1 (thin-film) 2363 (C-H), 1701 (C=O); 
1H NMR (300 MHz, CDCl3) δ 9.00 (1H, d, J = 2.7, CHO), 7.16 (2H, s, ArH), 4.33-4.09 (5H, m, o-
iPrH & CH2 & CHNR), 2.93-2.84 (1H, dt, J = 13.8, 7.1, p-iPrH), 1.81 (6H, d, J = 3.7, CMe2), 1.25 
(18H, t, J = 7.1); 13C NMR (75 MHz, CDCl3) δ 199.3 (C=O), 154.6 (4ryArC(p-iPr)), 151.4 (4ryArC(o-
iPr)), 131.6 (4ryArCSO2), 124.4 (ArCH), 100.7 (CMe2), 65.8 (CH(CHO)), 64.6 (CH2), 34.2 (p-
iPrC(CH3)), 29.3 (o-iPrC(CH3)), 27.9 (p-iPrC(CH3)2), 24.7 (CMe2, d, J = 26.8), 23.5 (p-iPrC(CH3)2); 
m/z (CI+) 396 ([M+H]+, 100%); HRMS (CI+) C21H33NO4S+ ([M+H]+) found 396.2209 requires 
396.2209 (+ 0.1 ppm). 
(R,Z)-N-((2,2-Dimethyl-3-((2,4,6-triisopropylphenyl)sulfonyl)oxazolidin-4-
yl)methylene)aniline oxide  144 
 144 was prepared according to general procedure D from 143 (1.00 g, 2.52 
mmol), MgSO4 (0.334 g, 1.1 eq, 2.77 mmol) and phenylhydroxylamine 72 (0.330 g, 1.2 eq, 3.02 
mmol) in CH2Cl2 (20 mL). The reaction mixture was then filtered and concentrated in vacuo to yield 
a crude brown semi-solid which was triturated from Et2O to yield 144 (0.558 g, 45%) as an off-
white solid; mp 112-113 °C (decomp.); [α]D
20 -12.5° (c = 0.97, CHCl3); νmax cm-1 (KBr) 3274 (N-O), 
2958 (C-H), 2959 (C-H), 1733 (C=O); 1H NMR (300 MHz, CDCl3) δ 7.32-7.27 (3H, m, PhH), 7.21 
(2H, s, ArH(TIPBS)), 7.06-7.03 (2H, m, PhH), 6.75 (1H, d, J = 5.3, HC=N+), 5.11 (1H, ddd, J = 
7.2, 5.3, 1.9, CHNR), 4.51-4.23 (4H, m, CH2 & o-iPrH), 2.89 (1H, dt, J = 13.8, 6.9, p-iPrH), 1.84 
(6H, d, J = 3.2, diMe), 1.29-1.20 (18H, m, iPrCH3); 13C NMR (75 MHz, CDCl3) δ 154.2 (4ryArC), 
151.8 (ArC), 146.3 (4ryArC), 139.1 (ArC), 132.4 (HC=N+), 130.4 (ArC), 129.0 (ArC), 124.4 (ArC), 
121.0 (ArC), 100.2 (CMe2), 68.0 (CH2), 56.1 (CHNR), 34.2 (p-iPrC), 29.2 (p-iPrCH3), 28.0 (o-iPrC), 
25.1 (CMe2), 24.8 (CMe2), 24.6 (o-iPrC), 23.6 (o-iPrCH3); m/z (EI+) 487 ([M+H]+, 100%); HRMS 
(EI+) C27H39O4N2S+ ([M+H]+) found 487.2633 requires 487.2625 (+ 0.8 ppm). 
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8.4. Experimental Details for Chapter 3: Application of N-TIPBS Nitrone in Synthesis 
3,3-Disubstituted Oxindoles 
(±)-3-Methyl-3-phenylindolin-2-one 145 
The oxindole was obtained from nitrone 48 (0.093 g, 0.400 mmol) and 
methylphenylketene 95 (0.053 g, 1.0 eq, 0.400 mmol) following general procedure E, to yield  
(±)-145 (0.076 g, 85%) as a white solid; mp 139-140 °C {lit.1 150-152 °C}; 1H NMR (300 MHz, 
CDCl3) δ 8.88 (1H, br s, NH), 7.35-7.25 (5H, m, ArH), 7.24 (1H, dd, J = 7.6, 1.2, ArH), 7.15 (1H, 
dd, J = 7.4, 0.6, ArH), 7.07 (1H, td, J = 7.5, 0.9, ArH), 6.99 (1H, d, J = 7.8, ArH(7)), 1.84 (3H, s, 
Me); HPLC analysis: racemic (Daicel Chiralcel OD-H column, eluent: hexane/i-PrOH 90:10, flow 
1.0 mL/min, wavelength: 254 nm, retention times: 9.6 min and 19.9 min). 
(S)-3-Methyl-3-phenylindolin-2-one 145 
 The oxindole was obtained from chiral nitrone 144 (0.070 g, 0.144 mmol) and 
methylphenylketene 95 (0.038 g, 2.0 eq, 0.288 mmol) following general procedure F, to yield 145 
(0.019 g, 60%) as an off-white solid; [α]D
20 -24.7° (c = 1.00, CHCl3); HPLC analysis: 98% e.e. (Daicel 
Chiralcel OD-H column, eluent: hexane/i-PrOH 90:10, flow 1.0 mL/min, wavelength: 254 nm, 
retention times: 9.6 min (major) and 20.0 min (minor)). 
(±)-3-Ethyl-3-phenylindolin-2-one 61 
 The oxindole was obtained from nitrone 48 (0.078 g, 0.400 mmol) and 
ethylphenylketene 94 (0.059 g, 1.0 eq, 0.400 mmol) following general procedure E, to yield (±)-61 
(0.090 g, 95%) as a white solid; mp 151-152 °C {lit.1 149-150 °C}; 1H NMR (300 MHz, CDCl3) δ 
8.61 (1H, br s, NH), 7.42-7.36 (2H, m, ArH), 7.35-7.23 (4H, m, ArH), 7.19 (1H, dt, J = 7.5, 0.7, 
ArH), 7.10 (1H, dt, J = 7.5, 1.1, ArH), 6.97 (1H, ddd, J = 7.8, 0.9, 0.6, ArH(7)), 2.47 (1H, dq, J = 
14.7, 7.5, CHaHb), 2.26 (1H, dq, J = 14.7, 7.5, CHaHb), 0.77 (3H, t, J = 7.4, CH3); HPLC analysis: 
racemic (Daicel Chiralcel OD-H column, eluent: hexane/i-PrOH 80:20, flow 1.5 mL/min, 
wavelength: 254 nm, retention times: 4.0 min and 8.5 min).  
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(S)-3-Ethyl-3-phenylindolin-2-one 61 
 The oxindole was obtained from chiral nitrone 144 (0.050 g, 0.103 mmol) and 
ethylphenylketene 94 (0.030 g, 2.0 eq, 0.206 mmol) following general procedure F, to yield 61 
(0.021 g, 86%) as an off-white solid; [α]D
20 -12.4° (c = 0.95, CHCl3); HPLC analysis: 96% e.e. (Daicel 
Chiralcel OD-H column, eluent: hexane/i-PrOH 80:20, flow 1.5 mL/min, wavelength: 254 nm, 
retention times: 4.1 min (major) and 8.5 min (minor)). 
(±)-3-Butyl-3-phenylindolin-2-one 146 
 For determination of ee, a racemic sample of (±)-146 prepared by Dr Nico Duguet 
was used for HPLC analysis; 1H NMR (400 MHz, CDCl3) δ 7.92 (1H, br s, NH), 7.37 (2H, dd, J = 
8.4, 1.2, ArH), 7.22- 7.32 (4H, m, ArH), 7.19 (1H, d, J = 7.1, ArH), 7.09 (1H, td, J = 7.5, 0.9, ArH), 
6.94 (1H, d, J = 7.7, ArH), 2.39 (1H, td, J = 12.7, 4.2, CHaHb), 2.19 (1H, td, J = 12.6, 3.9, CHaHb), 
1.15-1.35 (3H, m, CH2), 0.88-0.97 (1H, m, CH2), 0.81 (3H, t, J = 7.2, CH3); HPLC analysis: racemic 
(Daicel Chiralcel OD-H column, eluent: hexane/i-PrOH 90:10, flow 1.0 mL/min, wavelength: 254 
nm, retention times: 5.4 min and 13.1 min). 
 (S)-3-Butyl-3-phenylindolin-2-one 146 
 The oxindole was obtained from chiral nitrone 144 (0.070 g, 0.144 mmol) and  
n-butylphenylketene 366 (0.076 g, 2.0 eq, 0.288 mmol) following general procedure F, to yield 146 
(0.041 g, 94%) as a colourless oil; [α]D
20 -19.1° (c = 0.95, CHCl3); HPLC analysis: 96% e.e. (Daicel 
Chiralcel OD-H column, eluent: hexane/i-PrOH 90:10, flow 1.0 mL/min, wavelength: 254 nm, 
retention times: 5.6 min (major) and 13.0 min (minor)). 
(±)-3-Ethyl-3-(4-methoxyphenyl)indolin-2-one 147 
 For determination of ee, a racemic sample of (±)-147 prepared by Dr Nico Duguet 
was used for HPLC analysis; 1H NMR (400 MHz, CDCl3) δ 8.73 (1H, br s, NH), 7.27 (2H, d, J = 
8.9, ArH), 7.23 (1H, td, J = 7.6, 0.8, ArH), 7.15 (1H, d, J = 7.1, ArH), 7.06 (1H, t, J = 7.5, ArH), 
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6.94 (1H, d, J = 7.7, ArH), 6.83 (2H, d, J = 8.9, ArH), 3.76 (3H, s, OMe), 2.41 (1H, dq, J = 13.7, 7.0, 
CHaHb), 2.20 (1H, dq, J = 13.8, 7.0, CHaHb), 0.74 (3H, t, J = 7.3, CH3); HPLC analysis: racemic 
(Daicel Chiralcel OD-H column, eluent: hexane/i-PrOH 80:20, flow 1.0 mL/min, wavelength: 254 
nm, retention times: 10.2 min and 30.4 min). 
(S)-3-Ethyl-3-(4-methoxyphenyl)indolin-2-one 147 
 The oxindole was obtained from chiral nitrone 144 (0.070 g, 0.144 mmol) and 
ketene 99 (0.043 g, 1.8 eq, 0.259 mmol) following general procedure F, to yield 147 (0.031 g, 81%) 
as an off-white solid; [α]D
20 -44.9° (c = 1.10, CHCl3); HPLC analysis: 98% e.e. (Daicel Chiralcel OD-
H column, eluent: hexane/i-PrOH 80:20, flow 1.0 mL/min, wavelength: 254 nm, retention times: 
10.0 min (major) and 30.7 min (minor)). 
(±)-3-(4-Chlorophenyl)-3-ethylindolin-2-one 152 
 The oxindole was obtained from nitrone 48 (0.075 g, 0.380 mmol) and ketene 96 
(0.069 g, 1.0 eq, 0.380 mmol) following general procedure E, to yield (±)-152 (0.043 g, 42%) as a 
white solid; mp 147-148 °C; νmax cm-1 (KBr) 3186 (NH), 3084, 2968, 2929, 1705, 1613, 1492, 1470, 
1398, 1320; 1H NMR (300 MHz, CDCl3) δ 7.84 (1H, br s, NH), 7.28-7.21 (5H, m, ArH), 7.13 (1H, 
d, J = 6.8, ArH), 7.07 (1H, td, J = 7.5, 0.9, ArH), 6.92 (1H, d, J = 7.8, ArH(7)), 2.37 (1H, dq, J = 
13.7, 7.2, CHaHb), 2.16 (1H, dq, J = 13.7, 7.2, CHaHb), 0.71 (3H, t, J = 7.2, CH3); 13C NMR (75 
MHz, CDCl3) δ 180.1 (C=O), 141.0 (4ry ArC), 138.6 (4ry ArC), 133.3 (4ry ArC), 132.1 (4ry ArC), 
128.7 (Ar’C), 128.5 (Ar’C), 128.4 (ArC), 125.1 (ArC), 122.8 (ArC), 110.0 (ArC(7)), 57.2 (C3), 30.8 
(CH2), 9.0 (CH3); m/z (EI+) 272 ([M+H]+, 100%); HRMS (EI+) C16H15ClON ([M+H]+) found 
272.0840 requires 272.0837 (+ 0.3 ppm); HPLC analysis: racemic (Daicel Chiralcel OD-H column, 
eluent: hexane/i-PrOH 80:20, flow 1.5 mL/min, wavelength: 254 nm, retention times: 4.1 min and 
12.7 min). 
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(S)-3-(4-Chlorophenyl)-3-ethylindolin-2-one 152 
 The oxindole was obtained from chiral nitrone 144 (0.050 g, 0.103 mmol) and 
ketene 96 (0.037 g, 2.0 eq, 0.206 mmol) following general procedure F, to yield 152 (0.025 g, 89%) 
as an off-white solid; [α]D
20 -38.5° (c = 1.10, CHCl3); HPLC analysis: 96% e.e. (Daicel Chiralcel OD-
H column, eluent: hexane/i-PrOH 80:20, flow 1.5 mL/min, wavelength: 254 nm, retention times: 
3.9 min (major) and 12.8 min (minor)). 
(±)-3-(4-Bromophenyl)-3-ethylindolin-2-one 154 
 For determination of ee, a racemic sample of (±)-154 prepared by Dr Nico Duguet 
was used for HPLC analysis; 1H NMR (300 MHz, CDCl3) δ 9.41 (1H, br s, NH), 7.45-7.42 (2H, m, 
ArH), 7.34-7.22 (3H, m, ArH), 7.16 (1H, d, J = 6.1, ArH), 7.11 (1H, td, J = 7.3, 0.7, ArH), 6.99 
(1H, d, J = 7.7, ArH), 2.43 (1H, dq, J = 13.7, 7.0, CHaHb), 2.23 (1H, dq, J = 13.7, 7.0, CHaHb), 0.77 
(3H, t, J = 7.3, CH3); HPLC analysis: racemic (Daicel Chiralcel OD-H column, eluent: hexane/i-
PrOH 90:10, flow 1.0 mL/min, wavelength: 254 nm, retention times: 8.6 min and 41.1 min).  
(S)-3-(4-Bromophenyl)-3-ethylindolin-2-one 154 
 The oxindole was obtained from chiral nitrone 144 (0.080 g, 0.164 mmol) and 
ketene 368 (0.074 g, 2.0 eq, 0.328 mmol) following general procedure F, to yield 154 (0.021 g, 40%) 
as a white foam; [α]D
20 -35.2° (c = 1.15, CHCl3); HPLC analysis: 94% e.e. (Daicel Chiralcel OD-H 
column, eluent: hexane/i-PrOH 90:10, flow 1.0 mL/min, wavelength: 254 nm, retention times: 8.8 
min (major) and 40.7 min (minor)). 
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(±)-3-Ethyl-3-(4-fluorophenyl)indolin-2-one 150 
 The oxindole was obtained from nitrone 48 (0.060g, 0.304 mmol) and ketene 97 
(0.050 g, 1.0 eq, 0.304 mmol) following general procedure E, to yield (±)-150 (0.052 g, 67%) as a 
white solid; mp 179-180 °C {lit.1 180 °C}; 1H NMR (400 MHz, CDCl3) δ 8.12 (1H, br s, NH), 7.36-
7.32 (2H, m, ArH), 7.30-7.25 (1H, m, ArH), 7.18-7.16 (1H, m, ArH), 7.10 (1H, td, J = 7.5, 0.9, 
ArH), 7.00-6.95 (3H, m, ArH), 2.41 (1H, dq, J = 13.8, 7.1, CHaHb), 2.20 (1H, dq, J = 13.8, 7.1, 
CHaHb), 0.75 (3H, t, J = 7.1, CH3); HPLC analysis: racemic (Daicel Chiralcel OD-H column, eluent: 
hexane/i-PrOH 80:20, flow 1.5 mL/min, wavelength: 254 nm, retention times: 4.0 min and 11.0 
min). 
(S)-3-Ethyl-3-(4-fluorophenyl)indolin-2-one 150 
  The oxindole was obtained from chiral nitrone 144 (0.070 g, 0.144 mmol) and 
ketene 97 (0.047 g, 2.0 eq, 0.288 mmol) following general procedure F, to yield 150 (0.029 g, 79%) 
as an off-white solid; [α]D
20 -32.4° (c = 1.00, CHCl3); HPLC analysis: 98% e.e. (Daicel Chiralcel OD-
H column, eluent: hexane/i-PrOH 80:20, flow 1.5 mL/min, wavelength: 254 nm, retention times: 
3.8 min (major) and 11.1 min (minor)). 
(±)-3-Methyl-3-(p-tolyl)indolin-2-one 149 
 The oxindole was obtained from nitrone 48 (0.093 g, 0.400 mmol) and ketene 98 
(0.059 g, 1.0 eq, 0.400 mmol) following general procedure E, to yield (±)-149 (0.079 g, 83%) as a 
white solid; mp 118-119°C {lit.1 118-120°C}; 1H NMR (400 MHz, CDCl3) δ 8.44 (1H, br s, NH), 
7.26-7.20 (3H, m, ArH), 7.14-7.10 (3H, m, ArH), 7.07-7.03 (1H, m, ArH), 6.96 (1H, d, J = 7.7, 
ArH(7)), 2.31 (3H, s, ArCH3), 1.80 (3H, s, CH3); HPLC analysis: racemic (Daicel Chiralcel OD-H 
column, eluent: hexane/i-PrOH 80:20, flow 1.0 mL/min, wavelength: 254 nm, retention times: 6.4 
min and 15.6 min). 
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(S)-3-Methyl-3-(p-tolyl)indolin-2-one 149 
  The oxindole was obtained from chiral nitrone 144 (0.050 g, 0.103 mmol) and 
ketene 98 (0.030 g, 1.0 eq, 0.103 mmol) following general procedure F, to yield 149 (0.016 g, 66%) 
as an off-white solid; [α]D
20 -10.5° (c = 0.80, CHCl3); HPLC analysis: 96% e.e. (Daicel Chiralcel OD-
H column, eluent: hexane/i-PrOH 80:20, flow 1.0 mL/min, wavelength: 254 nm, retention times: 
6.3 min (major) and 15.6 min (minor)). 
(±)-3-Ethyl-3-(p-tolyl)indolin-2-one 148 
The oxindole was obtained from nitrone 48 (0.078 g, 0.396 mmol) and ketene 100 
(0.063 g, 1.0 eq, 0.396 mmol) following general procedure E, to yield (±)-148 (0.085 g, 85%) as a 
white solid; mp 104-106 °C {lit.1 105-106 °C}; 1H NMR (400 MHz, CDCl3) δ 7.32 (1H, br s, NH), 
7.32-7.27 (3H, m, ArH), 7.17 (1H, dt, J = 7.4, 0.2, ArH), 7.17-7.06 (3H, m, ArH), 6.93 (1H, d, J = 
7.7, ArH(7)), 2.44 (1H, dq, J = 13.7, 7.2, CHaHb), 2.29 (3H, s, ArCH3), 2.24 (1H, dq, J = 13.7, 7.2, 
CHaHb), 0.75 (3H, t, J = 7.2, CH3); HPLC analysis: racemic (Daicel Chiralcel OD-H column, eluent: 
hexane/i-PrOH 80:20, flow 1.0 mL/min, wavelength: 254 nm, retention times: 5.8 min and 17.7 
min). 
(S)-3-Ethyl-3-(p-tolyl)indolin-2-one 148 
The oxindole was obtained from chiral nitrone 144 (0.070 g, 0.144 mmol) and 
ketene 100 (0.035 g, 1.0 eq, 0.144 mmol) following general procedure F, to yield 148 (0.029 g, 85%) 
as an off-white solid; HPLC analysis: [α]D
20 -40.6° (c = 1.10, CHCl3); 96% e.e. (Daicel Chiralcel OD-
H column, eluent: hexane/i-PrOH 80:20, flow 1.0 mL/min, wavelength: 254 nm, retention times: 
5.9 min (major) and 18.1 min (minor)). 
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(±)-3-(4-Chlorophenyl)-3-methylindolin-2-one 153 
 The oxindole was obtained from nitrone 48 (0.080 g, 0.406 mmol) and ketene 369 
(0.068 g, 1.0 eq, 0.406 mmol) following general procedure E, to yield (±)-153 (0.102 g, 97%) as an 
off-white solid; mp 132-134 °C; νmax cm-1 (KBr) 3148 (NH), 3087, 2979, 1706 (C=O), 1619, 1474, 
1457, 1398, 1373, 1324; 1H NMR (300 MHz, CDCl3) δ 8.75 (1H, br s, NH), 7.27-7.23 (5H, m, 
ArH), 7.11-7.07 (2H, m, ArH), 6.98 (1H, d, J = 7.7, ArH(7)), 1.80 (3H, s, Me); 13C NMR (75 MHz, 
CDCl3) δ 182.1 (C=O), 140.7 (4ry ArC), 139.4 (4ry ArC), 135.4 (4ry ArC), 133.8 (4ry ArC), 129.2 
(Ar’C), 128.8 (Ar’C), 128.6 (ArC), 124.8 (ArC), 123.4 (ArC), 110.8 (ArC(7)), 52.7 (C3), 24.0 (CH3); 
m/z (EI+) 258 ([M+H]+, 100%); HRMS (EI+) C15H13ONCl ([M+H]+) found 258.0682 requires 
258.0680 (+ 0.2 ppm); HPLC analysis: racemic (Daicel Chiralcel OD-H column, eluent: hexane/i-
PrOH 95:5, flow 1.0 mL/min, wavelength: 254 nm, retention times: 8.9 min and 21.1 min). 
(S)-3-(4-Chlorophenyl)-3-methylindolin-2-one 153 
 The oxindole was obtained from chiral nitrone 144 (0.090 g, 0.185 mmol) and 
ketene 369 (0.062 g, 2.0 eq, 0.370 mmol) following general procedure F, to yield 153 (0.021 g, 44%) 
as an off-white solid; [α]D
20 -28.5° (c = 0.90, CHCl3); HPLC analysis: 94% e.e. (Daicel Chiralcel AD-
H column, eluent: hexane/i-PrOH 95:5, flow 1.0 mL/min, wavelength: 254 nm, retention times: 
9.0 min (major) and 21.3 min (minor)).  
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HPLC trace for oxindole (±)-153: 
 
Peak tR (min) Area (%) 
1 9.14 53.34 
2 21.45 46.68 
HPLC trace for oxindole (S)-153: 
 
Peak tR (min) Area (%) 
1 8.80 96.88 
2 21.25 3.12 
(±)-3-Isobutyl-3-phenylindolin-2-one 151 
 For determination of ee, a racemic sample of (±)-151 prepared by Dr Nico Duguet 
was used for HPLC analysis; 1H NMR (400 MHz, CDCl3) δ 9.27 (1H, br s, NH), 7.37-7.35 (2H, m, 
ArH), 7.28-7.20 (4H, m, ArH), 7.17 (1H, d, J = 7.1, ArH), 7.06 (1H, td, J = 7.5, 0.8, ArH), 6.95 
(1H, d, J = 7.7, ArH), 2.44 (1H, dd, J = 13.8, 7.4, CHaHb), 2.17 (1H, dd, J = 13.8, 5.2, CHaHb), 1.46 
(1H, app. dquint, J = 12.7, 6.4, CH), 0.80 (3H, d, J = 6.6, CH3), 0.67 (3H, d, J = 6.7, CH3); HPLC 
analysis: racemic (Daicel Chiralcel OD-H column, eluent: hexane/i-PrOH 95:5, flow 1.0 mL/min, 
wavelength: 254 nm, retention times: 12.0 min and 13.0 min). 
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(S)-3-Isobutyl-3-phenylindolin-2-one 151 
 The oxindole was obtained from chiral nitrone 144 (0.070 g, 0.144 mmol) and 
ketene 365 (0.050 g, 2.0 eq, 0.288 mmol) following general procedure F, to yield 151 (0.034 g, 89%) 
as an off-white solid; [α]D
20 -37.5° (c = 1.20, CHCl3); HPLC analysis: 84% e.e. (Daicel Chiralcel AD-
H column, eluent: hexane/i-PrOH 95:5, flow 1.0 mL/min, wavelength: 254 nm, retention times: 
11.8 min (minor) and 13.2 min (major)).  
(±)-3-Isopropyl-3-phenylindolin-2-one 155 
 The oxindole was obtained from nitrone 48 (0.080 g, 0.406 mmol) and ketene 367 
(0.065 g, 1.0 eq, 0.406 mmol) following general procedure E, to yield (±)-155 (0.055 g, 54%) as an 
off-white solid; mp 139-140 °C {lit.2 159-160 °C}; 1H NMR (300 MHz, CDCl3) δ 8.24 (1H, br s, 
NH), 7.47-7.44 (2H, m, ArH), 7.36-7.26 (5H, m, ArH), 7.12 (1H, dd, J = 7.6, 1.0, ArH), 6.95 (1H, 
d, J = 7.4, ArH(7)), 2.93 (1H, sept., J = 6.8, iPrCH), 0.97 (3H, d, J = 6.7, iPrCH3), 0.77 (3H, d, J = 
6.7, iPrCH3); HPLC analysis: racemic (Daicel Chiralcel AD-H column, eluent: hexane/i-PrOH 95:5, 
flow 1.0 mL/min, wavelength: 254 nm, retention times: 4.6 min and 20.2 min).  
(S)-3-Isopropyl-3-phenylindolin-2-one 155 
 The oxindole was obtained from chiral nitrone 144 (0.080 g, 0.164 mmol) and 
ketene 367 (0.053 g, 2.0 eq, 0.328 mmol) following general procedure F, to yield 155 (0.021 g, 51%) 
as an off-white solid; HPLC analysis: 3% e.e. (Daicel Chiralcel AD-H column, eluent: hexane/i-
PrOH 95:5, flow 1.0 mL/min, wavelength: 254 nm, retention times: 4.8 min (major) and 20.6 min 
(minor)).  
(±)-3-(2-Chlorophenyl)-3-ethylindolin-2-one 157 
 The oxindole was obtained from nitrone 48 (0.080 g, 0.406 mmol) and ketene 371 
(0.073 g, 1.0 eq, 0.406 mmol) following general procedure E, to yield (±)-157 (0.102 g, 92%) as a 
white solid; mp 136-137 °C {lit.1 138-140 °C}; 1H NMR (300 MHz, CDCl3) δ 8.87 (1H, br s, NH), 
7.72 (1H, dd, J = 8.0, 1.3, ArH), 7.37-7.16 (4H, m, ArH), 6.97-6.88 (2H, m, ArH), 6.74 (1H, dd, J = 
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7.4, 0.6, ArH(7)), 2.43-2.23 (2H, m, CH2), 0.78 (3H, t, J = 7.3, CH2CH3); HPLC analysis: racemic 
(Daicel Chiralcel AD-H column, eluent: hexane/i-PrOH 90:10, flow 1.0 mL/min, wavelength: 254 
nm, retention times: 11.7 min and 17.2 min). 
(S)-3-(2-Chlorophenyl)-3-ethylindolin-2-one 157 
 The oxindole was obtained from chiral nitrone 144 (0.050 g, 0.103 mmol) and 
ketene 371 (0.037 g, 2.0 eq, 0.206 mmol) following general procedure F, to yield 157 (0.020 g, 72%) 
as an off-white solid; [α]D
20 +4.1° (c = 1.00, CHCl3); HPLC analysis: 20% e.e. (Daicel Chiralcel AD-
H column, eluent: hexane/i-PrOH 90:10, flow 1.0 mL/min, wavelength: 254 nm, retention times: 
11.8 min (major) and 17.5 min (minor)).  
HPLC trace of oxindole (±)-157: 
 
Peak tR (min) Area (%) 
1 11.67 50.72 
2 16.92 49.28 
HPLC trace of oxindole (S)-157: 
 
Peak tR (min) Area (%) 
1 12.05 60.34 
2 17.78 39.66 
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(±)-3-Ethyl-3-(o-tolyl)indolin-2-one 156 
 The oxindole was obtained from nitrone 48 (0.080 g, 0.406 mmol) and ketene 372 
(0.065 g, 1.0 eq, 0.406 mmol) following general procedure E, to yield (±)-156 (0.077 g, 75%) as a 
white solid; mp 136-137 °C; νmax cm-1 (KBr) 3447, 3140 (NH), 3077, 3028, 2973, 2880, 1701 
(C=O), 1618, 1470, 1456, 1338; 1H NMR (300 MHz, CDCl3) δ 9.02 (1H, br s, NH), 7.69 (1H, dd, J 
=7.9, 0.8, ArH), 7.30 (1H, td, J = 7.6, 1.1, ArH), 7.20 (2H, td, J = 7.7, 1.1, ArH), 7.06 (1H, d, J = 
7.3, ArH), 6.99-6.91 (2H, m, ArH), 6.80 (1H, d, J = 7.4, ArH(7)), 2.48-2.29 (2H, m, CH2), 1.80 (3H, 
s, ArCH3), 0.78 (3H, t, J =7.3, CH3); 13C NMR (75 MHz, CDCl3) δ 181.5 (C=O), 141.3 (4ry ArC), 
138.1 (4ry ArC), 137.5 (4ry ArC), 133.5 (4ry ArC), 132.0 (ArC), 127.9 (ArC), 127.6 (ArC), 127.5 (ArC), 
126.0 (ArC), 123.5 (ArC), 129.9 (ArC), 109.6 (ArC(7)), 57.0 (C3), 31.3 (CH2), 19.6 (ArCH3), 8.0 
(CH2CH3); m/z (EI+) 252 ([M+H]+, 100%); HRMS (EI+) C17H18ON+ ([M+H]+) found 252.1383 
requires 252.1383 (+ 0.0 ppm); HPLC analysis: racemic (Daicel Chiralcel AD-H column, eluent: 
hexane/i-PrOH 95:5, flow 1.0 mL/min, wavelength: 254 nm, retention times: 16.8 min and 19.0 
min). 
(S)-3-Ethyl-3-(o-tolyl)indolin-2-one 156 
 The oxindole was obtained from chiral nitrone 144 (0.050 g, 0.103 mmol) and 
ketene 372 (0.033 g, 2.0 eq, 0.206 mmol) following general procedure F, to yield 156 (0.024 g, 93%) 
as an off-white solid; [α]D
20 +0.6° (c = 1.00, CHCl3); HPLC analysis: 58% e.e. (Daicel Chiralcel AD-
H column, eluent: hexane/i-PrOH 95:5, flow 1.0 mL/min, wavelength: 254 nm, retention times: 
17.1 min (major) and 19.1 min (minor)). 
(±)-3-Ethyl-3-(naphthalen-1-yl)indolin-2-one 158 
 The oxindole was obtained from nitrone 48 (0.060 g, 0.304 mmol) and ketene 370 
(0.060 g, 1.0 eq, 0.304 mmol) following general procedure E, to yield (±)-158 (0.064 g, 73%) as a 
white solid; mp 191-192 °C; νmax cm-1 (KBr) 3185 (NH), 1715 (C=O), 1471, 751; 1H NMR (300 
MHz, CDCl3) δ 9.14 (1H, br s, NH), 7.91 (1H, d, J = 7.4, ArH), 7.83 (2H, t, J = 7.7, ArH), 7.56 
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(1H, t, J = 7.8, ArH), 7.36-7.31 (2H, m, ArH), 7.18 (2H, qd, J = 8.0, 1.2, ArH), 6.97 (1H, d, J =7.7, 
ArH), 6.90 (1H, td, J = 7.5, 0.9, ArH), 6.78 (1H, d, J = 7.4, ArH), 2.66-2.41 (2H, m, CH2), 0.85 (3H, 
t, J = 7.3, CH3); 13C NMR (75 MHz, CDCl3) δ 182.1 (C=O), 140.5 (4ry ArC), 135.3 (4ry ArC), 135.2 
(4ry ArC), 134.6 (4ry ArC), 131.8 (4ry ArC), 129.2 (ArC), 128.0 (ArC), 126.4 (ArC), 126.2 (ArC), 125.4 
(ArC), 125.2 (ArC), 123.6 (ArC), 123.5 (ArC), 123.1 (ArC), 110.1 (ArC(7)), 57.0 (C3), 32.1 (CH2), 
8.1 (CH3); m/z (EI+) 288 ([M+H]+, 100%); HRMS (EI+) C20H18ON ([M+H]+) found 288.1386 
requires 288.1383 (+ 0.3 ppm); HPLC analysis: racemic (Daicel Chiralcel OD-H column, eluent: 
hexane/i-PrOH 80:20, flow 1.5 mL/min, wavelength: 254 nm, retention times:  4.4 min and 8.7 
min. 
(S)-3-Ethyl-3-(naphthalen-1-yl)indolin-2-one 158 
 The oxindole was obtained from chiral nitrone 144 (0.050 g, 0.103 mmol) and 
ketene 370 (0.040 g, 2.0 eq, 0.206 mmol) following general procedure F, to yield 158 (0.009 g, 30%) 
as an off-white solid; [α]D
20 +1.4° (c = 1.05, CHCl3); HPLC analysis: 40% e.e. (Daicel Chiralcel OD-
H column, eluent: hexane/i-PrOH 80:20, flow 1.5 mL/min, wavelength: 254 nm, retention times:  
4.4 min (major) and 8.8 min (minor)). 
(±)-3-Methylindolin-2-one 160 
 The oxindole was obtained from nitrone 48 (0.250 g, 1.27 mmol) and an excess of 
methylketene solution 159 following general procedure E, to yield (±)-160 (0.100 g, 54%) as an off-
white solid; mp 107-109 °C {lit.3 100-102 °C}; 1H NMR (400 MHz, CDCl3) δ 8.54 (1H, br s, NH), 
7.23-7.19 (2H, m, ArH), 7.03 (1H, td, J = 7.3, 1.0, ArH), 6.91-6.89 (1H, m, ArH(7)), 3.47 (1H, q, J 
= 7.7, CH(3)), 1.51 (3H, d, J = 7.7, CHMe). 
(±)-3-Phenylindolin-2-one 161 
 The oxindole was obtained from nitrone 48 (0.035 g, 0.072 mmol) and an excess of 
phenylketene solution following general procedure E, to yield (±)-161 (0.016 g, quant.) as a 
colourless oil; 1H NMR (300 MHz, CDCl3) δ 7.89 (1H, br s, NH), 7.38-7.28 (4H, m, ArH), 7.24-
7.21 (2H, m, ArH), 7.14 (1H, d, J = 7.4, ArH), 7.04 (1H, td, J = 7.4, 1.0, ArH), 6.94 (1H, d, J = 7.8, 
ArH). 
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(±)-3-Butylindolin-2-one 162 
 The oxindole was obtained from nitrone 48 (0.040 g, 0.203 mmol) and an excess of 
n-butylketene solution following general procedure E, to yield (±)-162 (0.032 g, 83%) as a 
colourless oil; 1H NMR (300 MHz, CDCl3) δ 8.54 (1H, br s, NH), 7.24-7.18 (2H, m, ArH), 7.05-
7.00 (1H, m, ArH), 6.90 (1H, d, J = 7.6, ArH(7)), 3.47 (1H, t, J = 6.0, CH(3)), 2.02-1.91 (2H, m, 
CHCH2), 1.41-1.27 (4H, m, -CH2CH2-), 0.88 (3H, t, J = 7.1, CH2CH3); HPLC analysis: racemic 
(Daicel Chiralcel AD-H column, eluent: hexane/i-PrOH 95:5, flow 1.0 mL/min, wavelength: 254 
nm, retention times: 9.1 min and 12.6 min). 
(S)-3-Butylindolin-2-one 162 
 The oxindole was obtained from nitrone 144 (0.050 g, 0.103 mmol) and an excess 
of n-butylketene solution following general procedure F, to yield 162 (0.014 g, 72%) as a pale 
orange oil; HPLC analysis: 50% e.e. (Daicel Chiralcel AD-H column, eluent: hexane/i-PrOH 95:5, 
flow 1.0 mL/min, wavelength: 254 nm, retention times: 9.5 min (minor) and 12.5 min (major)). 
Application to Spirocyclic Oxindoles 
1-Bromocyclohexanecarbonyl bromide 163 
 To a stirred solution of neat cyclohexanoic acid (12.0 g, 93.6 mmol) was added PBr3 
(2.65 mL, 0.3 eq, 28.1 mmol) and the reaction mixture heated to 110 °C. Bromine (5.78 mL, 1.15 
eq, 112 mmol) was then added dropwise until the reaction mixture retained the brown colour of the 
bromine. At this point, the reaction mixture was cooled, and whilst still stirring rapidly, was flushed 
with a stream of nitrogen into a saturated solution of sodium thiosulfate. The reaction mixture was 
then concentrated in vacuo to yield a crude pale brown liquid which was purified via Kugelrohr 
distillation (120-122 °C, 1 mmHg {lit.4 150 °C, 20 mmHg) to give 163 (10.2 g, 43%) as a yellow 
liquid; 1H NMR (400 MHz, CDCl3) δ 2.22 (4H, t, J = 5.7, CH2), 1.86-1.73 (2H, m, CH2), 1.67-1.53 
(4H, m, CH2). 
Cyclopentamethyleneketene 164 
An excess of activated zinc (0.400 g) was suspended in THF (20 mL) at 0 °C and to 
this was added a solution of 163 (1.20 g, 4.45 mmol) in THF (5 mL) dropwise over 30 mins. The 
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reaction mixture was stirred at 0 °C for 30 min before a yellowy/green colour became apparent, 
stirring ceased and the reaction mixture allowed to settle. Ketene 164 was then used as an 
unquantified solution in THF in the next reactions. 
Spiro[cyclohexane-1,3'-indolin]-2'-one 165 
 The oxindole was obtained from nitrone 48 (0.050 g, 0.254 mmol) and ketene 
solution 164 (3.0 mL) according to general procedure E, to yield 165 (0.033 g, 65%) as a white solid; 
mp 110-111 °C {lit.5 119-121 °C}; 1H NMR (400 MHz, CDCl3) δ 7.79 (1H, br s, NH), 7.45 (1H, d, 
J = 7.6, ArH(4’)), 7.21 (1H, td, J = 7.7, 1.1, ArH(6’)), 7.03 (1H, dd, J = 7.6, 1.1, ArH(5’)), 6.90 (1H, 
d, J = 7.7, ArH(7’)), 1.99-1.84 (4H, m, CH2(2,6)), 1.80-1.58 (6H, m, CH2(3,4,5)). 
5'-Methoxyspiro[cyclohexane-1,3'-indolin]-2'-one 174 
 The oxindole was obtained from nitrone 48 (0.098 g, 0.431 mmol) and ketene 
solution 164 (5.0 mL) according to general procedure E, to yield 174 (0.056 g, 56%) as an off-white 
solid; mp 208-209 °C {lit.6 226 °C}; 1H NMR (300 MHz, CDCl3) δ 7.45 (1H, br s, NH), 7.05 (1H, 
d, J = 2.4, ArH(4’)), 6.79 (1H, d, J = 8.4, ArH(7’)), 6.73 (1H, dd, J = 8.4, 2.4, ArH(6’)), 3.80 (3H, s, 
OMe), 1.96-1.82 (4H, m, CH2(2,6)), 1.78-1.54 (6H, m, CH2(3,4,5)).  
5'-Fluorospiro[cyclohexane-1,3'-indolin]-2'-one 175 
 The oxindole was obtained from nitrone 48 (0.080 g, 0.372 mmol) and ketene 
solution 164 (4.5 mL) according to general procedure E, to yield 175 (0.039 g, 48%) as an off-white 
solid; mp 101-102 °C {lit.7 114 °C}; 1H NMR (300 MHz, CDCl3) δ 8.40 (1H, br s, NH), 7.18 (1H, 
dd, J = 8.7, 2.5, ArH), 6.91 (1H, td, J = 8.7, 2.5, ArH), 6.84 (1H, dd, J = 8.7, 4.6, ArH), 1.98-1.83 
(4H, m, CH2(2,6)), 1.77-1.56 (6H, m, CH2(3,4,5)). 
Cyclohexamethyleneketene 167 
Cyclohexamethyleneketene 167 was prepared according to a literature procedure.8 To 
a stirred solution of cycloheptanecarboxylic acid (5.00 g, 352 mmol) in toluene (50 mL) was added 
thionyl chloride (5.14 mL, 2.0 eq, 704 mmol) dropwise, and the reaction stirred at 80 °C for 16 h. 
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The toluene and excess thionyl chloride were then removed under reduced pressure to leave a 
crude brown liquid which was purifed via Kugelrohr distillation (140 °C, 3 mmHg) to yield the 
intermediate acid chloride 166 (5.34 g, 94%) as a colourless liquid. To a stirred solution of acid 
chloride (4.00 g, 249 mmol) in dry Et2O (70 mL) under nitrogen was added N,N-
dimethylethylamine (2.97 mL, 1.1 eq, 274 mmol) dropwise. The reaction was then stirred for 40 h 
at rt. After this time, the reaction was filtered under argon to remove the amine hydrochloride salts. 
The Et2O was then removed under reduced pressure to leave a yellow oil which was partially 
purified via Kugelrohr distillation (50 °C, 3 mmHg) to remove residual acid chloride and yield 167 
as a yellow liquid which was taken up in THF (20 mL) and used immediately as a solution; 1H 
NMR (300 MHz, CDCl3) δ 2.25-2.21 (4H, m, CH2(2,7)), 1.71-1.64 (4H, m, CH2(3,6)), 1.62-1.52 
(4H, m, CH2(4,5)). 
Spiro[cycloheptane-1,3'-indolin]-2'-one 168 
 The oxindole was obtained from nitrone 48 (0.050 g, 0.254 mmol) and ketene 
solution 167 (1.0 mL) according to general procedure E, to yield 168 (0.043 g, 79%) as a white solid; 
mp 140-142 °C; νmax cm-1 (KBr) 3165 (N-H), 2932 (C-H) 1700 (C=O); 1H NMR (300 MHz, 
CDCl3) δ 7.66 (1H, br s, NH), 7.35 (1H, dd, J = 7.5, 0.4, ArH), 7.20 (1H, td, J = 7.7, 1.2, ArH), 7.03 
(1H, td, J = 7.5, 1.2, ArH), 6.88 (1H, dd, J = 7.7, 0.4, ArH), 2.08-1.93 (4H, m, CH2), 1.82-1.68 (8H, 
m, CH2); 13C NMR (75 MHz, CDCl3) δ 184.1 (C=O), 139.4 (ArC(3a)), 137.9 (ArC(7a)), 127.4 
(ArC), 123.2 (ArC), 122.4 (ArC), 109.4 (ArC), 50.5 (C(3)), 36.9 (CH2(2,7)), 31.3 (CH2(3,6)), 23.8 
(CH2(4,5)); m/z (ESI+) 216 ([M+H]+, 100%); HRMS (EI+) C14H18ON+ ([M+H]+) found 216.1383 
requires 216.1383 (+ 0.0 ppm). 
5'-Methylspiro[cycloheptane-1,3'-indolin]-2'-one 172 
 The oxindole was obtained from nitrone 48 (0.026 g, 0.123 mmol) and ketene 
solution 167 (1.0 mL) according to general procedure E, to yield 172 (0.023 g, 82%) as a white solid; 
mp 163-164 °C; νmax cm-1 (KBr) 3162 (NH), 2920, 2852, 1698 (C=O), 1625, 1492, 1457, 1354, 
1321; 1H NMR (400 MHz, CDCl3) δ 7.63 (1H, br s, NH), 7.14 (1H, t, J = 0.6, ArH(4)), 6.98 (1H, 
ddd, J = 7.9, 1.6, 0.6, ArH(6)), 6.76 (1H, d, J = 7.9, ArH(7)), 2.34 (3H, s, Me), 2.05-1.95 (4H, m, 
CH2(2,7)), 1.79-1.71 (8H, m, CH2(3,4,5,6)); 13C NMR (75 MHz, CDCl3) δ 184.5 (C=O), 138.0 
(ArC(3a)), 137.0 (ArC(7a)), 131.7 (ArC(5)Me), 127.6 (ArC), 124.0 (ArC), 109.2 (ArC(7)), 50.5 (C(3)), 
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36.9 (CH2(2,7)), 31.4 (CH2(3,6)), 23.9 (CH2(4,5)), 21.3 (ArCH3); m/z (ESI+) 230 ([M+H]+, 100%); 
HRMS (EI+) C15H20ON+ ([M+H]+) found 230.1541 requires 230.1539 (+ 0.7 ppm). 
7'-Methylspiro[cycloheptane-1,3'-indolin]-2'-one 173 
 The oxindole was obtained from nitrone 48 (0.023 g, 0.109 mmol) and ketene 
solution 167 (1.0 mL) according to general procedure E, to yield 173 (0.017 g, 68%) as a white solid; 
mp 218-221 °C; νmax cm-1 (KBr) 3155 (NH), 3097, 2963, 2904, 1719 (C=O), 1698, 1631, 1604, 
1489, 1465, 1438, 1350, 1328, 1320; 1H NMR (300 MHz, CDCl3) δ 7.42 (1H, br s, NH), 7.18 (1H, 
d, J = 7.2, ArH), 7.02-6.92 (2H, m, ArH), 2.26 (3H, s, Me), 2.06-1.91 (4H, m, CH2(2,7)), 1.80-1.66 
(8H, m, CH2(3,4,5,6)); 13C NMR (75 MHz, CDCl3) δ 184.4 (C=O), 138.1 (ArC(3a)), 137.5 
(ArC(7a)), 128.7 (ArC), 122.3 (ArC), 120.6 (ArC(3a)), 118.6 (ArC(7)Me), 50.9 (C(3)), 37.0 
(CH2(2,7)), 31.3 (CH2(3,6)), 23.8 (CH2(4,5)); m/z (ESI+) 230 ([M+H]+, 100%); HRMS (EI+) 
C15H20ON+ ([M+H]+) found 230.1541 requires 230.1539 (+ 0.7 ppm). 
5'-Fluorospiro[cycloheptane-1,3'-indolin]-2'-one 169 
 The oxindole was obtained from nitrone 48 (0.028 g, 0.130 mmol) and ketene 
solution 167 (1.0 mL) according to general procedure E, to yield 169 (0.022g, 79%) as a white solid; 
mp 151-152 °C; νmax cm-1 (KBr) 3192 (NH), 3081, 2923, 2852, 1696, 1625, 1608, 1482, 1348, 1319; 
1H NMR (400 MHz, CDCl3) δ 8.58 (1H, br s, NH), 6.99 (1H, dd, J = 8.4, 2.5, ArH(7)), 6.81 (1H, 
ddd, J = 9.1, 8.5, 2.6, ArH(6)), 6.70 (1H, dd, J = 8.4, 4.3), 2.05-1.93 (4H, m, CH2(2,7)), 1.78-1.69 
(8H, m, CH2(3,4,5,6)); 13C NMR (75 MHz, CDCl3) δ 184.3 (C=O), 159.3 (d, J = 239.8, ArC(5)), 
139.4 (d, J = 7.6, ArC(3a)), 135.3 (ArC(7a)), 113.6 (d, J = 23.5, ArC(4)), 111.2 (d, J = 24.5, ArC(6)), 
109.9 (d, J = 8.2, ArC(7)), 51.1 (C(3)), 36.8 (CH2(2,7)), 31.3 (CH2(3,6)), 23.8 (CH2(4,5)); m/z (ESI+) 
234 ([M+H]+, 100%);  HRMS (EI+) C14H17FON+ ([M+H]+) found 234.1291 requires 234.1289 (+ 
1.0 ppm). 
5'-(Trifluoromethyl)spiro[cycloheptane-1,3'-indolin]-2'-one 170 
 The oxindole was obtained from nitrone 48 (0.031 g, 0.117 mmol) and ketene 
solution 167 (1.0 mL) according to general procedure E, to yield 170 (0.027 g, 82%) as a white solid; 
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mp 146-147 °C; νmax cm-1 (KBr) 3168 (NH), 3076, 2900, 2847, 1712 (C=O), 1689, 1633, 1598, 
1485, 1463; 1H NMR (300 MHz, CDCl3) δ 7.77 (1H, br s, NH), 7.53 (1H, s, ArH(4)), 7.48 (1H, 
ddd, J = 8.1, 1.7, 0.8, ArH(6)), 6.94 (1H, d, J = 8.1, ArH(7)), 2.07-1.94 (4H, m, CH2(2,7)), 1.82-1.69 
(8H, m, CH2(3,4,5,6)); 13C NMR (125 MHz, CDCl3) δ 183.7 (C=O), 142.4 (ArC(7a)), 138.3 
(ArC(3a)), 125.2 (q, J = 3.7, ArC(4)), 124.7 (q, J = 32.5, ArC(5)CF3), 120.1 (q, J = 3.7, ArC(6)), 
109.2 (ArC(7)), 50.5 (C(3)), 36.8 (CH2(2,7)), 31.2 (CH2(3,6)), 23.8 (CH2(4,5)), CF3 carbon not 
observed; 19F NMR (470.3 MHz, CDCl3) δ -61.3 (CF3); m/z (ESI+) 284 ([M+H]+, 100%); HRMS 
(EI+) C15H17 F3ON+ ([M+H]+) found 284.1255 requires 284.1257 (- 0.6 ppm). 
5'-Methoxyspiro[cycloheptane-1,3'-indolin]-2'-one 171 
 The oxindole was obtained from nitrone 48 (0.036 g, 0.158 mmol) and ketene 
solution 167 (1.0 mL) according to general procedure E, to yield 171 (0.036 g, 92%) as a white solid; 
mp 162-163°C; νmax cm-1 (KBr) 3174 (NH), 3088, 2947, 2907, 2847, 1714 (C=O), 1687, 1633, 1601, 
1484, 1456, 1438, 1350, 1328, 1311; 1H NMR (300 MHz, CDCl3) δ 7.53 (1H, br s, NH), 6.94 (1H, 
d, J = 2.4, ArH(4)), 6.77 (1H, d, J = 8.4, ArH(7)), 6.71 (1H, dd, J = 8.4, 2.4, ArH(6)), 3.80 (3H, s, 
OMe), 2.05-1.91 (4H, m, CH2(2,7)), 1.79-1.68 (8H, m, CH2(3,4,5,6)); 13C NMR (75 MHz, CDCl3) δ 
184.2 (C=O), 155.7 (ArC(5)OMe), 139.3 (ArC(7a)), 132.9 (ArC(3a)), 111.2 (ArC), 111.0 (ArC), 
109.6 (ArC), 55.9 (OMe), 50.9 (C(3)), 36.9 (CH2(2,7)), 31.3 (CH2(3,6)), 23.8 (CH2(4,5)); m/z (ESI+) 
246 ([M+H]+, 100%); HRMS (EI+) C15H20O2N+ ([M+H]+) found 246.1491 requires 230.1491 (+ 
1.0 ppm). 
1,2,3,4-Tetrahydronaphthalene-1-ketene 176 
 Ketene 176 was prepared according to a literature procedure.9 To a flask containing 
liquid ammonia (ca. 400 mL) at -78 °C was added 1-naphthoic acid (11.5 g, 66.8 mmol), crushed ice 
(ca. 40 g), followed by lithium ribbon (ca. 2.50 g, 70 mmol). The reaction mixture was stirred for 1 
h at -78 °C until the blue/grey colour had disappeared, and the reaction was subsequently allowed 
to warm to rt under the hood to allow evaporation of excess NH3. After warming to rt, the reaction 
mixture was diluted with H2O (500 mL) and acidified (pH = 1) with conc. HCl. The resulting light 
brown solid was then collected by filtration. This crude solid was then taken up in EtOH (200 mL), 
Pd/C (4.25 g) added and the reaction stirred vigourously under an atmosphere of hydrogen gas for 
24 h. After such time, the crude reaction mixture was filtered through a pad of celite, the residue 
washed with EtOAc and the filtrate conc. in vacuo to give the desired intermediate acid (3.46 g, 33% 
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over 2 steps) as a light brown solid which was used without any further purification and with 
analytical data in accordance with the literature; mp 110-112 °C {lit.10 82-84 °C}; 1H NMR (400 
MHz, CDCl3) δ 11.05 (1H, br s, COOH), 7.25-7.11 (4H, m, ArH), 3.86-3.84 (1H, m, CH), 2.89-2.73 
(2H, m, CH2), 2.24-2.18 (1H, m, CHaHb), 2.08-1.95 (2H, m, CH2), 1.83-1.77 (1H, m, CHaHb). 
To a stirred solution of the intermediate acid (3.45 g, 1.96 mmol) in toluene (40 mL) was added 
thionyl chloride (2.86 mL, 2.0 eq, 3.96 mmol) and the reaction stirred at 80 °C for 5h. After this 
time, the reaction mixture was concentrated in vacuo and purified via Kugelrohr distillation (230 °C; 
3 mmHg) {lit.11 142.5-143 °C; 18 mmHg}; to yield the intermediate acid chloride (2.55 g, 67%) as a 
pale yellow liquid; 1H NMR (400 MHz, CDCl3) δ 7.24-7.20 (1H, m, ArH), 7.19-7.14 (3H, m, ArH), 
4.26 (1H, t, J = 6.1, CH), 2.90-2.74 (2H, m, CH2), 2.36 (1H, dddd, J = 13.4, 7.9, 5.7, 3.2, CH2), 2.19 
(1H, dddd, J = 13.4, 9.9, 6.5, 3.2, CH2), 1.99-1.89 (1H, m, CHaHb), 1.87-1.80 (1H, m, CHaHb). 
To a stirred solution of the intermediate acid chloride (3.10 g, 15.9 mmol) in dry Et2O (45 mL) at  
0 °C under nitrogen was added N,N-dimethylethylamine (1.90 mL, 1.1 eq, 17.5 mmol) dropwise 
over 15 min. The reaction was then stirred for 16 h at 0 °C. After this time, the reaction mixture 
was allowed to warm to rt before being filtered under nitrogen to remove the amine hydrochloride 
salts. The Et2O was then removed under reduced pressure to leave a yellow liquid which was 
purified via Kugelrohr distillation (154-160 °C, 3 mmHg) {lit.12 52-53 °C; 0.001 mmHg} to yield 
176 (1.14 g, 45%) a dark yellow/orange liquid which was stored in the freezer under argon and used 
within two weeks of preparation; 1H NMR (300 MHz, CDCl3) δ 7.15-7.08 (2H, m, ArH), 7.00-6.94 
(2H, m, ArH), 2.77 (2H, t, J = 6.2, CH2), 2.68-2.64 (2H, m, CH2), 1.96-1.87 (2H, m, CH2). 
6-Methoxy-3,4-dihydronaphthalen-1-yl trifluoromethanesulfonate 180 
To a stirred solution of 6-methoxytetralone (12.21 g, 69.3 mmol) in THF (80 
mL) at -78 °C was added LHMDS (1.0 M in THF, 69.0 mL, 1.10 eq, 76.2 mmol) dropwise and the 
reaction mixture stirred at -78 °C for 45 min. A solution of N,N-bis(trifluoromethylsulfonyl)aniline 
(25.0 g, 1.01 eq, 70.0 mmol) in THF (35 mL) was then added dropwise and upon completion of 
addition, the reaction was warmed to 0 °C and stirred for 3 h before quenching with H2O (50 mL). 
The reaction mixture was then partitioned between Et2O (120 mL) and H2O (100 mL), the aqueous 
layer collected and extracted with Et2O (70 mL× 3). The combined organic layers were then 
washed with brine (150 mL), dried over MgSO4, filtered and concentrated in vacuo to yield a crude 
brown oil. The crude product was purified via flash column chromatography over silica (20% 
EtOAc in petroleum ether) to yield 180 (22.6 g, quant.) as an orange oil; 1H NMR (500 MHz, 
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CDCl3) δ 7.15 (1H, s, ArH), 6.64 (1H, dd, J = 8.5, 2.5, ArH), 6.60 (1H, d, J = 2.5, ArH), 5.73 (1H, t, 
J = 4.8, CH), 3.69 (3H, s, OMe), 2.70 (2H, t, J = 8.1, CH2), 2.35 (2H, td, J = 8.1, 4.8, CH2). 
(±)-Methyl 6-methoxy-1,2,3,4-tetrahydronaphthalene-1-carboxylate 181 
To a stirred solution of 180 (10.0 g, 32.5 mmol) in DMF (80 mL) was added 
sequentially MeOH (60 mL), Et3N (7.20 mL, 1.6 eq, 52.0 mmol), PPh3 (3.41 g, 0.4 eq, 13.0 mmol) 
and Pd(OAc)2 (0.73 g, 0.1 eq, 3.25 mmol) under nitrogen. A balloon of carbon monoxide gas was 
then introduced to the reaction, the reaction vessel purged and heated to 65 °C. The reaction vessel 
was then sealed under an atmosphere of carbon monoxide and heated at 65 °C for 16 h. After this 
time, the reaction mixture was allowed to cool to rt before being partitioned between EtOAc (250 
mL) and H2O (150 mL). The layers were then separated and the organic layer washed with 1M HCl 
(100 mL) and brine (100 mL) before being dried over MgSO4, filtered and concentrated in vacuo to 
yield a crude brown oil which was purified by flash column chromatography over silica (20% 
EtOAc in petroleum ether) to yield the desired unsaturated ester (3.03 g, 43%) as a yellow oil; 1H 
NMR (300 MHz, CDCl3) δ 7.74 (1H, d, J = 8.6, ArH), 7.03 (1H, t, J = 4.9, CH), 6.76 (1H, dd, J = 
8.6, 2.8, ArH), 6.72 (1H, d, J = 2.6, ArH), 3.84 (3H, s, OMe), 3.81 (3H, s, OMe), 2.74 (2H, t, J = 7.9, 
CH2), 2.38 (2H, ddd, J = 8.6, 7.2, 4.9, CH2). 
To a stirred solution of this crude unsaturated ester (3.03 g, 13.9 mmol) in EtOH (150 mL) was 
added 10 mol % Pd/C (0.225 g) at rt. A balloon of hydrogen gas was then introduced to the 
reaction mixture, the vessel purged and then sealed before being stirred under an atmosphere of 
hydrogen at rt for 16 h. The reaction mixture was then filtered through a celite plug, the residue 
washed with EtOAc, and the filtrate concentrated in vacuo to yield (±)-181 (3.01 g, quant.) as a 
colourless oil which was used without further purification; 1H NMR (300 MHz, CDCl3) δ 7.08 (1H, 
d, J = 8.5, ArH), 6.71 (1H, dd, J = 8.5, 2.8, ArH), 6.63 (1H, d, J = 2.7, ArH), 3.79-3.76 (1H, m, 
CH), 3.77 (3H, s, ArOMe), 3.71 (3H, s, CO2Me), 2.87-2.67 (2H, m, CH2), 2.18-2.09 (1H, m, CHaHb), 
2.03-1.91 (1H, m, CHaHb), 1.80-1.69 (2H, m, CH2). 
(±)-6-Methoxy-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid 182 
To a stirred solution of 181 (3.00 g, 13.6 mmol) in H2O/MeOH (4:30 mL) was 
added LiOH (1.63 g, 5 eq, 68.0 mmol) and the reaction stirred at rt for 16 h. The reaction mixture 
was then concentrated in vacuo to give a white semi-solid which was taken up in H2O (25 mL) and 
the acid precipitated by dropwise addition of 2M HCl. The white precipitate was then collected by 
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filtration and dried under high vacuum to yield (±)-182 (2.80 g, quant.) as a white solid; mp 78-80 
°C {lit.13 83-84 °C}; 1H NMR (300 MHz, CDCl3) δ 7.14 (1H, d, J = 8.5, ArH), 6.73 (1H, dd, J = 
8.5, 2.7, ArH), 6.64 (1H, d, J = 2.7, ArH), 3.81-3.78 (1H, m, CH), 3.78 (3H, s, ArOMe), 2.87-2.65 
(2H, m, CH2), 2.24-2.09 (1H, m, CHaHb), 2.06-1.86 (2H, m, CH2), 1.85-1.70 (1H, m, CHaHb). 
(±)-6-Methoxy-1,2,3,4-tetrahydronaphthalene-1-carbonyl chloride 183 
(±)-183 was prepared according to general procedure I from 182 (2.80 g, 13.6 
mmol), DMF (0.212 mL, 0.2 eq, 2.72 mmol) and oxalyl chloride (2.37 mL, 2.0 eq, 27.2 mmol) in 
toluene (30 mL). The reaction mixture was stirred for 3 h at rt before being concentrated in vacuo 
multiple times with additional toluene (to remove excess oxalyl chloride) to yield (±)-183 as a 
yellow oil (2.29 g, 75%) which was used without further purification; 1H NMR (300 MHz, CDCl3) δ 
7.08 (1H, d, J = 8.5, ArH), 6.75 (1H, dd, J = 8.5, 2.7, ArH), 6.66 (1H, d, J = 2.7, ArH), 4.19 (1H, t, J 
= 6.0, CH), 3.79 (3H, s, ArOMe), 2.91-2.69 (2H, m, CH2), 2.39-2.29 (1H, m, CHaHb), 2.21-2.10 
(1H, m, CHaHb), 1.98-1.74 (2H, m, CH2). 
6-Methoxy-1,2,3,4-tetrahydronaphthalene-1-ketene 184 
  To a stirred solution of 183 (1.0 g, 4.45 mmol) in Et2O (18 mL) at 0 °C was 
added N,N-dimethylethylamine (0.531 mL, 1.1 eq, 4.90 mmol) dropwise and the reaction mixture 
stirred at 0 °C for 16h. After such time, the reaction mixture was filtered under argon to remove 
amine hydrochloride salts and the reaction mixture concentrated under reduced pressure to yield a 
dark yellow oil. The crude ketene was suspended in THF (10 mL) and used as a crude solution in 
all further reactions. This ketene was not distilled, but used as a crude solution in THF assumed to 
be 40 mg per 1 mL of THF. As such, only limited spectroscopic data was obtained for this species; 
1H NMR (400 MHz, CDCl3) δ 6.85 (1H, d, J = 8.5, ArH), 6.72 (1H, dd, J = 8.5, 2.7, ArH), 6.66 
(1H, d, J = 2.7, ArH), 3.77 (3H, s, ArOMe), 2.73 (2H, t, J = 6.2, CH2), 2.64-2.61 (2H, m, CH2), 1.92-
1.84 (2H, m, CH2). 
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7-Methoxy-3,4-dihydronaphthalen-1-yl trifluoromethanesulfonate 186 
 To a stirred solution of 7-methoxytetralone (12.00 g, 68.0 mmol) in THF 
(100 mL) at -78 °C was added LHMDS (1.0 M in THF, 74.8 mL, 1.10 eq, 74.8 mmol) dropwise  
and the reaction mixture stirred at -78 °C for 45 min. A solution of N,N-
bis(trifluoromethylsulfonyl)aniline (25.0 g, 1.01 eq, 70.0 mmol) in THF (35 mL) was then added 
dropwise and upon completion of addition, the reaction was warmed to 0 °C and stirred for 3 h 
before quenching with H2O (50 mL). The reaction mixture was then partitioned between Et2O 
(120 mL) and H2O (100 mL), the aqueous layer collected and extracted with Et2O (70 mL x 3). The 
combined organic layers were then washed with brine (150 mL), dried over MgSO4, filtered and 
concentrated in vacuo to yield a crude brown oil. The crude product was purified via flash column 
chromatography over silica (20% EtOAc in petroleum ether) to yield 186 (22.4 g, quant.) as an 
orange oil; 1H NMR (300 MHz, CDCl3) δ 7.09 (1H, d, J = 8.2, ArH), 6.91 (1H, d, J = 2.6, ArH), 
6.80 (1H, dd, J = 8.2, 2.6, ArH), 6.03 (1H, t, J = 4.8, CH), 3.81 (3H, s, OMe), 2.80 (2H, J = 8.2, 
CH2), 2.53-2.45 (2H, m, CH2). 
(±)-Methyl 7-methoxy-1,2,3,4-tetrahydronaphthalene-1-carboxylate 187 
 To a stirred solution of 186 (17.0 g, 55.2 mmol) in DMF (135mL) was added 
sequentially MeOH (110 mL), Et3N (12.24 mL, 1.6 eq, 88.3 mmol), PPh3 (5.79 g, 0.4 eq, 22.1 
mmol) and Pd(OAc)2 (1.24 g, 0.1 eq, 5.52 mmol) under nitrogen. A balloon of carbon monoxide 
gas was then introduced to the reaction, the reaction vessel purged and heated to 65 °C. The 
reaction vessel was then sealed under an atmosphere of carbon monoxide and heated at 65 °C for 
16 h. After this time, the reaction mixture was allowed to cool to rt before being partitioned 
between EtOAc (250 mL) and H2O (150 mL). The layers were then separated and the organic layer 
washed with 1M HCl (100 mL) and brine (100 mL) before being dried over MgSO4, filtered and 
concentrated in vacuo to yield a crude brown oil which was purified by flash column 
chromatography over silica (20% EtOAc in petroleum ether) to yield the desired intermediate 
unsaturated ester (7.43 g, 62%) as a yellow oil; 1H NMR (400 MHz, CDCl3) δ 7.45 (1H, d, J = 2.7, 
ArH), 7.20 (1H, t, J = 4.9, CH), 7.07 (1H, d, J = 8.2, ArH), 6.75 (1H, dd, J = 8.2, 2.7, ArH), 3.85 
(3H, s, OMe), 3.81 (3H, s, OMe), 2.70 (2H, t, J = 7.9, CH2), 2.41-2.36 (2H, m, CH2). 
To a stirred solution of the unsaturated ester (7.43 g, 34.0 mmol) in EtOH (250 mL) was added 10 
mol % Pd/C (0.440 g) at rt. A balloon of hydrogen gas was then introduced to the reaction 
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mixture, the vessel purged and then sealed before being stirred under an atmosphere of hydrogen 
and stirred at rt for 16 h. The reaction mixture was then filtered through a celite plug, the residue 
washed with EtOAc, and the filtrate concentrated in vacuo to yield (±)-187 (7.40 g, quant.) as a 
colourless oil which was used without further purification; 1H NMR (300 MHz, CDCl3) δ 7.02 (1H, 
d, J = 8.3, ArH), 6.77-6.71 (2H, m, ArH), 3.81 (1H, t, J = 5.7, CH), 3.79 (3H, s, OMe), 3.72 (3H, s, 
OMe), 2.82-2.63 (2H, m, CH2), 2.14-2.08 (1H, m, CHaHb), 2.00-1.93 (2H, m, CH2), 1.79-1.73 (1H, 
m, CHaHb). 
(±)-7-Methoxy-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid 188 
To a stirred solution of 187 (7.40 g, 33.6 mmol) in H2O/MeOH (10/75 mL) 
was added LiOH (4.02 g, 5.0 eq, 170.2 mmol) and the reaction stirred at rt for 16 h. The reaction 
mixture was then concentrated in vacuo to give a white semi-solid which was taken up in H2O (75 
mL) and the acid precipitated by dropwise addition of 2M HCl. The white precipitate was then 
collected by filtration and dried under high vacuum to yield (±)-188 (6.20 g, 89%) as a white solid; 
mp 120-121 °C {lit.14 137-138 °C}; 1H NMR (300 MHz, CDCl3) δ 7.03 (1H, d, J = 9.2, ArH), 6.78-
6.75 (2H, m, ArH), 3.82 (1H, t, J = 5.5, CH), 3.77 (3H, s, ArOMe), 2.83-2.63 (2H, m, CH2), 2.22-
2.11 (1H, m, CHaHb), 2.06-1.90 (2H, m, CH2), 1.81-1.71 (1H, m, CHaHb). 
(±)-7-Methoxy-1,2,3,4-tetrahydronaphthalene-1-carbonyl chloride 189 
 (±)-189 was prepared according to general procedure I from 188 (6.20 g, 30.1 
mmol), DMF (0.47 mL, 0.2 eq, 6.02 mmol) and oxalyl chloride (5.25 mL, 2.0 eq, 60.2 mmol) in 
toluene (65 mL). The reaction mixture was then stirred for 3 h at rt before being filtered and 
concentrated in vacuo multiple times with additional toluene (to remove excess oxalyl chloride) to 
yield (±)-189 as a yellow oil (5.10 g, 78%) which was used without further purification; νmax cm-1 
(thin-film) 2351, 1786, 1599, 1585, 1489; 1H NMR (300 MHz, CDCl3) δ 7.06 (1H, d, J = 8.5, ArH), 
6.81 (1H, dd, J = 8.5, 2.6, ArH), 6.68 (1H, d, J = 2.6, ArH), 4.21 (1H, t, J = 6.1, CH), 3.78 (3H, s, 
OMe), 2.84–2.65 (2H, m, CH2), 2.38-2.28 (1H, m, CHaHb), 2.22-2.11 (1H, m, CHaHb), 1.99-1.74 
(2H, m, CH2); 13C NMR (75 MHz, CDCl3) δ 176.0 (C=O), 157.8 (ArC(7)), 131.8 (4ry ArC), 130.6 
(ArC), 129.3 (4ry ArC), 114.5 (ArC), 114.3 (ArC), 56.6 (OMe), 55.4 (CH(1)), 28.1 (CH2), 26.7 (CH2), 
20.4 (CH2). 
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7-Methoxy-1,2,3,4-tetrahydronaphthalene-1-ketene 190 
 To a stirred solution of (±)-189 (1.0 g, 4.45 mmol) in Et2O (18 mL) at 0 °C was 
added N,N-dimethylethylamine (0.531 mL, 1.1 eq, 4.90 mmol) dropwise and the reaction mixture 
stirred at 0 °C for 16h. After such time, the reaction mixture was filtered under argon to remove 
amine hydrochloride salts and the reaction mixture concentrated under reduced pressure to yield a 
dark yellow oil. The crude ketene was suspended in THF (10 mL) and used as a crude solution in 
all further reactions. This ketene was not distilled, but used as a crude solution in THF assumed to 
be 40 mg per 1 mL of THF. As such, only limited spectroscopic data was obtained for this species; 
1H NMR (400 MHz, CDCl3) δ 6.97 (1H, d, J = 8.4, ArH), 6.54 (1H, dd, J = 8.4, 2.6, ArH), 6.44 
(1H, d, J = 2.6, ArH), 3.75 (3H, s, OMe), 2.68 (2H, t, J = 6.1, CH2), 2.63-2.60 (2H, m, CH2), 1.86-
1.84 (2H, m, CH2). 
(S)-1-(2-((E)-(((R)-2,2-Dimethyl-3-((2,4,6-triisopropylphenyl)sulfonyl)oxazolidin-4-
yl)methylene) amino)phenyl)-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid 177 
  To a stirred solution of nitrone 144 (0.050 g, 0.103 mmol) in THF (3 mL) was 
added ketene 176 (0.020g, 1.2 eq, 0.124 mmol) and the reaction stirred at rt for 1h 30 min before 
quenching with sat. aq. NH4Cl (1 mL). The reaction mixture was extracted with Et2O (10 mL) and 
washed with brine (10 mL) before being dried over MgSO4, filtered and concentrated in vacuo to 
yield a crude yellow oil which was purified via column chromatography over silica (0-20% EtOAc in 
petroleum ether) to yield 177 (0.017 g, 26%) as a colourless oil in >99:1 dr; νmax cm-1 (thin-film) 
3441, 1697, 1653; 1H NMR (500 MHz, CDCl3) δ 7.36 (1H, d, J = 8.0, ArH), 7.22-7.11 (4H, m, ArH 
& CH=N), 7.15 (2H, s, ArH(TIPBS)), 6.93 (2H, dt, J = 24.1, 7.5, Ar’H), 6.40 (1H, d, J = 7.6, Ar’H), 
5.78 (d, J = 7.6, Ar’H), 4.47-4.45 (1H, m, CHN), 4.34 (2H, dt, J = 13.4, 6.7, iPrH), 4.25 (1H, dd, J = 
9.2, 2.0, CHaHb(5)), 4.14 (1H, dd, J = 9.0, 7.3, CHaHb(5)), 2.88-2.84 (2H, m, CHaHb(4’) & 1 x iPrH), 
2.76-2.73 (1H, m, CHaHb(4’)), 2.59-2.54 (1H, m, CHaHb(2’)), 2.46-2.43 (1H, m, CHaHb(2’)), 1.80 
(6H, s, CMe2), 1.29-1.19 (20H, m, CH2(3’) & i-PrCH3); 13C NMR (125 MHz, CDCl3) δ 177.8 (C=O), 
163.1 (HC=N), 154.1 (ArC), 151.6 (ArC), 147.5 (ArC), 139.2 (ArC), 138.8 (ArC), 135.0 (ArC), 132.6 
(ArC), 130.1 (ArC), 129.9 (ArC), 129.6 (ArC), 127.6 (ArC), 127.4 (ArC), 126.1 (ArC), 125.7 (ArC), 
124.2 (ArC), 117.6 (ArC), 100.4 (CMe2), 67.3 (CH2), 61.2 (CH), 54.8 (C(3)), 34.2 (p-iPrC), 32.3 (p-
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iPrCH3), 29.2 (CH2(4’)), 28.1 (CH2(2’)), 25.1 (CMe2), 24.5 (CMe2), 23.5 (o-iPrC), 22.7 (o-iPrCH3), 19.5 
(CH2(3’)); m/z (ESI+) 667.42 ([M+Na]+, 100%). 
(±)-3',4'-Dihydro-2'H-spiro[indoline-3,1'-naphthalen]-2-one (±)-178 
The oxindole was obtained from nitrone 48 (0.050 g, 0.254 mmol) and ketene 176 
(0.040 g, 1.1 eq, 0.279 mmol) following general procedure E to yield (±)-178 (0.047 g, 74%) as a 
white solid; mp 211-213 °C {lit.15 213-215 °C}; 1H NMR (300 MHz, CDCl3) δ 8.24 (1H, br s, ArH), 
7.26-7.11 (3H, m, ArH), 7.05-6.94 (4H, m, ArH), 6.61 (1H, dd, J = 7.8, 0.7, ArH(7)), 3.07-2.92 (2H, 
m, CH2), 2.39-2.22 (2H, m, CH2), 2.07-1.97 (2H, m, CH2). 
(S)-3',4'-Dihydro-2'H-spiro[indoline-3,1'-naphthalen]-2-one 178 
The oxindole was obtained from chiral nitrone 144 (0.110g, 22.6 mmol) and ketene 
176 (0.054 g, 33.9 mmol) following general procedure F to yield 178 (0.054 g, 96%) as an off-white 
solid; [α]D
20 +0.8° (c = 0.75, CHCl3); HPLC analysis: 98% e.e. (Daicel Chiralcel AD-H column, 
eluent: hexane/i-PrOH 95:5, flow 1.0 mL/min, wavelength: 254 nm, retention times: 18.0 min 
(major) and 19.7 min (minor)). 
HPLC trace for oxindole (±)-178: 
 
Peak tR (min) Area (%) 
1 18.02 50.33 
2 19.64 49.67 
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HPLC trace for oxindole (S)-178: 
 
Peak tR (min) Area (%) 
1 18.07 99.41 
2 19.69 0.59 
(±)-6'-Methoxy-3',4'-dihydro-2'H-spiro[indoline-3,1'-naphthalen]-2-one (±)-196 
The oxindole was obtained from nitrone 48 (0.084 g, 0.353 mmol) and ketene 
solution 184 (0.080 g, 0.425 mmol) following general procedure E to yield (±)-196 (0.093 g, 94%) 
as a white solid; mp 149-150 °C; νmax cm-1 (thin-film) 3130, 3080, 2934, 1697, 1620, 1499, 1474; 1H 
NMR (300 MHz, CDCl3) δ 7.87 (1H, br s, NH), 7.21 (1H, td, J = 7.5, 1.5, ArH), 7.03-6.92 (3H, m, 
ArH), 6.70 (1H, d, J = 2.4, Ar’H), 6.57-6.50 (2H, m, Ar’H), 3.75 (3H, s, OMe), 3.04-2.88 (2H, m, 
CH2(4’)), 2.42-2.30 (1H, m, CHaHb(2’)), 2.26-2.18 (1H, m, CHaHb(2’)), 2.03-1.95 (2H, m, CH2(3’)); 
13C NMR (100 MHz, CDCl3) δ 181.5 (C=O), 157.4 (ArC(6’)OMe), 138.9 (4ry ArC), 138.2 (4ry ArC), 
136.9 (4ry ArC), 128.2 (ArC), 126.7 (ArC), 126.0 (4ry ArC), 123.3 (ArC), 121.8 (ArC), 112.8 (ArC), 
112.1 (ArC), 108.5 (ArC), 54.2 (OMe), 50.9 (C(3)), 33.3 (CH2(4’)), 28.6 (CH2(2’)), 17.7 (CH2(3’)); 
m/z (ESI+) 280 ([M+H]+, 100%); HRMS (EI+) C18H17NO2+ ([M+H]+) found 280.1334 requires 
280.1332 (+ 0.2 ppm). 
(S)-6'-Methoxy-3',4'-dihydro-2'H-spiro[indoline-3,1'-naphthalen]-2-one 196 
 The oxindole was obtained from chiral nitrone 144 (0.104 g, 0.214 mmol) and 
ketene solution 184 (1.6 mL) following general procedure F to yield 196 (0.036 g, 85%) as an off-
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white solid; [α]D
20 -8.8° (c = 0.50, CHCl3); HPLC analysis: 98% e.e. (Daicel Chiralcel AD-H column, 
eluent: hexane/i-PrOH 95:5, flow 1.0 mL/min, wavelength: 254 nm, retention times: 26.3 min 
(major) and 31.7 min (minor)).  
(±)-5-Fluoro-6'-methoxy-3',4'-dihydro-2'H-spiro[indoline-3,1'-naphthalen]-2-one (±)-197 
 The oxindole was obtained from nitrone 89 (0.091 g, 0.353 mmol) and ketene 
solution 184 (0.080 g, 0.425 mmol) following general procedure E to yield (±)-197 (0.093 g, 89%) 
as a white solid; mp 71-73 °C; νmax cm-1 (thin-film) 3067, 2930, 1699, 1609, 1503, 1472; 1H NMR 
(300 MHz, CDCl3) δ 7.80 (1H, br s, NH), 6.95-6.83 (2H, m, ArH(4,7)), 6.78 (1H, dd, J = 8.1, 2.5, 
ArH(6)), 6.70 (1H, d, J = 2.5, ArH(5’)), 6.60 (1H, dd, J = 8.6, 2.5, ArH(7’)), 6.51 (1H, d, J = 8.6, 
ArH(8’)), 3.76 (3H, s, OMe), 3.03-2.90 (2H, m, CH2(4’)), 2.42-2.30 (1H, m, CHaHb(2’)), 2.23-2.18 
(1H, m, CHaHb(2’)), 2.01-1.93 (2H, m, CH2(3’)); 13C NMR (125 MHz, CDCl3) δ 183.5 (C=O), 158.9 
(d, J = 237.5, ArC(5)F), 158.6 (ArC(6’)OMe), 139.4 (d, J = 7.6, ArC(3a)), 139.2 (ArC(8a’)), 136.1 
(ArC(4a’)), 129.2 (ArC(8’)), 126.4 (ArC(7a)), 114.1 (d, J = 25.0, ArC(4)), 114.0 (Ar’C), 113.3 (Ar’C), 
112.0 (d, J = 25.0, ArC(6)), 110.5 (d, J = 7.9, ArC(7)), 55.2 (OMe), 52.7 (C(3)), 34.2 (CH2(4’)), 29.6 
(CH2(2’)), 18.7 (CH2(3’)); 19F NMR (282 MHz, CDCl3) δ -120.5 (ArF); m/z (ESI+) 298 ([M+H]+, 
100%); HRMS (EI+) C18H16FNO2+ ([M+H]+) found 298.1241 requires 280.1238 (+ 0.3 ppm). 
(S)-5-Fluoro-6'-methoxy-3',4'-dihydro-2'H-spiro[indoline-3,1'-naphthalen]-2-one 197 
 The oxindole was obtained from chiral nitrone 191 (0.108 g, 0.214 mmol) and 
ketene solution 184 (1.6 mL) following general procedure F to yield 197 (0.063 g, 99%) as a white 
solid; [α]D
20 -6.7° (c = 0.55, CHCl3); HPLC analysis: 98% e.e. (Daicel Chiralcel AD-H column, 
eluent: hexane/i-PrOH 95:5, flow 1.0 mL/min, wavelength: 254 nm, retention times: 23.3 min 
(major) and 30.1 min (minor)).  
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(±)-6'-Methoxy-5-(trifluoromethyl)-3',4'-dihydro-2'H-spiro[indoline-3,1'-naphthalen]-2-one 
(±)-198 
 The oxindole was obtained from nitrone 90 (0.113 g, 0.353 mmol) and ketene 
solution 184 (0.080 g, 0.425 mmol) following general procedure E to yield (±)-198 (0.101 g, 82%) 
as a white solid; mp 70-71 °C; νmax cm-1 (thin-film) 3157, 2934, 2841, 1694, 1622, 1497; 1H NMR 
(300 MHz, CDCl3) δ 8.29 (1H, br s, NH), 7.52 (1H, dd, J = 8.2, 0.9, ArH(6)), 7.27 (1H, s, ArH(4)), 
7.04 (1H, d, J = 8.2, ArH(7)), 6.75 (1H, d, J = 2.7, ArH(5’)), 6.62 (1H, dd, J = 8.6, 2.7, ArH(8’)), 
6.50 (1H, d, J = 8.6, ArH(7’)), 3.79 (3H, s, OMe), 3.01 (2H, app. br t, J = 6.3, CH2(4’)), 2.45-2.36 
(1H, m, CHaHb(2’)), 2.28-2.20 (1H, m, CHaHb(3’)), 2.07-1.96 (2H, m, CHaHb(3’) & CHaHb(2’)); 13C 
NMR (100 MHz, CDCl3) δ 183.6 (C=O), 158.8 (ArC(6’)OMe), 143.5 (4ry ArC), 139.4 (4ry ArC), 
138.3 (4ry ArC), 129.1 (ArC(8’)), 125.9 (4ryArC), 125.6 (app. d, J = 3.9, ArC(4)), 125.3 (q, J = 32.7, 
ArC(5)CF3), 124.0 (q, J = 252.5, ArCF3), 121.2 (app. d, J = 3.9, ArC(6)), 114.1 (ArC(5’)), 113.4 
(ArC(7’)), 109.9 (ArC(7)), 55.2 (OMe), 52.2 (C(3)), 34.3 (CH2(2’)), 29.6 (CH2(4’)), 18.6 (CH2(3’)); 19F 
NMR (376 MHz, CDCl3) δ -61.9 (ArCF3); m/z (ESI+) 348 ([M+H]+, 100%); HRMS (EI+) 
C19H16F3NO2+ ([M+H]+) found 348.1205 requires 348.1206 (+ 0.1 ppm). 
(S)-6'-Methoxy-5-(trifluoromethyl)-3',4'-dihydro-2'H-spiro[indoline-3,1'-naphthalen]-2-one 
198 
 The oxindole was obtained from chiral nitrone 192 (0.119 g, 0.214 mmol) and 
ketene solution 184 (1.6 mL) following general procedure F to yield 198 (0.036 g, 48%) as a white 
solid; [α]D
20 -52.0° (c = 0.40, CHCl3); HPLC analysis: 98% e.e. (Daicel Chiralcel OD-H column, 
eluent: hexane/i-PrOH 95:5, flow 1.0 mL/min, wavelength: 254 nm, retention times: 39.8 min 
(major) and 49.0 min (minor)).  
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(±)-5,6'-Dimethoxy-3',4'-dihydro-2'H-spiro[indoline-3,1'-naphthalen]-2-one (±)-199 
 The oxindole was obtained from nitrone 70 (0.074 g, 0.326 mmol) and ketene 
solution 184 (0.080 g, 0.425 mmol) following general procedure E to yield (±)-199 (0.078 g, 77%) 
as a white solid; mp 109-110 °C; νmax cm-1 (thin-film) 3190, 2934, 1683, 1605, 1495; 1H NMR (300 
MHz, CDCl3) δ 7.61 (1H, br s, NH), 6.84 (1H, d, J = 8.5, ArH(7)), 6.74 (1H, dd, J = 8.5, 2.5, 
ArH(6)), 6.69 (1H, d, J = 2.5, ArH(4)), 6.63 (1H, d, J = 2.5, ArH(5’)), 6.59 (1H, dd, J = 8.5, 2.5, 
ArH(7’)), 6.53 (1H, d, J = 8.5, ArH(8’)), 3.75 (3H, s, OMe), 3.72 (3H, s, OMe), 3.05-2.87 (2H, m, 
CH2(4’)), 2.43-2.30 (1H, m, CHaHb(2’)), 2.26-2.16 (2H, m, CH2(3’)), 2.03-1.92 (1H, m, HaHb(2’)); 
13C NMR (100 MHz, CDCl3) δ 182.5 (C=O), 158.4 (ArCOMe), 156.0 (ArCOMe), 139.2 (ArC), 
133.4 (ArC), 129.3 (ArC), 127.0 (ArC), 113.8 (ArC), 113.1 (ArC), 112.4 (ArC), 111.4 (ArC), 111.4 
(ArC), 109.8 (ArC), 55.8 (OMe), 55.2 (OMe), 52.4 (C(3)), 34.4 (CH2(4’)), 29.6 (CH2(2’)), 18.7 
(CH2(3’)); m/z (ESI+) 310 ([M+H]+, 100%); HRMS (EI+) C19H19NO3+ ([M+H]+) found 310.1441 
requires 310.1438 (+ 0.3 ppm). 
(S)-5,6'-Dimethoxy-3',4'-dihydro-2'H-spiro[indoline-3,1'-naphthalen]-2-one 199 
 The oxindole was obtained from chiral nitrone 193 (0.111 g, 0.214 mmol) and 
ketene solution 184 (1.6 mL) following general procedure F to yield 199 (0.034 g, 52%) as a white 
solid; [α]D
20 -75.2° (c = 0.25, CHCl3); HPLC analysis: 99% e.e. (Daicel Chiralcel AD-H column, 
eluent: hexane/i-PrOH 95:5, flow 1.0 mL/min, wavelength: 254 nm, retention times: 35.6 min 
(major) and 50.3 min (minor)).  
(±)-7'-Methoxy-3',4'-dihydro-2'H-spiro[indoline-3,1'-naphthalen]-2-one (±)-200 
 The oxindole was obtained from nitrone 48 (0.028 g, 0.142 mmol) and ketene 
solution 190 (2.0 mL) following general procedure E to yield (±)-200 (0.033 g, 83%) as a white 
solid; mp 101-103 °C; νmax cm-1 (thin-film) 3179, 2934, 2836, 1687, 1620, 1497; 1H NMR (300 
MHz, CDCl3) δ 7.74 (1H, br s, NH), 7.21 (1H, td, J = 7.6, 1.5, ArH(6)), 7.10 (1H, d, J = 8.5, 
ArH(5’)), 7.06-7.03 (1H, m, ArH(4)), 6.99 (1H, dd, J = 7.4, 1.0, ArH(5)), 6.93 (1H, d, J = 7.7, 
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ArH(7)), 6.73 (1H, dd, J = 8.5, 2.7, ArH(6’)), 6.12 (1H, d, J = 2.7, ArH(8’)), 3.61 (3H, s, OMe), 2.99-
2.84 (2H, m, CH2(4’)), 2.35-2.17 (2H, m, CH2(2’)), 2.05-1.95 (2H, m, CH2(3’)); 13C NMR (125 MHz, 
CDCl3) δ 182.6 (C=O), 157.8 (ArC(7’)OMe), 140.1 (4ry ArC), 137.7 (4ry ArC), 135.7 (ArC(7a)), 
130.5 (ArC), 130.1 (4ry ArC(4a’)), 127.9 (ArC), 124.3 (ArC), 122.8 (ArC), 113.3 (Ar’C), 113.1 (Ar’C), 
109.8 (ArC(7)), 55.2 (OMe), 52.8 (C(3)), 34.1 (CH2(4’)), 28.5 (CH2(2’)), 18.9 (CH2(3’)); m/z (ESI+) 
280 ([M+H]+, 100%); HRMS (EI+) C18H17NO2+ ([M+H]+) found 280.1336 requires 280.1332 (+ 
0.4 ppm). 
(S)-7'-Methoxy-3',4'-dihydro-2'H-spiro[indoline-3,1'-naphthalen]-2-one 200 
 The oxindole was obtained from chiral nitrone 144 (0.075 g, 0.154 mmol) and 
ketene solution 190 (2.0 mL) following general procedure F to yield 200 (0.034 g, 79%) as a white 
solid; [α]D
20 -9.4° (c = 0.70, CHCl3); HPLC analysis: 98% e.e. (Daicel Chiralcel AD-H column, 
eluent: hexane/i-PrOH 95:5, flow 1.0 mL/min, wavelength: 254 nm, retention times: 25.3 min 
(major) and 28.7 min (minor)).  
(±)-7'-Methoxy-5-methyl-3',4'-dihydro-2'H-spiro[indoline-3,1'-naphthalen]-2-one (±)-201 
The oxindole was obtained from nitrone 86 (0.031 g, 0.106 mmol) and ketene 
solution 190 (2.0 mL) following general procedure E to yield (±)-201 (0.036 g, 84%) as a white 
solid; mp 180-181 °C; νmax cm-1 (thin-film) 3146, 3024, 2833, 1689, 1610, 1499; 1H NMR (500 
MHz, CDCl3) δ 7.86 (1H, br s, NH), 7.10 (1H, d, J = 8.5, ArH(5’)), 7.00 (1H, dd, J = 7.9, 0.6, 
ArH(6)), 6.86 (1H, s, ArH(4)), 6.82 (1H, d, J = 7.9, ArH(7)), 6.73 (1H, dd, J = 8.5, 2.6, ArH(6’)), 
6.13 (1H, d, J = 2.6, ArH(8’)), 3.62 (3H, s, OMe), 2.96-2.87 (2H, m, CH2(4’)), 2.36-2.28 (1H, m, 
CHaHb(2’)), 2.25 (3H, s, ArCH3), 2.23-2.18 (1H, m, CHaHb(2’)), 2.03-1.95 (2H, m, CH2(3’)); 13C 
NMR (125 MHz, CDCl3) δ 182.3 (C=O), 157.8 (ArC(7’)OMe), 137.7 (4ry ArC), 137.4 (4ry ArC), 
135.9 (4ry ArC), 132.3 (4ry ArC), 130.5 (ArC), 130.1 (4ry ArC), 128.2 (ArC), 125.1 (ArC), 113.3 
(Ar’C), 113.1 (Ar’C), 109.3 (ArC(7)), 55.2 (OMe), 52.8 (C(3)), 34.1 (CH2(4’)), 28.4 (CH2(2’)), 21.1 
(ArCH3), 18.9 (CH2(3’)); m/z (ESI+) 294 ([M+H]+, 100%); HRMS (EI+) C19H19NO2+ ([M+H]+) 
found 294.1492 requires 294.1492 (+ 0.0 ppm). 
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(S)-7'-Methoxy-5-methyl-3',4'-dihydro-2'H-spiro[indoline-3,1'-naphthalen]-2-one 201 
 The oxindole was obtained from chiral nitrone 194 (0.075 g, 0.150 mmol) and 
ketene solution 190 (2.0 mL) following general procedure F to yield 201 (0.039 g, 89%) as a white 
semi-solid; [α]D
20  +39.5° (c = 0.45, CHCl3); HPLC analysis: 94% e.e. (Daicel Chiralcel AD-H 
column, eluent: hexane/i-PrOH 95:5, flow 1.0 mL/min, wavelength: 254 nm, retention times: 20.7 
min (major) and 26.2 min (minor)).  
(±)-7'-Methoxy-7-methyl-3',4'-dihydro-2'H-spiro[indoline-3,1'-naphthalen]-2-one (±)-205 
The oxindole was obtained from nitrone 71 (0.031 g, 0.106 mmol) and ketene 
solution 190 (2.0 mL) following general procedure E to yield (±)-205 (0.038 g, 88%) as a white 
solid; mp 216-218 °C; νmax cm-1 (thin-film) 3173, 3148, 2936, 2837, 1690, 1624, 1601, 1497; 1H 
NMR (500 MHz, CDCl3) δ 8.82 (1H, br s, NH), 7.10 (1H, d, J = 8.5, ArH(5’)), 7.02 (1H, d, J = 6.6, 
ArH), 6.91-6.86 (2H, m, ArH), 6.73 (1H, dd, J = 8.5, 2.6, ArH(6’)), 6.13 (1H, d, J = 2.6, ArH(8’)), 
3.59 (3H, s, OMe), 2.98-2.87 (2H, m, CH2(4’)), 2.37-2.33 (1H, m, CHaHb(C2’)), 2.29 (3H, s, ArCH3), 
2.24-2.19 (1H, m, CHaHb(C2’)), 2.00-1.98 (2H, m, CH2(3’)); 13C NMR (125 MHz, CDCl3) δ 183.0 
(C=O), 157.8 (ArC(7’)OMe), 138.9 (4ry ArC), 137.3 (4ry ArC), 135.9 (4ry ArC), 130.5 (ArC), 130.0 
(4ry ArC), 129.2 (ArC), 122.7 (ArC), 121.7 (ArC), 119.1 (ArC(7)CH3), 113.2 (Ar’C), 113.1 (Ar’C), 
55.2 (OMe), 53.2 (C(3)), 34.1 (CH2(4’)), 28.5 (CH2(2’)), 18.8 (CH2(3’)), 16.6 (ArCH3); m/z (ESI+) 
294 ([M+H]+, 100%); HRMS (EI+) C19H19NO2+ ([M+H]+) found 294.1492 requires 294.1489 (+ 
0.3 ppm). 
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(S)-7'-Methoxy-7-methyl-3',4'-dihydro-2'H-spiro[indoline-3,1'-naphthalen]-2-one 205 
 The oxindole was obtained from chiral nitrone 195 (0.057 g, 0.113 mmol) and 
ketene solution 190 (2.0 mL) following general procedure F to yield 205 (0.018 g, 55%) as a white 
solid; [α]D
20 -3.0° (c = 0.40, CHCl3); HPLC analysis: 90% e.e. (Daicel Chiralcel AD-H column, 
eluent: hexane/i-PrOH 95:5, flow 1.0 mL/min, wavelength: 254 nm, retention times: 19.2 min 
(minor) and 25.1 min (major)).  
(±)-7'-Methoxy-5-(trifluoromethyl)-3',4'-dihydro-2'H-spiro[indoline-3,1'-naphthalen]-2-one 
(±)-202 
The oxindole was obtained from nitrone 90 (0.040 g, 0.151 mmol) and ketene 
solution 190 (2.0 mL) following general procedure E to yield (±)-202 (0.034 g, 65%) as a colourless 
oil; νmax cm-1 (thin-film) 2849, 1701, 1466; 1H NMR (300 MHz, CDCl3) δ 8.22 (1H, br s, NH), 7.51 
(1H, dd, J = 8.2, 0.8, ArH), 7.28 (1H, s, ArH(4)), 7.14 (1H, d, J = 8.5, ArH(5’)), 7.02 (1H, d, J = 8.2, 
ArH(7)), 6.77 (1H, dd, J = 8.5, 2.7, ArH(6’)), 6.07 (1H, d, J = 2.7, ArH(8’)), 3.62 (3H, s, OMe), 2.94 
(2H, br t, J = 6.4, CH), 2.39-2.32 (1H, m, CHaHb(2’)), 2.27-2.18 (1H, m, CHaHb(2’)), 2.04-1.95 (2H, 
m, CH2(3’)); 13C NMR (100 MHz, CDCl3); 182.6 (C=O), 158.0 (ArC(7’)OMe), 143.2 (ArC), 138.1 
(ArC), 134.6 (ArC), 130.8 (ArC), 130.1 (ArC), 125.7 (app. d, J = 2.3, ArC), 125.4 (q, J = 25.7, 
ArC(CF3)), 121.4 (app. d, J = 4.0, ArC), 113.4 (app. d, J = 5.3, ArC), 113.2 (ArC), 109.8 (ArC), 55.2 
(OMe), 52.8 (C(3)), 34.1 (CH2(4’)), 28.3 (CH2(2’)), 18.8 (CH2(3’)), (CF3 carbon not observed); 19F 
NMR (470.3 MHz, CDCl3) δ -61.4 (CF3); m/z (ESI+) 348 ([M+H]+, 100%); HRMS (EI+) 
C19H17NO2F3+ ([M+H]+) found 348.1209 requires 348.1206 (+ 0.9 ppm). 
N
H
O
MeO
Me
N
H
O
MeO
F3C
 
 Chapter 8: Experimental Details 
 171 
(S)-7'-Methoxy-5-(trifluoromethyl)-3',4'-dihydro-2'H-spiro[indoline-3,1'-naphthalen]-2-one 
202 
 The oxindole was obtained from chiral nitrone 192 (0.075 g, 0.135 mmol) and 
ketene solution 190 (2.0 mL) following general procedure F to yield 202 (0.032 g, 64%) as a 
colourless oil; [α]D
20 -3.1° (c = 0.60, CHCl3); HPLC analysis: 97% e.e. (Daicel Chiralcel AD-H 
column, eluent: hexane/i-PrOH 95:5, flow 1.0 mL/min, wavelength: 254 nm, retention times: 13.0 
min (major) and 15.8 min (minor)).  
(±)-5-Fluoro-7'-methoxy-3',4'-dihydro-2'H-spiro[indoline-3,1'-naphthalen]-2-one (±)-203 
The oxindole was obtained from nitrone 89 (0.028 g, 0.094 mmol) and ketene 
solution 190 (2.0 mL) following general procedure E to yield (±)-203 (0.025 g, 65%) as a white 
solid; mp 104-106 °C; νmax cm-1 (thin-film) 3146, 3024, 2849, 1691, 1611, 1500, 1487; 1H NMR (500 
MHz, CDCl3) δ 8.37 (1H, br s, NH), 7.11 (1H, d, J = 8.5, ArH(5’)), 6.91 (1H, td, J = 8.7, 2.5, ArH), 
6.87 (1H, dd, J = 8.5, 4.5, ArH), 6.79 (1H, dd, J = 8.1, 2.5, ArH), 6.75 (1H, dd, J = 8.5, 2.6, 
ArH(6’)), 6.11 (1H, d, J = 2.6, ArH(8’)), 3.63 (3H, s, OMe), 2.97-2.86 (2H, m, CH2(4’)), 2.37-2.30 
(1H, m, CHaHb(2’)), 2.25-2.17 (1H, m, CHaHb(2’)), 2.01-1.94 (2H, m, CH2(3’)); 13C NMR (125 
MHz, CDCl3) δ 182.4 (C=O), 159.1 (d, J = 239.3, ArC(5)F), 158.3 (ArC(7’)OMe), 139.2 (d, J = 7.9, 
ArC(3a)), 135.9 (d, J = 1.1, ArC(7a)), 135.0 (ArC(8a’)), 130.7 (ArC(5’)), 130.0 (ArC(4a’)), 114.3 (d, J 
= 23.3, ArC(6)), 113.4 (Ar’C), 113.1 (Ar’C), 112.3 (d, J = 24.7 ArC(4)), 110.3 (d, J = 8.1 ArC(7)), 
55.2 (OMe), 53.3 (C(3)), 34.0 (CH2(4’)), 28.3 (CH2(2’)), 18.8 (CH2(3’)); 19F NMR (282 MHz, CDCl3) 
δ -120.5 (ArF); m/z (ESI+) 298 ([M+H]+, 100%); HRMS (EI+) C18H16FNO2+ ([M+H]+) found 
298.1242 requires 298.1238 (+ 0.4 ppm). 
(S)-5-Fluoro-7'-methoxy-3',4'-dihydro-2'H-spiro[indoline-3,1'-naphthalen]-2-one 203 
 The oxindole was obtained from chiral nitrone 191 (0.059 g, 0.149 mmol) and 
ketene solution 190 (2.0 mL) following general procedure F to yield 203 (0.033 g, 74%) as a off-
white solid; [α]D
20 -4.4° (c = 0.65, CHCl3); HPLC analysis: 97% e.e. (Daicel Chiralcel AD-H column, 
N
H
O
MeO
F3C
N
H
O
MeO
F
N
H
O
MeO
F
 
 Chapter 8: Experimental Details 
 172 
eluent: hexane/i-PrOH 95:5, flow 1.0 mL/min, wavelength: 254 nm, retention times: 18.9 min 
(major) and 28.3 min (minor)).  
(±)-5,7'-Dimethoxy-3',4'-dihydro-2'H-spiro[indoline-3,1'-naphthalen]-2-one (±)-204 
The oxindole was obtained from nitrone 70 (0.029 g, 0.094 mmol) and ketene 
solution 190 (2.0 mL) following general procedure E to yield (±)-204 (0.036 g, 92%) as a white 
solid; mp 136-137 °C; νmax cm-1 (thin-film) 3154, 3024, 2833, 1693, 1612, 1499, 1485; 1H NMR (500 
MHz, CDCl3) δ 8.45 (1H, br s, NH), 7.10 (1H, d, J = 8.5, ArH(7)), 6.85 (1H, d, J = 8.5, ArH(4’)), 
6.74 (2H, dd, J = 8.5, 2.5, ArH(6 & 6’)), 6.64 (1H, d, J = 2.3, ArH(4)), 6.14 (1H, d, J = 2.5, 
ArH(8’)), 3.72 (3H, s, OMe), 3.62 (3H, s, OMe), 2.98-2.86 (2H, m, CH2(4’)), 2.38-2.30 (1H, m, 
CHaHb(2’)), 2.24–2.17 (2H, m, CH2(3’)), 2.02-1.95 (1H, m, CHaHb(2’)); 13C NMR (125 MHz, 
CDCl3) δ 182.7 (C=O), 157.9 (ArC(7’)OMe), 156.0 (ArC(5)OMe), 139.0 (ArC(8a’)), 135.6 
(ArC(3a)), 133.5 (ArC(7a)), 130.5 (ArC(4’)), 130.0 (ArC(4a’)), 113.3 (Ar’C), 113.2 (Ar’C), 112.4 
(ArC), 111.4 (ArC), 110.1 (ArC(7)), 55.8 (OMe), 55.2 (OMe), 53.3 (C(3)), 34.1 (CH2(4’)), 28.4 
(CH2(2’)), 18.8 (CH2(3’)); m/z (ESI+) 310 ([M+H]+, 100%); HRMS (EI+) C19H19NO3+ ([M+H]+) 
found 310.1441 requires 310.1438 (+ 0.3 ppm). 
(S)-5,7'-Dimethoxy-3',4'-dihydro-2'H-spiro[indoline-3,1'-naphthalen]-2-one 204 
 The oxindole was obtained from chiral nitrone 193 (0.075 g, 0.145 mmol) and 
ketene solution 190 (2.0 mL) following general procedure F to yield 204 (0.043 g, 96%) as a very 
viscous orange oil; [α]D
20 -13.3° (c = 0.95, CHCl3); HPLC analysis: 97% e.e. (Daicel Chiralcel AD-H 
column, eluent: hexane/i-PrOH 95:5, flow 1.0 mL/min, wavelength: 254 nm, retention times: 31.6 
min (major) and 43.0 min (minor)). 
 (±)-1-Tosylpyrrolidine-2-carboxylic acid 376 
 A mixture of (±)-proline (3.00 g, 26.2 mmol) and TsCl (4.98 g, 1.0 eq, 26.2 mmol) was 
taken up in 1M NaOH (60 mL) and the reaction mixture stirred rapidly at rt for 16 h. The reaction 
mixture was then acidifed carefully with 2M HCl until pH ca. 3 and extracted with Et2O (3 ×100 
mL). The combined organic layers were dried over MgSO4, filtered and concentrated in vacuo to give 
(±)-376 (7.04 g, quant.) as a white solid; mp 131-132 °C {lit.16 134 °C}; 1H NMR (300 MHz, 
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CDCl3) δ 7.76 (2H, d, J = 8.0, TsH), 7.35 (2H, d, J = 8.0, TsH), 4.26 (1H, dd, J = 8.3, 3.5, CH), 3.53 
(1H, ddd, J = 9.7, 6.7, 4.1, CHaHb), 3.29-3.21 (1H, m, CHaHb), 2.45 (3H, s, TsCH3), 2.23-2.10 (1H, 
m, CHaHb), 1.99-1.90 (2H, m, CH2), 1.80-1.71 (1H, m, CHaHb). 
(±)-1-Tosylpyrrolidine-2-carbonyl chloride 206 
 The title compound was prepared according to general procedure I from carboxylic acid 
376 (3.00 g, 11.2 mmol), (COCl)2 (2.70 mL, 2.0 eq, 22.4 mmol) and DMF (6 drops) in CH2Cl2 (30 
mL). After stirring at rt for 1 h, the reaction mixture was concentrated in vacuo before being taken 
up in toluene (60 mL), washed with sat. aq. NaHCO3 (30 mL) followed by brine (30 mL), dried 
over MgSO4, filtered and concentrated in vacuo to give (±)-206 (3.47 g, quant.) as a white solid; mp 
92-94 °C {lit.17 54-55.5 °C}; 1H NMR (300 MHz, CDCl3) δ 7.77-7.73 (2H, m, TsH), 7.36-7.32 (2H, 
m, TsH), 4.61 (1H, t, J = 6.5, CH), 3.53-3.46 (1H, m, CHaHb), 3.35 (1H, dt, J = 9.6, 7.3, CHaHb), 
2.44 (3H, s, TsCH3), 2.23-2.16 (2H, m, CH2), 1.99-1.80 (2H, m, CH2). 
(±)-N-Benzoyl-N-phenyl-1-tosylpyrrolidine-2-carboxamide 208 
To a stirred solution of nitrone 48 (0.050 g, 0.254 mmol) and acid chloride 206 
(0.146 g, 2.0 eq, 0.508 mmol) in CH2Cl2 (5 mL) at 0 °C was added Et3N (0.105 mL, 3.0 eq, 0.762 
mmol) dropwise and the reaction stirred 16 h, allowing to warm to rt. The reaction was quenched 
with 2M HCl and extracted with CH2Cl2 (3 x 25 mL). The combined organic layers were washed 
with sat. aq. NaHCO3 (50 mL), dried over MgSO4, filtered and concentrated in vacuo to give a 
yellow oil which was purified via column chromatography to give 208 (0.112 g, 98%) as an off-
white solid; mp 64-65 °C (decomp.); νmax cm-1 (thin-film) 1715, 1682, 1597; 1H NMR (400 MHz, 
CDCl3) δ 7.68-7.66 (2H, m, TsH), 7.60-7.58 (2H, m, TsH), 7.36-7.31 (1H, m, ArH), 7.27-7.22 (4H, 
m, ArH), 7.20-7.15 (5H, m, ArH), 4.62 (1H, dd, J = 8.0, 5.1, CH), 3.48 (1H, dt, J = 9.8, 6.4, 
CHaHb), 3.23 (1H, dt, J = 9.8, 6.6, CHaHb), 2.32 (3H, s, TsCH3), 2.24-2.16 (1H, m, CH2), 2.12-1.98 
(2H, m, CH2), 1.58-1.49 (1H, m, CH2); 13C NMR (100 MHz, CDCl3) δ 177.3 (C=O), 173.3 (C=O), 
143.7 (4ry ArC), 138.8 (4ry ArC), 134.7 (4ry ArC), 134.1 (4ry ArC), 132.3 (ArH), 129.8 (ArH), 129.8 
(ArH), 129.4 (ArH), 128.6 (ArH), 128.3 (ArH), 128.1 (ArH), 127.5 (ArH), 61.6 (CH), 49.4 (CH2), 
31.7 (CH2), 25.1 (CH2), 21.5 (TsCH3); m/z (EI+) 449 ([M+H]+, 100%); HRMS (EI+) C25H25N2O4S 
([M+H]+) found 449.1527 requires 449.1530 (- 0.6 ppm). 
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8.5. Experimental Details for Chapter 4: Mechanistic Investigations 
(Z)-N-Benzylidene-2,6-dimethylaniline oxide 222 
 222 was obtained according to general procedure C from 1,3-dimethyl-2-
nitrobenzene (8.10 mL, 59.0 mmol), benzaldehyde (6.00 mL, 1.0 eq, 59.0 mmol), NH4Cl (4.14 g, 1.3 
eq, 76.7 mmol) and zinc powder (7.80 g, 2.0 eq, 118 mmol) in EtOH:H2O (1:1 360 mL) to yield 
222 (7.89 g, 59%) as an off-white solid; mp 110-111 °C {lit.1 127-128 °C}; 1H NMR (300 MHz, 
CDCl3) δ 8.38-8.35 (2H, m, ArH), 7.50-7.48 (3H, m, ArH), 7.46 (1H, s, HC=N+), 7.22-7.19 (1H, m, 
ArH), 7.14-7.11 (2H, m, ArH), 2.37 (6H, s, ArCH3). 
(±)-(3RS ,3aRS ,7aRS)-7a-((E)-Benzylideneamino)-3-ethyl-3a,7-dimethyl-3-phenyl-3,3a-
dihydrobenzofuran-2(7aH)-one 224  
   224 was obtained according to general procedure E from nitrone 222 (0.050 g, 
0.022 mmol) and ethylphenylketene (0.045 g, 1.4 eq, 0.031 mmol). Concentration of the organic 
material gave a crude mixture of compounds with 224 as the major component, in approximately 
3.5:1 dr as an off-white foam. Recrystallisation from MeOH gave major diastereomer 224 (0.054 g, 
66%) as a white solid; mp 128-130 °C (dec.); νmax cm-1 (ATR) 3061, 2976, 2918, 1748, 1497, 1449; 
1H NMR (400 MHz, CDCl3) δ 8.45 (1H, s, HC=N), 7.80 (2H, dd, J = 7.9, 1.6, N=CHArH(2,6)), 
7.47-7.39 (3H, m, ArH), 7.36-7.33 (3H, m, ArH), 7.27-7.25 (2H, m, ArH), 6.20 (1H, dd, J = 9.8, 5.6, 
C(4)), 5.90 (1H, ddd, J = 5.6, 1.6, 0.8, C(5)), 5.50 (1H, dt, J = 9.8, 0.7, C(6)), 2.55 (1H, dq, J = 14.8, 
7.4, CHaHb(CH2CH3)), 2.44 (1H, dq, J = 14.7, 7.4, CHaHb(CH2CH3)), 1.75 (3H, d, J = 1.5, 
C=CCH3), 0.73 (3H, t, J = 7.4, CH2CH3), 0.56 (3H, s); 13C NMR (100 MHz, CDCl3) δ 175.3 
(C=O), 155.7 (HC=N), 136.7 (C(4)), 135.5 (ArC), 134.0 (ArC), 131.3 (ArC), 128.9 (ArC), 128.7 
(ArC), 128.6 (ArC), 128.3 (ArC), 126.9 (ArC), 124.6 (ArC), 122.4 (ArC), 99.4 (C(6)), 77.2 (C(7a)) 
61.2 (C(3)), 50.9 (C(3a)), 25.9 (CH2), 22.7 (C(3a)Me), 15.3 (C(7)Me), 9.0 (CH2CH3); m/z (CI+) 370 
([M-H]+, 100%); HRMS (EI+) C25H24O2N ([M-H]+) found 370.1804 requires 370.1802 (+0.7 ppm) 
(Z)-N-Benzylidene-2-methylpropan-2-amine oxide 225 
 To a stirred solution of benzaldehyde (0.347 mL, 3.41 mmol) in THF:H2O (1:1 6 mL) 
was added tBu-hydroxylamine hydrochloride (0.570 g, 1.5 eq, 5.12 mmol) and Na2CO3 (0.271 g, 
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0.75 eq, 2.58 mmol) and the reaction mixture heated to 60 °C for 48 h. After allowing to cool, the 
reaction mixture was partitioned between Et2O (25 mL) and H2O (25 mL) and the aqueous layer 
extracted with Et2O (3 ×25 mL) and the combined organic layers dried over MgSO4, filtered and 
concentrated in vacuo to give a crude semi-solid which was triturated from petroleum ether to give 
225 (0.537 g, 89%) as a pale yellow solid; mp 79-80 °C {lit.2 68-70 °C}; 1H NMR (500 MHz, 
CDCl3) δ 8.29 (2H, dd, J = 7.7, 1.9, ArH(2,6)), 7.54 (1H, s, HCN+), 7.42-7.39 (3H, m, ArH), 1.62 
(9H, s, tBuCH3). 
(R ,Z)-N-((2,2-Dimethyl-3-((2,4,6-triisopropylphenyl)sulfonyl)oxazolidin-4-yl)methylene)-2-
methylpropan-2-amine oxide 377 
 To a stirred solution of aldehyde 143 (0.100 g, 0.253 mmol) in THF:H2O (1:1 2 mL) 
was added tBu-hydroxylamine hydrochloride (0.048 g, 1.5 eq, 0.380 mmol) and Na2CO3 (0.020 g, 
0.75 eq, 0.190 mmol) and the reaction mixture heated to 60 °C for 24 h. After allowing to cool, the 
reaction mixture was partitioned between Et2O (25 mL) and H2O (25 mL) and the aqueous layer 
extracted once more with Et2O (25 mL) and the combined organic layers dried over MgSO4, 
filtered and concentrated in vacuo to give a crude colourless semi-solid which was purified by 
column chromatography over silica (0-20% EtOAc in petrol) to yield 377 (0.088 g, 75%) as a white 
solid; mp 120-121 °C; [α]D
20 +18.9° (c = 1.45, CHCl3); νmax cm-1 (ATR) 2971, 2954, 1601, 1574, 
1462; 1H NMR (300 MHz, CDCl3) δ 7.18 (2H, s, ArH(TIPBS)), 6.19 (1H, d, J = 7.3, HC=N+), 4.84 
(1H, ddd, J = 7.1, 4.9, 2.0, CHN), 4.42-4.33 (3H, m, CHaHb & o-iPrCH), 4.02 (1H, dd, J = 9.6, 2.0, 
CHaHb), 2.90 (1H, sept., J = 6.9, p-iPrCH), 1.80 (6H, d,  J = 4.5, CMe2), 1.30-1.21 (18H, m, iPrCH3), 
1.07 (9H, s, tBuCH3); 13C NMR (125 MHz, CDCl3) δ 153.9 (HC=N+), 151.6 (ArCSO2), 135.1 
(ArC(o-iPr)), 132.4 (ArC(p-iPr)), 124.3 (ArCH(TIPBS)), 100.0 (CMe2), 68.7 (tBuC), 68.2 (CH2), 56.0 
(CHN), 34.3 (p-iPrC), 29.0 (p-iPrCH3), 28.1 (o-iPrC), 27.5 (tBuCH3), 25.1 (CMe2), 24.8 (CMe2), 24.3 
(o-iPrC), 23.7 (o-iPrCH3), 23.6 (o-iPrCH3); m/z (EI+) 467 ([M+H]+, 100%); HRMS (EI+) 
C25H43O4N2S ([M+H]+) found 467.2930 requires 467.2938 (-1.7 ppm). 
(±)-ant i-(2SR ,4RS)-3-(t e r t-butyl)-4-(4-chlorophenyl)-4-ethyl-2-phenyloxazolidin-5-one 227 
and (±)-syn-(2RS ,4RS)-3-(t e r t-butyl)-4-(4-chlorophenyl)-4-ethyl-2-phenyloxazolidin-5-one 
227a 
The oxazolidinones were prepared according to general procedure E from nitrone 225 (0.025 g, 
0.141 mmol) and ethyl(p-chlorophenyl)ketene (0.026 g, 1.0 eq, 0.141 mmol), however the reaction 
mixture was stirred for 5 min at rt before quenching with H2O (0.5 mL). The aqueous layer was 
then extracted with Et2O (3 × 20 mL), the combined organic layers dried over MgSO4, filtered and 
concentrated in vacuo to yield a crude colourless oil. The major product (ca. 55%) in the crude 1H 
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NMR was determined to be N-tBu imine 228, however due to decomposition upon purification, 
this species was not isolated. The crude dr of 227:227a was determined as 3:1 based on the crude 
1H NMR integration of the characteristic C(2) singlet protons. Purification by column 
chromatography over silica (0-10% EtOAc in petroleum ether gave 227 (0.018 g, 36%) as a white 
solid and 227a (0.006 g, 12%) as a colourless oil. 
Major ‘anti’ diastereomer 227: 
White solid; mp 152-153 °C; νmax cm-1 (ATR) 2960, 1776, 1494; 1H NMR (300 
MHz, CDCl3) δ 7.61-7.58 (2H, m, ClArH), 7.45-7.35 (7H, m, ArH), 6.32 (1H, s, CH(2)), 2.64 (1H, 
dq, J = 14.1, 7.0, CHaHb), 2.39 (1H, dq, J = 14.1, 7.0, CHaHb), 1.34 (3H, t, J = 7.0, CH3), 0.80 (9H, 
s, tBuCH3); 13C NMR (125 MHz, CDCl3) δ 175.3 (C=O), 141.0 (4ry ArC), 140.0 (4ry ArC), 134.3 (4ry 
ArC), 129.9 (PhC(5)), 129.4 (ArC), 128.8 (ArC), 128.6 (ArC), 128.3 (ArC), 92.5 (C(2)), 70.4 (C(4)), 
55.1 (tBuC), 29.8 (CH2), 29.7 (tBuCCH3), 10.4 (CH3); m/z (EI+) 358 ([M(35Cl)+H]+, 55%), 302 
(100%); HRMS (EI+) C21H25O2N35Cl ([M+H]+) found 358.1573 requires 358.1568 (+ 1.3 ppm). 
Minor ‘syn’ diastereomer 227a: 
Colourless oil; νmax cm-1 (ATR) 2976, 1771, 1489; 1H NMR (300 MHz, CDCl3) δ 
7.67 (2H, d, J = 8.7, ClArH(3,5)), 7.62-7.59 (2H, m, ArH), 7.45-7.37 (5H, m, ArH & ClArH(2,6)), 
6.26 (1H, s, CH(2)), 2.64 (1H, dq, J = 14.5, 7.3, CHaHb), 2.48 (1H, dq, J = 14.5, 7.3, CHaHb), 1.30 
(3H, t, J = 7.3, CH3), 0.90 (9H, s, tBuCH3); 13C NMR (125 MHz, CDCl3) δ 174.5 (C=O), 142.6 (4ry 
ArC), 140.3 (4ry ArC), 133.5 (4ry ArC), 130.0 (PhC(5)), 129.4 (ArC), 128.6 (ArC), 128.5 (ArC), 128.4 
(ArC), 92.4 (C(2)), 70.9 (C(4)), 55.0 (tBuC), 30.9 (CH2), 29.7 (tBuCCH3), 10.8 (CH3); m/z (EI+) 358 
([M(35Cl)+H]+, 35%), 302 (100%); HRMS (EI+) C21H25O2N35Cl ([M+H]+) found 358.1571 requires 
358.1568 (+ 0.7 ppm). 
References for this section: 
1. Heine, H. W.; Zibuck, R.; VandenHeuvel, W. J. A. J. Am. Chem. Soc. 1982, 104, 3691-3694.  
2. Newcomb, M.; Reeder, R. A. J. Org. Chem. 1980, 45, 1489-1493. 
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8.6. Experimental Details for Chapter 5: Regioselectivity Studies 
Enantiopure Nitrones 
(R,Z)-N-((3-(t e r t-Butoxycarbonyl)-2,2-dimethyloxazolidin-4-yl)methylene)-2-methylaniline 
oxide 249 
 The nitrone was obtained from Garner’s aldehyde 64 (0.200 g, 0.870 mmol), 
hydroxylamine 73 (0.107 g, 1.0 eq, 0.870 mmol) and MgSO4 (0.116 g, 1.1 eq, 0.960 mmol) according 
to general procedure D and purified by column chromatography over silica to yield 249 (0.148 g, 
51%) as a white solid; mp 68-69 °C; 
€ 
α[ ]D
20 -69.6° (c = 1.23, CH2Cl2); νmax cm-1 (KBr) 3044 (C-H), 
2974 (C-H), 1708 (C=O), 1379 (N+-O-); 1H NMR (400 MHz, CDCl3, rot.) δ 7.36-7.29 (4H, m, 
ArH), 7.00 (1H, d, J = 5.0, H(R)C=N+), 5.16-5.14 (1H, m, CH(NRBoc)), 4.30-4.27 (2H, m, 
CH2OR), 2.41 (3H, s, ArCH3), 1.63-1.57 (6H, m, CMe2), 1.48 (9H, s, tBu); 13C NMR (75 MHz, 
CD2Cl2, rot.) 152.9 & 152.3 (C=O), 147.7 (ArC), 144.3 & 144.1 (ArC), 132.6 & 132.1 (ArC), 130.5 
& 130.3 (ArC), 127.4 (ArC), 124.3 & 124.1 (ArC), 95.3 & 94.8 (CMe2), 81.5 & 81.1 (C(CH3)3), 67.6 
& 66.9 (CHCH2), 56.1 (CHCH2), 29.0 & 28.9 (C(CH3)3), 27.8 & 27.0 (CMe2), 25.0 & 23.7 (CMe2), 
17.5 (ArCH3). 
(R,Z)-N-((3-(t e r t-Butoxycarbonyl)-2,2-dimethyloxazolidin-4-yl)methylene)-3-methylaniline 
oxide 252 
 The nitrone was obtained from Garner’s aldehyde 64 (0.200 g, 0.870 mmol), 
hydroxylamine 74 (0.107 g, 1.0 eq, 0.870 mmol) and MgSO4 (0.116 g, 1.1 eq, 0.960 mmol) according 
to general procedure D and purified by column chromatography over silica to yield 252 (0.152 g, 
52%) as a colourless oil; 
€ 
α[ ]D
20 -70.8° (c = 0.50, CHCl3); νmax cm-1 (thin-film) 3336 (C-H), 2927 (C-
H), 2854, 1719 (C=O); 1H NMR (400 MHz, CDCl3, rot.) δ 7.60-7.53 (2H, m, ArH), 7.36-7.19 (3H, 
m, ArH & H(R)C=N+), 5.18-5.12 (1H, m, CH(NRBoc)), 4.34-4.19 (2H, m, CH2OR), 2.41 (3H, s, 
ArCH3), 1.64 (3H, d, J = 20.7, CMe), 1.54 (3H, d, J = 20.7, CMe), 1.44 (9H, s, tBu); 13C NMR (75 
MHz, CDCl3, rot.) 151.7 (C=O), 146.8 (4ryArCNO), 140.1 & 139.6 (HCN+), 131.2 & 131.0 (ArC), 
129.0 & 128.8 (ArC), 122.2 (ArC), 118.6 & 118.4 (ArC), 94.7 & 94.1 (CMe2), 81.0 & 80.6 (C(CH3)3), 
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66.6 & 66.0 (CH2), 56.2 & 55.4 (CHCH2), 28.5 (C(CH3)3) 27.4 & 26.5 (CMe2), 24.3 & 23.3 (CMe2), 
21.4 (ArCH3). 
(R,Z)-N-((3-(t e r t-Butoxycarbonyl)-2,2-dimethyloxazolidin-4-yl)methylene)-4-methylaniline 
oxide 246 
 The nitrone was obtained from Garner’s aldehyde 64 (0.200 g, 0.870 mmol), 
hydroxylamine 75 (0.107 g, 1.0 eq, 0.870 mmol) and MgSO4 (0.116 g, 1.1 eq, 0.960 mmol) according 
to general procedure D and purified by column chromatography over silica to yield 246 (0.174 g, 
60%) as a white solid; mp 120-121 °C; 
€ 
α[ ]D
20 -59.9° (c = 1.15, CH2Cl2); νmax cm-1 (KBr) 2978 (C-H), 
1698 (C=O), 1385 (N+-O-); 1H NMR (400 MHz, CDCl3, rot.) δ 7.51 (1H, s, H(R)C=N+), 7.47-7.39 
(1H, m, ArH), 7.35-7.28 (3H, m, ArH), 5.19-5.12 (1H, m, CH(NRBoc)), 4.35-4.19 (2H, m, 
CH2OR), 2.42 (3H, s, ArCH3), 1.64 (3H, d, J = 14.9, CMe), 1.56 (3H, d, J = 14.9, CMe), 1.47 (9H, d, 
J = 24.4, tBu); 13C NMR (75 MHz, CD2Cl2, rot.) δ 145.1 (4ry ArC-N), 141.0 (HC=N+), 139.4 (ArC), 
137.1 (4ry ArCCH3), 129.9 (ArC), 121.5 (ArC), 94.8 & 94.4 (CMe2), 81.0 & 80.5 (CH2), 66.9 & 66.4 
(CHCH2), 28.5 (tBu), 27.5 &26.6 (CMe2), 24.6 & 23.4 (CMe2), 21.3 (ArCH3). 
(R,Z)-2-Bromo-N-((3-(t e r t-butoxycarbonyl)-2,2-dimethyloxazolidin-4-yl)methylene)aniline 
oxide 250 
 The nitrone was obtained from Garner’s aldehyde 64 (0.200 g, 0.870 mmol), 
hydroxylamine 82 (0.162 g, 1.0 eq, 0.870 mmol) and MgSO4 (0.105 g, 1.1 eq, 0.960 mmol) according 
to general procedure D and purified by column chromatography through a silica plug to yield 250 
(0.215 g, 61%) as a white foam; mp 38-39 °C (decomp.); 1H NMR (400 MHz, CDCl3, rot.) δ 7.43 
(2H, d, J = 7.8, ArH), 7.30 (2H, d, J = 4.0, ArH), 6.85-6.83 (1H, m, H(R)C=N+), 5.17-5.06 (1H, m, 
CH(NRBoc)), 4.39-4.23 (2H, m, CH2OR), 1.66-1.42 (15H, m, CMe2 & tBu). Upon attempted full 
characterisation, 250 decomposed and no more useful data could be obtained. 
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(R,Z)-3-Bromo-N-((3-(t e r t-butoxycarbonyl)-2,2-dimethyloxazolidin-4-yl)methylene)aniline 
oxide 253 
 The nitrone was obtained from Garner’s aldehyde 64 (0.200 g, 0.870 mmol), 
hydroxylamine 83 (0.162 g, 1.0 eq, 0.870 mmol) and MgSO4 (0.105 g, 1.1 eq, 0.960 mmol) according 
to general procedure D and purified by column chromatography through a silica plug to yield 253 
(0.178 g, 51%) as a white foam; mp 39-40 °C (decomp.); 1H NMR (300 MHz, CDCl3, rot.) δ 7.84 
(1H, s, H(R)C=N+), 7.61-7.54 (2H, m, ArH), 7.32-7.29 (2H, m, ArH), 5.13-5.10 (1H, m, 
CH(NRBoc)), 4.28-4.06 (2H, m, CH2OR), 1.64-1.40 (15H, m, CMe2 & tBu). Upon attempted full 
characterisation, 253 decomposed and no more useful data could be obtained. 
(R,Z)-4-Bromo-N-((3-(t e r t-butoxycarbonyl)-2,2-dimethyloxazolidin-4-yl)methylene)aniline 
oxide 248 
 The nitrone was obtained from Garner’s aldehyde 64 (0.200 g, 0.870 mmol), 
hydroxylamine 84 (0.162 g, 1.0 eq, 0.870 mmol) and MgSO4 (0.105 g, 1.1 eq, 0.960 mmol) according 
to general procedure D and purified by column chromatography over silica to yield 248 (0.134 g, 
38%) as a white foam; mp 40-41 °C (decomp.); 1H NMR (400 MHz, CDCl3, rot.) δ 7.62-7.57 (3H, 
m, ArH & H(R)C=N+), 7.37-7.35 (2H, m, ArH), 5.15-5.12 (1H, m, CH(NRBoc)), 4.30-4.21 (2H, m, 
CH2OR), 1.66-1.42 (15H, m, CMe2 & tBu). Upon attempted full characterisation, 248 decomposed 
and no more useful data could be obtained. 
(R,Z)-N-((3-(t e r t-Butoxycarbonyl)-2,2-dimethyloxazolidin-4-yl)methylene)-4-
methoxyaniline oxide 247 
 The nitrone was obtained from Garner’s aldehyde 64 (0.165 g, 0.720 
mmol), hydroxylamine 81 (0.100 g, 1.0 eq, 0.720 mmol) and MgSO4 (0.095 g, 1.1 eq, 0.790 mmol) 
according to general procedure D and purified by column chromatography over silica to yield 247 
(0.134 g, 54%) as a slightly pink viscous oil; 
€ 
α[ ]D
20 -97.8° (c = 0.45, CH2Cl2); νmax cm-1 (thin-film) 
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3430 (C-H), 2976 (C-H), 1698 (C=O), 1376 (N-O); 1H NMR (400 MHz, CDCl3, rot.) δ 7.62 (2H, d, 
J = 8.5, ArH), 7.30-7.25 (1H, m, H(R)C=N+), 6.93 (2H, d, J = 8.5, ArH), 5.16-5.13 (1H, m, 
CH(NRBoc)), 4.30-4.19 (2H, m, CH2OR), 3.85 (3H, s, OMe), 1.66-1.42 (15H, m, CMe2 & tBu); 13C 
NMR (75 MHz, CD2Cl2, rot.) δ 161.3 (4ry ArCOMe), 152.0 (C=O), 140.5 (HCN+), 139.0 (4ry 
ArCN), 123.0 (ArC), 114.3 (ArC), 94.8 & 94.5 (CMe2), 81.1 & 80.5 C(CH3)3, 66.9 & 66.4 (CH2), 
56.4 & 55.9 (CHCH2), 56.0 (OMe), 28.5 & 28.4 (tBuCH3), 27.5 & 26.6 (1 × CMe2), 24.5 & 23.4 (1 × 
CMe2); m/z (ESI+) 351.18 ([M+H]+, 100%); HRMS (ESI+) C18H26O5N2+ ([M+H]+) found 351.1840 
requires 351.1842 (-0.2 ppm). 
(R ,Z)-N-((2,2-Dimethyl-3-((2,4,6-triisopropylphenyl)sulfonyl)oxazolidin-4-yl)methylene)-4-
methoxyaniline oxide 193 
 The nitrone was obtained from hydroxylamine 81 (0.116 g, 8.32 mmol), 
MgSO4 (0.091 g, 1.0 eq, 8.32 mmol) and aldehyde 143 (0.300 g, 0.91 eq, 7.57 mmol) in CH2Cl2 (10 
mL) according to general procedure D to yield a crude brown foam which was purified by 
recrystallisation from Et2O followed by trituration from petroleum ether to yield 193 (0.229 g, 54%) 
as a pale brown solid; mp 103-104 °C; [α]D
20 -64.1° (c = 0.90, CHCl3); 1H NMR (500 MHz, CDCl3) δ 
7.19 (2H, s, ArH(TIPBS)), 6.96 (2H app. qd, J = 4.6, 3.4, ArH), 6.74 (2H, d, J = 9.0, ArH), 6.67 
(1H, d, J = 5.2, +N=CH), 5.06 (1H, t, J = 5.2, CH), 4.45 (1H, dd, J = 9.3, 7.4, CHaHb), 4.34 (2H, dt, 
J = 13.4, 6.7, iPrH), 4.22 (1H, dd, J = 9.3, 1.6, CHaHb), 3.78 (3H, s, OMe), 2.88 (1H, dt, J = 13.7, 
6.9, iPrH), 1.82 (6H, d, J = 8.4, CMe2), 1.27-1.16 (18H, m, iPrCH3); 13C NMR (75 MHz, CDCl3) δ 
160.9 (4ry ArCOMe), 154.1 (4ry ArC), 151.8 (ArC), 139.6 (4ry ArC), 137.8 (4ry ArC), 132.5 
(HC=N+), 124.3 (ArC), 122.3 (ArC), 113.9 (ArC), 100.1 (CMe2), 68.1 (CH2), 56.0 (OMe), 55.6 
(CHNR), 34.2 (p-iPrC), 29.1 (p-iPrCH3), 28.0 (o-iPrC), 25.0 (o-iPrC), 24.8 (CMe2), 24.6 (o-iPrCH3), 
23.6 (o-iPrCH3); m/z (ESI+) 517 ([M+H]+, 100%); HRMS (ESI+) C28H41O5N2S+ ([M+H]+) found 
517.2720 requires 517.2731 (-2.1 ppm). 
(R ,Z)-N-((2,2-Dimethyl-3-((2,4,6-triisopropylphenyl)sulfonyl)oxazolidin-4-yl)methylene)-4-
fluoroaniline oxide 191 
 The nitrone was obtained from hydroxylamine 79 (0.106 g, 83.2 mmol), 
MgSO4 (0.091 g, 1.0 eq, 83.2 mmol) and aldehyde 143 (0.300 g, 0.91 eq, 75.7 mmol) in CH2Cl2 (10 
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mL) according to general procedure D to yield a crude brown foam which was purified by 
recrystallisation from Et2O followed by trituration from petroleum ether to yield 191 as a pale 
orange solid; mp 138-140 °C; [α]D
20 -12.3° (c = 0.75, CHCl3); νmax cm-1 (thin-film) 2961, 2868, 1595, 
1558, 1501, 1458; 1H NMR (300 MHz, CDCl3) δ 7.19 (2H, s, ArH(TIPBS)), 7.07-7.02 (2H, m, 
ArH(2,6)), 6.99-6.93 (2H, m, ArH(3,5)), 6.71 (1H, d, J = 5.1, +N=CH), 5.06 (1H, td, J = 5.1, 2.1, 
CH), 4.46 (1H, dd, J = 9.5, 7.3, CHaHb), 4.35 (2H, quint., J = 6.8, iPrH), 4.22 (1H, dd, J = 9.5, 2.1, 
CHaHb), 2.88 (1H, dt, J = 13.8, 6.9, iPrH), 1.83 (6H, d, J = 4.8, CMe2), 1.27-1.20 (18H, m, iPrCH3); 
13C NMR (75 MHz, CDCl3) δ 162.3 (d, J = 251.6, ArC(4)F), 153.2 (+NArCipso), 150.8 (ArC), 141.5 
(d, J = 3.0, ArC(2,6)), 131.4 (HC=N+), 123.3 (ArC), 122.0 (d, J = 8.9, ArC(3,5)), 114.9 (d, J = 23.3), 
99.2 (CMe2), 66.9 (CH2), 55.0 (CHNR), 33.2 (p-iPrC), 28.1 (p-iPrCH3), 27.0 (o-iPrC), 24.0 (o-iPrC), 
23.7 (CMe2), 23.5 (CMe2), 22.6 (o-iPrCH3); 19F NMR (282 MHz, CDCl3) δ -109.8 (ArF); m/z (ESI+) 
505 ([M+H]+, 100%); HRMS (ESI+) C27H38O4N2SF+ ([M+H]+) found 505.2524 requires 505.2531 
(-1.4 ppm). 
(R ,Z)-N-((2,2-Dimethyl-3-((2,4,6-triisopropylphenyl)sulfonyl)oxazolidin-4-yl)methylene)-4-
(trifluoromethyl)aniline oxide 192 
 The nitrone was obtained from hydroxylamine 80 (0.268 g, 1.52 mmol), 
MgSO4 (0.134 g, 0.75 eq, 1.11 mmol) and aldehyde 143 (0.400 g, 0.75 eq, 1.01 mmol) in CH2Cl2 (15 
mL) according to general procedure D and purified by column chromatography over silica (0-30% 
EtOAc in petroleum ether) followed by trituration from petroleum ether to yield 192 (0.350g, 63%) 
as an off-white solid; mp 52-54 °C; [α]D
20 -110.0° (c = 1.0, CHCl3); νmax cm-1 (thin-film) 2961, 2868, 
1595, 1558, 1501, 1456; 1H NMR (300 MHz, CDCl3) δ 7.26-7.21 (2H, m, ArH(3,5)), 7.18 (2H, s, 
ArH(TIPBS)), 7.00 (2H, d, J = 8.5, ArH(2,6)), 6.79 (1H, d, J = 5.4, +N=CH), 5.12 (1H, ddd, J = 
7.2, 5.4, 1.9, CHN), 4.47 (1H, dd, J = 9.6, 7.3, CHaHb), 4.35 (2H, dt, J = 13.7, 6.8, iPrH), 4.22 (1H, 
dd, J = 9.6, 2.0, CHaHb), 2.86 (1H, dt, J = 13.7, 6.8, iPrH), 1.83 (6H, d,  J = 7.8, CMe2), 1.27-1.23 
(12H, m, iPrCH3), 1.17 (6H, dd, J = 6.8, 4.5, iPrCH3); 13C NMR (100 MHz, CDCl3) δ 153.3 
(+NArCipso), 150.8 (ArC), 147.4 (ArC), 139.2 (ArC), 131.5 (app. d, J = 33.2, ArC(4)), 131.3 
(HC=N+), 125.3 (ArC), 123.3 (ArC), 123.3 (q, J = 267.5, CF3), 120.5 (ArC), 99.3 (CMe2), 66.8 
(CH2), 55.1 (CHNR), 33.2 (p-iPrC), 28.1 (p-iPrCH3), 27.0 (o-iPrC), 24.1 (o-iPrC), 23.7 (CMe2), 23.5 
(CMe2), 22.5 (d, J = 2.4, o-iPrCH3); m/z (ESI+) 577 ([M+Na]+, 100%); HRMS (ESI+) 
C28H37O4N2SF3+ ([M+Na]+) found 577.2324 requires 577.2317 (-1.2 ppm). 
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(R ,Z)-N-((2,2-Dimethyl-3-((2,4,6-triisopropylphenyl)sulfonyl)oxazolidin-4-yl)methylene)-4-
methylaniline oxide 194 
 The nitrone was obtained from hydroxylamine 75 (0.051 g, 1.1 eq, 4.12 
mmol), MgSO4 (0.050 g, 1.1 eq, 4.12 mmol) and aldehyde 143 (0.150 g, 3.79 mmol) in CH2Cl2 (20 
mL) according to general procedure D to yield a crude a yellow semi-solid which was purified by 
column chromatography to give 194 (0.082 g, 43%) as an off-white solid; [α]D
20!-101.4° (c = 0.96, 
CHCl3); mp 44-45 °C; νmax cm-1 (ATR) 2957, 2932, 1601; 1H NMR (300 MHz, CDCl3) δ 7.19 (2H, 
s, ArH(TIPBS)), 7.06 (2H, dd, J = 8.6, 0.6, ArH(2,6)), 6.91 (2H, d, J = 8.6, ArH(3,5)), 6.71 (1H, d, J 
= 5.3, +N=CH), 5.10-5.05 (1H, m, CHCH2), 4.46 (1H, dd, J = 9.5, 7.2, CHaHb), 4.35 (2H, app. 
quint., J = 6.8, iPrH), 4.24 (1H, dd, J = 9.5, 2.0, CHaHb), 2.88 (1H, dt, J = 13.8, 6.9, iPrH), 2.33 (3H, 
s, ArCH3), 1.83 (6H, d, J = 3.9, diMe), 1.27-1.18 (18H, m, iPrCH3); 13C NMR (75 MHz, CDCl3) δ 
154.5 (ArCipso-N+), 152.1 (ArC), 144.5 (4ry ArC), 141.1 (4ry ArC), 138.9 (4ry ArC), 132.8 (HC=N+), 
129.9 (ArC), 124.7 (ArC), 121.2 (ArC), 100.5 (CMe2), 68.5 (CH2), 56.4 (CHNR), 34.6 (p-iPrC), 29.5 
(p-iPrCH3), 28.4 (o-iPrC), 25.4 (o-iPrCH3), 25.2 (o-iPrCH3), 25.0 (o-iPrC), 24.0 (CMe2), 24.0 (CMe2), 
21.5 (ArCH3); m/z (ESI+) 501 ([M+H]+, 95%), 443 (100%); HRMS (EI+) C28H41O4N2S+ ([M+H]+) 
found 501.2784 requires 501.2782 (+ 0.5 ppm). 
(R ,Z)-N-((2,2-Dimethyl-3-((2,4,6-triisopropylphenyl)sulfonyl)oxazolidin-4-yl)methylene)-3-
methylaniline oxide 260 
 The nitrone was obtained from hydroxylamine 74 (0.051 g, 1.1 eq, 4.12 
mmol), MgSO4 (0.050 g, 1.1 eq, 4.12 mmol) and aldehyde 143 (0.150 g, 3.79 mmol) in CH2Cl2 (20 
mL) according to general procedure D to yield a crude a yellow semi-solid which was purified by 
column chromatography to give 260 (0.124 g, 65%) as a yellow solid; [α]D
20 !-87.9° (c = 0.96, CHCl3); 
mp 40-42 °C; νmax cm-1 (ATR) 2959, 2866; 1H NMR (300 MHz, CDCl3) δ 7.19 (2H, s, 
ArH(TIPBS)), 7.16-7.08 (3H, m, ArH), 6.76 (1H, d, J = 5.3, +N=CH), 6.62-6.60 (1H, m, ArH(2)), 
5.07 (1H, ddd, J = 7.1, 5.3, 1.8, CHCH2), 4.45 (1H, dd, J = 9.5, 7.1, CHaHb), 4.35 (2H, dt, J = 13.5, 
6.8, iPrH), 4.23 (1H, dd, J = 9.5, 1.8, CHaHb), 2.87 (1H, dt, J = 13.8, 6.9, iPrH), 2.31 (3H, s, ArCH3), 
1.83 (6H, d, J = 2.7, diMe), 1.26 (12H, dd, J = 6.7, 5.1, iPrCH3), 1.19 (6H, dd, J = 6.9, 4.7, iPrCH3); 
13C NMR (75 MHz, CDCl3) δ 154.5 (ArCipso-N+), 152.1 (ArC), 146.7 (4ry ArC), 139.9 (4ry ArC), 139.4 
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(4ry ArC), 132.8 (HC=N+), 131.5 (4ry ArC), 129.0 (ArC), 124.7 (ArC), 122.3 (ArC), 118.1 (ArC), 
100.5 (CMe2), 68.5 (CH2), 56.4 (CHNR), 34.6 (p-iPrC), 29.6 (p-iPrCH3), 28.5 (o-iPrC), 25.4 (CMe2), 
25.2 (CMe2), 25.0 (o-iPrC), 24.0 (o-iPrCH3), 23.8 (o-iPrCH3), 21.7 (ArCH3); m/z (ESI+) 501 ([M+H]+, 
80%), 443 (100%); HRMS (EI+) C28H41O4N2S+ ([M+H]+) found 501.2783 requires 501.2782 (+ 0.3 
ppm). 
(R ,Z)-N-((2,2-Dimethyl-3-((2,4,6-triisopropylphenyl)sulfonyl)oxazolidin-4-yl)methylene)-2-
methylaniline oxide 195 
 The nitrone was prepared according to general procedure D from 143 (0.150 g, 
3.79 mmol), MgSO4 (0.050 g, 1.1 eq, 4.12 mmol) and hydroxylamine 73 (0.051 g, 1.1 eq, 4.12 
mmol) in CH2Cl2 (10 mL). The reaction mixture was filtered and concentrated in vacuo to yield a 
brown foam which was purified via column chromatography over silica (10-30% EtOAc in 
petroleum ether) to yield 195 (0.100 g, 52 %) as an off-white solid; mp 51-53 °C; [α]D
20 +37.1° (c = 
0.99, CH2Cl2); νmax cm-1 (ATR) 2957, 2928, 1599, 1568, 1460; 1H NMR (500 MHz, CD2Cl2) δ 7.24 
(2H, s, ArH(TIPBS)), 7.23 (1H, d, J = 8.2, ArH(6)), 7.15 (1H, t, J = 7.6, ArH(4)), 7.02 (1H, t, J = 
7.6, ArH(5)), 6.48 (1H, d, J = 5.5, +N=CH), 6.23 (1H, d, J = 7.7, ArH(3)), 5.08 (1H, app. t, J = 5.5, 
CHCH2), 4.45 (1H, dd, J = 9.4, 6.9, CHaHb), 4.32 (2H, sept., J = 6.8, iPrH), 4.20 (1H, dd, J = 9.4, 
1.3, CHaHb), 2.94 (1H, sept., J = 6.9, iPrH), 2.09 (3H, s, ArCH3), 1.80 (3H, s, CMe), 1.76 (3H, s, 
CMe), 1.28-1.26 (12H, m, iPrCH3), 1.20 (6H, d, J = 6.7, iPrCH3); 13C NMR (125 MHz, CD2Cl2) δ 
154.3 (ArCipso-N+), 151.7 (ArC), 146.2 (4ry ArC), 142.1 (4ry ArC), 132.3 (HC=N+), 131.9 (ArCMe), 
131.4 (ArC), 129.5 (ArC), 126.2 (ArC), 124.5 (ArC(TIPBS)), 122.7 (ArC), 100.1 (CMe2), 68.6 (CH2), 
55.5 (CHNR), 34.3 (p-iPrC), 29.1 (p-iPrCH3), 28.1 (o-iPrC), 24.7 (CMe2), 24.5 (CMe2), 24.4 (o-iPrC), 
23.4 (o-iPrCH3), 23.3 (o-iPrCH3), 16.6 (ArCH3); m/z (ESI+) 501 ([M+H]+, 85%), 443 (100%); HRMS 
(EI+) C28H41O4N2S+ ([M+H]+) found 501.2785 requires 501.2782 (+ 0.7 ppm). 
(Z)-4-Chloro-N-((2,2-dimethyl-3-((2,4,6-triisopropylphenyl)sulfonyl)oxazolidin-4-
yl)methylene)aniline oxide 258 
 The nitrone was prepared according to general procedure D from 143 (0.100 
g, 2.53 mmol), MgSO4 (0.033 g, 1.1 eq, 2.78 mmol) and hydroxylamine 78 (0.040 g, 1.1 eq, 2.78 
mmol) in CH2Cl2 (10 mL). The reaction mixture was then filtered and concentrated in vacuo to yield 
N
H
O
N
O
TIPBS
Me
N
H
O
N
O
TIPBS
Cl
 
 Chapter 8: Experimental Details 
 185 
a pale yellow foam which was purified via frit column chromatography over silica (10-30% EtOAc 
in petroleum ether) to yield 258 (0.100 g, 76%) as a pale yellow solid; mp 95-96 °C; [α]D
20 -19.6° (c = 
1.0, CHCl3); νmax cm-1 (ATR) 2957, 1599, 1483; 1H NMR (500 MHz, CDCl3) δ 7.29 (2H, d, J = 8.5, 
ArH(2,6)), 7.22 (2H, s, ArH(TIPBS)), 7.03 (2H, d, J = 8.5, ArH(3,5)), 6.76 (1H, d, J = 5.4, 
+N=CH), 5.11-5.09 (1H, app. br t, J = 5.4, CHCH2), 4.51-4.48 (1H, dd, J = 9.4, 7.5, CHaHb), 4.38 
(2H, dt, J = 13.5, 6.7, o-iPrCH), 4.26-4.24 (1H, dd, J = 9.4, 1.5, CHaHb), 2.91 (1H, dt, J = 13.8, 6.9, 
p-iPrCH), 1.86 (6H, d, J = 8.9, CMe2), 1.30-1.23 (18H, m, i-PrCH3); 13C NMR (125 MHz, CDCl3) δ 
154.2 (ArCipso-N+), 151.8 (ArC), 144.7 (4ry ArC), 139.3 (4ry ArC), 136.4 (ArCCl), 132.4 (HC=N+), 
129.2 (ArC), 124.3 (ArC), 122.3 (ArC), 100.3 (CMe2), 68.0 (CH2), 56.0 (CHNR), 34.2 (p-iPrC), 29.2 
(p-iPrCH3), 28.0 (o-iPrC), 25.1 (CMe2), 24.8 (CMe2), 24.5 (o-iPrC), 23.6 (2 x o-iPrCH3); m/z (EI+) 521 
([M(35Cl)+H]+, 100%); HRMS (ESI+) C27H38O4N2S35Cl+ ([M+H]+) found 521.2223 requires 
521.2235 (-2.4 ppm). 
(Z)-3-Chloro-N-((2,2-dimethyl-3-((2,4,6-triisopropylphenyl)sulfonyl)oxazolidin-4-
yl)methylene)aniline oxide 261 
 The nitrone was prepared according to general procedure D from 143 (1.00 
g, 2.53 mmol), MgSO4 (0.334 g, 1.1 eq, 2.78 mmol) and hydroxylamine 77 (0.545g, 1.5 eq, 3.80 
mmol) in CH2Cl2 (15 mL). The reaction mixture was then filtered and concentrated in vacuo to yield 
a pale yellow foam which was purified via frit column chromatography over silica (10-30% EtOAc 
in petroleum ether) to yield 261 (0.923 g, 71%) as a pale yellow solid; mp 91-92 °C; [α]D
20 -23.8° (c = 
0.95, CHCl3); νmax cm-1 (ATR) 2959, 1597, 1462; 1H NMR (300 MHz, CDCl3) δ 7.36 (1H, ddd, J = 
8.1, 2.0, 1.0, ArH(6)), 7.20 (2H, s, ArH(TIPBS)), 7.18-7.16 (1H, m, ArH(5)), 6.97-6.93 (1H, m, 
ArH(2)) 6.89 (1H, ddd, J = 8.1, 2.1, 1.0, ArH(4)), 6.76 (1H, d, J = 5.4, HC=N+), 5.07 (1H, ddd, J = 
7.2, 5.4, 1.8, CHCH2), 4.45 (1H, dd, J = 9.6, 7.2, CHaHb), 4.35 (2H, app. quint., J = 6.8, o-iPrCH), 
4.20 (1H, dd, J = 9.6, 2.0, CHaHb), 2.90 (1H, dt, J = 13.8, 6.9, p-iPrCH), 1.83 (6H, d, J = 3.7, CMe2), 
1.27 (12H, t, J = 6.8, o-iPrCH3), 1.19 (6H, dd, J = 6.9, 4.6, p-iPrCH3); 13C NMR (125 MHz, CDCl3) δ 
154.3 (ArCipso-N+), 151.7 (ArC), 147.0 (4ry ArC), 139.7 (4ry ArC), 135.0 (HC=N+), 130.7 (4ry ArC), 
130.0 (4ry ArC), 124.4 (ArCH(TIPBS)), 121.7 (ArC), 119.0 (ArC), 100.2 (CMe2), 67.9 (CH2), 56.0 
(CHNR), 34.1 (p-iPrC), 29.2 (p-iPrCH3), 28.1 (o-iPrC), 25.1 (CMe2), 24.8 (CMe2), 24.6 (o-iPrC), 23.7 
(o-iPrCH3), 23.3 (o-iPrCH3); m/z (EI+) 521 ([M(35Cl)+H]+, 100%); HRMS (ESI+) C27H38O4N2S35Cl+ 
([M+H]+) found 521.2222 requires 521.2235 (-2.6 ppm). 
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(Z)-2-Chloro-N-((2,2-dimethyl-3-((2,4,6-triisopropylphenyl)sulfonyl)oxazolidin-4-
yl)methylene)aniline oxide 259 
 The nitrone was prepared according to general procedure D from 143 (0.136 g, 
0.343 mmol), MgSO4 (0.046 g, 1.1 eq, 0.377 mmol) and hydroxylamine 76 (0.054 g, 1.1 eq, 0.377 
mmol) in CH2Cl2 (10 mL). The reaction mixture was then filtered and concentrated in vacuo to yield 
a pale yellow foam which was purified via frit column chromatography over silica (10-30% EtOAc 
in petroleum ether) to yield 259 (0.037 g, 19%) as a white foam in greater than 80% purity 
(contamination with residual aldehyde); mp 53-54 °C; [α]D
20 -8.9° (c = 1.13, CHCl3); νmax cm-1 (ATR) 
2959, 1599, 1460; 1H NMR (500 MHz, CDCl3) δ 7.36 (1H, dd, J = 8.1, 2.6, ArH), 7.30 (1H, td, J = 
7.7, 1.5, ArH), 7.21 (2H, s, ArH(TIPBS)), 7.18 (1H, td, J = 7.7, 1.2, ArH), 6.69 (1H, dd, J = 7.9, 1.4, 
ArH), 6.50 (1H, d, J = 5.6, +N=CH), 5.11-5.08 (1H, m, CHN), 4.44 (1H, dd, J = 9.4, 6.9, CHaHb), 
4.32 (2H, sept., J = 6.8, iPrH), 4.25 (1H, dd, J = 9.4, 6.9, CHaHb), 2.91 (1H, sept., J = 6.9, iPrH), 
1.78 (6H, d, J = 19.5, CMe2), 1.28 (6H, d, J = 6.8, iPrCH3), 1.24 (6H, dd, J = 6.9, 4.2, iPrCH3), 1.21 
(6H, d, J = 6.8, iPrCH3); 13C NMR (125 MHz, CDCl3) δ 154.2 (ArCipso-N+), 151.7 (ArC), 144.4 (4ry 
ArC), 143.6 (4ry ArC), 132.2 (HC=N+), 130.8 (4ry ArC), 130.6 (ArC), 127.6 (ArC), 126.9 (ArC), 
125.0 (ArC), 124.4 (ArC(TIPBS)), 100.2 (CMe2), 68.2 (CH2), 55.6 (CHNR), 34.2 (p-iPrC), 29.1 (p-
iPrCH3), 28.0 (o-iPrC), 24.7 (CMe2), 24.5 (CMe2), 24.4 (o-iPrC), 23.4 (o-iPrCH3), 23.3 (o-iPrCH3); m/z 
(EI+) 521 ([M(35Cl)+H]+, 100%); HRMS (ESI+) C27H38O4N2S35Cl+ ([M+H]+) found 521.2224 
requires 521.2235 (-2.2 ppm). 
C(4) to C(7) Substituted Oxindoles  
(±)-3-Ethyl-3-phenylindolin-2-one 61 
The oxindole was obtained from nitrone 48 (0.079 g, 0.400 mmol) and 
ethylphenylketene (0.059 g, 1.0 eq, 0.400 mmol) in THF (3 mL) following general procedure E and 
purified to give (±)-61 (0.090 g, 95%) as a white solid; mp 151-152 °C {lit.1 149-150 °C}; 1H NMR 
(300 MHz, CDCl3) δ 7.39-7.28 (4H, m, ArH), 7.27-7.23 (2H, m, ArH), 7.19 (1H, d, J = 7.0, ArH), 
7.09 (1H, t, J = 7.5, ArH), 6.94 (1H, d, J = 7.5, ArH), 2.45 (1H, dq, J = 13.8, 7.2, CHaHbCH3), 2.25 
(1H, dq, J = 13.8, 7.2, CHaHbCH3), 0.76 (3H, t, J = 7.2, CH2CH3). 
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(±)-3-Ethyl-5-methoxy-3-phenylindolin-2-one 229 
 The oxindole was obtained from 70 (0.040 g, 0.176 mmol) and 
ethylphenylketene (0.026 g, 1.0 eq, 0.176 mmol) following general procedure E to yield (±)-229 
(0.028 g, 60%) as an off-white solid; mp 134-135 °C {lit.2 195-197 °C}; 1H NMR (400 MHz, 
CDCl3) δ 8.22 (1H, br s, NH), 8.25 (1H, dd, J = 8.5, 2.4, ArH), 7.38-7.35 (2H, m, ArH), 7.31 (2H, 
tt, J = 7.3, 1.9, ArH), 6.86 (1H, d, J = 8.5, ArH), 6.80 (1H, d, J = 2.4, ArH), 6.77 (1H, m, ArH), 3.78 
(3H, s, OCH3), 2.47 (1H, dq, J = 13.8, 7.1, CHaHbCH3), 2.21 (1H, dq, J = 13.8, 7.1, CHaHbCH3), 
0.77 (3H, t, J = 7.1, CH2CH3); HPLC analysis: racemic (Daicel Chiralcel OD-H column, eluent: 
hexane/i-PrOH 80:20, flow 1.5 mL/min, wavelength: 254 nm, retention times: 4.4 min and 9.5 
min). 
(S)-3-Ethyl-5-methoxy-3-phenylindolin-2-one 229 
The oxindole was obtained from chiral nitrone 247 (0.095 g, 0.270 mmol) and 
ethylphenylketene (0.040 g, 1.0 eq, 0.270 mmol) following general procedure F, to yield 229 (0.030 
g, 41%) as an off-white solid; HPLC analysis: 81% e.e. (Daicel Chiralcel OD-H column, eluent: 
hexane/i-PrOH 80:20, flow 1.5 mL/min, wavelength: 254 nm, retention times: 4.5 min (major) and 
10.4 min (minor)). 
(±)-5-Chloro-3-ethyl-3-phenylindolin-2-one 230  
 The oxindole was prepared according to general procedure E from 69 (0.050 g, 
0.216 mmol) and ethylphenylketene (0.032 g, 1.0 eq, 0.216 mmol) to yield (±)-230 (0.053 g, 90%) as 
a white solid; mp 126-127 °C {lit.2 152-153 °C}; 1H NMR (300 MHz, CDCl3) δ 8.73 (1H, br s, NH), 
7.29-7.19 (5H, m, ArH), 7.17 (1H, dd, J = 8.3, 2.1, ArH(6)), 7.08 (1H, d, J = 2.1, ArH(4)), 6.83 (1H, 
d, J = 8.3, ArH(7)), 2.39 (1H, dq, J = 13.8, 7.0, CHaHb), 2.17 (1H, dq, J = 13.8, 7.0, CHaHb), 0.71 
(3H, t, J = 7.4, CH3); HPLC analysis: racemic (Daicel Chiralcel OD-H column, eluent: hexane/i-
PrOH 80:20, flow 1.5 mL/min, wavelength: 254 nm, retention times: 3.6 min and 7.0 min). 
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(S)-5-Chloro-3-ethyl-3-phenylindolin-2-one 230 
 The oxindole was prepared according to general procedure F from 258 (0.060 
g, 0.115 mmol) and ethylphenylketene (0.017 g, 1.0 eq, 0.115 mmol) to yield 230 (0.027 g, 87%) as a 
white solid; [α]D
20 -54.2° (c = 1.20, CHCl3); HPLC analysis: 97% ee (Daicel Chiralcel OD-H column, 
eluent: hexane/i-PrOH 80:20, flow 1.5 mL/min, wavelength: 254 nm, retention times: 3.6 min and 
7.0 min). 
(±)-3-Ethyl-5-methyl-3-phenylindolin-2-one 231 
 The oxindole was obtained from 86 (0.090 g, 0.430 mmol) and 
ethylphenylketene (0.062 g, 1.0 eq, 0.430 mmol) following general procedure E, to yield (±)-231 
(0.064 g, 60%) as a white solid; mp 158-159 °C {lit.1 160-161 °C}; 1H NMR (400 MHz, CDCl3) δ 
8.73 (1H, br s, NH), 7.39-7.24 (5H, m, ArH), 7.04 (1H, ddd, J = 7.9, 1.7, 0.6, ArH), 6.96 (1H, t, J = 
0.6, ArH), 6.85 (1H, d, J = 7.9, ArH), 2.45 (1H, dq, J = 13.4, 7.3, CHaHbCH3), 2.33 (3H, s, ArCH3), 
2.23 (1H, dq, J = 13.4, 7.3, CHaHbCH3), 0.76 (3H, t, J = 7.3, CH2CH3); HPLC analysis: racemic 
(Daicel Chiralcel OD-H column, eluent: hexane/i-PrOH 80:20, flow 1.5 mL/min, wavelength: 254 
nm, retention times: 3.6 min and 5.8 min). 
(S)-3-Ethyl-5-methyl-3-phenylindolin-2-one 231 
The oxindole was obtained from chiral nitrone 194 (0.045 g, 0.090 mmol) and 
ethylphenylketene (0.013 g, 1.0 eq, 0.090 mmol) following general procedure F, to yield 231 (0.016 
g, 48%) as an off-white solid; [α]D
20 -21.2 (c = 0.95, CHCl3); HPLC analysis: 94% e.e. (Daicel 
Chiralcel OD-H column, eluent: hexane/i-PrOH 80:20, flow 1.5 mL/min, wavelength: 254 nm, 
retention times: 3.6 min (major) and 5.8 min (minor)). 
(±)-3-Ethyl-3-phenyl-5-(trifluoromethyl)indolin-2-one 232  
 The oxindole was obtained from 90 (2.00 g, 7.54 mmol) and ethylphenylketene 
(1.10 g, 1.0 eq, 7.54 mmol) following general procedure E to yield (±)-232 (1.77 g, 77%) as a white 
solid; mp 162-164 °C; νmax cm-1 (ATR) 3186, 3147, 1715, 1624, 1418; 1H NMR (500 MHz, CDCl3) δ 
9.33 (1H, br s, NH), 7.47 (1H, d, J = 8.2, ArH(6)), 7.34 (1H, s, ArH(4)), 7.29-7.19 (5H, m, ArH), 
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6.98 (1H, d, J = 8.2, ArH(7)), 2.42 (1H, dq, J = 13.9, 7.0, CHaHbCH3), 2.23 (1H, dq, J = 13.9, 7.0, 
CHaHbCH3), 0.70 (3H, t, J = 7.3, CH2CH3); 13C NMR (125 MHz, CDCl3) δ 181.6 (C=O), 144.4 
(C(3a)), 139.1 (C(7a)), 133.5 (ArC), 128.9 (ArC), 127.8 (ArC), 126.8 (ArC), 126.0 (d, J = 3.9, ArC), 
125.3 (q, J = 32.2, ArC(5)CF3), 124.2 (q, J = 255.5, CF3), 121.9 (d, J = 3.5, ArC), 110.1 (ArC), 58.0 
(C(3)), 30.4 (CH2CH3) , 9.0 (CH2CH3); m/z (EI+) 306 ([M+H]+, 100%); HRMS (EI+) C17H15ONF3 
([M+H]+) found 306.1103 requires 306.1100 (+ 0.9 ppm). 
(±)-5-Bromo-3-ethyl-3-phenylindolin-2-one 234  
 The oxindole was obtained from 93 (0.050 g, 0.181 mmol) and 
ethylphenylketene (0.026 g, 1.0 eq, 0.181 mmol) according to general procedure E, to yield (±)-234 
(0.042 g, 73%) as an off-white foam; mp 147-148 °C; νmax cm-1 (KBr) 3209 (N-H), 1712 (C=O); 1H 
NMR (300 MHz, CDCl3) δ 8.19 (1H, br s, NH), 7.33 (2H, dd, J = 8.3, 2.0, ArH), 7.28-7.19 (5H, m, 
ArH), 6.79 (1H, d, J = 8.3, ArH), 2.39 (1H, dq, J = 13.8, 7.1, CHaHbCH3), 2.17 (1H, dq, J = 13.8, 
7.1, CHaHbCH3), 1.20 (3H, t, J = 7.1, CH2CH3); 13C NMR (75 MHz, CDCl3) δ 180.7 (C=O), 140.3 
(C(3a)), 139.4 (C(7a)), 135.2 (ArC), 131.1 (ArC), 128.8 (ArC), 128.0 (ArC), 127.6 (ArC), 126.8 (ArC), 
115.4 (ArC), 111.6 (ArCBr), 58.2 (C(3)), 30.4 (CH2CH3), 9.0 (CH2CH3); m/z (EI+) 315 
([M(79Br)+H]+, 100%) 317 ([M(81Br)+H]+, 100%); HRMS (EI+) C16H1479BrON+ ([M+H]+) found 
315.0257 requires 315.0253 (+ 0.4 ppm); HPLC analysis: racemic (Daicel Chiralcel OD-H column, 
eluent: hexane/i-PrOH 80:20, flow 1.5 mL/min, wavelength: 254 nm, retention times: 4.0 min and 
7.6 min). 
(S)-5-Bromo-3-ethyl-3-phenylindolin-2-one 234 
 The oxindole was obtained from N-Boc nitrone 248 (0.061 g, 0.150 mmol) and 
ethylphenylketene (0.022 g, 1.0 eq, 0.150 mmol) according to general procedure F, stirring 16 h 
allowing to warm to rt, to yield 234 (0.011 g, 23%) as a colourless oil; HPLC analysis: 70% e.e. 
(Daicel Chiralcel OD-H column, eluent: hexane/i-PrOH 80:20, flow 1.5 mL/min, wavelength: 254 
nm, retention times: 4.0 min (major) and 7.6 min (minor)). 
(±)-3-Ethyl-3,5-diphenylindolin-2-one 235  
5-Bromo-oxindole 234 (0.030 g, 0.095 mmol), 10 mol % PdCl2 (1.7 mg), 40 
mol % PPh3 (10 mg) and phenyl boronic acid (0.035 g, 3.0 eq, 0.285 mmol) were suspended in a 
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1,4-dioxane/water mix (10 mL / 2mL). To this stirred solution was added dropwise a solution of 
Na2CO3 (0.030 g, 3.0 eq, 0.285 mmol) in 2 mL of water. The reaction was then heated at reflux for 
16 h before being cooled and filtered through a celite plug. The residue was then washed with 
EtOAc (30 mL) and concentrated in vacuo to yield a crude yellow oil which was purified by column 
chromatography over silica (0-30% EtOAc in petroleum ether) to yield 235 (0.0243 g, 82%) as a 
white foam; mp 68-69 °C; νmax cm-1 (KBr) 3213 (N-H), 2969 (C-H), 2931 (C-H), 1708 (C=O); 1H 
NMR (300 MHz, CDCl3) δ 8.35 (1H, br s, NH), 7.57-7.53 (2H, m, ArH), 7.52-7.48 (1H, m, ArH), 
7.44-7.38 (5H, m, ArH), 7.36-7.24 (4H, m, ArH), 7.02 (1H, dd, J = 8.1, 0.2, ArH), 2.50 (1H, dq, J = 
13.8, 7.0, CHaHbCH3), 2.30 (1H, dq, J = 13.8, 7.0, CHaHbCH3), 0.81 (3H, t, J = 7.0, CH2CH3); 13C 
NMR (100 MHz, CDCl3) δ 180.7 (C=O), 140.9 (4ryArC), 140.5 (4ryArC), 140.0 (4ryArC), 136.1 
(4ryArC), 133.4 (4ryArC), 128.8 (ArC), 128.7 (ArC), 127.4 (C(5)), 127.1 (ArC), 127.0 (ArC), 127.0 
(ArC), 126.9 (ArC), 123.9 (C(4)), 110.1 (C(7)), 58.0 (C(3)), 30.7 (CH2CH3), 9.1 (CH2CH3); m/z (EI+) 
314 ([M+H]+, 100%); HRMS (ESI+) C22H20ON+ ([M+H]+) found 314.1543 requires 314.1539 (+ 
0.4 ppm). 
(±)-3-Ethyl-7-methyl-3-phenylindolin-2-one 236  
 The oxindole was obtained from 71 (0.080 g, 0.380 mmol) and ethylphenylketene 
(0.055 g, 1.0 eq, 0.380 mmol) following general procedure E, to yield (±)-236 (0.061 g, 64%) as an 
off-white solid; mp 136-137 °C {lit.1 138-139 °C}; 1H NMR (300 MHz, CDCl3) δ 9.29 (1H, br s, 
NH), 7.39 (2H, dt, J = 6.7, 1.6, ArH), 7.31-7.22 (3H, m, ArH), 7.07-6.98 (3H, m, ArH), 2.44 (1H, 
dq, J = 13.7, 7.1, CHaHbCH3), 2.28 (3H, s, ArCH3), 2.23 (1H, dq, J = 13.7, 7.1, CHaHbCH3), 0.75 
(3H, t, J = 7.1, CH2CH3); HPLC analysis: racemic (Daicel Chiralcel OD-H column, eluent: 
hexane/i-PrOH 80:20, flow 1.5 mL/min, wavelength: 254 nm, retention times: 4.0 min and 5.5 
min). 
(S)-3-Ethyl-7-methyl-3-phenylindolin-2-one 236 
The oxindole was obtained from chiral nitrone 195 (0.040 g, 0.060 mmol) and 
ethylphenylketene (0.012 g, 1.0 eq, 0.060 mmol) following general procedure F, to yield 236 (0.016 
g, 80%) as an off-white solid; [α]D
20 -22.6° (c = 0.90, CHCl3); HPLC analysis: 80 % e.e. (Daicel 
Chiralcel OD-H column, eluent: hexane/i-PrOH 80:20, flow 1.5 mL/min, wavelength: 254 nm, 
retention times: 4.0 min (major) and 5.6 min (minor)). 
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(±)-7-Chloro-3-ethyl-3-phenylindolin-2-one 237  
The oxindole was obtained from 87 (0.050 g, 0.216 mmol) and ethylphenylketene 
(0.032 g, 1.0 eq, 0.216 mmol) according to general procedure E to give (±)-237 (0.051 g, 86%) as a 
white solid; mp 128-130 °C; νmax cm-1 (ATR) 3182, 3154, 3076, 2916, 2848, 1705, 1616, 1597, 1474; 
1H NMR (300 MHz, CDCl3) δ 8.00 (1H, br s, NH), 7.41-7.25 (6H, m, ArH), 7.13 (1H, ddd, J = 7.5, 
1.5, 0.5, ArH), 7.10-7.05 (1H, m, ArH), 2.50 (1H, dq, J = 13.5, 7.3, CHaHb), 2.33-2.21 (1H, m, 
CHaHb), 0.80 (3H, t, J = 7.4, CH3); 13C NMR (75 MHz, CDCl3) δ 179.1 (C=O), 139.4 (4ry ArC), 
138.8 (4ry ArC), 134.0 (4ry ArC), 128.7 (ArC), 128.1 (ArC), 127.6 (ArC), 126.8 (ArC), 123.5 (ArC), 
123.4 (ArC), 115.1 (ArCCl), 59.0 (C3), 30.8 (CH2), 9.1 (CH3); m/z (ESI+) 272 ([M(35Cl)+H]+, 
100%); HRMS (ESI+) C16H15ON35Cl+ ([M+H]+) found 272.0840 requires 272.0837 (+ 1.2 ppm); 
HPLC analysis: racemic (Daicel Chiralcel OD-H column, eluent: hexane/i-PrOH 80:20, flow 1.5 
mL/min, wavelength: 254 nm, retention times: 4.4 min and 5.6 min). 
(S)-7-Chloro-3-ethyl-3-phenylindolin-2-one 237 
 The oxindole was prepared according to general procedure F from nitrone 259 
(0.029 g, 0.056 mmol) and ethylphenylketene (0.008 g, 1.0 eq, 0.056 mmol) to yield 237 (0.010g, 
66%) as a colourless oil; [α]D
20 -12.4° (c = 1.00, CHCl3); HPLC analysis: 68% ee (Daicel Chiralcel 
OD-H column, eluent: hexane/i-PrOH 80:20, flow 1.5 mL/min, wavelength: 254 nm, retention 
times: 4.3 min (major) and 5.4 min (minor)). 
(±)-6-Chloro-3-ethyl-3-phenylindolin-2-one 241 and (±)-4-Chloro-3-ethyl-3-phenylindolin-
2-one 240  
 The oxindoles were obtained from 88 (0.100 g, 0.432 mmol) 
and ethylphenylketene (0.064 g, 0.432 mmol) according to general procedure E, to yield (±)-241 
and (±)-240 in a crude 60:40 ratio based on 1H NMR integration. The regioisomers were separated 
by column chromatography over silica to yield (±)-241 (0.052 g, 44%) as a white solid and (±)-240 
(0.046 g, 39%) as a white solid. 
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(±)-6-Chloro-3-ethyl-3-phenylindolin-2-one 241  
mp 142-143 °C; νmax cm-1 (ATR) 3190, 3167, 3048, 2970, 2940, 1713, 1611, 1595; 1H NMR (500 
MHz, CDCl3) δ 8.78 (1H, br s, NH), 7.35-7.30 (4H, m, ArH), 7.28-7.26 (1H, m, ArH), 7.10-7.06 
(2H, m, ArH), 6.99 (1H, s, ArH(7)), 2.50 (1H, dq, J = 13.8, 6.9, CHaHb), 2.23 (1H, dq, J = 13.9, 7.0, 
CHaHb), 0.76 (3H, t, J = 7.3, CH3); 13C NMR (125 MHz, CDCl3) δ 181.1 (C=O), 142.3 (4ry ArC), 
139.5 (4ry ArC), 133.8 (4ry ArC), 131.2 (4ry ArC), 128.7 (ArC), 127.6 (ArC), 126.9 (ArC), 126.0 (ArC), 
122.7 (ArC), 110.7 (ArC(7)), 57.6 (C3), 30.4 (CH2), 9.0 (CH3); m/z (ESI+) 272 ([M(35Cl)+H]+, 
100%); HRMS (ESI+) C16H15ON35Cl+ ([M+H]+) found 272.0838 requires 272.0837 (+ 0.5 ppm); 
HPLC analysis: racemic (Daicel Chiralcel OD-H column, eluent: hexane/i-PrOH 80:20, flow 1.5 
mL/min, wavelength: 254 nm, retention times: 4.3 min and 14.4 min). 
(±)-4-Chloro-3-ethyl-3-phenylindolin-2-one 240  
mp 198-199 °C; νmax cm-1 (ATR) 3188, 3163, 2974, 2938, 1711, 1611, 1585, 1443; 1H NMR (500 
MHz, CDCl3) δ 8.82 (1H, br s, NH), 7.38-7.29 (5H, m, ArH), 7.27 (1H, d, J = 8.0, ArH(6)), 7.08 
(1H, d, J = 8.0, ArH(5)), 6.93 (1H, d, J = 8.0, ArH(7)), 2.71 (2H, app. qq, J = 15.1, 7.5, CH2), 0.78 
(3H, t, J = 7.4, CH3); 13C NMR (125 MHz, CDCl3) δ 180.4 (C=O), 143.2 (4ry ArC), 138.2 (4ry ArC), 
131.6 (4ry ArC), 129.6 (ArC), 129.3 (4ry ArC), 128.6 (ArC), 127.6 (ArC), 126.7 (ArC), 123.8 (ArC), 
108.5 (ArC(7)), 59.2 (C3), 26.5 (CH2), 9.1 (CH3); m/z (ESI+) 272 ([M(35Cl)+H]+, 100%); HRMS 
(ESI+) C16H15ON35Cl+ ([M+H]+) found 272.0840 requires 272.0837 (+ 1.2 ppm); HPLC analysis: 
racemic (Daicel Chiralcel OD-H column, eluent: hexane/i-PrOH 80:20, flow 1.5 mL/min, 
wavelength: 254 nm, retention times: 4.9 min and 12.1 min).  
(S)-6-Chloro-3-ethyl-3-phenylindolin-2-one 241 and (S)-4-Chloro-3-ethyl-3-phenylindolin-2-
one 240  
 The oxindoles were prepared according to general procedure 
F from 261 (0.065 g, 0.125 mmol) and ethylphenylketene (0.018 g, 1.0 eq, 0.125 mmol) to give 
oxindoles 241 and 240 in a crude 60:40 ratio based on 1H NMR integration. The crude oxindoles 
were purified and separated via column chromatography over silica to yield 240 (0.011 g, 32%) as a 
white solid and 241 (0.016 g, 47%) as a white solid. 
(S)-6-Chloro-3-ethyl-3-phenylindolin-2-one 241 HPLC analysis: racemic (Daicel Chiralcel OD-
H column, eluent: hexane/i-PrOH 80:20, flow 1.5 mL/min, wavelength: 254 nm, retention times: 
4.3 min (major) and 14.1 min (minor)). 
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(S)-4-Chloro-3-ethyl-3-phenylindolin-2-one 240 HPLC analysis: racemic (Daicel Chiralcel OD-
H column, eluent: hexane/i-PrOH 80:20, flow 1.5 mL/min, wavelength: 254 nm, retention times: 
4.8 min (major) and 12.2 min (minor)). 
(±)-3-Ethyl-4-methyl-3-phenylindolin-2-one 244 and (±)-3-ethyl-6-methyl-3-phenylindolin-
2-one 245  
The oxindoles were obtained from 85 (0.080 g, 0.380 mmol) 
and ethylphenylketene (0.055 g, 1.0 eq, 0.380 mmol) following general procedure E, to yield 244 
and 245 (combined yield; 0.040 g, 42%) as a 40:60 mixture of (±)-244 to (±)-245 based upon 1H 
NMR integration of the characteristic methyl singlets, and separation via chiral HPLC. HPLC 
analysis: racemic (Daicel Chiralcel OD-H column, eluent: hexane/i-PrOH 80:20, flow 1.5 mL/min, 
wavelength: 254 nm, retention times: (±)-244; 4.0 min and 13.1 min; (±)-245; 4.8 min and 9.7 min). 
(S)-3-Ethyl-4-methyl-3-phenylindolin-2-one 244 and (S)-3-ethyl-6-methyl-3-phenylindolin-
2-one 245  
The oxindoles were obtained from chiral nitrone 260 (0.075 
g, 0.150 mmol) and ethylphenylketene (0.022 g, 1.0 eq, 0.150 mmol) following general procedure F, 
to yield a mixture of 244 and 245 (0.036 g, 88%) as an off-white foam in 40:60 ratio of 244 to 245 
based upon 1H NMR integration and separation via chiral HPLC. HPLC analysis: 244 91% e.e. & 
245 91% e.e. (Daicel Chiralcel OD-H column, eluent: hexane/i-PrOH 80:20, flow 1.5 mL/min, 
wavelength: 254 nm, retention times: 244; 4.0 min (major) and 13.2 min (minor); 245; 4.8 min 
(major) and 10.0 min (minor)). 
(±)-7-Bromo-3-ethyl-3-phenylindolin-2-one 251 
The oxindole was obtained from 91 (0.124 g, 0.449 mmol) and ethylphenylketene 
(0.066 g, 1.0 eq, 0.449 mmol) according to general procedure E, to yield (±)-251 (0.119 g, 84%) as 
an off-white solid; mp 79-80 °C; νmax cm-1 (KBr) 3149 (N-H), 1713 (C=O); 1H NMR (400 MHz, 
CDCl3) δ 7.82-7.79 (1H, m, ArH), 7.69-7.66 (1H, m, ArH), 7.43-7.34 (2H, m, ArH), 7.17 (1H, t, J = 
8.0, ArH), 7.02-6.89 (2H, m, ArH), 6.75-6.70 (1H, m, ArH), 2.75 (1H, dq, J = 13.6, 7.0, 
CHaHbCH3), 2.04 (1H, dq, J = 13.6, 7.0, CHaHbCH3), 0.69 (3H, t, J = 7.0, CH2CH3); 13C NMR (75 
MHz, CDCl3) δ 168.2 (C=O), 146.7 (C(3a)), 142.9 (C(7a)), 137.4 (ArC), 129.4 (ArC), 128.9 (ArC) 
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128.2 (ArC), 127.9 (ArC), 126.8 (ArC), 126.7 (ArC), 115.4 (ArCBr), 61.2 (C(3)), 32.0 (CH2CH3), 9.8 
(CH2CH3); m/z (EI+) 315 ([M(79Br)+H]+, 100%) 317 ([M(81Br)+H]+, 100%); HRMS (EI+) 
C16H1479BrON+ ([M+H]+) found 315.0258 requires 315.0253 (+ 0.5 ppm). HPLC analysis: racemic 
(Daicel Chiralcel OD-H column, eluent: hexane/i-PrOH 80:20, flow 1.5 mL/min, wavelength: 254 
nm, retention times: 4.5 min and 5.5 min). 
(S)-7-Bromo-3-ethyl-3-phenylindolin-2-one 251 
The oxindole was obtained from N-Boc nitrone 250 (0.145 g, 0.360 mmol) and 
ethylphenylketene (0.053 g, 1.0 eq, 0.360 mmol) according to general procedure F, stirring 16 h 
allowing to warm to rt, to yield 251 (0.015 g, 13%) as an off-white solid; HPLC analysis: 31% e.e. 
(Daicel Chiralcel OD-H column, eluent: hexane/i-PrOH 80:20, flow 1.5 mL/min, wavelength: 254 
nm, retention times: 4.5 min (major) and 5.6 min (minor)).  
(±)-4-Bromo-3-ethyl-3-phenylindolin-2-one 256 and (±)-6-bromo-3-ethyl-3-phenylindolin-
2-one 257 
The oxindoles were obtained from 92 (0.100 g, 0.362 mmol) 
and ethylphenylketene (0.053 g, 1.0 eq, 0.362 mmol) according to general procedure E, to yield 256 
and 257 (combined yield; 0.084 g, 73%) in a 4:6 ratio (based on crude 1H NMR integration). The 
two regioisomers were partially separated via column chromatography to yield authentic analytical 
samples of both 256 and 257, which were definitively assigned via their 1H NMR coupling 
constants and multiplicities.  
257: mp 199-200 °C; νmax cm-1 (KBr) 3146 (N-H), 1714 (C=O); 1H NMR (300 MHz, CDCl3) δ 8.17 
(1H, br s, NH), 7.33-7.22 (5H, m, ArH), 7.19 (1H, d, J = 1.3, ArH), 7.15 (1H, t, J = 7.6, ArH), 6.91 
(1H, dd, J = 7.6, 1.3, ArH), 2.75 (1H, dq, J = 13.7, 7.0, CHaHbCH3), 2.58 (1H, dq, J = 13.7, 7.0, 
CHaHbCH3), 0.71 (3H, t, J = 7.0, CH2CH3); 13C NMR (75 MHz, CDCl3) δ 180.2 (C=O), 143.7 
(C(3a)), 138.5 (C(7a)), 131.5 (ArC), 130.2 (ArC), 129.0 (ArC), 127.9 (ArC), 127.4 (ArC), 127.3 (ArC), 
123.8 (ArC), 109.2 (ArCBr), 60.3 (C(3)), 26.6 (CH2CH3), 9.4 (CH2CH3); m/z (EI+) 315 ([M+H]+, 
65%) 317 ([M+H]+, 65%); HRMS (EI+) C16H1479BrON+ ([M+H]+) found 315.0256 requires 
315.0253 (+ 0.3 ppm); HPLC analysis: racemic (Daicel Chiralcel OD-H column, eluent: hexane/i-
PrOH 80:20, flow 1.5 mL/min, wavelength: 254 nm, retention times: 4.4 min and 13.3 min). 
256: mp 160-161 °C; 1H NMR (300 MHz, CDCl3) δ 7.33-7.31 (2H, m, ArH), 7.28 (1H, d, J = 1.9, 
ArH), 7.25-7.22 (3H, m, ArH), 7.13 (1H, d, J = 1.9, ArH), 7.04 (1H, d, J = 8.0, ArH), 2.45 (1H, dq, 
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J = 13.8, 7.0, CHaHbCH3), 2.22 (1H, dq, J = 13.8, 7.0, CHaHbCH3), 0.76 (3H, t, J = 7.0, CH2CH3); 
13C NMR (75 MHz, CDCl3) δ 180.5 (C=O), 139.8 (C(3a)), 132.1 (C(7a)), 129.1 (ArC), 128.0 (ArC), 
127.2 (ArC), 126.9 (ArC), 126.0 (ArC), 121.9 (ArC), 121.6 (ArC), 113.6 (ArCBr), 57.9 (C(3)), 30.9 
(CH2CH3), 9.4 (CH2CH3); m/z (EI+) 315 ([M(79Br)+H]+, 37%) 317 ([M(81Br)+H]+, 36%); HRMS 
(EI+) C16H1479BrON+ ([M+H]+) found 315.0258 requires 315.0253 (+ 0.5 ppm); HPLC analysis: 
racemic (Daicel Chiralcel OD-H column, eluent: hexane/i-PrOH 80:20, flow 1.5 mL/min, 
wavelength: 254 nm, retention times: 5.1 min and 11.9 min). 
(S)-4-Bromo-3-ethyl-3-phenylindolin-2-one 256 and (S)-6-bromo-3-ethyl-3-phenylindolin-2-
one 257 
The oxindoles were obtained from N-Boc nitrone 253 
(0.120g, 0.300 mmol) and ethylphenylketene (0.044 g, 1.0 eq, 0.300 mmol) according to general 
procedure F, stirring 16 h allowing to warm to rt, to yield 256 and 257 (0.053 g, 56% combined 
yield) in a 6:4 ratio of (based on crude 1H NMR integration), which were partially separated via 
column chromatography to yield authentic analytical samples of each regioisomer.  
257: a yellow oil; HPLC analysis: 84% e.e. (Daicel Chiralcel OD-H column, eluent: hexane/i-PrOH 
80:20, flow 1.5 mL/min, wavelength: 254 nm, retention times: 4.3 min (major) and 12.7 min 
(minor)). 
256: an off-white foam; HPLC analysis: 76% e.e. (Daicel Chiralcel OD-H column, eluent: hexane/i-
PrOH 80:20, flow 1.5 mL/min, wavelength: 254 nm, retention times: 5.1 min (major) and 11.4 min 
(minor)). 
References for this section: 
1. Duguet, N.; Slawin, A. M. Z.; Smith, A. D. Org. Lett. 2009, 17, 3858-3861. 
2. Mashevskaya, M. S.; Petyunin, P. A. Pharmaceutical Chemistry Journal, 1970, 4, 370-371. 
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8.7. Experimental Details for Chapter 6: Further Areas of Investigation 
(Z)-N-(Naphthalen-2-ylmethylene)aniline oxide 270 
  The nitrone was obtained from 2-naphthaldehyde (0.781 g, 5.00 mmol), 
(0.662 g, 1.1 eq, 5.50 mmol) and PhNHOH (0.654 g, 1.2 eq, 6.00 mmol) according to general 
procedure D to give 270 (0.951 g, 77%) as an off-white solid; mp 132-133 °C; {lit.1 130 °C}; 1H 
NMR (300 MHz, CDCl3) δ 9.45 (1H, s, ArH), 8.09 (1H, s, HC=N+), 8.00 (2H, td, J = 8.1, 1.9, 
ArH), 7.90 (1H, d, J = 8.7, ArH), 7.86-7.82 (3H, m, ArH), 7.57-7.48 (5H, m, ArH). 
(Z)-N-(Naphthalen-1-ylmethylene)aniline oxide 271 
 The nitrone was obtained from 1-naphthaldehyde (0.781 g, 5.00 mmol), (0.662 
g, 1.1 eq, 5.50 mmol) and PhNHOH (0.654 g, 1.2 eq, 6.00 mmol) according to general procedure D 
to give 271 (1.03 g, 84%) as a pale yellow solid; mp 140-141 °C; {lit.2 141-143 °C}; 1H NMR (300 
MHz, CDCl3) δ 9.77 (1H, dd, J = 7.5, 0.7, ArH), 8.72 (1H, s, HC=N+), 8.11-8.08 (1H, m, ArH), 
7.97 (1H, d, J = 8.2, ArH), 7.93 (1H, dd, J = 7.0, 2.5, ArH), 7.88-7.84 (2H, m, ArH), 7.64 (1H, t, J = 
8.0, ArH), 7.60-7.50 (5H, m, ArH). 
(Z)-N-(4-(Trifluoromethyl)benzylidene)aniline oxide 272 
 The nitrone was obtained from 4-trifluoromethylbenzaldehyde (0.871 g, 
5.00 mmol), MgSO4 (0.662 g, 1.1 eq, 5.50 mmol) and PhNHOH (0.654 g, 1.2 eq, 6.00 mmol) 
according to general procedure D to give 272 (0.889 g, 67%) as a white solid; mp 216-217 °C (dec.); 
1H NMR (300 MHz, CDCl3) δ 8.51 (2H, d, J = 8.5, ArH(3,5)), 8.00 (1H, s, HC=N+), 7.80-7.77 (2H, 
m, PhH(2,6)), 7.73 (2H, d, J = 8.4, ArH(2,6)), 7.52-7.50 (3H, m, PhH(3,4,5)); 19F NMR (282 MHz, 
CDCl3) δ -63.4 (ArCF3); Data in accordance with the literature.3 
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(Z)-N-((Perfluorophenyl)methylene)aniline oxide 273 
 The nitrone was obtained from pentafluorobenzaldehyde (0.490 g, 5.00 
mmol), (0.662 g, 1.1 eq, 5.50 mmol) and PhNHOH (0.327 g, 1.2 eq, 6.00 mmol) according to 
general procedure D to give 273 (1.11 g, 77%) as a white solid; mp 124-126 °C (dec.); {lit.4 130-133 
°C}; 1H NMR (300 MHz, CDCl3) δ 7.92 (1H, d, J = 0.9, HC=N+), 7.80 (2H, dd, J = 7.8, 1.9, 
ArH(2,6)), 7.56-7.49 (3H, m, ArH(3,4,5)); 19F NMR (282 MHz, CDCl3) δ -132.2 (2F, d, J = 19.1, 
ArF(2,6)), -151.6 (1F, t, J = 20.8, ArF(4)), -161.8 (2F, td, J = 20.2, 4.5, ArF(3,5)) 
(Z)-N-(4-Nitrobenzylidene)aniline oxide 274 
 The nitrone was obtained from 2-naphthaldehyde (0.781 g, 5.00 mmol), 
(0.662 g, 1.1 eq, 5.50 mmol) and PhNHOH (0.654 g, 1.2 eq, 6.00 mmol) according to general 
procedure D to give 274 (0.790 g, 65%) as a yellow solid; mp 170-172 °C {lit.5 175-178 °C}; 1H 
NMR (300 MHz, CDCl3) δ 8.55 (2H, d, J = 9.0, ArH(3,5)), 8.32 (2H, d, J = 9.0, ArH(2,6)), 8.07 
(1H, s, HC=N+), 7.80-7.77 (2H, m, PhH(2,6)), 7.54-7.52 (3H, m, PhH(3,4,5)). 
(Z)-N-(2,2-Dimethylpropylidene)aniline oxide 275 
 The nitrone was obtained from pivaldehyde (0.543 mL, 5.00 mmol), (0.662 g, 1.1 eq, 
5.50 mmol) and PhNHOH (0.654 g, 1.2 eq, 6.00 mmol) according to general procedure D to give 
275 (0.247 g, 28%) as a pale yellow oil with data in accordance with the literature.6 1H NMR (300 
MHz, CDCl3) δ 7.66-7.63 (2H, m, ArH(2,6)), 7.43-7.40 (3H, m, ArH(3,4,5)), 7.03 (1H, s, HC=N+), 
1.40 (9H, s, tBuCH3). 
N-(4-Methoxyphenyl)-2-phenylacetamide 278 
To a stirred solution of p-anisidine (9.25 g, 1.5 eq, 48.8 mmol) in CH2Cl2 
(125 mL) at rt was added phenylacetyl chloride (6.50 mL, 32.5 mmol) and the reaction stirred for 2 
h. aq. 1M HCl (100 mL) was then added slowly and the reaction mixture extracted with CH2Cl2 (2 
× 100 mL). The combined organic layers were then washed with sat. aq. NaHCO3 (100 mL), dried 
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over MgSO4, filtered and concentrated in vacuo to give a crude semi-solid. Purification by 
recrystallisation from EtOAc afforded 278 (8.65 g, 73%) as a lilac solid; mp 120-121 °C {lit.7 122-
123 °C}; 1H NMR (300 MHz, CDCl3) δ 7.40 (2H, t, J = 7.2, ArH), 7.34-7.30 (5H, m, ArH), 7.03 
(1H, br s, NH), 6.83-6.79 (2H, m, ArH), 3.76 (3H, s, OMe), 3.72 (2H, s, CH2Ph). 
Phenylketene-N-4-methoxyphenylimine 280 
To a stirred solution of amide 278 (1.03 g, 4.25 mmol) in toluene (20 mL) 
at rt was added PCl5 (0.89 g, 1.0 eq, 4.25 mmol) and the reaction mixture heated at 80 °C for 1 h. 
The reaction mixture was then concentrated in vacuo. The crude material was dissolved once more 
in toluene (20 mL) and Et3N (0.60 mL, 1.05 eq, 4.46 mmol) added slowly. The reaction mixture was 
heated at 80 °C for 4 h before being concentrated in vacuo. The crude residue was then suspended in 
pentane (16 mL) and stirred rapidly for 10 min. The solids were filtered and the filtrate 
concentrated in vacuo to give 280 as a yellow liquid which was used without further purification with 
data in accordance with the literature;8 1H NMR (500 MHz, CDCl3) δ 7.32-7.30 (2H, m, ArH), 7.19-
7.15 (4H, m, ArH), 7.12-7.09 (1H, m, ArH), 6.91-6.89 (2H, m, ArH), 5.23 (1H, s, CH), 3.83 (3H, s, 
OMe). 
N-(4-Fluorophenyl)-2-phenylacetamide 277 
 To a stirred solution of 4-fluoroaniline (5.42 g, 1.5 eq, 48.8 mmol) in CH2Cl2 
(125 mL) at rt was added phenylacetyl chloride (6.50 mL, 32.5 mmol) and the reaction stirred for 2 
h. aq. 1M HCl (100 mL) was then added slowly and the reaction mixture extracted with CH2Cl2 (2 x 
100 mL). The combined organic layers were washed with sat. aq. NaHCO3 (100 mL), dried over 
MgSO4, filtered and concentrated in vacuo to give a crude semi-solid. Purification by recrystallisation 
from EtOAc afforded 277 (6.82 g, 62%) as a white solid; mp 134-135 °C {lit.9 123-125 °C}; 1H 
NMR (300 MHz, CDCl3) δ 7.44-7.32 (7H, m, ArH), 7.08 (1H, br s, NH), 7.00-6.93 (2H, ArH), 3.73 
(2H, s, CH2Ph); 19F NMR (282 MHz, CDCl3) δ -118.3 (ArF). 
Phenylketene-N-4-fluorophenylimine 279 
 To a stirred solution of amide 277 (0.97 g, 4.25 mmol) in toluene (20 mL) at 
rt was added PCl5 (0.89 g, 1.0 eq, 4.25 mmol) and the reaction mixture heated at 80 °C for 1 h. The 
reaction mixture was then concentrated in vacuo. The crude material was dissolved once more in 
toluene (20 mL) and Et3N (0.60 mL, 1.05 eq, 4.46 mmol) added slowly. The reaction mixture was 
then heated at 80 °C for 4 h before being concentrated in vacuo. The crude residue was suspended in 
pentane (16 mL) and stirred rapidly for 10 minutes. The solids were filtered and the filtrate 
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concentrated in vacuo to give 279 as a yellow liquid which was used without further purification with 
data in accordance with the literature;10 1H NMR (500 MHz, CDCl3) δ 7.36-7.33 (2H, m, ArH), 7.30 
(1H, t, J = 7.7), 7.19-7.18 (2H, m, ArH), 7.14 (1H, t, J = 7.4, ArH), 7.10-7.06 (2H, m, ArH), 5.29 
(1H, s, CH). 
N-Phenylisobutyramide 281 
 To a stirred solution of aniline (6.43 mL, 1.5 eq, 70.4 mmol) in CH2Cl2 (150 mL) at 
rt was added isobutyryl chloride (5.00 g, 46.9 mmol) and the reaction stirred for 3 h. aq. 1M HCl 
(100 mL) was then added slowly and the reaction mixture extracted with CH2Cl2 (2 × 100 mL). The 
combined organic layers were then washed with sat. aq. NaHCO3 (100 mL), dried over MgSO4, 
filtered and concentrated in vacuo to give a crude semi-solid. Purification by recrystallisation from 
CH2Cl2:petroleum ether gave 281 (4.89 g, 64%) as an off-white solid; mp 104-105 °C {lit.11 104-105 
°C}; 1H NMR (300 MHz, CDCl3) δ 7.53 (2H, d, J = 7.8, ArH), 7.33-7.29 (2H, m, ArH), 7.20 (1H, 
br s, NH), 7.10 (1H, t, J = 7.4, ArH), 2.51 (1H, sept., J = 6.9, CH), 1.26 (6H, d, J = 6.9, iPrCH3). 
N-Tosylisobutyramide 282 
  A mixture of tosylamine (5.00 g, 29.2 mmol), iosbutyric anhydride (9.70 mL, 2.0 
eq, 58.4 mmol), silica gel (0.500 g) and conc. H2SO4 (4 drops) was stirred for 1 h at rt. After this 
time, the reaction mixture had formed a viscous paste, to which Et2O (100 mL) was added carefully 
and the reaction stirred a further 15 min at rt. The solid was then collected via suction filtration, 
washed multiple times with cold Et2O and multiple times with petrol. Excess anhydride was 
removed by heating to 90 °C under vacuum (3 mmHg) for 2 h, to leave 282 (5.99 g, 85%) as an off-
white solid; mp 119-120 °C {lit.12  127-128 °C}; 1H NMR (300 MHz, CDCl3) δ 7.92 (2H, d, J = 8.4, 
TsH), 7.31 (2H, d, J = 8.4, TsH), 6.60 (1H, br s, NH), 2.60 (1H, sept., J = 7.0, CH), 2.43 (3H, s, 
TsCH3), 1.09 (6H, d, J = 7.0, iPrCH3). 
(±)-(E)-2-(2-(Benzylideneamino)phenyl)-N-(4-fluorophenyl)-2-phenylacetamide 283 
To a stirred solution of nitrone 48 (0.100 g, 0.508 mmol) in THF (2 mL) 
at rt was added a THF solution of ketenimine 279 (1.10 mL, approx. 0.500 mmol per mL) dropwise 
and the reaction mixture stirred 18 h at rt. The reaction was quenched with aq. 1M HCl (2 mL) and 
extracted with Et2O (3 × 20 mL). The combined organic layers were then washed with sat. aq. 
NaHCO3, dried over MgSO4, filtered and concentrated in vacuo to give a yellow solid which was 
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purified by recrystallisation from cyclohexane to give 283 (0.153 g, 74%) as a pale yellow solid; mp 
140-142 °C; νmax cm-1 (ATR) 3319, 1668, 1626, 1506; 1H NMR (300 MHz, CDCl3) δ 8.64 (1H, br s, 
NH), 8.38 (1H, s, HC=N), 7.81 (2H, d, J = 6.7, ArH), 7.53-7.20 (13H, m, ArH), 7.15-7.12 (1H, m, 
ArH), 6.98-6.92 (2H, m, ArH), 5.58 (1H, s, CH); 13C NMR (75 MHz, CDCl3) δ 170.6 (C=O), 160.5 
(C=N), 159.1 (d, J = 243.1, ArCF), 149.6 (4ry ArC), 138.9 (4ry ArC), 135.9 (4ry ArC), 134.4 (4ry ArC), 
133.8 (4ry ArC), 131.8 (ArC), 130.1 (ArC), 128.9 (ArC), 128.8 (ArC), 128.8 (ArC), 128.6 (ArC), 127.1 
(ArC), 126.8 (ArC), 121.3 (d, J = 7.8), 118.3 (ArC), 115.5 (d, J = 22.3), 56.4 (CH); 19F NMR (282 
MHz MHz, CDCl3) δ -119.1 (ArF); m/z (EI+) 409 ([M+H]+, 100%); HRMS (EI+) C27H22FN2O 
([M+H]+) found 409.1710 requires 409.1711 (- 0.2 ppm). 
 (±)-N-(4-Fluorophenyl)-2-phenylbutanamide 284 
 To a stirred solution of p-fluoroaniline (9.25 g, 1.50 eq, 48.8 mmol) in 
CH2Cl2 (125 mL) at rt was added 2-phenylbutanoyl chloride (5.90 mL, 1.0 eq, 32.5 mmol) dropwise 
and the reaction stirred 2 h at rt before quenching with aq. 1M HCl. The crude reaction mixture 
was extracted with EtOAc (2 x 200 mL), the combined organic layers washed with sat. aq. 
NaHCO3, dried over MgSO4, filtered and concentrated in vacuo to give 284 (2.98 g, 36%) as an off-
white solid; mp 98-99 °C; νmax cm-1 (ATR) 3260, 1655, 1614, 1545; 1H NMR (300 MHz, d6-DMSO) 
δ 7.41-7.30 (7H, m, ArH), 7.10 (1H, br s, NH), 6.99-6.93 (2H, m, ArH), 3.38 (1H, t, J = 7.5), 2.27 
(1H, dquint., J = 14.1, 7.1), 1.87 (1H, app. dquint., J = 14.1, 7.1), 0.93 (3H, t, J = 7.4); 13C NMR (75 
MHz, d6-DMSO) δ 171.9 (C=O), 158.3 (d, J = 239.6, ArCF), 140.8 (4ry PhC), 135.9 (d, J = 2.3, 
ArCNH), 128.7 (PhC), 128.0 (PhC), 127.2 (PhC), 121.2 (d, J = 7.7, ArC(2)), 115.6 (d, J = 22.1, 
ArC(3)), 54.3 (CH), 26.7 (CH2), 12.6 (CH3); 19F NMR (282 MHz, d6-DMSO) δ -118.6 (ArF); m/z 
(EI+) 258 ([M+H]+, 100%); HRMS (EI+) C16H17FNO ([M+H]+) found 258.1290 requires 258.1289 
(- 0.2 ppm). 
Ethylphenylketene-N-4-fluorophenylimine 285 
To a stirred solution of amide 284 (1.09 g, 4.25 mmol) in toluene (20 mL) at 
rt was added PCl5 (0.89 g, 1.0 eq, 4.25 mmol) and the reaction mixture heated at 80 °C for 1 h. The 
reaction mixture was then concentrated in vacuo. The crude material was dissolved once more in 
toluene (20 mL) and Et3N (0.60 mL, 1.05 eq, 4.46 mmol) added slowly. The reaction mixture was 
then heated at 80 °C for 3 h before being concentrated in vacuo. The crude residue was then 
suspended in pentane (16 mL) and stirred rapidly for 10 minutes. The solids were then filtered and 
the filtrate concentrated in vacuo to give 285 as a yellow liquid which was used without further 
purification; 1H NMR (300 MHz) δ 7.34-7.29 (4H, m, ArH), 7.25-7.22 (2H, m, ArH), 7.16-7.11 
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(1H, m, ArH), 7.11-7.03 (2H, m, ArH), 2.54 (2H, q, CH2), 1.24 (3H, t, J = 7.4, CH3); 19F NMR (282 
MHz) δ -114.9 (ArF). 
References for this section: 
1. Medyansteva et al. Russian J. Org. Chem. 1972, 8, 146-151. 
2. Nelson, D. W.; Owens, J.; Hiraldo, D. J. Org. Chem. 2011, 66, 2572-2582. 
3. Jiao, P.; Nakashima, D.; Yamamoto, H. Angew. Chem., Int. Ed. 2008, 47, 2411-2413.  
4. Petrenko, N. I.; Gerasimova, T. N.; Fokin, E. P. B. Acad. Sci. USSR CH+, 1984, 33, 1268-1273. 
5. Sapeta, K.; Kerr, M. A. J. Org. Chem. 2007, 72, 8597-8599. 
6. Christensen, D.; Jørgensen, K. A. J. Org. Chem. 1989, 54, 126-131. 
7. Lanigan, R. M.; Starkov, P.; Sheppard, T. D. J. Org. Chem. 2013, 78, 4512-4523. 
8. Sung, K.; Chen, F-L.; Huang, P-M.; Chiang, S-M. Tetrahedron, 2006, 62, 171-181. 
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8.8. Experimental Details for Chapter 7: Applications towards the synthesis of  Biologically 
Relevant Species 
8.8.1 Roche p53 inhibitor 
(±)-3-(3-Chlorophenyl)-2-(3-methoxyphenyl)propanoic acid 287 
To a stirred solution of 3-methoxyphenylacetic acid (10.03 g, 60.2 mmol) in 
THF (200 mL) at -78 °C was added n-BuLi (60 mL, 2.5 eq, 2.5M in hexanes) dropwise and the 
reaction then allowed to warm to rt. 3-Chlorobenzyl bromide (8.75 mL, 1.1 eq, 66.2 mmol) was 
then added slowly and the reaction stirred 6 h at rt before quenching with aq. 1M HCl (60 mL). 
The reaction mixture was then extracted with Et2O (2 ×250 mL) and the combined organic layers 
washed with brine (300 mL), dried over MgSO4, filtered and concentrated in vacuo to yield a crude 
yellow oil which was purifed via column chromatography over silica (0-50% EtOAc in petroleum 
ether) to yield 287 (15.21 g, 87%) as a viscous yellow oil which slowly crystallised to an off-white 
solid upon standing, with analytical data in accordance with the literature;1 1H NMR (400 MHz, 
CDCl3) δ 7.30-7.28 (1H, m, MeOArH(5)), 7.21-7.17 (3H, m, ArH), 7.02-6.97 (1H, m, ArH), 6.94-
6.85 (3H, m, MeOArH(2,4,6), 3.85-3.83 (1H, m, CH), 3.84 (3H, s, ArOMe), 3.40 (1H, dd, J = 13.8, 
7.5, CHaHb), 3.04 (1H, dd, J = 13.8, 7.5, CHaHb). 
(±)-3-(3-Chlorophenyl)-2-(3-methoxyphenyl)propanoyl chloride 288 
According to a literature procedure, 1 a stirred solution of acid 287 (8.00 g, 27.5 
mmol) in toluene (80 mL) was treated with thionyl chloride (4.00 mL, 2.0 eq, 55.0 mmol), and the 
reaction mixture stirred at 80 °C for 16 h. After cooling to rt, the reaction mixture was 
concentrated in vacuo to leave 288 (8.74 g, quant.) as a light brown oil which was used without 
further purification; 1H NMR (400 MHz, CDCl3) δ 7.27-7.24 (3H, m, ArH), 7.06-7.02 (1H, m, 
ArH), 6.97-6.89 (3H, m, ArH), 6.85-6.84 (1H, m, ArH), 4.28 (1H, t, J = 7.5, CH), 3.88 (3H, s, 
ArOMe), 3.51 (1H, dd, J = 14.0, 7.5, CHaHb), 3.11 (1H, dd, J = 14.0, 7.5, CHaHb). 
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(±)-4-Chloro-3-(3-chlorobenzyl)-3-(3-methoxyphenyl)indolin-2-one (±)-297 &  
(±)-6-Chloro-3-(3-chlorobenzyl)-3-(3-methoxyphenyl)indolin-2-one (±)-14 
To a stirred solution of acid chloride 288 
(3.00 g, 9.70 mmol) in Et2O (40 mL) at 0 °C was added N,N-dimethylethylamine (1.10 mL, 1.05 eq, 
10.2 mmol) dropwise over 15 min and the reaction mixture stirred at 0 °C for 16 h. After this time, 
the reaction mixture was allowed to warm to rt before being filtered under nitrogen to remove the 
amine hydrochloride salts and then concentrated in vacuo. The resulting orange liquid (assumed as a 
50% yield of ketene with respect to the acid chloride starting material) was then re-suspended in 
THF (20 mL) under nitrogen and cooled to -78 °C. A solution of nitrone 88 (1.12 g, 4.85 mmol) in 
THF (30 mL) was then added slowly over 15 min and the reaction mixture stirred at -78 °C for 4 h. 
The reaction was then quenched with aq. 1M HCl (5 mL) and stirred for 2 h allowing to warm to rt. 
The reaction mixture was then partitioned between Et2O (100 mL) and H2O (50 mL), the layers 
separated and the aqueous layer extracted once more with Et2O (75 mL). The combined organic 
layers were then washed with NaHCO3 (2 ×100 mL), brine (75 mL), dried over MgSO4, filtered 
and concentrated in vacuo to yield a crude dark orange oil.  The crude product was purified via 
column chromatography over silica (0-30% EtOAc in petrol) to yield a mixture of the two oxindole 
regioisomers (1.41 g, 73% as a pale yellow foam). 0.124 g of these regioisomers was then separated 
via a second column chromatography over silica (10% Et2O in toluene) to yield (±)-14 (0.064 g, 
52%) as a white solid and (±)-297 (0.045 g, 36%) as a white solid. 
(±)-14 as a white solid: mp 152-153 °C; νmax cm-1 (ATR) 3204, 1717, 1613, 1580; 1H NMR (300 
MHz, CDCl3) δ 7.53 (1H, br s, NH), 7.27 (1H, t, J = 8.0, ArH), 7.12-6.97 (6H, m, ArH), 6.91-6.74 
(4H, m, ArH), 3.77 (3H, s, OMe), 3.65 (1H, d, J = 13.0, CHaHbPh), 3.40 (1H, d, J = 13.0, 
CHaHbPh); 13C NMR (125 MHz, CDCl3) δ 178.9 (C=O), 159.8 (ArCOMe), 141.6 (4ry ArC), 140.4 
(4ry ArC), 137.4 (4ry ArC), 134.1 (ArCCl), 133.6 (ArCCl), 130.2 (ArC), 129.8 (ArC), 129.8 (ArC), 
129.1 (ArC), 128.3 (4ry ArC), 127.1 (ArC), 126.8 (ArC), 122.5 (ArC), 119.3 (ArC), 113.6 (ArC), 112.6 
(ArC), 110.5 (ArC(7)), 57.6 (C(3)), 55.3 (OMe), 43.0 (CH2Ph); m/z (EI+) 398 ([M(35Cl35Cl)+H]+, 
100%); HRMS (EI+) C22H18O2N35Cl2 ([M+H]+) found 398.0710 requires 398.0709 (+ 0.2 ppm). 
(±)-297 as a white solid: mp 110-111 °C; νmax cm-1 (ATR) 3159, 1715, 1614; 1H NMR (300 MHz, 
CDCl3) δ 7.52 (1H, br s, NH), 7.27-7.24 (1H, m, ArH), 7.12 (1H, t, J = 7.8, ArH), 7.06-7.00 (3H, m, 
ArH), 6.98-6.95 (2H, m, ArH), 6.91-6.81 (3H, m, ArH), 6.59 (1H, dd, J = 7.8, 0.9, ArH), 3.83 (1H, 
d, J = 5.5, CHaHbPh), 3.79 (3H, s, OMe), 3.78 (1H, d, J = 5.5, CHaHbPh); 13C NMR (125 MHz, 
CDCl3) δ 178.3 (C=O), 159.8 (ArCOMe), 142.4 (4ry ArC), 138.9 (4ry ArC), 137.7 (4ry ArC), 133.6 (4ry 
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ArC), 131.8 (ArC), 130.0 (ArC), 129.7 (ArC), 129.6 (4ry ArC), 129.6 (4ry ArC), 129.1 (ArC), 127.9 
(ArC), 127.0 (ArC), 123.8 (ArC), 119.2 (ArC), 113.6 (ArC), 112.5 (ArC), 108.2 (ArC(7)), 59.6 (C(3)), 
55.3 (OMe), 38.2 (CH2); m/z (EI+) 398 ([M(35Cl35Cl)+H]+, 100%); HRMS (EI+) C22H18O2N35Cl2 
([M+H]+) found 398.0709 requires 398.0709 (+ 0.0 ppm). 
(S)-6-Chloro-3-(3-chlorobenzyl)-3-(3-methoxyphenyl)indolin-2-one 14 &  
(S)-4-Chloro-3-(3-chlorobenzyl)-3-(3-methoxyphenyl)indolin-2-one 297 
To a stirred solution of acid chloride 288 
(0.800 g, 2.59 mmol) in Et2O (15 mL) at 0 °C was added N,N-dimethylethylamine (0.294 mL, 1.05 
eq, 2.72 mmol) dropwise over 15 min and the reaction mixture stirred at 0 °C for 16 h. After this 
time, the reaction mixture was allowed to warm to rt before being filtered under nitrogen to 
remove the amine hydrochloride salts and then concentrated in vacuo. The resulting orange liquid 
(assumed as a 50% yield of ketene with respect to the acid chloride starting material) was then re-
suspended in THF (6 mL) under nitrogen and cooled to -78 °C. A solution of nitrone 261 (0.575 g, 
1.10 mmol) in THF (10 mL) was then added slowly over 15 min and the reaction mixture stirred at 
-78 °C for 4 h. The reaction was then quenched with aq. 8M HCl (3 mL) and stirred for 2 h 
allowing to warm to rt. The reaction mixture was then partitioned between Et2O (30 mL) and H2O 
(20 mL), the layers separated and the aqueous layer extracted once more with Et2O (30 mL). The 
combined organic layers were then washed with NaHCO3 (2 x 20 mL), brine (25 mL), dried over 
MgSO4, filtered and concentrated in vacuo to yield a crude viscous yellow oil which was purified via 
column chromatography over silica to yield a mixture of both regioisomeric products (combined 
isolated yield 67%). authentic samples of each isomer were obtained for analytical analysis via a 
second column chromatography over silica (10% Et2O in toluene). 
14 as an off-white foam HPLC analysis: 96% e.e. (Daicel Chiralcel OD-H column, eluent: hexane/i-
PrOH 80:20, flow 1.5 mL/min, wavelength: 254 nm, retention times: 6.5 min (major) and 23.0 min 
(minor)); [α]D
20 -22.8° (c = 0.45, CHCl3).   
297 as a pale-yellow oil HPLC analysis: 65% e.e. (Daicel Chiralcel OD-H column, eluent: hexane/i-
PrOH 80:20, flow 1.5 mL/min, wavelength: 254 nm, retention times: 4.4 min (major) and 13.6 min 
(minor)); [α]D
20 -39.3° (c = 0.58, CHCl3).   
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8.8.2 Towards (±)-Gliocladin C  
2-(1-Methyl-1H-indol-3-yl)acetic acid 316 
 To a stirred suspension of NaH (47.0 g, 5.0 eq, 1.17 mol, 60% disp. in mineral 
oil) in THF (1.5 L) at 0 °C was added a solution of the commercially available indol-3-ylacetic acid 
(41.1 g, 0.23 mol) in THF (500 mL). The reaction mixture was stirred 30 min at 0 °C and then a 
solution of MeI (90.0 g, 2.7 eq, 0.63 mmol) in THF (500 mL) was added slowly over 30 min. The 
reaction mixture was stirred for 16 h, allowing to warm to rt, before being quenched with MeOH 
(100 mL), followed by H2O (1 L). The subsequent aquous phase was washed with Et2O (2 × 800 
mL), before being acidifed with aq. 6M HCl and extracted with CH2Cl2 (4 × 500 mL). The 
combined organic layers were then dried over MgSO4, filtered and concentrated in vacuo to give 316 
(38.1 g, 86%) as an off-white solid; mp 116-117 °C {lit.2 121-123 °C}; 1H NMR (300 MHz, CDCl3) 
δ 7.60 (1H, dt, J = 7.9, 0.9, ArH), 7.31 (1H, dt, J = 8.0, 0.9, ArH), 7.25 (1H, td, J = 7.5, 1.1, ArH), 
7.14 (1H, ddd, J = 7.9, 6.8, 1.2, ArH), 7.05 (1H, s, ArH(2)), 3.81 (2H, d, J = 0.7, CH2), 3.77 (3H, s, 
NMe). 
(±)-2-(1-Methyl-1H-indol-3-yl)-3-phenylpropanoic acid 317 
 The title compound 317 was prepared from acid 316 (8.50 g, 44.9 mmol), n-BuLi 
(37.7 mL, 2.1 eq, 94.3 mmol, 2.5M in hexanes) and BnBr (11.22 mL, 2.1 eq, 94.3 mmol) in THF 
(500 mL) according to general procedure G as an off-white solid (11.60 g, 97%); mp 155-157 °C 
{lit.3 162-163.5 °C}; 1H NMR (500 MHz, CDCl3) δ 7.94 (1H, d, J = 7.9, IndH(4)), 7.30 (1H, d, J = 
8.2 IndH(7)), 7.26-7.21 (3H, m, ArH), 7.19-7.17 (3H, m, ArH), 7.13 (1H, t, J = 7.4, IndH(5)), 7.00 
(1H, s, IndH(2), 4.17 (1H, dd, J = 8.9, 6.4, CHCOOH), 3.74 (3H, s, NMe), 3.45 (1H, dd, J = 13.8, 
8.9, CHaHb), 3.19 (1H, dd, J = 13.8, 6.3, CHaHb). 
(±)-2-(1-Methyl-1H-indol-3-yl)-3-phenylpropanoyl chloride 318 
 The title compound 318 was prepared from acid 317 (2.60 g, 9.31 mmol), DMF (1 
drop) and (COCl)2 (2.40 mL, 3.0 eq, 27.9 mmol) in toluene (70 mL) according to a general 
procedure I as a brown oil (2.60 g, 94%) with analytical data in accordance with the literature;4 1H 
NMR (500 MHz, CDCl3) δ 7.77 (1H, dt, J = 8.0, 0.9, IndH(4)), 7.44-7.41 (1H, m, IndH(7)), 7.40-
7.36 (3H, m, ArH), 7.34-7.27 (4H, m, ArH), 7.12 (1H, s, IndH(2)), 4.69 (1H, ddd, J = 8.5, 6.5, 0.4, 
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CHCOCl), 3.82 (3H, s, NMe), 3.70 (1H, dd, J = 14.0, 8.6, CHaHb), 3.38 (1H, dd, J = 14.0, 6.5, 
CHaHb). 
N-(Methyl-3-indolyl)benzylketene 319 
Ketene 319 was prepared according to a literature procedure4 by Fu from acid 
chloride 318 (2.60 g, 8.73 mmol) and N,N-dimethylethylamine (3.78 mL, 4.0 eq, 34.9 mmol) in 
THF (40 mL) to give an orange oil that was used crude without isolation or purification in the next 
reaction. 
(±)-2-(1-Methyl-1H-indol-3-yl)propanoic acid 321 
 The title compound 321 was prepared from acid 316 (4.0 g, 21.1 mmol), n-BuLi 
(17.6 mL, 2.1 eq, 44.3 mmol, 2.5M in hexanes) and MeI (1.31 mL, 2.1 eq, 44.3 mmol) in THF (170 
mL) according to general procedure G to give 321 (3.87 g, 90%) as an off-white solid; mp 97-99 °C 
{lit.5 117-119 °C}; 1H NMR (300 MHz, CDCl3) δ 7.67 (1H, dd, J = 7.9. 0.9, IndH(4)), 7.32-7.20 
(2H, m, IndH(6 & 7)), 7.15-7.09 (1H, m IndH(5)), 7.02 (1H, s, IndH(2)), 4.04 (1H, dq, J = 7.2, 0.6, 
CHCOOH), 3.76 (3H, s, NMe), 1.62 (3H, d, J = 7.2, CH3). 
(±)-2-(1-Methyl-1H-indol-3-yl)propanoyl chloride 322 
The title compound 322 was prepared according to general procedure I from acid 
321 (1.87 g, 9.31 mmol), DMF (1 drop) and (COCl)2 (2.40 mL, 3.0 eq, 27.9 mmol) in toluene (70 
mL) to give a crude brown oil used directly in the next reaction; 1H NMR (75 MHz, CDCl3) δ 7.71 
(1H, dt, J = 8.0, 1.0, IndH(4)), 7.41 (1H, ddd, J = 8.2, 1.2, 0.9, IndH(6)), 7.38-7.34 (1H, m, 
IndH(7)), 7.26 (1H, ddd, J = 8.0, 6.8, 1.2, IndH(5)), 7.12 (1H, s, IndH(2)), 4.48 (1H, qd, J = 7.1, 0.6, 
CHCOCl), 3.83 (3H, s, NMe), 1.80 (3H, d, J = 7.1, CH3); 13C NMR (75 MHz, CDCl3) δ 175.9 
(C=O), 137.1 (ArC(7a)), 127.3 (ArC(2)), 126.5 (ArC(3a)), 122.3 (ArC), 119.8 (ArC), 118.9 (ArC), 
110.9 (ArC(3)), 109.7 (ArC(7)), 49.0 (CH), 33.0 (NCH3), 18.1 (CH3). 
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N-(Methyl-3-indolyl)methylketene 323 
Ketene 323 was prepared from acid chloride 322 (2.60 g, 6.98 mmol) and N,N-
dimethylethylamine (2.27 mL, 3.0 eq, 21.0 mmol) in THF (20 mL) according to a modification of 
general procedure A. After stirring 16 h at 0 °C, hexane (15 mL) was added, and the reaction stirred 
5 min at rt before filtering under nitrogen to give a yellow solution of ketene 323 in THF/hexane 
that was used without isolation or purification in the next reaction. 
2-Vinylisoindoline-1,3-dione 326 
mp 84-85 °C {lit.6 84 °C}; 1H NMR (400 MHz, CDCl3) δ 7.90-7.85 (2H, m, 
ArH(2,5), 7.70-7.63 (2H, m, ArH(3,4)), 6.88 (1H, dd, J = 16.4, 9.9), 6.09 (1H, d, J = 16.4), 5.05 (1H, 
d, J = 9.9). 
Methyl 2-(1-methyl-1H-indol-3-yl)acetate 327 
Indole-3-acetic acid (6.00 g, 29.6 mmol), dimethylcarbonate (18.6 mL, 7.46 eq, 
221.0 mmol) and K2CO3 (6.00 g, 1.46 eq 43.2 mmol) were dissolved in DMF (70 mL) and the 
reaction mixture heated at 130 °C for 16h. After cooling, and concentrating in vacuo, the crude 
reaction product was purified by column chromatography over silica (10% EtOAc in petroleum 
ether) to give 327 (5.41 g, 89%) as a yellow liquid with analytical data in accordance with the 
literature;7 1H NMR (500 MHz, CDCl3) δ 7.60 (1H, d, J = 8.0, ArC(4)), 7.30 (1H, d, J = 8.2, 
ArC(7)), 7.24 (1H, td, J = 7.6, 0.9, ArC(6)), 7.15-7.11 (1H, m, ArC(5)), 7.04 (1H, s, ArC(2)), 3.78 
(2H, s, CH2), 3.77 (3H, s, CO2Me), 3.70 (3H, s, NMe). 
Dimethyl 2-(1-methyl-1H-indol-3-yl)malonate 328 
328 was kindly donated by Dr James Douglas; 1H NMR (300 MHz, CDCl3) δ 
7.62 (1H, d, J = 7.9, ArH(4)), 7.35 (1H, d, J = 8.1, ArH(7)), 7.32 (1H, s, ArH(2)) 7.25 (1H, td, J = 
7.5, 1.1, ArH(6)), 7.15 (1H, ddd, J = 7.9, 6.9, 1.1, ArH(5)), 4.98 (1H, s, CH), 3.79 (3H, s, NMe), 3.76 
(6H, s, OMe). 
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Dimethyl 2-(2-bromoethyl)-2-(1-methyl-1H-indol-3-yl)malonate 330 
328 (0.190 g, 0.73 mmol), NaH (0.043 g, 1.5 eq, 1.10 mmol (60% disp. in mineral 
oil)) and 1,2-dibromoethane (0.125 mL, 2.0 eq, 1.46 mmol) were charged in a vial, to which THF (4 
mL) was added and the reaction heated to 75 °C for 16 h. After allowing to cool, the reaction was 
partitioned between Et2O (15 mL) and H2O (10 mL), the layers separated and the aqueous layer 
extracted with Et2O (2 ×15 mL). The combined organic layers were dried over MgSO4, filtered 
and concentrated in vacuo to yield a crude oil which was purified by column chromatography over 
silica (0-15% EtOAc in petrol) to give 330 (0.164 g, 61%) as a colourless oil; 1H NMR (300 MHz, 
CDCl3) δ 7.49 (1H, s, ArH(2)), 7.46 (1H, d, J = 8.1, ArH), 7.32 (1H, d, J = 8.2, ArH), 7.26-7.21 
(1H, m, ArH), 7.10 (1H, ddd, J = 8.1, 6.9, 1.1, ArH(5)), 3.79 (3H, s, NMe), 3.76 (6H, s, OMe), 3.27-
3.21 (2H, m, CH2), 3.01-2.96 (2H, m, CH2). 
Dimethyl 2-(2-(1,3-dioxoisoindolin-2-yl)ethyl)-2-(1-methyl-1H-indol-3-yl)malonate 329 and 
(±)-Methyl 4-(1,3-dioxoisoindolin-2-yl)-2-(1-methyl-1H-indol-3-yl)butanoate 331 
  
330 (0.160 g, 0.435 mmol) and potassium phthalimide (0.097 g, 1.2 eq, 0.522 mmol) were dissolved 
in DMF (1 mL) and heated to 140 °C in a sealed vial for 16 h. After allowing to cool, the reaction 
was partitioned between Et2O (15 mL) and H2O (10 mL), the layers separated and the aqueous 
layer extracted with Et2O (2 ×15 mL). The combined organic layers were dried over MgSO4, 
filtered and concentrated in vacuo to yield a crude brown oil which was purified by column 
chromatography over silica (10-40% EtOAc in petroleum ether) to yield 329 (0.056 g, 30%) as a 
yellow solid and 331 (0.101 g, 62%) as a white solid. 
329: mp 139-140 °C; νmax cm-1 (ATR) 3400, 2970, 1771, 1709; 1H NMR (300 MHz, CDCl3) δ 7.77-
7.71 (2H, m, ArH(Phthal)), 7.69-7.64 (2H, m, ArH(Phthal)), 7.57 (1H, s, ArH(2)), 7.53 (1H, dt, J = 
7.9, 0.9, ArH), 7.21-7.12 (2H, m, ArH), 7.06 (1H, ddd, J = 8.0, 6.5, 1.6, ArH(5)), 3.76 (6H, s, OMe), 
3.76 (3H, s, NMe), 3.73-3.68 (2H, m, CH2), 2.87-2.82 (2H, m, CH2); 13C NMR δ 170.8 (CO2Me), 
167.9 ((CO)2NAr)), 137.0 (ArC), 133.8 (ArC), 132.0 (ArC), 128.9 (ArC), 126.0 (ArC), 123.0 (ArC), 
121.8 (ArC), 120.4 (ArC), 119.6 (ArC), 109.4 (ArC), 108.4 (ArC), 56.5 (C(CO2Me)2), 52.9 (CO2Me), 
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34.4 (NCH2), 33.0 (NMe), 32.9 (CH2); m/z (EI+) 435 ([M+H]+, 100%); HRMS (EI+) C24H23N2O6 
([M+H]+) found 435.1547 requires 435.1551 (- 0.8 ppm). 
331: mp 110-110 °C; νmax cm-1 (ATR) 2947, 1771, 1728, 1705; 1H NMR (300 MHz, CDCl3) δ 7.78-
7.75 (2H, m, ArH(Phthal)), 7.69-7.64 (3H, m, ArH & ArH(Phthal)), 7.20-7.17 (2H, m, ArH), 7.12-
7.08 (1H, m, ArH), 7.06 (1H, s, ArH(2)), 3.96 (1H, dd, J = 8.1, 7.0, CH), 3.82-3.77 (2H, m, CH2), 
3.71 (3H, NMe), 3.62 (3H, s, OMe), 2.57-2.34 (2H, m, CH2); 13C NMR (100 MHz, CDCl3) δ 174.2 
(CO2Me), 168.3 ((CO)2NAr)), 136.9 (IndC(7a)), 133.8 (ArC(Phthal)), 132.0 (ArC(Phthal(3a))), 127.2 
(IndCH), 126.7 (IndC(3a)), 123.1 (ArC(Phthal)), 121.8 (IndCH), 119.4 (IndCH), 119.3 (IndCH), 
110.0 (IndC(3)), 109.3 (ArC(7)), 52.1 (CO2Me), 40.6 (CH), 36.4 (NCH2), 32.8 (NMe), 30.8 (CH2); 
m/z (EI+) 377 ([M+H]+, 100%); HRMS (EI+) C22H21N2O4 ([M+H]+) found 377.1496 requires 
377.1496 (- 0.0 ppm). 
Diethyl 2-(2-bromoethyl)-2-phenylmalonate 333 
 NaH (2.35 g, 2.0 eq, 65.2 mmol, 60% disp. in mineral oil) was suspended in DMF 
(70 mL) at 0 °C to which phenyldiethylmalonate (7.0 mL, 32.6 mmol) was added and the reaction 
stirred 1h at 0 °C. 1,2-Dibromoethane (5.62 mL, 2.0 eq, 65.2 mmol) was then added and the 
reaction heated at 90 °C for 16 h. After allowing to cool, the reaction was partitioned between Et2O 
(150 mL) and H2O (100 mL), the layers separated and the aqueous layer extracted with Et2O (2 ×
150 mL). The combined organic layers were dried over MgSO4, filtered and concentrated in vacuo to 
yield an orange oil which was purified via column chromatography over silica (10% EtOAc in 
petrol) to give 333 (3.80 g, 34%) as a colurless liquid; 1H NMR (300 MHz, CDCl3) δ 7.36-7.31 (5H, 
m, PhH), 4.25 (4H, qd, J = 7.1, 2.2, OCH2), 3.30-3.25 (2H, m, CH2), 2.87-2.81 (2H, m, CH2), 1.26 
(6H, t, J = 7.1, CH3). Data in accordance with the literature.8 
Diethyl 2-(2-(1,3-dioxoisoindolin-2-yl)ethyl)-2-phenylmalonate 334 
 A stirred solution of 333 (3.78 g, 11.0 mmol) and potassium phthalimide 
(2.22 g, 1.2 eq, 13.2 mmol) in DMF (40 mL) was heated to 80 °C for 16 h before concentrating in 
vacuo to leave 334 (4.23 g, quant.) as a cloudy yellow oil that was used directly without purification 
in the next reaction; 1H NMR (400 MHz, CDCl3) δ 7.83-7.80 (2H, m, ArH(Phthal)), 7.72-7.68 (2H, 
m, ArH(Phthal)), 7.52-7.50 (2H, m, ArH), 7.38 (2H, t, J = 7.6, ArH), 7.29 (1H, t, J = 7.3, ArH), 4.27 
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(4H, qq, J = 10.4, 7.1, OCH2), 3.69 (2H, dt, J = 7.4, 4.1, NCH2), 2.70-2.66 (2H, m, CH2), 1.28 (6H, 
t, J = 7.1, CH3). 
(±)-Ethyl 4-(1,3-dioxoisoindolin-2-yl)-2-phenylbutanoate 335 
A stirred solution of 334 (3.80 g, 9.28 mmol), LiCl (1.97 g, 5.0 eq, 46.4 
mmol) and H2O (0.33 mL, 2.0 eq, 18.6 mmol) in DMF (40 mL) was heated to 180 °C for 4h (above 
170 °C, gas evolution became apparent). After cooling and concentrating in vacuo, the crude 
reaction mixture was directly subjected to column chromatography over silica (0-20% EtOAc in 
petroleum ether) to yield 335 (1.37 g, 44%) as a pale yellow oil; 1H NMR (300 MHz, CDCl3) δ 7.82-
7.78 (2H, m, ArH(Phthal)), 7.72-7.67 (2H, m, ArH(Phthal)), 7.32-7.27 (4H, m, ArH), 7.21-7.16 (1H, 
m, ArH), 4.15-4.01 (2H, m, OCH2), 3.70 (2H, t, J = 7.1, NCH2), 3.60 (1H, t, J = 7.6, CH), 2.45 (1H, 
dq, J = 14.0, 7.1, CHaHb), 2.23 (1H, dq, J = 14.0, 7.1, CHaHb), 1.18 (3H, t, J = 7.1, CH3). 
(±)-4-(1,3-Dioxoisoindolin-2-yl)-2-phenylbutanoic acid 336 
To a stirred solution of 335 (1.37 g, 4.06 mmol) in EtOH:H2O (11:1.5 mL) 
was added LiOH (0.965 g, 5.0 eq, 20.3 mmol) and the reaction mixture stirred 4 h at rt before 
concentration in vacuo to leave a white solid. This solid was taken up in H2O (20 mL), washed with 
Et2O (20 mL) and the aqueous phase acidified with aq. 2M HCl. The aqueous phase was then 
extracted with EtOAc (2 x 50 mL), dried over MgSO4, filtered and concentrated in vacuo to give 
336 (1.22 g, 97%) as a white solid; mp 159-160 °C {lit.9 140-141 °C}; 1H NMR (300 MHz, d6-
DMSO) δ 12.64 (1H, br s, COOH), 8.32 (1H, t, J = 5.5, ArH), 7.76 (1H, dd, J = 7.5, 1.3, ArH), 
7.57 (1H, td, J = 7.4, 1.3, ArH), 7.49 (1H, td, J = 7.5, 1.3, ArH), 7.38 (1H, dd, J = 7.3, 1.3, ArH), 
7.35-7.23 (4H, m, ArH), 3.68 (1H, t, J = 7.5, CH), 3.11 (2H, q, J = 6.3, NCH2), 2.20 (1H, dq, J = 
13.8, 7.0, CHaHb), 1.87 (1H, dq, J = 13.8, 7.0, CHaHb). 
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(±)-4-(1,3-Dioxoisoindolin-2-yl)-2-phenylbutanoyl chloride 337 
 336 was prepared according to general procedure I from 336 (1.00 g, 3.23 
mmol), DMF (1 drop) and (COCl)2 (0.564 mL, 2.0 eq, 6.46 mmol) to give 337 (1.12 g, quant.) as a 
viscous yellow oil that was used without purification with data in accordance with the literature;9  
1H NMR (300 MHz, CDCl3) δ 8.16 (1H, ddd, J = 48.7, 7.9, 0.9, ArH), 7.70 (1H, dtd, J = 16.9, 7.6, 
1.3, ArH), 7.53 (1H, dtd, J = 19.8, 7.7, 1.3, ArH), 7.35-7.16 (6H, m, ArH), 4.27 (1H, ddt, J = 11.6, 
8.7, 2.8, CH), 3.95 (1H, dddd, J = 11.7, 9.4, 7.1, 2.5, NCHaHb), 3.84 (1H, ddd, J = 10.6, 8.8, 3.9, 
NCHaHb), 2.68-2.56 (1H, m, CHaHb), 2.40-2.25 (1H, m, CHaHb). 
2-(1-Benzyl-1H-indol-3-yl)acetic acid 338 
To a stirred suspension of NaH (9.13 g, 4.0 eq, 228 mmol, 60% disp. in mineral 
oil) in DMF (150 mL) at 0 °C was added the commercially available indol-3-ylacetic acid (10.00 g, 
57.1 mmol). The reaction mixture was stirred 30 min at 0 °C and then BnBr (8.15 mL, 1.2 eq, 68.5 
mmol) was added dropwise over 30 min. The reaction mixture was stirred for 2 h, allowing to 
warm to rt, before being quenched with H2O (250 mL) and acidifed with aq. 6M HCl (100 mL). 
The resulting precipitate was collcted by filtration and washed sequentially with H2O and EtOH. 
The filtrate was then recrystallised from EtOH to give 338 (9.27 g, 61%) as a white solid; mp 140-
142 °C {lit.10 154-156 °C}; 1H NMR (300 MHz, CDCl3) δ 7.66 (1H, dd, J = 7.0, 1.3, ArH), 7.35-
7.29 (4H, m, ArH), 7.23 (1H, dd, J = 6.9, 1.3, ArH), 7.19 (1H, t, J = 1.7, ArH), 7.17-7.14 (3H, m, 
ArH), 5.32 (2H, s, CH2Ph), 3.84 (2H, d, J = 0.5, CH2). 
(±)-2-(1-Methyl-1H-indol-3-yl)pent-4-enoic acid 339 
 The title compound 339 was prepared from acid 316 (8.50 g, 44.9 mmol), n-BuLi 
(37.7 mL, 2.1 eq, 94.3 mmol, 2.5M in hexanes) and allyl bromide (8.18 mL, 2.1 eq, 94.3 mmol) in 
THF (500 mL) according to general procedure G as an off-white solid (9.80 g, 95%); mp 89-90 °C 
{lit.11 97-99 °C}; 1H NMR (400 MHz, CDCl3) δ 7.71 (1H, d, J = 7.9, IndH(4)), 7.33-7.24 (2H, m, 
IndH(5) & (7)), 7.15 (1H, t, J = 7.4, IndH(6)), 7.06 (1H, s, IndH(2)), 5.84 (1H, ddt, J = 17.1, 10.2, 
6.9, CH2CH=CH2), 5.15 (1H, dd, J = 17.1, 1.3, CH2CH=CH2 trans), 5.05 (1H, dd, J = 10.2, 0.9, 
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CH2CH=CH2 cis), 3.99 (1H, t, J = 7.7, CHCOOH), 3.78 (3H, s, NMe), 2.91 (1H, dt, J = 14.6, 7.5, 
CHaHb), 2.69 (1H, dt, J = 14.1, 6.9, CHaHb). 
(±)-2-(1-Benzyl-1H-indol-3-yl)pent-4-enoic acid 340 
 The title compound 340 was prepared from acid 338 (7.00 g, 26.4 mmol), n-BuLi 
(22.2 mL, 2.1 eq, 55.4 mmol, 2.5M in hexanes) and allyl bromide (3.42 mL, 1.5 eq, 31.7 mmol) in 
THF (300 mL) according to general procedure G as an off-white solid (6.85 g, 85%); mp 84-85 °C; 
νmax cm-1 (ATR) 3050, 1715, 1686; 1H NMR (300 MHz, CDCl3) δ 7.77-7.74 (1H, m, ArH), 7.35-
7.27 (5H, m, ArH), 7.22 (1H, td, J = 7.7, 1.5, ArH), 7.17-7.12 (3H, m), 5.86 (1H, ddt, J = 17.1, 10.2, 
6.9, CH2CH=CH2), 5.33 (2H, s, CH2Bn), 5.15 (1H, dq, J = 17.1, 1.6, CH2CH=CH2 trans), 5.08-5.04 
(1H, m, CH2CH=CH2 cis), 4.03 (1H, dd,  J = 8.3, 6.9, CHCOOH), 2.99-2.89 (1H, m, CHaHb), 2.77-
2.67 (1H, m, CHaHb); 13C NMR (75 MHz, CDCl3) δ 180.4 (C=O), 137.8 (4ry ArC), 137.0 (4ry ArC), 
135.8 (ArC), 129.2 (ArC), 128.1 (ArC), 127.6 (4ry ArC), 127.2 (ArC), 127.0 (ArC), 122.5 (ArC), 120.0 
(ArC), 119.9 (ArC), 117.5 (CH=CH2), 112.3 (C(3)), 110.3 (CH=CH2), 50.5 (CH2Ph), 43.3 (CHCH2), 
37.0 (CHCH2); m/z (EI+) 306 ([M+H]+, 100%); HRMS (EI+) C20H20NO2 ([M+H]+) found 
306.1494 requires 306.1489 (+ 1.8 ppm). 
(±)-2-(1-Methyl-1H-indol-3-yl)pent-4-enoyl chloride 341 
 The title compound 341 was prepared from acid 339 (1.00 g, 4.36 mmol), DMF (1 
drop) and (COCl)2 (0.411 mL, 1.1 eq, 4.80 mmol) in toluene (20 mL) according to general 
procedure I to give a crude brown oil that was used directly in the next reaction; 1H NMR (300 
MHz, CDCl3) δ 7.64-7.61 (1H, m, IndH(4)), 7.34 (1H, dt, J = 8.2, 1.0, IndH(7)), 7.27 (1H, td, J = 
7.5, 1.2 IndH(6)), 7.19-7.14 (1H, m, IndH(5)), 7.08 (1H, s, IndH(2)), 5.87-5.73 (1H, m, 
CH2CH=CH2), 5.18 (1H, dq, J = 17.1, 1.5, CH2CH=CH2 trans), 5.11-5.07 (1H, m, CH2CH=CH2 
cis), 4.35 (1H, dd, J = 7.8, 7.2, CHCOOH), 3.81 (3H, s, NMe), 3.06-2.94 (1H, m, CHaHb), 2.79-2.67 
(1H, m, CHaHb). 
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(±)-2-(1-Benzyl-1H-indol-3-yl)pent-4-enoyl chloride 342 
 Acid chloride 342 was prepared from carboxylic acid 340 (1.00 g, 3.27 mmol), 
DMF (1 drop) and (COCl)2 (0.31 mL, 1.1 eq, 3.60 mmol) in toluene (25 mL) according to general 
procedure I to give a crude brown oil that was used directly in the next reaction; 1H NMR (300 
MHz, CDCl3) δ 7.68 (1H, dd, J = 7.0, 1.5, ArH), 7.35-7.27 (4H, m, ArH), 7.25-7.18 (3H, m, ArH), 
7.13 (2H, dd, J = 7.3, 1.7, ArH), 5.84 (1H, ddt, J = 17.1, 10.2, 6.9, CH2CH=CH2), 5.37 (2H, s, 
CH2Ph), 5.20 (1H, dd, J = 17.1, 1.5, CH2CH=CH2 trans), 5.13 (1H, dd, J = 10.2, 1.1, CH2CH=CH2 
cis), 4.41 (1H, t, J = 7.5, CH), 3.10-3.00 (1H, m, CHaHb), 2.83-2.73 (1H, m, CHaHb). 
N-(Benzyl-3-indolyl)allylketene 344 
 Ketene 344 was prepared from acid chloride 342 (1.00 g, 3.09 mmol) and N,N-
dimethylethylamine (0.510 mL, 1.5 eq, 4.64 mmol) in THF (20 mL) according to a modification of 
general procedure A. After stirring for 2 h at 0 °C, hexane (15 mL) was added, and the reaction 
stirred 5 min at rt before filtering under nitrogen to give a yellow solution of ketene 344 in 
THF/hexane that was used without isolation or purification in the next reaction.  
(Z)-N-(Cyclohexylmethylene)aniline oxide 345 
  To a stirred solution of PhNHOH (1.00 g, 9.17 mmol) and MgSO4 (1.21 g, 1.1 
eq, 10.1 mmol) in toluene (20 mL) at rt was added cyclohexanecarbaldehyde (1.11 mL, 1.0 eq, 9.17 
mmol) and the reaction stirred for 3 h. After such time, the reaction mixture was filtered and the 
solid washed with Et2O. The filtrate was then concentrated in vacuo and the resulting crude semi-
solid triturated with petroleum ether to give 345 (1.02 g, 55%) as a white solid that was collected by 
filtration; mp 94-96 °C {lit.12 100-101 °C}; 1H NMR (300 MHz, CDCl3) δ 7.66-7.62 (2H, m, 
ArH(2,6)), 7.44-7.40 (3H, m, ArH(3,4,5)), 7.03 (1H, d, J = 7.5, HC=N+), 3.21 (1H, tdt, J = 11.0, 
7.3, 3.7, CH), 2.04-1.99 (2H, m, CH2), 1.79-1.68 (3H, m, CH2), 1.52-1.38 (2H, m, CH2), 1.35-1.22 
(3H, m, CH2). 
N
Bn
Cl
O
N
Bn
O
N
H
O
 
 Chapter 8: Experimental Details 
 214 
(±)-Methyl piperidine-2-carboxylate hydrochloride 348 
  To a stirred solution of the commercially avaialable (±)-pipecolinic acid (0.30 g, 
2.32 mmol) in MeOH (10 mL) at 0 °C was added SOCl2 (0.67 mL, 4.0 eq, 9.28 mmol) dropwise 
and the reaction stirred 16 h, allowing to warm to rt. The reaction mixture was then diluted with 
Et2O and concentrated in vacuo multiple times (from Et2O). The resulting solid was then taken up in 
Et2O, filtered and washed multiple times with Et2O to yield 348 (0.400 g, 96%) as a white solid; mp 
199-201 °C {lit.13 195-196 °C}; 1H NMR (500 MHz, H2O) δ 3.94 (1H, dd, J = 11.8, 3.4, CHN), 
3.73 (3H, s, OMe), 3.37 (1H, d, J = 13.0, CH2), 2.97-2.92 (1H, m, CH2), 2.19 (1H, dd, J = 14.3, 3.4, 
CH2), 1.81-1.77 (2H, m, CH2), 1.66-1.61 (1H, m, CH2), 1.59-1.58 (2H, m, CH2). 
(±)-Methyl 1-((2,4,6-triisopropylphenyl)sulfonyl)piperidine-2-carboxylate 349 
 To a stirred solution of amino ester hydrochloride 348 (0.400 g, 2.23 mmol) in 
CH2Cl2 (10 mL) at 0 °C was added Et3N (0.742 mL, 2.4 eq, 5.35 mmol) dropwise, followed by 
2,4,6-triisopropylsulfonyl chloride (0.708 g, 1.05 eq, 2.42 mmol) and the reaction mixture stirred 16 
h, allowing to warm to rt. The reaction was quenched with H2O, extracted with CH2Cl2 (3 × 20 
mL), and the combined organic layers washed sequentially with sat. aq. NaHCO3 (40 mL), 10% 
citric acid solution (40 mL) and brine (40 mL). The combined organic layers were dried over 
MgSO4, filtered and concentrated in vacuo to yield a white semi-solid which crystallised from Et2O 
to yield 349 (0.501 g, 66%) as a white solid; mp 76-78 °C; νmax cm-1 (ATR) 2947, 2866, 1746 (C=O); 
1H NMR (400 MHz, CDCl3) δ 7.15 (2H, s, ArH(TIPBS)), 4.66 (1H, dd, J = 5.8, 1.9, CHN), 4.05 
(2H, sept., J = 6.8, o-iPrH), 3.74 (3H, s, OMe), 3.47-3.44 (2H, m, CH2), 2.89 (1H, sept., J = 6.9, p-
iPrH), 2.14 (1H, br d, J = 13.5, CH2), 1.77-1.65 (3H, m, CH2), 1.51-1.39 (2H, m, CH2), 1.25 (18H, 
dd, J = 6.8, 2.0, iPrCH3); 13C NMR (100 MHz, CDCl3) δ 171.7 (C=O), 152.9 (4ryArC-SO2), 151.5 
(4ryArC), 131.3 (4ryArC), 123.9 (ArC(TIPBS)), 53.9 (OMe), 52.1 (CHN), 41.6 (CH2(3)), 34.2 (p-iPrC), 
29.5 (p-iPrCH3), 27.7 (CH2(6)), 25.1 (o-iPrCH3), 24.9 (o-iPrCH3), 24.5 (o-iPrC), 23.6 (CH2), 20.2 
(CH2); m/z (EI+) 382 ([M+H]+, 100%); HRMS (EI+) C22H36NO4S ([M+H]+) found 410.2358 
requires 410.2360 (- 0.4 ppm). 
(±)-(1-((2,4,6-Triisopropylphenyl)sulfonyl)piperidin-2-yl)methanol 350 
 To a stirred solution of ester 349 (0.500 g, 1.22 mmol) in THF (10 mL) at 0 °C was 
added LiAlH4 (0.92 mL, 1.5 eq, 1.83 mmol, 2.0 M in THF) dropwise and the reaction stirred for 30 
min at 0 °C. The reaction mixture was then quenched carefully with a saturated solution of 
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Rochelle salt (5 mL) and stirred for 1 h, allowing to warm to rt, before being filtered through a 
celite plug, and the filter cake washed repeatedly with EtOAc (100 mL total). The filtrate was then 
washed with H2O (50 mL), brine (50 mL), dried over MgSO4, filtered and concentrated in vacuo to 
yield 350 (0.412 g, 88%) as a white solid which was used without further purification; mp 96-98 °C; 
νmax cm-1 (ATR) 3550 (OH), 2953, 2930, 2866; 1H NMR (300 MHz, CDCl3) δ 7.16 (2H, s, 
ArH(TIPBS)), 4.16-4.03 (4H, m, CHaHbOH & o-iPrH & CHCH2OH), 3.69 (1H, dd, J = 10.8, 5.0, 
CHaHbOH), 3.35-3.30 (1H, m, CH2), 3.08 (1H, td, J = 12.5, 2.2, CH2), 2.90 (1H, sept., J = 6.9, p-
iPrH), 1.87-1.83 (1H, m, CH2), 1.71-1.57 (5H, m, CH2), 1.28-1.23 (18H, m, iPrCH3); 13C NMR (75 
MHz, CDCl3) δ 153.1 (4ry ArCSO2), 151.5 (4ry ArC), 130.9 (4ry ArC), 124.0 (ArC), 60.6 (CH2OH), 
53.9 (CH), 40.5 (CH2(6)), 34.2 (p-iPrC), 29.4 (o-iPrC), 26.1 (CH2(3)), 25.1 (p-iPrCH3), 24.9 (CH2(5)), 
24.8 (o-iPrCH3), 23.6 (o-iPrCH3), 19.3 (CH2(4)); m/z (EI+) 382 ([M+H]+, 100%); HRMS (EI+) 
C21H36NO3S ([M+H]+) found 382.2410 requires 382.2410 (- 0.1 ppm). 
(±)-1-((2,4,6-Triisopropylphenyl)sulfonyl)piperidine-2-carbaldehyde 351 
  A solution of DMSO (0.112 mL, 2.0 eq, 1.57 mmol) in CH2Cl2 (5 mL) was added 
dropwise to a stirred solution of oxalyl chloride (0.081 mL, 1.2 eq, 0.94 mmol) in CH2Cl2 (5 mL) 
cooled to -78 °C and stirred at -78 °C for 15 min. A solution of alcohol 350 (0.300 g, 1.0 eq, 0.079 
mmol) in CH2Cl2 (7 mL) was then added slowly and the reaction stirred for 35 min. At -78 °C was 
added DIPEA (0.549 mL, 4.0 eq, 3.14 mmol) and the reaction mixture stirred allowing to warm to 
rt before being quenched with sat. aq. NH4Cl (10 mL). The organic phase was then separated and 
washed with sat. aq. NaHCO3 (10 mL) and brine (2 × 10 mL) before being dried over Na2SO4, 
filtered and concentrated in vacuo to yield 351 (0.312 g, quant.) as a pale yellow oil which was used 
without further purification; νmax cm-1 (ATR) 3523, 2955, 2868, 1732; 1H NMR (400 MHz, CDCl3) 
δ 9.87 (1H, d, J = 0.9, CHO), 7.17 (2H, s, ArH), 4.42 (1H, br d, J = 4.2, CH), 4.09 (2H, sept., J = 
6.8, o-iPrCH), 3.60-3.55 (1H, m, CHaHb(6)), 3.11-3.03 (1H, m, CHaHb(6)), 2.91 (1H, sept., J = 6.9, p-
iPrCH), 2.26 (1H, br dd, J = 13.6, 3.1, CHaHb), 1.71-1.66 (1H, m, CHaHb), 1.61-1.58 (1H, m, 
CHaHb), 1.56-1.52 (3H, m, CH2), 1.45 (1H, dd,  J = 6.7, 1.3, CHaHb), 1.28-1.25 (18H, m, iPrCH3); 
13C NMR (125 MHz, CDCl3) δ 202.2 (CHO), 153.4 (ArC(4)), 151.6 (ArC(2,6)), 130.3 (ArC(1)), 
124.1 (ArC(3,5)), 61.0 (CH), 43.2 (CH2(6)), 34.2 (p-iPrC), 29.5 (o-iPrC), 25.0 (o-iPrCH3), 24.9 (o-
iPrCH3), 24.3 (CH2), 24.2 (CH2) 23.6 (p-iPrCH3), 20.6 (CH2(4)); m/z (EI+) 380 ([M+H]+, 100%); 
HRMS (EI+) C21H34NO3S ([M+H]+) found 380.2254 requires 380.2254 (+ 0.0 ppm). 
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(±)-(Z)-N-((1-((2,4,6-Triisopropylphenyl)sulfonyl)piperidin-2-yl)methylene)aniline oxide 
352 
 A mixture of aldehyde 351 (0.075 g, 0.263 mmol) and PhNHOH (0.030 g, 1.05 eq, 
0.276 mmol) was dissolved in the minimum quantity of EtOH, and the reaction vial left to stand 
for 16 h in the fridge. After such time, the resulting precipitate was collected by filtration and 
washed with ice cold EtOH, followed by ice-cold petroleum ether. 352 was isolated as an off-white 
solid (0.070 g, 56%) that was stored in the fridge; mp 102-103 °C; νmax cm-1 (ATR) 2959, 2928, 
2860, 1599, 1596; 1H NMR (500 MHz, CD2Cl2) δ 7.68-7.66 (3H, m, ArH & HC=N+), 7.47 (3H, 
app. dd, J = 5.17, 1.77, ArH), 7.19 (2H, s, ArH(TIPBS)), 5.07 (1H, br s, CH), 4.08 (2H, sept., J = 
6.8, o-iPrCH), 3.63 (1H, br d, J = 12.2, CHaHb(6)), 3.10-3.02 (1H, m, CHaHb(6)), 2.91 (1H, sept., J = 
6.9, p-iPrCH), 2.46 (1H, d, J = 13.6, CHaHb(3)), 1.78-1.71 (2H, m, CHaHb(5) & CHaHb(4)), 1.64 
(1H, app. dtd, J = 13.6, 9.1, 4.5, CHaHb(3)), 1.55-1.46 (1H, m, CHaHb(5)), 1.38-1.32 (1H, m, 
CHaHb(4)), 1.25 (6H, d, J = 6.9, p-iPrCH3), 1.23 (12H, app. t, J = 7.3, o-iPrCH3); 13C NMR (125 
MHz, CD2Cl2) δ 153.6 (ArC(p-iPr)), 151.9 (ArC(o-iPr)), 147.6  (ArCN+(1)), 136.9 (HC=N+), 130.2 
(ArC(4)), 129.9 (ArC(SO2)), 129.1 (ArC(2)), 124.1 (ArCH(TIPBS)), 121.7 (ArC(3)), 50.9 (CH(2)), 
41.6 (CH2(6)), 34.3 (p-iPrCH), 29.3 (o-iPrCH), 25.9 (CH2(3)), 25.1 (CH2(5)), 24.6 (p-iPrCH3), 23.3 (o-
iPrCH3), 23.3 (o-iPrCH3), 21.6 (CH2(4)); m/z (EI+) 471 ([M+H]+, 100%); HRMS (EI+) C27H39N2O3S 
([M+H]+) found 471.2664 requires 471.2676 (- 2.5 ppm). 
Oxindoles 
(±)-3-Methyl-3-(1-methyl-1H-indol-3-yl)indolin-2-one 324 
The oxindole was obtained from nitrone 48 (0.070 g, 0.355 mmol) and crude 
ketene solution 323 (2.0 mL) according to general procedure E as a crude brown oil. Purification 
via column chromatography (0-50% EtOAc in petrol) gave (±)-324 (0.050 g, 51%) as an off-white 
solid; mp 251-253 °C {lit.14 255-257 °C}; 1H NMR (400 MHz, CDCl3) δ 8.33 (1H, br s, NH), 7.24-
7.21 (2H, m, ArH), 7.15-7.09 (3H, m, ArH), 7.01-6.93 (3H, m, ArH), 6.90-6.86 (1H, m, ArH), 3.77 
(3H, s, CH3), 1.88 (3H, s, NMe); HPLC analysis: racemic (Daicel Chiralcel AD-H column, eluent: 
hexane/i-PrOH 80:20, flow 1.5 mL/min, wavelength: 211 nm, retention times: 6.52 min (minor) 
and 19.6 min (major)).  
N
N
TIPBS
H
OPh
N
H
O
Me
Me
N
 
 Chapter 8: Experimental Details 
 217 
(S)-3-Methyl-3-(1-methyl-1H-indol-3-yl)indolin-2-one 324 
The oxindole was obtained from N-TIPBS nitrone 144 (0.118 g, 0.242 mmol) and 
crude ketene solution 323 (2.0 mL) according to general procedure F as a crude brown oil. 
Purification via column chromatography (0-50% EtOAc in petrol) gave 324 (0.039 g, 58 %) as a 
yellow oil; [α]D
20 -36.2° (c = 0.40, CHCl3); HPLC analysis: 84% e.e. (Daicel Chiralcel AD-H column, 
eluent: hexane/i-PrOH 80:20, flow 1.5 mL/min, wavelength: 211 nm, retention times: 6.52 min 
(minor) and 19.6 min (major)).  
(±)-3-Benzyl-3-(1-methyl-1H-indol-3-yl)indolin-2-one 320 
 The oxindole was obtained from nitrone 48 (0.060 g, 0.304 mmol) and crude 
ketene solution 319 (3.5 mL) according to general procedure E as a crude brown oil. Purification via 
column chromatography (0-50% EtOAc in petrol) gave (±)-320 (0.038 g, 36%) as a yellow solid; 
mp 219-221 °C; νmax cm-1 (ATR) 3057, 2351, 1701, 1618, 1470; 1H NMR (300 MHz, CDCl3) δ 7.63 
(1H, br s, NH), 7.34-7.30 (1H, m, ArH), 7.25-7.16 (5H, m, ArH), 7.13-7.05 (4H, m, ArH), 7.02-6.94 
(3H, m, ArH), 6.72 (1H, d, J = 7.7, ArH(7)), 3.92 (1H, d, J = 12.6, CHaHb), 3.82 (3H, s, NMe), 3.60 
(1H, d, J = 12.6, CHaHb); 13C NMR (75 MHz, CDCl3) δ 179.8 (C=O), 140.6 (4ry ArC), 137.6 (4ry 
ArC), 135.4 (4ry ArC), 132.5 (4ry ArC), 130.3 (ArC(Bn)), 128.1 (ArC), 127.6 (ArC(Bn)), 127.5 (ArC), 
126.6 (4ry ArC), 126.0 (ArC), 125.2 (ArC), 122.3 (ArC), 121.9 (ArC), 120.5 (ArC), 119.3 (ArC), 113.7 
(4ry ArC(3’)), 109.5 (ArC), 109.4 (ArC), 54.5 (CH2), 42.5 (C(3)), 32.9 (NMe); m/z (EI+) 353 
([M+H]+, 100%); HRMS (EI+) C24H21N2O ([M+H]+) found 353.1648 requires 353.1648 (- 0.1 
ppm); HPLC analysis: racemic (Daicel Chiralcel AD-H column, eluent: hexane/i-PrOH 80:20, flow 
1.5 mL/min, wavelength: 211 nm, retention times: 11.0 min (major) and 50.1min (minor)).  
(S)-3-Benzyl-3-(1-methyl-1H-indol-3-yl)indolin-2-one 320 
The oxindole was obtained from N-TIPBS nitrone 144 (0.060 g, 0.123 mmol) and 
crude ketene solution 319 (2.5 mL) according to general procedure F as a crude brown oil. 
Purification via column chromatography (0-50% EtOAc in petrol) gave 320 (0.038 g, 88 %) as a 
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yellow semi-solid; [α]D
20 -48.8° (c = 0.25, CHCl3); HPLC analysis: 88% e.e. (Daicel Chiralcel AD-H 
column, eluent: hexane/i-PrOH 80:20, flow 1.5 mL/min, wavelength: 211 nm, retention times: 11.0 
min (major) and 52.1min (minor)).  
 (±)-3-Allyl-3-(1-benzyl-1H-indol-3-yl)indolin-2-one 346 
 Oxindole 346 was prepared according to general procedure E from nitrone 345 
(0.165 g, mmol) and crude ketene solution 344 (4 mL) in THF (4 mL). Purification via column 
chromatography over silica (0-50% EtOAc in petrol) gave 346 (0.177 g, 58%) as an off-white solid; 
mp 138-140 °C; νmax cm-1 (ATR) 3323, 3152, 2974, 1713, 1670, 1618; 1H NMR (500 MHz, CDCl3) 
δ 7.94 (1H, br s, NH), 7.38-7.28 (6H, m, ArH), 7.28-7.12 (5H, m, ArH), 7.05 (1H, t, J = 7.5, ArH), 
6.99 (1H, d, J = 7.8 ArH), 6.95 (1H, td, J = 7.6, 0.9, ArH), 5.55 (1H, dddd, J = 17.0, 10.2, 7.8, 6.7, 
CH2CH=CH2), 5.31 (2H, d, J = 5.5, CH2Bn), 5.11 (1H, dd, J = 17.0, 1.6, CH2CH=CH2 trans), 4.99 
(1H, dd, J = 10.1, 1.0, CH2CH=CH2 cis), 3.23 (1H, dd, J = 13.3, 8.0, CHaHb), 3.12 (1H, dd, J = 13.2, 
6.6, CHaHb); 13C NMR (125 MHz, CDCl3) δ 180.6 (C=O), 140.8 (4ry ArC), 137.3 (4ry ArC), 137.2 
(4ry ArC), 132.9 (4ry ArC), 132.2 (ArC), 128.8 ((CH=CH2)), 128.1 (ArC), 127.7 (ArC), 127.0 (ArC), 
126.8 (ArC), 126.2 (4ry ArC), 124.8 (ArC), 122.6 (ArC), 122.0 (ArC), 119.6 (ArC), 119.6 (ArC), 119.3 
(CH=CH2), 114.0 (4ry ArC(3’)), 109.9 (ArC), 109.9 (ArC), 53.0 (C(3)), 50.2 (CH2Ph), 40.9 (CH2). 
m/z (EI+) 379 ([M+H]+, 100%); HRMS (EI+) C26H23N2O ([M+H]+) found 379.1805 requires 
379.1805 (+ 0.0 ppm); HPLC analysis: racemic (Daicel Chiralcel AD-H column, eluent: hexane/i-
PrOH 80:20, flow 1.5 mL/min, wavelength: 254 nm, retention times: 24.2 min and 48.9 min).  
HPLC trace of oxindole (±)-346: 
 
Peak tR (min) Area (%) 
1 24.21 49.92 
2 48.87 50.08 
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(±)-3-Allyl-1-benzyl-3-(1-benzyl-1H-indol-3-yl)indolin-2-one 355 
 To a stirred solution of oxindole 346 (0.129 g, 0.34 mmol) in DMF (5 mL) at 0 
°C was added NaH (60% disp. in mineral oil, 16.2 mg, 1.2 eq, 0.41 mmol), and the reaction stirred 
for 30 min at 0 °C. Benzyl bromide (0.05 mL, 1.2 eq, 0.41 mmol) was then added and the reaction 
mixture stirred 3 h at rt. After such time, the reaction was quenched with H2O (3 mL), extracted 
with Et2O (3 × 20 mL), the combined organic layers washed with brine (30 mL), dried over 
MgSO4, filtered and concentrated in vacuo to yield a yellow semi-solid. The crude reaction product 
was purified by column chromatography over silica (0-30% EtOAc in petrol) to yield 355 (0.150 g, 
94%) as a white solid; mp 197-198 °C; νmax cm-1 (ATR) 3383, 2974, 1709, 1611, 1487; 1H NMR 
(300 MHz, CDCl3) δ 7.34 (8H, m), 7.20 (3H, app. t, J = 7.6), 7.13-7.06 (5H, m), 7.01 (1H, td, J = 
7.5, 1.1), 6.88 (1H, ddd, J = 8.1, 7.0, 1.1), 6.81 (1H, dd, J = 7.4, 1.0), 5.48 (1H, dddd, J = 16.9, 10.2, 
8.1, 6.5), 5.35-5.23 (2H, m), 5.09 (1H, dd, J = 17.0, 1.7), 4.96 (2H, q, J = 13.1), 4.94 (1H, dd, J = 
10.1, 1.9), 3.28 (1H, dd, J = 13.3, 8.1), 3.14 (1H, qt, J = 6.3, 1.2); 13C NMR (125 MHz, CDCl3) δ 
178.3 (C=O), 143.0 (4ry ArC), 137.4 (4ry ArC), 137.3 (4ry ArC), 136.0 (4ry ArC), 132.4 (ArC), 132.3 
(4ry ArC), 128.8 (ArC), 128.7 (ArC), 128.1 (ArC), 127.7 (ArC), 127.6 (ArC), 127.6 (ArC), 127.0 
(ArC), 126.8 (ArC), 126.3 (4ry ArC), 124.7 (ArC), 122.6 (ArC), 122.0 (ArC), 120.8 (ArC), 119.5 
(ArC), 119.3 (ArC), 114.4 (4ry ArC), 109.9 (ArC), 109.1 (ArC), 52.6 (C(3)), 50.2 (CH2Ph), 44.1 
(CH2Ph), 41.0 (CH2CH); m/z (EI+) 469 ([M+H]+, 100%); HRMS (EI+) C33H29N2O ([M+H]+) 
found 469.2279 requires 469.2274 (+ 1.0 ppm). 
(±)-2-(1-Benzyl-3-(1-benzyl-1H-indol-3-yl)-2-oxoindolin-3-yl)acetaldehyde 357 
 To a stirred solution of 355 (0.100 g, 0.213 mmol) in CH2Cl2 (4 mL) was added 
NMO (0.050 g, 2.0 eq, 0.426 mmol), followed by OsO4 (1 drop of a 4% soln. in H2O). The reaction 
mixture was allowed to stir for 48 h before being quenched with a saturated aqueous solution of 
Na2SO3 (1 mL). The reaction mixture was then partitioned between CH2Cl2 (10 mL) and H2O (10 
mL), separated, and the aqueous phase extracted with CH2Cl2 (10 mL). The combined organic 
phases were then washed with brine (15 mL), dried over MgSO4, filtered and concentrated in vacuo 
to give intermediate dihydroxyl species 356 as a pale yellow solid. The crude product was dissolved 
in a 4:1 mixture of acetone:H2O (4 mL) at rt, to which was added NaIO4 (0.091 g, 2.0 eq, 0.426 
mmol) and the reaction stirred 2 h at rt. The reaction was quenched with NaHCO3 (2 mL), diluted 
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with H2O (5 mL) and extracted with EtOAc (3 × 10 mL). The combined organic layers were 
washed with brine (20 mL), dried over MgSO4, filtered and concentrated in vacuo to give 357 (0.111 
g, quant.) as a pale yellow solid which was used without further purification; mp 96-97 °C; νmax cm-1 
(ATR) 3055, 2922, 2849, 2729, 1713, 1609, 1541; 1H NMR (300 MHz, CDCl3) δ 9.67 (1H, t, J = 
1.8, CHO), 7.35-7.20 (12H, m, ArH), 7.15-6.92 (5H, m, ArH), 6.96 (1H, s, C2’H), 6.86-6.83 (1H, m, 
ArH), 5.27 (2H, s, BnH), 5.00 (2H, q, J = 13.0, BnH), 3.64 (1H, dd, J = 17.0, 1.4, CHaHb), 3.48 (1H, 
dd, J = 17.0, 2.2, CHaHb); 13C NMR (125 MHz, CD2Cl2) δ 199.2 (CHO), 177.5 (NHC=O), 143.1 
(4ry ArC), 137.4 (4ry ArC), 137.3 (4ry ArC), 136.1 (4ry ArC), 131.7 (4ry ArC), 128.8 (ArC), 128.7 (ArC), 
128.5 (ArC), 127.6 (ArC), 127.6 (ArC), 127.5 (ArC), 127.1 (ArC), 127.0 (ArC), 125.7 (4ry ArC), 124.1 
(ArC), 122.7 (ArC), 122.2 (ArC), 120.7 (ArC), 119.6 (ArC), 113.4 (4ry ArC), 110.1 (ArC), 109.4 
(ArC), 50.2 (CH2CHO), 49.4 (CH2Ph), 49.0 (C(3)), 44.1 (CH2Ph); m/z (EI+) 471 ([M+H]+, 100%); 
HRMS (EI+) C32H27N2O2 ([M+H]+) found 471.2063 requires 471.2067 (-0.9 ppm). 
(±)-1-Benzyl-3-(1-benzyl-1H-indol-3-yl)-3-(2-(benzylimino)ethyl)indolin-2-one 358 
 To a stirred solution of aldehyde 357 (0.060 g, 0.128 mmol) in THF (5 mL) at 
rt was added MgSO4 (0.015 g, 1.0 eq, 0.128 mmol), followed by benzylamine (0.014 g, 1.05 eq, 
0.134 mmol) and the reaction mixture stirred 16 h at rt before being quenched with sat. aq. 
NaHCO3 (2 mL), diluted with H2O (4 mL) and extracted with EtOAc (3 x 10 mL). The combined 
organic layers were washed with brine (20 mL) and concentrated in vacuo to give intermediate imine 
358 (0.102 g, 72%) as an off-white solid which was used without further putification in the next 
reaction immediately; mp 91-92 °C; 1H NMR (500 MHz, CDCl3) δ 7.61 (1H, dd, J = 5.6, 4.2, 
N=CH), 7.31-7.27 (5H, m, ArH), 7.25-7.15 (10H, m, ArH), 7.11-7.08 (4H, m, ArH), 7.01-6.98 (1H, 
m, ArH), 6.91-6.88 (1H, m, ArH), 6.83 (3H, app. dt, J = 7.2, 3.5, ArH), 5.27 (1H, d, J = 16.1, 
CHaHb), 5.24 (1H, d, J = 16.1, CHaHb), 4.92 (2H, q, J = 18.8, BnH), 4.39 (1H, d, J = 13.8, CHaHb), 
4.33 (1H, d, J = 13.5, CHaHb), 3.56 (1H, dd, J = 14.5, 4.2, CHaHb), 3.36 (1H, dd, J = 14.5, 5.6, 
CHaHb). 
(±)-N-Benzyl-2-(N-benzyl-2,2,2-trifluoroacetamido)-3-(1-benzyl-3-(1-benzyl-1H-indol-3-
yl)-2-oxoindolin-3-yl)propanamide 359 
To a stirred solution of 358 (0.030 g, 0.054 mmol) in CH2Cl2 (1 mL) at rt 
was added benzyl isocyanide (0.0062 mL, 0.95 eq, 0.051 mmol) followed by TFA (0.0041 mL, 1.0 
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eq, 0.054 mmol) and the reaction mixture stirred 24 h at rt before being concentrated in vacuo. The 
resulting crude material (dr 1.5:1) was purified by column chromatography over silica (0-30% 
EtOAc in petrol) to give 359 (0.018 g, 42%) as a white solid of unknown relative configuration (the 
minor diastereomer was isolated as a mixture with 359 and other material as an off-white foam 
(0.013 g, 30%)); mp 138-139 °C; νmax cm-1 (ATR) 3402, 2972, 2901, 1699, 1684, 1611; 1H NMR 
(500 MHz, CDCl3) δ 7.35-7.16 (17H, m, ArH), 7.14-7.05 (6H, m, ArH), 6.99 (1H, t, J = 7.4, ArH), 
6.89-6.86 (3H, m, ArH), 6.82 (2H, d, J = 9.2, ArH), 5.55 (1H, t, J = 5.5, NHBn), 5.20 (2H, q, J = 
14.4, IndNCH2Ph), 5.07 (1H, d, J = 15.5, NCHaHbPh), 4.85 (1H, d, J = 15.5, NCHaHbPh), 4.68 
(1H, d, J = 16.7, N(COCF3)CHaHbPh), 4.56 (1H, t, J = 5.5, CH), 4.28 (1H, d, J = 16.7, 
N(COCF3)CHaHbPh), 3.97 (1H, dd, J = 14.8, 5.8, NHCHaHbPh), 3.74 (1H, dd, J = 14.8, 5.2, 
NHCHaHbPh), 3.24 (1H, dd, J = 14.3, 4.7, CHaHb), 3.16 (1H, dd, J = 14.3, 6.7, CHaHb); 13C NMR 
(125 MHz, CD2Cl2) δ 177.68 (C=O(2)), 167.6 (NHC=O), 157.6 (q, J = 36.2, CF3C=O), 142.5 (4ry 
ArC), 137.7 (4ry ArC), 137.4 (4ry ArC), 137.2 (4ry ArC), 135.9 (4ry ArC), 135.2 (4ry ArC), 131.3 (4ry 
ArC), 128.9 (ArC), 128.8 (ArC), 128.7 (ArC), 128.6 (ArC), 128.4 (ArC), 128.3 (ArC), 127.8 (ArC), 
127.7 (ArC), 127.6 (ArC), 127.4 (ArC), 127.2 (ArC), 127.0 (ArC), 126.8 (ArC), 125.8 (ArC), 125.5 
(ArC), 122.9 (ArC), 122.0 (ArC), 120.8 (ArC), 119.5 (ArC), 114.2 (ArC), 110.0 (ArC), 109.4 (ArC), 
57.2 (CH), 51.1 (IndNCH2Ph), 50.3 (C(3)), 50.1 (NHCH2Ph), 43.9 (CH2Ph), 43.4 (CH2Ph), 34.2 
(CH2), (4ry CF3  not observed); 19F NMR (376 MHz) δ -68.42 (N(CO)CF3); m/z (EI+) 791 ([M+H]+, 
100%); HRMS (EI+) C49H42F3N4O3 ([M+H]+) found 791.3201 requires 791.3204 (- 0.3 ppm). 
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